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ABSTRACT 
Porcine circovirus type 2 (PCV2) is associated with several disease manifestations in 
pigs including postweaning multisystemic wasting syndrome (PMWS). The hallmark 
microscopic lesions of PCV2-infection are lymphoid depletion or granulomatous 
lymphadentitis (or both) and the presence of PCV2 antigen or nucleic acids associated with 
the lymphoid lesions. PCV2 alone is limited in its ability to induce the full spectrum of 
disease and lesions associated with PMWS in pigs.  
PCV2 is widespread in the global swine population and in order to establish a PCV2 
model in conventional pigs it was necessary to identify a method to derive pigs free of PCV2 
or anti-PCV2 antibodies. We obtained more than 500 PCV2-free pigs from six seropositive 
breeding herds and demonstrated that segregated early weaning is an effective technique to 
derive PCV2-free pigs from positive breeding herds for research or for commercial 
production. 
We determined that vaccination with commercially available adjuvanted bacterins 
enhances PCV2 replication and PCV2-associated lesions. We also found that timing of 
vaccination in relationship to PCV2 infection is important in the outcome of vaccine-induced 
enhancement of PCV2 replication and PCV2-associated lesions.  
Field reports indicated that PCV2-infection may also decrease the efficacy of 
vaccines used at the time of PCV2 infection. When we vaccinated pigs with a modified-live 
porcine reproductive and respiratory syndrome virus (PRRSV) vaccine 14 days post PCV2 
inoculation we found that PCV2 infection significantly decreased the efficacy of the PRRSV 
vaccine as measured by gross and microscopic lesions. 
It is thought that coinfections may be an important trigger for progression of PCV2 to 
PMWS and other PCV2-associated diseases. We experimentally confirmed that PCV2 and 
porcine parvovirus coinfection resulted in clinical PMWS in conventional pigs whereas 
singular infection does not. Coinfecting conventional pigs with PCV2 and Mycoplasma 
hyopneumoniae resulted in severe respiratory disease, reduced average daily gain, and severe 
lung and lymphoid lesions associated with PCV2-antigen in dual-infected pigs implying that 
M. hyopneumoniae potentiates the severity of PCV2-associcated lung and lymphoid lesions 
and increases the incidence of PMWS.  
 
 ix
Host and virus differences may also be important in the outcome of PCV2 infection. 
In our conventional pig model, we found a predisposition of Landrace pigs to PCV2-
associated lesions and disease when compared to Duroc and Large White pigs. Finally, we 
were the first to experimentally confirm that PCV2-field isolates differ significantly in 
virulence in our conventional pig model.  
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CHAPTER 1.  GENERAL INTRODUCTION 
 
Dissertation Organization 
 
This dissertation is prepared as an alternate manuscript format. The dissertation 
includes a general introduction and a literature review, eight separate scientific manuscripts, 
and general conclusions. The appendix includes a short communication related to this 
project. References to literature cited in the general introduction and the general conclusions 
chapters are listed at the end of the dissertation. Seven manuscripts have been published in 
refereed scientific journals relevant to the focus of this dissertation and two manuscripts are 
submitted for publication. The Ph.D. candidate, Tanja Ilse Opriessnig is the primary author 
of the manuscripts and is the principal investigator for the experimental work described in the 
manuscripts.  
The first manuscript describes the derivation of porcine circovirus type 2 (PCV2) free 
pigs from positive sow herds and has been published in the Journal of Swine Health and 
Production. The second manuscript describes the effect of vaccination with selected 
bacterins on PCV2-associated lesions and has been published in Veterinary Pathology. The 
third manuscript describes the effect of timing of vaccination on PCV2-associated lesions 
and has been published in the Veterinary Record. The fourth manuscript describes the effect 
of acute PCV2-infetion on the efficacy of a modified life porcine reproductive and 
respiratory syndrome virus (PRRSV) vaccine and has been submitted to Clinical Vaccine 
Immunology. The fifth manuscript describes the effect of porcine parvovirus (PPV) 
vaccination on PCV2 -associated lesions in the PPV and PCV2 coinfection model and has 
been published in Veterinary Microbiology. The sixth manuscript describes experimental 
reproduction of postweaning multisystemic wasting syndrome in the PCV2 and Mycoplasma 
hyopneumoniae coinfection model and has been published in Veterinary Pathology. The 
seventh manuscript describes differences in host susceptibility to PCV2-associated disease 
and lesions and has been published in Veterinary Pathology. The eighth manuscript describes 
differences in virulence of PCV2-field isolates recovered from pigs with and without PCV2-
associated lymphoid depletion and has been submitted to the Journal of General Virology. 
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The appendix contains a brief communication that describes cardiovascular lesions 
associated with natural and experimental PCV2 infection and has been published in the 
Journal of Comparative Pathology. 
 
Introduction 
 
Porcine circovirus (PCV) was first isolated from pigs suffering from postweaning 
multisystemic wasting syndrome (PMWS) in 1997 (Allan et al., 1998b). Subsequent 
characterization showed that the PMWS-associated PCV was genetically and antigenically 
different from the cell culture contaminating apathogenic PCV that had been identified more 
than 20 years earlier (Tischer et al., 1974) and the name “PCV type 2 (PCV2)” was proposed 
for the newly identified PMWS-associated circovirus variant (Allan et al., 1998a; Allan et al., 
1998b; Ellis et al., 1998; Hamel et al., 1998; Meehan et al., 1998; Morozov et al., 1998).  
PMWS was first recognized in the early 1990’s in high health commercial herds in 
western Canada (Harding, 1996; Harding and Clark, 1997). Shortly after the initial 
recognition and description of PMWS, the syndrome was almost simultaneously observed in 
France (LeCann et al., 1997) and in the USA (Daft et al., 1996) followed by reports from 
most European countries and Southeast Asia (Allan and Ellis, 2000). 
In North America, PMWS usually results in low but persistent death losses and only 
on rare occasions severe epidemics resulting in 3- to 4-fold increases in mortality have 
occurred (Harding, 2004). In Europe the situation is different, and PMWS is often associated 
with persistent and high mortality in many areas (Done, 2001). The close association 
between PMWS and PCV2 has been confirmed experimentally; PMWS has been reproduced 
in experimental models following PCV2-infection (Bolin et al., 2001; Harms et al., 2001; 
Ladekjær-Mikkelsen et al., 2002) and case-control studies have proven that PMWS is 
strongly associated with PCV2-infection (Pogranichniy et al., 2002; Wellenberg et al., 2004). 
PCV2 is not only linked to PMWS but is also associated with other diseases and syndromes 
such as the porcine respiratory disease complex (PRDC) (Harms et al., 2002a, Kim et al., 
2003b) and porcine dermatitis and nephropathy syndrome (PDNS) (Rosell et al., 2000). 
PCV2 is associated with sporadic outbreaks of reproductive failure mainly in gilts 
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(Ladekjaer-Mikkelsen et al., 2001; O’Connor et al., 2001; West et al., 1999) and enteritis in 
grow/finish pigs (Kim et al., 2004a).  
We have much more to learn about the epidemiology and pathogenesis of PCV2-
associated diseases. Most swine herds in the global pig population are seropositive (Allan 
and Ellis, 2000). Its ubiquitous distribution and its presence in clinically healthy pigs makes 
it difficult to evaluate the true impact of PCV2 and it also makes it difficult to understand the 
pathogenesis of the disease. Although PCV2 has consistently been shown to be the necessary 
cause of PMWS, it is clear that other factors are necessary for full expression of PCV-
associated disease. These factors include external factors such as coinfecting agents or 
immunostimulation, pig specific factors such as genetics and antibody status at the time of 
infection, and virus specific factors such as differences in PCV2 isolates. 
The main focus area of our PCV2 research was to develop a model for PCV2-
infection in conventional pigs suitable for application to the US field situation. Most 
available research data described experiments that were conducted in Europe where housing 
and vaccination practices are different from what is common practice in the US. It was also 
important to us to develop a model using conventional colostrum-fed pigs as opposed to 
gnotobiotic pigs, cesarean-derived, colostrum-deprived pigs (CDCD), or colostrum-deprived 
(CD) pigs. In order to develop a model for PCV2-associated diseases in conventional pigs it 
was first necessary to find a way to derive pigs free of PCV2 and anti-PCV2 antibodies from 
commercial US breeding herds. We attempted to do this by segregated early weaning (SEW).  
There is evidence in the literature suggesting that immune stimulation may trigger 
progression of PCV2 infection to disease and lesions characteristic of PMWS. Krakowka et 
al. (2001) reproduced PMWS in gnotobiotic pigs stimulated with keyhole limpet hemocyanin 
in Freund’s incomplete adjuvant and infected with PCV2. Furthermore, commercially 
available vaccines have been implicated in the enhancement of PCV2 replication and PCV2-
associated disease. Allan et al. (2000c) observed PMWS in 21% of PCV2-infected pigs that 
were vaccinated with a commercial M. hyopneumoniae and Actinobacillus 
pleuropneumoniae bacterin. Field trials further supported this hypothesis. Allan et al. (2002b) 
observed a significant increase in losses associated with PMWS in M. hyopneumoniae 
vaccinated pigs. A similar observation was made by Kyriakis et al. (2002) who vaccinated a 
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portion of the pigs in a herd experiencing a PMWS outbreak with a M. hyopneumoniae 
vaccine and observed PMWS in 43% of the vaccinated pigs compared with 11% of the non-
vaccinated pigs. The results of these European studies are not ideally suited for extrapolation 
to the US field situation. One of our objectives was to determine whether vaccination with 
bacterins commonly used in the US, when administered at a time typical of US protocol, 
enhances PCV2 replication and the incidence and severity of PCV2-associated microscopic 
lesions in conventional pigs. Vaccinations, however, play a very important role in the swine 
industry to minimize losses associated with pathogens such as M. hyopneumoniae, swine 
influenza virus and others. Therefore, simply eliminating a successful vaccination program 
might be contraindicated. Therefore, another objective we addressed was to determine if 
there is an effect of timing of vaccination on PCV2 replication and PCV2-associated lesions. 
We compared commonly used two-dose regimens and one-dose regimens with the goal to 
understand and advise producers on the best point in time to use M. hyopneumoniae vaccines 
in herds with recurrent PCV2-associated diseases. 
PCV2-infection can induce varying degrees of lymphoid depletion and histiocytic 
replacement of follicles in lymphoid tissues. The presence of this hallmark lesion implies a 
temporarily impaired adaptive immune response that may compromise vaccine efficacy. 
Porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia is a 
major global problem. The next study was designed to investigate the effect of acute PCV2-
infection on the efficacy of a modified live virus (MLV) PRRSV vaccine to protect growing 
pigs against PRRSV-induced respiratory disease and lesions.  
Coinfecting pathogens have been shown to trigger PCV2-infection to progress to full 
blown PMWS. Ellis et al. (1999) reproduced most of the lesions typical of PMWS in 
gnotobiotic pigs inoculated with filtered cell culture material and filtered lymphoid tissues 
from pigs with naturally acquired PMWS. Both PCV2 and porcine parvovirus (PPV) were 
detected in the experimentally infected pigs. It was determined, that the same PPV that is 
typically associated with reproductive disease is able to enhance PCV2-replication and PCV-
associated disease in growing pigs (Allan et al., 1999a; Kennedy et al., 2000). PPV is not a 
pathogen typically associated with grow-finisher operations but practitioners were 
increasingly interested in eliminating or minimizing the potential effect of PPV on promoting 
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PCV2-infection. Another objective of our work was to determine if coinfection of 
conventional SPF pigs with PCV2 and PPV induces an increase in the incidence of PMWS 
compared to singular PCV2 infection, and to determine if vaccination against PPV protects 
pigs against PMWS associated with PCV2/PPV coinfection. 
Recent diagnostic investigations of field cases have indicated that M. hyopneumoniae 
vaccination in herds affected by PMWS may actually increase the incidence of PMWS. This 
information has led some practitioners to discontinue the use of M. hyopneumnoniae 
vaccination programs in affected herds. However, M. hyopneumoniae vaccines are well 
established in the field and have been shown to be economically beneficial in reducing losses 
associated with respiratory disease. Thus, the fifth animal trial was conducted to investigate 
the interactions between M. hyopneumoniae and PCV2 and to evaluate the effect of M. 
hyopneumoniae/PCV2 coinfection.  
Essentially all farms are infected with PCV2; however, relatively few experience 
PCV2-associated disease. Differences in susceptibility among pigs might be one possible 
explanation for the variability in disease manifestation seen with PCV2. We designed and 
conducted an experiment to determine whether host genetic differences in the susceptibility 
to PCV2 associated disease exist among selected breeds of pigs. It is also not clear if PCV2 
isolates vary in virulence. If so, this may explain much of the difference in severity of PCV2-
associated diseases from farm-to-farm. Distinct, purified PCV2 isolates had not yet been 
compared in a controlled study in SPF pigs. Thus, the last objective of the work included in 
this thesis was to compare the pathogenicity of PCV2 isolates obtained from field cases with 
or without PCV2-associated lymphoid lesions and disease. 
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CHAPTER 2.  LITERATURE REVIEW 
 
Historical Background 
Porcine circovirus (PCV) was first recognized as a contaminant of the continuous pig 
kidney cell line PK-15 (ATCC-CCL31) in 1974 in Germany and described as picornavirus-
like virus (Tischer et al., 1974). PCV is a very small, nonenveloped, single stranded DNA 
virus with a circular genome (Tischer et al., 1982). Under experimental conditions, the PCV-
PK-15-isolate did not produce disease in pigs (Allan et al., 1995; Tischer et al., 1986). In the 
late 1990’s PCV was associated with a newly emerged disease syndrome in pigs 
“postweaning multisystemic wasting syndrome” (PMWS) (Allan et al., 1998b). Sequence 
analysis of the PMWS-associated PCV revealed differences compared to the earlier 
described PCV (Allan et al., 1998a; Allan et al., 1999b; Ellis et al., 1998; Hamel et al., 1998; 
Meehan et al., 1998; Morozov et al., 1998). In order to distinguish the pathogenic PMWS-
associated PCV from the non-pathogenic PCV, the first was designated porcine circovirus 
type 2 (PCV2) and the later porcine circovirus type 1 (PCV1). 
The presence of PCV2 can be dated back to 1985 in Canada (Magar et al, 2000b), 
Belgium, and Spain (Rodríguez-Arrioja, 2003b), to 1973 in Ireland (Walker et al., 2000), 
1970 in the UK (Grierson et al., 2004a), and 1969 in Belgium (Sanchez et al., 2000). Magar 
et al. (2000) tested 177 serum samples from 1985, 145 serum samples from 1989, and 147 
serum samples from 1997. All sera were obtained from Canadian slaughterhouses and tested 
by immunofluorescence assay (IFA) for antibodies to PCV1 and PCV2. In 1985, 8% of the 
sera were positive for PCV1 and 13.6% were positive for PCV2. In 1989, 41.4% of the sera 
were positive for PCV1 and 72.4% were positive for PCV2. In 1997, 38.1% of the sera were 
positive for PCV1 and 66.7% were positive for PCV2 (Magar et al., 2000b). Walker et al. 
(2000) detected PCV2-antibodies in the majority of pig serum samples collected in Northern 
Ireland from 1973 until 1999. The percentage of sera containing PCV2-antibodies showed an 
increased incidence in the samples collected in 1988 (100%; 80/80) and 1999 (92.1%; 
129/140) when compared to 1973 (69.1%; 56/80), 1981 (61.3%; 49/80), and 1984 (55%; 
44/80). Sporadic cases of PMWS were identified in archived tissues before the emergence of 
PMWS in the 1990’s. Grierson et al. (2004a) reviewed formalin-fixed tissues from 68 
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porcine cases that had been submitted to a laboratory in England between 1970 and 1997 by 
PCR, open reading frame (ORF) 2-sequencing, and immunohistochemistry (IHC) for PCV2 
specific nucleic acids and antigen. The authors found PCV2-specific nucleic acids in 41% 
(9/22) of submission from the 1990’s, in 31% (4/13) of submission from the 1980’s, and in 
32% (8/25) of submissions from the 1970’s. Sequence analysis of 5 archived tissues revealed 
a high identity to PCV2 sequences obtained from a 2000 porcine dermatitis and nephropathy 
syndrome (PDNS) case implying that a similar PCV2 isolate has been present in the UK pig 
population for more than 30 years (Grierson et al., 2004a). Rodríguez-Arrioja (2003b) 
investigated archived tissues from 189 pigs for the presence of PCV2-DNA by in-situ-
hybridization (ISH) and archived sera from 388 pigs for the presence of PCV2-specific 
antibodies by indirect immunoperoxidase monolayer assay (IPMA) collected from 1985 to 
1997 in Spain and found 41.3% (78/189) tissues ISH positive and 72.7% (282/388) sera 
IPMA positive. This is indicative of enzootic infection in Spain since 1985 (Rodríguez-
Arrioja, 2003b). Sanchez et al. (2001) tested 50 serum samples from 1969, 50 serum samples 
from 1975, and 50 serum samples from 2000 obtained in slaughter houses in Belgium. All 
serum samples were postive for PCV2-specific antibodies by IPMA (Sanchez et al., 2001). 
 
Taxonomy 
Both, PCV1 and PCV2 are members of the Circoviridae family (Todd et al., 2005). 
The Circoviridae family is divided into the genera Circovirus (Circo indicates that the virus 
has a circular conformation) and Gyrovirus (Gyro is a derivation from the Greek work 
“gyrus” meaning “ring” or “circuit”). The genus Circovirus contains the following species: 
beak and feather disease virus (BFDV), canary circovirus (CaCV), goose circovirus (GoCV), 
pigeon circovirus (PiCV), PCV1, and PCV2, and the tentative species in this genus are duck 
circovirus (DuCV), finch circovirus (FiCV), and gull circovirus (GuCV). The genus 
Gyrovirus contains only chicken anemia virus (CAV) (Todd et al., 2005).  
Viruses that belong to the Circoviridae family have characteristic virions that exhibit 
icosahedral symmetry and do not posses an envelope. The genomes are covalently closed, 
circular, ssDNAs, which range in size from 1.8 to 2.3 kb. The genome organization of CAV 
is negative sense, whereas those of the other circoviruses are ambisense (Todd et al., 2005). 
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CAV, PCV2, and BFDV were found to have an icosahedral T=1 structure containing 60 
capsid protein molecules arranged in 12 pentamer clustered units (Crowther et al., 2003). 
Circoviruses are host-specific or exhibit a narrow host range and the majority of those 
reported to date infect avian species (Todd et al., 2005). Subclinical infections are common; 
however, circovirus infections are associated with clinical disease in some cases such as with 
infectious chicken anemia, psittacine beak and feather disease, circovirus disease of pigeons, 
and PMWS in pigs. Circovirus infections in all species cause varying degrees of lymphoid 
depletion and are thought to be immunosuppressive (Todd et al., 2005). 
Phylogenetic analysis of PCV1, avian circovirus, plant geminiviruses, and 
nanoviruses classified PCV1 as most closely related to BFDV and were intermediate between 
the two plant viral groups (Niagro et al., 1998). Furthermore, it has been proposed that a 
predecessor to PCV1 and BFDV may have originated from a plant nanovirus that infected a 
vertebrate host and recombined with a vertebrate-infecting RNA virus, most likely a 
calicivirus (Gibbs and Weiller, 1999). 
 
Biological and Physical Properties 
Allan et al. (1994) demonstrated that PCV1 was stable at pH 3, was stable at 56˚C 
and at 70˚C for 15 minutes, and was resistant to inactivation after exposure to chloroform. 
The buoyant density of PCV1 in CsCl has been reported to be 1.37 g per cm3 by Tischer et 
al. (1974), and it has been reported to be 1.36-1.37 g per ml CsCl by Allan et al. (1994). The 
sedimentation coefficient (S) was determined to be 57S when compared with the 
sedimentation coefficient of a bovine enterovirus (Allan et al., 1994).  
PCV2 is readily isolated from tissue samples that have been stored at -70˚C (Ellis et 
al., 1998). PCV2 was shown to be resistant to some disinfectants (Nolvasan®, DC&R®, 
Weladol®, or ethanol) but virus titers were significantly reduced by sodium hydroxide , 
Virkon® S, and others (Royer et al., 2001). 
 
Replication and Binding Strategy 
All viruses of the Circoviridae family are thought to have a similar replication 
strategy. A circular, double stranded replicative form DNA intermediate is produced using 
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host cell DNA polymerases during S phase of cell division. The replicative form serves as 
template for generation of viral ssDNA using the rolling circle replication mechanism (Todd 
et al., 2005). Viral DNA intermediates are generated in nuclei and require host cell enzymes 
for completion of the replication cycle (Tischer et al., 1987). Virions are assembled in both 
nuclei and cytoplasm and released from infected cells in the absence of viral cytopathic 
effects.  
Misinzo et al. (2005) studied the binding characteristics of PCV2 in the porcine 
monocytic line 3D4/31 and found that PCV2 enters 3D4/31 cells predominantly via clathrin-
mediated endocytosis and requires an acidic environment for infection.  
Meerts et al. (2005a) found that PCV2 capsid protein was expressed between 6 to 12 
hours post inoculation and nuclear relocation occurred around 12 to 24 hours post inoculation 
in PK-15 cells. In porcine alveolar macrophages or fetal cardiomyocytes, nuclear localized 
antigens appeared approximately at 48 hours post inoculation and in fewer cells compared to 
PK-15 cells. 
When seven different PCV2 strains were compared in PK-15 cells, it was found that 
abortion-associated strains had different replication kinetics compared with PMWS or 
PDNS-associated PCV2 isolates. A higher number of infected cells were observed at 24 
hours post inoculation and the percentage of infected cells with nuclear localized antigens 
was lower compared to that of the other strains. The same authors found also differences in 
susceptibility to PCV2 infection between porcine alveolar macrophages from different pigs 
(Meerts et al., 2005a). 
It has been demonstrated that treatment of PK-15 cell cultures with IFN-γ causes a 20 
times higher production of PCV2 progeny (Meerts et al., 2005b). The enhancing effect of 
IFN-γ on PCV2 infection was found to be due to increased internalization of PCV2 virion-
like particles. Expression of PCV2 proteins in infected cells were not altered by IFN-γ 
treatment (Meerts et al., 2005b). 
During productive infection of PK-15 cells, nine RNAs, capsid RNA, five Rep-
associated RNAs (Rep, Rep’, Rep3a, Rep3b, and Rep3c), and three NS-associated RNAs 
(NS515, NS672, and NS0) are synthesized by PCV2 (Cheung, 2003c), and it was 
demonstrated that Rep and Rep’ are essential for PCV2 replication (Cheung, 2003b). PCV1 
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and PCV2 were found to differ from each other in expression levels of NS- and Rep3c-
associated RNAs (Cheung, 2003a).  
 
Genome Organization, Genetic Characterization, and Proteins 
The non-pathogenic PCV1 and the pathogenic PCV2 share less than 80% nucleotide 
sequence identity (Fenaux et al., 2000; Hamel et al., 1998; Meehan et al., 1998). The lengths 
of the genomic DNAs of the PCV1 isolates range from 1,758 to 1,760 bp (Fenaux et al., 
2000). Sequence analyses of the complete genomes of PCV-2 isolates showed that the 
complete genome of each PCV2 isolate is 1,767 to 1,768 bp in length (Fenaux et al., 2000; 
Mankertz et al., 2000). Analysis and comparison of PCV2 isolates demonstrated that PCV2 
isolates share 94.6-99.0% nucleotide sequence identities (de Boisséson et al., 2004; Fenaux et 
al., 2000). The two main viral genes are ORF1 and ORF2 which are oriented in opposite 
directions and which represent 93% of the PCV2 genome. ORF1 is associated with 
replication, it is highly conserved among isolates, and it encodes a protein of 35.7 kDa. 
(Mankertz et al., 1998). The ORF2 gene encodes for the 27.8 kDa capsid protein (Nawagitgul 
et al., 2000a, 2002) and shares about 91-100% nucleotide sequence identity and about 90-
100% amino acid sequence identity among PCV2 isolates (Fenaux et al. 2000; de Boisseson 
et al., 2004). In addition to ORF1 and ORF2, it is predicted that there are another four 
potential ORFs encoding proteins larger than 5kDa (Meehan et al., 1998). Recently, it has 
been shown that ORF3 protein is not essential for PCV2 replication in vitro but is involved in 
PCV2 induced apoptosis by activating caspase-8 and caspase-3 pathways (Liu et al., 2005) 
 
Host Range 
Pigs  
PCV2 was first detected and described in pigs where it is widely distributed. PCV2-
specific antibodies have been demonstrated in domestic pigs (Allan and Ellis, 2000) in most 
countries and most continents. PCV2 was associated with PMWS in 6-week-old wild boar 
piglets raised under free-range conditions (Ellis et al., 2003). Similarly, PMWS was observed 
in a 10-month-old male European wild boar in Germany (Schulze et al., 2004), and in a 6-
month-old Spanish wild boar (Vicente et al., 2004). 
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Ruminants 
Tischer et al. (1995a) tested 90 bovine serum samples and found a weak reactivity to 
PCV1 antigen (35% reacted positive) as determined by IFA. Nayar et al. (1999) found 
PCV2-nucleic acids in cattle with respiratory disease and in aborted bovine fetuses. The 
authors investigated 100 cases of bovine respiratory disease and detected PCV2 nucleic acids 
in six of 100 lung tissue samples. In addition, PCV2-antigen was detected by IHC in one of 
these cases. The virus was tentatively named bovine circovirus (BCV) and it was found to be 
more than 99% homologous to PCV2 (Nayar et al. 1999). No other reports have confirmed 
these findings. 
In contrast, sera of 200 sheep, 350 cattle, and 150 goats were found to be negative for 
PCV1-specific antibodies as determined by an IFA (Allan et al. 1994). In addition, Allan et 
al. (2000e) tested 185 bovine serum samples from 40 herds from Northern Ireland, 120 
bovine serum samples from France, and 120 sheep serum samples from 14 flocks in Northern 
Ireland by IFA and enzyme-linked immunosorbent assay (ELISA) for PCV2-specific 
antibodies. All sera were found negative for antibodies to PCV2 (Allan et al., 2000g). Ellis et 
al. (2001) tested 100 serum samples from beef and dairy cattle with various clinical 
conditions collected from 42 Canadian farms and 100 colostrum samples collected randomly 
from dairy cows from 53 Canadian farms for PCV1 and PCV2 antibodies by ELISA and 
found no evidence of PCV2- or PCV1-specific antibodies. Rodríguez-Arrioja et al. (2003a) 
tested tissues from 26 cattle, 24 sheep, and 8 goats for PCV2-nucleic acids by ISH and serum 
from 20 cattle and 20 goats for PCV2-antibodies by IPMA. In total, 58 samples were tested 
by ISH and 40 samples were tested by IPMA and all were found negative for PCV2-nucleic 
acids and PCV2-specific antibodies. Six, one-day-old lambs free of PCV2-antibodies were 
inoculated oronasally with a PCV2 stock that had been previously shown to be pathogenic in 
the pig model (Allan et al., 2000e). Two lambs were necropsied at 13, 26, and 36 days post 
inoculation (DPI). There were no microscopic lesions observed in the animals, PCV2 antigen 
was not detected by IFA, and the lambs did not seroconvert to PCV2 (Allan et al., 2000e). 
Ellis et al. (2001) inoculated one 1-day-old calf and six 6-month-old beef calves with PCV2. 
The 1-day-old calf was necropsied at 14 DPI and no gross or microscopic lesions were 
detected and IHC for PCV2 was negative on all tissues examined. Blood was collected from 
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the six beef calves and tested for PCV2-and PCV1-specific antibodies on the day of 
inoculation and again 6 weeks later. No antibodies to PCV2 or PCV1 were detected before 
inoculation or 6 weeks later (Ellis et al., 2001). 
 
Mice 
Reactivity to PCV1 antigen by IFA was found in serum from mice (Tischer et al., 
1995a). Seventy-three mice were tested and found to be negative for PCV2-specific 
antibodies by IPMA (Rodríguez-Arrioja et al., 2003a) and 50 mice were found to be negative 
for PCV1-specific antibodies as determined by IFA (Allan et al. 1994).  
Several studies have investigated the susceptibility of mice for PCV2-infection. One 
study using BALB/c mice found detectable PCV2 antigen in the nuclei and cytoplasm of 
histiocytes and apoptotic cells in germinal centers of lymph follicles as well as in hepatocytes 
in the liver (Kiupel et al., 2001). This group also showed mild lymphoid depletion and 
histiocytic infiltration of lymphoid follicles. The mice in this study were infected 
intraperitoneally as well as intranasally with a PCV2-isolate that had been passaged four 
times in cell culture and originated from a case with naturally occurring PMWS. Four mice 
were necropsied at 7, 14, 28, and 42 DPI, respectively. Microscopic lesions were first 
detected at 7 DPI, were most prominent at 14 and 21 DPI in bronchial and mesenteric lymph 
nodes and spleen and Peyer’s patches, and were less severe at 42 DPI (Kiupel et al., 2001). 
PCV2 replicated in the mice and upregulated caspase 1, 2, 3, 6, 7, 8, 11, and 12, the 
transcripts of apoptosis inhibitors bcl-2, bcl-w, bcl-X, and apoptosis promoters bax, bak and 
bad, and was associated with apoptosis in spleens, Peyer’s patches and lymph nodes of 
infected BALB/c mice (Kiupel et al., 2005). 
Another study infected ICR-CD1 mice with the 4th cell culture passage of a PCV2-
isolate from another case of naturally occurring PMWS (Quintana et al., 2002). Three 
intraperitoneally PCV2-infected mice were necropsied at 3, 7, 10, 14, and 20 DPI, 
respectively. Despite the detection of PCV2-DNA in sera, there was no evidence of PCV2 
antigen or nucleic acids in microscopic sections; however, this group apparently did not 
examine the relevant lymphoid tissues (lymph nodes, spleen) that are the major sites of 
PCV2-associated lesions in pigs (Quintana et al., 2002).  
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Three different mouse lines (BALB/c, C57BL/6, and C3H/HeN) were used to 
investigate possible differences in host susceptibility to PCV2 (Opriessnig et al., 2004b). 
C57BL/6 and C3H/HeN were selected based on markedly different responses to certain 
pathogens compared to BALB/c mice. Forty-eight mice of each line were purchased at 4 
weeks of age. Thirty-six mice in each line were inoculated with 104TCID50 PCV2-isolate 
ISU-40895. The inoculation was done twice intranasally and intramuscularly at 5 and 6 
weeks of age. At the time of inoculation, half of the mice in each line received additional 
immunostimulation in the form of subcutaneous injections with keyhole limpet hemocyanin 
in incomplete Freund’s adjuvant. Necropsies were performed at 12, 17, 22, 27, 32, and 37 
DPI. Mice within all breeds were found to be positive for PCV2-nucleic acids based on PCR 
performed on tissue homogenates. There was a trend towards more PCR positive mice in the 
BALB/c group. PCV2-associated microscopic lesions were not observed and efforts to detect 
PCV2 antigen by IHC and PCV2 nucleic acids by ISH were unsuccessful (Opriessnig et al., 
2004b). 
 
Rabbits 
Quintana et al. (2002) inoculated 16 female New Zealand rabbits intranasally with 
each PCV2 and PCV1. Necropsies were performed at 3, 7, 10, 14, and 20 DPI. None of the 
rabbits seroconverted to PCV1 or PCV2, PCV2 nucleic acids as determined by ISH were not 
detected in any of the rabbits, and there were no PCV2-associated microscopic lesions 
(Quintana et al., 2002). Fifteen rabbits were found to be negative for PCV2-specific 
antibodies by IPMA (Rodríguez-Arrioja et al., 2003a) and 60 rabbits were negative for 
PCV1-specific antibodies by IFA (Allan et al. 1994). Rabbits are commonly used to produce 
polyclonal anti-PCV2-antibodies for usage in immunohistochemistry assays (Sorden et al., 
1999). 
 
Humans 
Tischer et al. (1995a) found weak reactivity to PCV1 antigen in serum samples from 
healthy humans (116 tested, 20.07% positive), blood donors (175 tested, 8.6% positive), and 
hospitalized adult patients with fevers (188 tested, 23.9% positive) by IFA. In contrast, sera 
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of 200 humans were found to be negative for PCV1-specific antibodies by IFA (Allan et al. 
1994) and 120 randomly selected samples from healthy humans in Northern Ireland were 
found to be negative by IFA and ELISA for PCV2-specific antibodies (Allan et al., 2000e). 
Ellis et al. (2000b) tested serum from 54 swine veterinarians and 6 academic veterinarians 
and laboratory workers (involved in PCV2 research for several years) with a competitive 
PCV2 ELISA, a whole cell PCV2 ELISA, and a whole cell PCV1 ELISA. All samples were 
found to be negative for PCV2 and PCV1 specific antibodies (Ellis et al., 2000b). 
 
Poultry, Horses, Guinea pigs, Cats, and Dogs 
Two-hundred turkey, 200 chickens, and 200 ducks were found to be negative for 
PCV1-specific antibodies as determined by an IFA (Allan et al. 1994). Rodríguez-Arrioja et 
al. (2003a) tested 20 poultry by ISH. All were found negative for PCV2-specific nucleic 
acids. Ellis et al. (2001) tested sera from 100 Canadian horses for PCV-antibodies by ELISA 
and found no evidence of PCV2- or PCV1-specific antibodies. Seven horses were negative 
by ISH for PCV2-specific antibodies and 21 horses were negative for PCV2-specific 
antibodies by IPMA (Rodríguez-Arrioja et al., 2003a). Three Guinea pigs and 21 dogs were 
negative for PCV2-nucleic acids by ISH, and 13 dogs and 15 cats were negative for PCV2-
antibodies by IPMA (Rodríguez-Arrioja et al., 2003a). 
 
Growth in cell culture 
Allan et al. (1994) found PCV1 growth confined to porcine derived cell cultures and 
Vero cultures. Primary bovine and ovine cell cultures were also found to be susceptible; 
however, passage of cell lysates resulted in reduction or elimination of cytoplasmic staining. 
There was no indication of growth in avian-derived cell cultures (Allan et al., 1994). 
Hattermann et al. (2004) infected 9 different human cell lines with PCV1 and PCV2 to 
investigate whether PCV2 can infect and replicate in human epithelial cells and lymphocytes. 
The results indicated that although PCV gene expression and replication took place in human 
cells, the infection was non-productive, since the infection was not passed when virus-free 
cells were inoculated with supernatant of PCV-infected human cells. The authors suggested 
protein targeting to be disturbed in human cells (Hattermann et al. 2004). 
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Epidemiology 
Prevalence of anti-PCV2-antibodies 
The mean PCV2-antibody half-life in weanling pigs is estimated to be 19.0 days and 
the window for PCV2-passive antibody decay within a population is relatively wide 
(Opriessnig et al., 2004d).  Serological studies have demonstrated that passively-acquired 
PCV2 antibodies decay during the lactation and nursery periods to negative or near negative 
levels at the end of the nursery period (7 weeks of age) followed by active seroconversion of 
the majority of the population starting around 12 weeks of age (Roríguez-Arrioja et al., 
2002). Allan et al. (1994) showed a similar trend for PCV1. Larochelle et al. (2003) did a 
comparative serologic and virologic study in 5 PMWS-affected herds and 2 herds without 
PMWS in Quebec. Sixty blood samples were collected in each herd in 4-week-intervals from 
3-to 23-week-old pigs and it was found that all herds had similar PCV2 profiles: low PCV2-
antibody levels were present at 3 weeks of age and reached very low-to-negative levels by 11 
weeks of age. PCV2-infection as determined by PCR took place from 11 to 15 weeks of age 
at which time PCV2 seroconversion occurred. All pigs were seropositive at 23 week of age.  
PCV2 passively acquired antibodies present at 10 to 12 days of age were found to 
decay below ELISA cutoff level by approximately 4.9 ± 1.2 weeks of age in piglets with low 
levels of antibodies at weaning, by approximately 8.1 ± 1.9 weeks of age in piglets with 
moderate levels of antibodies at weaning, and by approximately 11.1 ± 2.5 weeks of age in 
piglets with high levels of antibodies at weaning (Opriessnig et al., 2004d).  
Serological surveys found that PCV-antibodies are present globally in almost all 
swine herds tested and in up to 100% of individual pigs within herds. There is a high 
prevalence of PCV infection in the global swine populations of Canada, France, Germany, 
New Zealand, Northern Ireland, United Kingdom, and the United States (Allan et al., 1994; 
Dulac and Afshar,1989; Edwards and Sands, 1994; Hines and Lukert, 1995; Horner, 1991; 
Magar et al., 2000b; Tischer et al., 1982, 1986, 1995a; 1995b; Walker et al., 2000). Magar et 
al. (2000b) found that PCV2 appeared to be the main PCV2 type circulating in Canadian pig 
herds and that serological evaluation using PCV1 underestimated the seroprevalence of 
PCV2. Most U.S. breeding herds and the majority of the sows within those herds were found 
to be seropositive for PCV2 (Opriessnig et al., 2004d). Sibila et al. (2004) determined the 
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presence of PCV2-antibodies by ELISA in 5 farms without a history of PMWS and in 4 
farms with PMWS. Serum antibodies were detected in a higher percentage of pigs from 
PMWS farms but overall a high prevalence of PCV2 infection was found (Sibila et al., 
2004).  
 
Persistence of PCV2 
There is evidence from experimental inoculations that persistent infections may be a 
feature of PCV2 (Bolin et al., 2001). Viral DNA was detected in some cesarian derived, 
colostrum deprived (CDCD) PCV2-inoculated pigs up to 125 days post infection. To confirm 
presence of infectious virus, viral isolation was done on homogenates of tissues that were 
PCR positive. Virus was isolated from all tissues in which viral DNA was detected (Bolin et 
al., 2001). Proof of persistent infection in the field is contradictory. PCV2 viremia was 
detected in the same animals for at least 8 weeks by PCR confirming persistence of PCV2 in 
pigs after natural exposure (Larochelle et al., 2003). Rodríguez-Arrioja et al. (2002) found a 
long duration of PCV2 viremia (up to 28 week of age) in a high percentage of naturally-
PCV2-infected pigs on a PMWS-affected farm in Spain. PCV2 nucleic acids were detected in 
sera from 52.6% of 386 healthy slaughter-age pigs (Liu et al., 2002). In another survey 
however, researchers were unable to demonstrate microscopic lymphoid lesions or PCV2 
nucleic acids at slaughter suggesting that pigs typically clear the virus (Quintana et al., 2001). 
 
Transmission of PCV2 
Transmission of PCV2 is thought to occur through direct contact via oronasal, fecal, 
and urinary routes (Bolin et al., 2001; Magar et al., 2000a). Shibata et al. (2003) investigated 
PCV2 shedding in experimentally infected CDCD pigs and in pigs with naturally acquired 
PMWS by PCR. Sixteen pigs were inoculated with PCV2, and oropharyngeal and nasal 
swabs, feces, whole blood, and serum became PCV2-DNA positive immediately after 
inoculation and all samples with the exception of oropharyngeal swabs (1/2 positive) 
remained positive up to 70 DPI. In field samples collected from 313 pigs, PCV2 was 
detected in 95 (30.4%) of the whole blood samples, 60 (19.2%) of the nasal swabs, and 64 
(20.4%) of the feces implying that whole blood and serum are the best samples for detection 
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of PCV2 by PCR (Shibata et al., 2003). Segalés et al. (2005a) quantified PCV2 DNA in 
tonsillar, nasal, tracheo-bronchial, urinary and fecal swabs of pigs with and without PMWS. 
The authors were able to detect PCV2 DNA in a high percentage of the samples and 
concluded that PCV2 is most likely excreted through respiratory secretions, oral secretions, 
urine, and feces of both PMWS-affected and clinically healthy pigs, with higher viral loads 
in the PMWS-affected pigs. Yang et al. (2003) detected PCV2 nucleic acids in feces in pigs 
with (14/54 intestines, and 4/9 feces) and without (3/14 intestines and 16/20 feces) enteric 
disease by PCR suggesting fecal-oral transmission of PCV2 in feces.  
Direct contact with pigs inoculated with virus 42 days previously resulted in 
transmission of virus to 3 of 3 control CDCD pigs (Bolin et al., 2001). Vertical transmission 
has been demonstrated to occur in individual sows in the field (Ladekjær-Mikkelsen et al., 
2001; O’Conner et al., 2001) and experimentally (Johnson et al., 2002). There are reports of 
vertical intrauterine transfer of PCV2 resulting in viremic or persistently infected piglets at 
birth (West et al., 1999). Vertical PCV2 infection may not always cause fetal death, and 
virus, antibody, or both were detected in clinically normal fetuses (Sanches 2003). 
Larochelle et al. (2000) infected four 7-month-old boars intranasally with PCV2. 
Serum samples were collected at 4, 7, 11, 13, 18, 21, 25, 28, 35, 55, and 90 DPI and were 
tested for the presence of PCV2 DNA by nested PCR. PCV2 DNA was detected as early as 4 
DPI in 3 of the 4 boars and serum samples were positive up to 35 DPI but negative by 90 
DPI. Semen was collected at 5, 8, 11, 13, 18, 21, 25, 28, 33, and 47 DPI and analyzed by 
nested PCR. PCV2 was detected as soon as 5 DPI in semen of two of the boars and 
intermittently through 47 DPI in all 4 boars. The semen of 2/4 infected boars was positive for 
PCV2 DNA at 47 DPI (Larochelle et al., 2000). Kim et al. (2003c) tested semen from ninety-
eight 1-year-old boars from 49 herds in Korea and found 13 of 98 semen samples to be 
positive for PCV2 by first round (conventional) PCR, 26 of 98 semen samples were positive 
by semi nested PCR, and 11 of 98 semen samples were positive by virus isolation. The same 
study also investigated prevalence of PCV2 in seminal fluid, non-sperm cells, and sperm 
heads, and detected the greatest amount of PCV2 DNA in the seminal fluid and nonsperm 
fraction (Kim et al., 2003c). The frequency of PCV2 DNA in semen from naturally infected 
boars was found to be low and sporadic (McIntosh et al., 2005). The authors concluded that 
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boars seropositive for PCV2 may have persistent shedding of the virus in semen. PCV2 DNA 
in semen didn’t appear to affect the percent of morphologically-normal or live sperm cells in 
PCV2-shedding boars and boars older than 17.5 month of age did not appear to shed PCV2 
DNA in semen (McIntosh et al., 2005). 
PCV1 and PCV2 DNA were detected in porcine-derived commercial pepsin (Fenaux 
et al., 2004c). It was found that the PCV-contaminated pepsin lacks infectivity in vitro and 
also in vivo as determined by culture in PK-15 cells and experimental inoculation of pigs 
(Fenaux et al., 2004c). 
 
Derivation of PCV2-free pigs 
It has been demonstrated that PCV2-free pigs can be achieved by derivation of pigs 
through cesarean-section and colostrum deprivation (Tucker et al., 2003). Segregated early 
weaning (SEW) techniques are also effective for derivation of PCV2-free pigs (Opriessnig et 
al., 2004d). 
 
Pathogenesis 
The pathogenesis of PCV2 infection and the major cell types that support PCV2 
replication are poorly understood. It has been suggested that PCV2 initially replicates in the 
tonsil. Allan et al. (2000b) reported that in porcine parvovirus (PPV) and PCV2 coinfected 
pigs, PPV antigen predominates in the tissues of the pigs killed between 3 and 14 DPI with a 
maximum observed between 6 and 14 DPI. PCV2 antigen was first observed in minimal 
amounts in mesenteric lymph nodes at 10 DPI with increasing density and distribution of 
PCV2 antigen at 14, 17, 21, and 26 DPI (Allan et al., 2000b). 
Large numbers of PCV2 antigen or nucleic acids are often detected in the cytoplasm 
of macrophages and dendritic cells by IHC or ISH (Allan and Ellis, 2000; Sorden, 2000). A 
recent study found that antigen presenting cells in general, and not only macrophages stained 
positive by IHC for PCV2 antigen (Chianini et al., 2003). In contrast, PCV2 antigen in 
lymphocytes was only sporadically detected. In thymus, PCV2 was only detected in few 
histiocytic cells in the medulla suggesting that thymocytes and T cells might be more 
resistant to PCV2 infection (Chianini et al., 2003).To a lesser extent, PCV2 antigen is also 
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found in epithelial cells in lungs and kidneys, in smooth muscle cells, and in endothelial cells 
in several tissues in pigs experimentally infected with PCV2 (Kennedy et al., 2000) as well 
as in pigs with naturally occurring PCV2-associated PMWS (McNeilly et al., 1999; Rosell et 
al., 1999). Kennedy et al (2000) demonstrated PCV2-antigen in infiltrating macrophages in 
the tunica albuginea, in interstitial macrophages and in germinal epithelial cells in the testes, 
and in infiltrating macrophages in the epidiymides of boars 24 to 29 days after they had been 
coinfected with PCV2 and PPV at 3 days of age. PCV2 was also found in the parenchyma of 
the secondary sex glands in a naturally infected boar (Opriessnig et al., 2006d). PCV2 targets 
mainly cardiomyocytes, hepatocytes, and macrophages during fetal life, and mainly 
monocytes in early post-natal life (Sanchez et al., 2003). 
 
PCV2 and macrophages 
Viruses that replicate in the monocyte/macrophage lineage, PPV (Allan et al., 1999a; 
Opriessnig et al., 2004a) and porcine reproductive and respiratory virus (PRRSV) (Allan et 
al., 2000a; Harms et al., 2001; Rovira et al., 2002), have been shown to increase the 
replication of PCV2 in coinfected pigs and increase the incidence of PMWS. Despite the 
presence of PCV2 in macrophages and dentritic cells, recent in vitro studies suggest that 
monocytic cells may not represent the primary target for PCV2 replication (Gilpin et al., 
2003). Monocytes and macrophages were tested for the ability to support PCV2-replication 
in vitro. PCV2-replication in these cell types was not observed; however, PCV2 was not 
degraded and was stored in the cytoplasm of the cells (Gilpin et al., 2003). Similarly, no 
evidence of in vitro virus replication in dendritic cells was found by Vincent et al. (2002); 
however, PCV2 did persist in dendritic cells without loss of infectivity or the induction of 
cell death. It has been speculated that because of their migratory capacity, dendritic cells can 
provide a potent vehicle for transport of the virus throughout the host without the need for 
replication (Vincent et al., 2003).  
 
PCV2 and lymphoid depletion 
Lymphoid depletion and lymphopenia in peripheral blood is a consistent feature in 
pigs that develop clinical PMWS. The reduction of lymphocytes might be due to reduced 
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production in the bone marrow, reduced proliferation in secondary lymphoid tissues, or due 
to increased loss of lymphocytes in the bone marrow or peripheral blood or secondary 
lymphoid tissues via necrosis or apoptosis. The lymph node reaction can be graded as initial, 
intermediate, and end stage (Sarli et al., 2001). Studies on pigs with naturally acquired 
PMWS revealed that associated with absence of follicles and depletion of lymphocytes there 
was a reduction in number of interfollicular dendritic cells and interdigitating cells as well as 
a reduction or absence of B cells and CD4+ T lymphocytes (Sarli et al., 2001). By IHC 
characterization of PCV2-associated lesions in naturally PMWS-affected pigs, Chianini et al. 
(2003) found increased numbers of macrophages and partial loss and redistribution of antigen 
presenting cells throughout lymphoid tissues when compared to healthy control pigs. In 
particular, a reduction or loss of CD79α and 3C3/9-positive cells and diminution in T-cell 
areas of CD3-positive lymphocytes was observed. Decrease of proliferation of both, 
lymphoid and medulla-like tissues in the initial stage of PMWS, but not in the intermediate 
or final stage has been reported. It was also demonstrated, that there is increase of 
subcapsular and peritrabecular lysozyme-positive macrophages, and partial loss and 
redistribution of BL2H5-positive antigen presenting cells throughout lymphoid tissues 
(Chianini et al., 2003).  
Shibahara et al. (2000) found a loss of lymphocytes in B-cell areas and attributed this 
to increased PCV2-induced apoptosis since PCV2-antigen was found in nuclei of 
macrophages and apoptotic lymphocytes. In contrast, Mandrioli et al. (2004) investigated 
inguinal lymph nodes of 10 pigs with naturally acquired PMWS and found that decreased 
cell proliferation and not increased apoptosis seemed to be the most important variable 
leading to lymphoid depletion in PMWS. Krakowka et al. (2004) investigated tissues from 
experimentally PCV2 infected pigs for TUNEL staining and found positive signals only 
within the cytoplasm of virus-positive phagocytic mononuclear cells. It was concluded that 
apoptosis is not the primary mechanism of lymphoid depletion and hepatocyte loss in PMWS 
(Krakowka et al., 2004).  
 
PCV2-induced alterations in peripheral blood cells 
Segalés et al. (2000) studied hematological parameters of 50 pigs with naturally 
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acquired PMWS, 8 experimentally-PCV2-infected pigs, and 11 PCV2-free control pigs. 
PMWS-affected pigs had significantly lower red blood cells counts and hematocrit values 
which was associated with the presence of gastric ulcerations rather than with PCV2-
infection. The mean lymphocyte percentages were lower in PMWS-affected pigs; however, 
this was not statistically significant (Segalés et al., 2000). Segalés et al. (2001a) analyzed 
changes in peripheral blood leukocyte populations in pigs with PMWS by comparing data 
obtained from 13 PMWS-affected pigs with 11 clinically healthy pigs. It was found that pigs 
suffering from PMWS had lower proportions of CD4+ and IgM+ cells in blood than 
clinically healthy pigs (Segalés et al., 2001). Darwich et al. (2002) used twenty-four 8- to 12-
week-old PMWS affected pigs and 17 healthy control pigs from conventional farms in Spain 
to determine changes in peripheral blood monocytes. The authors found that PMWS-affected 
pigs had significantly (P < 0.05) decreased numbers of CD8+ and double-positive cells 
compared to control pigs. The amount of PCV2 in lymphoid tissues was correlated to the 
degree of cell depletion and to the relative decrease in IgM+ and CD8+ cells in peripheral 
blood (Darwich et al., 2002). Nielsen et al. (2003) found primarily lymphopenia in 
experimentally PCV2-inoculated pigs. All T lymphocyte subpopulations were susceptible to 
PCV2 induced lymphopenia with the conclusion that memory/activated Th-lymphocytes 
might be affected more than other T cell subpopulations. Only pigs that subsequently 
developed PMWS had lymphopenia (Nielsen et al., 2003). Bassaganya-Riera et al. (2003) 
demonstrated significant B-cell depletion in PCV2-infected pigs and found that the most 
depleted B-cell subset (IgM+) expressed an immature phenotype characterized by expression 
of a myeloid marker (SWC3). Segalés et al. (2004) determined the serum concentrations of 
acute phase proteins, haptoglobulin, and pig-major acute phase protein, in pigs with and 
without PMWS and found that mean haptoglobulin and pig-major acute phase protein levels 
were significantly increased in PMWS-affected pigs. In a second study, pigs were divided 
into 2 groups based on PCV2-PCR status done on serum samples and no significant 
differences between groups were detected. The authors concluded that acute phase proteins 
levels are significantly increased in pigs that develop PMWS but not in pigs with subclinial 
PCV2 infection (Segalés et al., 2004). 
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PCV2, cytokines, and chemokines 
The majority of studies investigating cytokine profiles in PCV2-infected pigs that 
have been published to date where done on pigs with naturally-acquired PMWS. Sipos et al. 
(2004) found an increase of IL-1α and IL-10 mRNA and down-regulation of IL-2 and IL-
2Rα mRNA associated with PMWS by comparing 10 pigs with naturally acquired PMWS 
with 10 clinically healthy pigs. Pigs with naturally acquired PMWS pigs had an altered 
cytokine mRNA expression pattern with overexpression of IL-10 mRNA in thymus and IFN-
γ mRNA in tonsil (Darwich et al., 2003b). Mononuclear cells from pigs with naturally 
acquired PMWS did not produce normal levels of IFN-γ, IL-1β, IL-2, IL-4 or IL-8 when they 
were challenged with a T-cell mitogen such as phytohemaglutinin or superantigens but they 
did produce some IFN-γ or IL-10 when challenged with recall PCV2 antigens (Darwich et 
al., 2003a). Sipos et al. (2005) compared 5 pigs affected by PDNS, 5 pigs with naturally 
acquired PMWS, and 5 healthy control pigs and found IL-1α, IL-6, and IFN-γ mRNA 
expressions elevated as well as an increased capacity of peripheral blood mononuclear cells 
to produce IL-2, IL-4, IL-6, IL-12, TNF-α, and IFN-γ in PDNS pigs compared to PMWS 
pigs. In PMWS pigs, IL-10 mRNA was significantly decreased compared to control pigs 
(Sipos et al., 2005). 
Kim and Chae (2004c) observed maximum expression of monocyte chemoattractant 
protein-1 (MCP-1) and macrophage inflammatory protein-1 (MIP-1) at 17 and 21 DPI in 
lymphoid tissues of experimentally PCV2-infected pigs by ISH and semiquantitive reverse 
transcriptase PCR. MCP-1 was correlated with PCV2 as determined by ISH done on serial 
sections of lymph nodes from PMWS-affected pigs, whereas IL-8 was not detected in the 
lesions (Kim and Chae, 2003c). Injection of granulocyte-macrophage colony stimulating 
factor (GM-CSF) encoding DNA had no significant effect on PCV2 replication in 5-week-
old specific pathogen free (SPF) pigs injected with a tandem-cloned PCV2 DNA when 
compared to non-GM-CSF-injected pigs (Loizel et al., 2005). Further in vitro studies found 
that in the presence of intracytoplasmic PCV2, the function of natural interferon producing 
cells (conventional blood dendritic ells and plamacytoid dendritic cells) is disrupted which 
would impair the maturation of associated myeloid dendritic cells favoring the establishment 
of concurrent infections (Vincent et al., 2005). 
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PCV2-associated Diseases 
Postweaning multisystemic wasting syndrome (PMWS) 
a. Definition
PMWS is considered a multifactorial disease in pigs, in which a necessary factor is 
the presence of PCV2. Since PCV2 is ubiquitous in the pig population and infection doesn’t 
necessarily equal disease, a definition for PMWS was proposed (Sorden, 2000). Based on 
this definition, a diagnosis of PMWS requires (1) the presence of clinical signs such as 
wasting, weight loss, and respiratory disease, (2) the presence of the hallmark PCV2-
associated microscopic lesions (lymphoid depletion or histiocytic replacement of follicles in 
lymphoid tissues or both), and (3) PCV-antigen or nucleic acids associated with the 
microscopic lesions as determined by IHC or ISH (Sorden, 2000). 
b. Historical background.  
PCV2-associated PMWS was first identified in Canadian high health herds in 1991 
(Harding, 1996; Harding and Clark, 1997). Affected herds were free of major enteric and 
respiratory pathogens including Mycoplasma hyopneumoniae (M. hyopneumoniae), 
Actinobacillus pleuropneumoniae (APP), salmonellosis, swine dysentery, transmissible 
gastroenteritis virus (TGEV), pseudorabies virus, and PRRSV. The herd sizes varied from 
small (50 sows) to large (1,200 sows) and genetics also varied widely. In 1996, interstitial 
pneumonia and lymphadenopathy was observed in a 6-week-old pig in California (Daft et al., 
1996). Also in 1996, workers in France observed a piglet wasting disease (LeCann et al., 
1997). Subsequently, PCV2 was isolated from material of affected French and Californian 
pigs (Allan et al., 1998b).  
c. Clinical disease, macroscopic and microscopic lesions
PMWS is a disease complex characterized by wasting and pneumonia in pigs in the 
late nursery and early grower stages typically affecting pigs between 5 and 20 weeks of age 
(Allan and Ellis, 2000; Harding, 2004). Harding (2004) emphasizes six fundamental clinical 
signs of PMWS: wasting, dyspnea, enlarged lymph nodes, diarrhea, pallor, and jaundice. 
While all the fundamental clinical signs may not be noted in a single pig, affected farms will 
present with the majority of them over a period of time. Other clinical signs include coughing 
fever, gastric ulceration, meningitis, and sudden death (Harding et al., 2004).  
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Macroscopic lesions associated with PCV2 infection include generalized 
lymphadenopathy, non-collapsed, rubbery lungs with mottling and increased firmness, 
enlarged spleen, and enlarged kidneys (Clark, 1997). 
Characteristic microscopic lesions associated with PCV2-infection and PMWS 
include lymphoid depletion and histiocytic replacement of follicles in lymphoid tissues. The 
lymphocellular depletion affects both, lymphoid follicles and parafollicular zones (Rosell et 
al., 1999). Mild-to-severe granulomatous inflammation in lymphoid and other tissues also is 
commonly observed (Allan and Ellis, 2000; Sorden, 2000). Syncytial cells can be seen 
frequently, especially in lymph nodes, Peyer’s patches, and lamina propria of the intestinal 
villi (Rosell et al., 1999). Macrophages in affected lymphoid tissues may contain sharply 
demarcated, spherical, basophilic cytoplasmic inclusion bodies (Clark, 1997; Rosell et al., 
1999). The inclusions are either large and single or smaller and multiple with groups of up to 
12 inclusions (Rosell et al., 1999).   
d. Prevalence
PMWS has been reported from almost all swine producing countries. Morbidity due 
to PMWS reportedly varies from as little as 4% to as high as 30% and mortality in affected 
pigs is typically 70 to 80% (Allan and Ellis, 2000, Harding and Clark, 1997; Madec et al., 
2000; Rodríguez-Arrioja et al., 2002). Rodríguez-Arrioja et al. (2002) collected blood 
samples from 3-, 7-, 12-, and 28-week-old pigs from a PMWS-affected herd. Clinical PMWS 
started when the pigs were 8 weeks old and had a prevalence of 30% in 8- to 10-week-old 
pigs.  
There are two forms of PMWS, an endemic and an epidemic form. The endemic form 
is seen in North America, where PMWS usually results in low grade but persistent death 
losses. Rarely, 3- to 4-fold increase in postweaning mortality can be observed. The epidemic 
form, which is characterized by persistent mortality, appears to be restricted to Europe and 
based on recent evidence, eastern Canada (Delay et al., 2005) and North Carolina. Pork 
producers in Eastern Canada and North Carolina have experienced a devastating disease in 
growing pigs manifest as wasting and pneumonia and resulting in persistent mortality of 20-
40% of the pigs between 10 weeks and market age (25 weeks). The recent severe outbreaks 
most resemble porcine circovirus type 2 (PCV2) associated postweaning multisystemic 
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wasting syndrome (PMWS); however, the severity and persistence of the disease and 
apparent ability of the disease to spread quickly throughout the area is different then expected 
with classic PCV2-associated PMWS. 
e. Experimental reproduction  
Experimental PCV2-infection models indicate that PCV2 is an opportunist, 
depending on immunostimulation (Allan et al., 2000c and 2001; Krakowka et al., 2001) or 
coinfecting agents like PPV (Allan et al., 1999a and 2000b, Ellis et al., 1999; Hasslung et al., 
2005; Kennedy et al., 2000; Kim and Chae, 2004a; Krakowka et al., 2000; Opriessnig et al., 
2004a; Ostanello et al., 2005), PRRSV (Allan et al., 2000a; Harms et al., 2001; Rovira et al., 
2002), or M. hyopneumoniae (Opriessnig et al., 2004c) for PCV2-infection to progress to 
clinical PMWS. While most research groups have not been able to reproduce clinical disease 
in pigs inoculated singularly with PCV2, some groups have succeeded in this regard.  
Experimental infection of gnotobiotic pigs. Krakowka et al. (2000) inoculated 1-day-
old gnotobiotic pigs intranasally with PCV2 (n = 3), PCV2 and PCV1 (n = 4), and PCV2 and 
PPV (n = 4), and found that all PCV2/PPV developed clinical PMWS whereas the singular 
infected pigs and PCV1/PCV2-inoculated pigs did not. Microscopically, hepatic necrosis 
with severe granulomatous hepatitis and prominent bile retention was observed (Krakowka et 
al 2000). 
Experimental infection of colostrum deprived cesarian derived (CDCD): Bolin et al. 
(2001) inoculated twenty-three 20- to 25-day-old CDCD pigs intranasally and 
intramuscularly with PCV2 and induced clinical PMWS in the majority of the pigs. Harms et 
al. (2001) inoculated 36 CDCD pigs with PCV2 (17 of the 36 pig were concurrently infected 
with PRRSV) and induced severe clinical disease consistent with PMWS in singular and 
coinfected pigs. Pogranichnyy et al. (2000) inoculated five 8-week-old CDCD pigs 
intranasally and intramuscularly with PCV2, necropsied all pigs at 35 DPI, and observed 
mild microscopic lesions associated with PCV2.  
Experimental infection of colostrum deprived (CD) pigs: Allan et al. (1999a) 
inoculated eleven 1- to 2-day-old CD pigs with PCV2 (5 of 11 pigs were coinfected with 
PPV, and 2 of 11 pigs were coinfected with a formalin-treated PCV2/PPV mixture) and 3 of 
the 11 pigs died from clinical PMWS (one singular and two coinfected pigs). Allan et al. 
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(2000a) inoculated eight 1- to 2-day-old CD pigs intranasally with PCV2 (5 of 8 pigs were 
coinfected with PRRSV) and found enhancement of PCV2 but no clinical signs or gross 
lesions in dual-infected pigs. Allan et al. (2003) inoculated thirteen 4-day-old CD pigs 
intranasally with PCV2 (9 of 13 pigs were coinfected with PPV), and reproduced clinical 
PMWS in 1 of 4 singular PCV2-inoculated and 9 of 9 PCV2/PPV coinfected pigs. 
Experimental infection of conventional pigs. Albina et al. (2001) inoculated four 6- to 
7-week old specific pathogen free piglets intratracheally with a lung tissue homogenate 
obtained from two French naturally PMWS-affected pigs. Thereafter, 7 passages of 6 to 8 
pigs per group were subsequently intratracheally and intramusucullarly infected with lymph 
node homogenates from the previous passage. PMWS was reproduced in 4 of 55 (7.2%) of 
the pigs (Albina et al., 2001). Clinical PMWS was recently induced in 3 of 5 non-
immunostimulated and in 1 of 5 with keyhole limpet hemocyanin in Freund’s incomplete 
adjuvant (KLH/ICFA) stimulated 3-week-old conventional colostrum-fed pigs singularly-
infected with PCV2 (Ladekjær-Mikkelson et al., 2002). Balasch et al. (1999) infected eight 
8-week-old conventional pigs intranasally with tissue homogenates from naturally PMWS-
affected pigs and reproduced PMWS-like lesions in the pigs. Allan et al (2000) inoculated 28 
conventional pigs at 13, 31, and 47 days of age oronasally with PCV2. Half of the pigs were 
vaccinated with a M. hyopneumoniae vaccine at 13 and at 31 days of age and with an APP 
vaccine at 47 days of age. Three of fourteen vaccinated pigs developed clinical PMWS.  
f. PCV2 infectious genomic DNA 
Fenaux et al. (2002, 2003) investigated the infectivity of an US PCV2 molecular 
DNA clone when infected directly into the liver or inguinal lymph nodes. Mild PCV2-
associated lesions were observed in 4-week-old conventional pigs confirming the role of 
PCV2 in PMWS. Similar results (mild microscopic lesions and no clinical disease) were 
observed in another study using a European clone (Roca et al. 2004). Grasland et al. (2005) 
reported of the reproduction of PMWS in immunostimulated (injections of KLH/ICFA and 
thioglycollate medium) conventional pigs inoculated with a European PCV2 DNA clone. 
g. Coinfections present in cases of naturally occurring PMWS
Ellis et al. (2000a) demonstrated PPV and PCV2 coinfection in 12/69 cases of 
naturally acquired PMWS. A retrospective analysis of 484 PMWS cases in the Midwest 
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United States revealed that PCV2 alone was found in only 9 of 484 (1.9%) cases investigated 
(Pallarés et al., 2002). PRRSV was detected in 251 of 484 (51.9%) cases, M. hyopneumoniae 
was found in combination with PCV2 in 172 of 484 (35.5%) cases, and SIV was detected in 
26 of 484 (5.4%) cases (Pallarés et al., 2002). Aujeszky’s disease virus infection concurrent 
with PMWS was demonstrated in pigs associated with multifocal necrotizing tonsilitis and 
lymphadenitis (Rodríguez-Arrioja et al., 1999). Pogranichniy et al. (2002) did a case control 
study on pigs with a clinical history of wasting and microscopic lesions characteristic of 
PMWS (n = 31) and on control pigs without clinical signs or microscopic lesions typical of 
PMWS (n = 56). Among all viruses tested, PCV2, PRRSV, PPV, porcine enterovirus types 1-
3, swine influenza virus (SIV), porcine respiratory coronavirus, TGEV, porcine endogenous 
retrovirus, porcine lymphotropic herpesvirus type 1, and bovine virus diarrhea virus, PCV2 
had the strongest association with PMWS. The risk for PMWS was much higher if the pig 
was PCV2/PRRSV coinfected (Pogranichniy et al., 2002). Wellenberg et al. (2004a) did a 
case-control study to investigate the presence of coinfections in the Netherlands. They 
compared 60 pigs affected with PMWS from 20 different farms and 180 pigs without clinical 
signs of PMWS. Concurrent PRRSV-infection was found in 83% of the PMWS-affected pigs 
and in 35% of the pigs from PMWS-free herds (Wellenberg et al., 2004a). 
 
PCV2-associated pneumonia 
Recent field investigations suggest that PCV2 may be playing an important role in 
some cases of porcine respiratory disease complex (PRDC) (Harms et al., 2002a; Kim et al., 
2003b). PRDC is a condition observed mainly in 8- to 26-week-old pigs and associated with 
multiple respiratory pathogens including PRRSV, SIV, and M. hyopneumoniae. PRDC is 
characterized by decreased rate of growth, decreased feed efficiency, anorexia, fever, cough, 
and dyspnea. There is diagnostic overlap between PMWS and PCV2-associated pneumonia. 
The presence of prolonged and unusually severe clinical respiratory disease, granulomatous 
bronchointerstitial pneumonia with bonchiolitis and bronchiolar fibrosis, and abundant PCV2 
antigen associated with the lesions is suggestive of PCV2-associated pneumonia and PRDC. 
There is experimental evidence of unique lung lesions associated with PCV2 antigen in the 
literature. Interstitial pneumonia with bronchiolitis was reported in the first cases of PMWS 
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(Clark, 1996; Ellis et al., 1998). Magar et al. (2000a) reproduced bronchointerstitial 
pneumonia in addition to the hallmark lymphoid lesions of PMWS in conventional pigs 
inoculated with PCV2. Bolin et al. (2001) induced mild respiratory disease and multifocal 
interstitial pneumonia in CDCD pigs inoculated with PCV2. Rovira et al. (2002) induced 
mild interstitial pneumonia and lymphoplasmacytic rhinitis in conventional pigs inoculated 
with PCV2. Mild granulomatous bronchointerstitial pneumonia was reproduced in 
conventional pigs using an infectious DNA clone of PCV2 (Fenaux et al., 2002). 
Coinfections with PCV2 and other pathogens in lung lesions have been reported. 
Pneumocystis carinii was reported to occur in approximately 0.5% of cases with PMWS in 
western Canada (Clark, 1997). Pulmonary aspergillosis was diagnosed in a pig affected by 
PMWS (Segalés et al., 2003). Harms et al. (2002a) demonstrated a high prevalence of 
coinfection with PRRSV in cases of PRDC in the Midwestern United States. Coinfection 
with SIV and M. hyopneumoniae was also reported in this study (Harms et al., 2002a). 
Proliferative and necrotizing pneumonia (PNP) which is characterized microscopically by 
lymphohistiocytic interstitial pneumonia with marked proliferation of type 2 pneumocytes, 
multifocal coagulates of necrotic cells in the alveoli, hyaline membranes, intra-alveolar 
lymphoplasmacytic infiltrates, and bronchiolar necrosis has been implicated to be the result 
of coinfection with PRRSV and PCV2 (Larochelle et al., 1999). Drolet et al. (2003) did a 
retrospective study on 60 cases of PNP diagnosed between 1988 and 2001 and found PRRSV 
antigen in 55/60 PNP cases, SIV antigen in 1/60 PNP cases, and PCV2 in 25/55 PNP cases. 
The authors concluded that coinfection with PCV2 is not a determining factor in PNP and 
that PRRSV is consistently and predominately associated with PNP (Drolet et al., 2003).  
 
PCV2-associated lymphoid depletion 
PCV2-associated lymphoid depletion is a hallmark lesion of PMWS but can also be 
observed in subclinically infected pigs (Quintana et al., 2001). Sanchez et al. (2004) 
investigated the development of PCV2-associated lymphoid lesions in pigs that had been 
inoculated in utero at 92 to 104 gestational days (n = 12) or at 1 day of age (n = 14) and 
found that high PCV2 titers in lymphoid organs may lead to the development of severe 
microscopic lymphoid lesions without causing clinical manifest disease. The infection 
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appears to occur mainly in infiltrating monocytic cells and to a lesser extend in cells bearing 
lymphocyte markers (Sanchez et al., 2004). 
Kim and Chae (2005) described seven field cases of PCV2-associated necrotizing 
lymphadenitis. The main lesion was follicular necrosis in the center of prominent lymphoid 
follicles. PCV2 was detected in all lymph nodes with necrotic foci but was absent in other 
lymph nodes. No other infectious cause could be found and granulomatous inflammation and 
intracytoplasmic inclusion bodies were not observed in these cases (Kim and Chae, 2005). In 
three pigs experimentally infected with PCV2, viral antigen was also associated with 
obliterated blood vessels in areas of granulomatous and necrotizing lymphadenitis 
(Opriessnig et al., 2006c).  
 
PCV2-associated abortions and reproductive failure 
There have been several reports (O’Conner et al., 2001; Ladekjær-Mikkelsen et al. 
2000) of PCV2-associated reproductive failure since the original report of West et al. (1999) 
in western Canada in 1999. Consistent signs on affected farms include increased numbers of 
abortions, stillbirths, fetal mummification, and increased pre-weaning mortalities. Affected 
herds are typically gilt-start-ups or new populations. A nonsuppurative-to-necrotizing or 
fibrosing myocarditis associated with abundant PCV2 antigen are the major lesions in 
stillborn and neonatal pigs from field cases (Mikami et al., 2005). PCV2-infection has been 
confirmed in PMWS outbreaks in CDCD piglets (Harms et al., 1999; Jolie et al., 2000) 
suggesting that a vertical transmission is possible. Experimental intrauterine infection of 
fetues with PCV2 resulted in virus replication in the fetuses and supports the heart as primary 
site of PCV2 replication in fetuses (Sanchez et al. 2001). Johnson et al. (2002) inoculated 37 
fetuses from 3 pregnant sows at 86, 92, and 93 days of gestation intramuscularly and 
observed 24 normal pigs and 13 mummified, stillborn, or weak-born pigs at farrowing 
confirming that PCV2 can infect late-term fetuses and cause reproductive abnormalities.  
A retrospective study failed to detect PV2 antigen and nucleic acids in cases of 
reproductive failure prior to 1999 in areas of endemic PCV2 infection (Bogdan et al. 2001). 
The authors concluded that reproductive failure may be a new clinical manifestation of PCV2 
infection, and that vertical transmission may not have been the primary mechanism of initial 
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dissemination of the virus in the pig population. Farnham et al. (2003) tested 171 sera from 
stillborn fetuses from 3 different farms for PCV2-specific antibodies by IPMA and found 28 
of 171 positive. Thirteen of the 28 sera were also positive for PCV2 nucleic acids as 
determined by PCR, and 9 of 13 PCR PCV2 positive sera were positive for PCV2 by virus 
isolation. Kim et al. (2004b) tested 350 aborted fetuses and stillborn pigs from 321 Korean 
farms submitted between 2000 and 2002 for PCV2, PPV, and PRRSV by PCR and virus 
isolation. PCV2 was found by PCR in 46 of 350 (13.1%) fetuses and by virus isolation in 25 
of 350 (7.1%) fetuses and it was associated with all stages of gestation. 
Mauch et al. (2004) observed abortions and death loss in dams after 94 gilts in mid-
pregnancy were transported to four PCV2 positive farms. Pensaert et al. (2004) inoculated 
four 8-month-old nonpregnant gilts with a PCV2 strain isolated from a dead fetus in Canada. 
The gilts seroconverted to PCV2 by 21 DPI. Viral DNA was found in plasma between 14 and 
49 DPI and in peripheral blood monocytes between 7 and 63 DPI. The 21 DPI PCV2 was 
determined to be infectious by pig inoculation. Park et al. (2005) inoculated 6 pregnant sows 
3 weeks before expected farrowing date intranasally with a PCV2 recovered from an aborted 
fetus. Four of the 6 sows aborted between 7 and 21 DPI and 2 sows farrowed 4-5 days 
prematurely. The six sows delivered a total of 65 stillborn and 10 live-born piglets. PCV2 
DNA was detected by ISH in lymph node, spleen, thymus, lung, tonsil, and liver from 
stillborn and live-born piglets.  
 
PCV2-associated myocarditis and vasculitis in growing pigs 
Abundant intracytoplasmic PCV2 antigen was associated with myocardiocyte swelling or 
necrosis, or myocardial fibrosis (or both) in three naturally-infected pigs aged 4 to 7 weeks 
from three different farms (Opiessnig et al., 2006c). Marco (2002) reported of cardiomegaly, 
especially on the right side of the heart with pericardial effusion in Spanish pigs naturally 
affected by PMWS. PCV2-associated myocarditis was found to be the primary cause of 
congestive heart failure in these cases (Marco, 2002). 
Severe diffuse segmental to circumferential lymphohistiocytic and plasmacytic 
periarteritis and endarteritis in several organs was observed in a pig naturally infected with 
PCV2 (Opriessnig et al., 2006c). PCV2 antigen was demonstrated in endothelial cells and 
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inflammatory cells in the arterial walls.  
 
Porcine dermatitis and nephropathy syndrome (PDNS) 
PDNS is characterized clinically by acute onset of skin lesions (raised purple skin 
lesions progressing to multifocal raised red scabs with black centers most prominent on the 
rear legs), fever, and lethargy and is almost always fatal. Macroscopically, there are enlarged 
tan waxy kidneys with white foci and streaks. Microscopically, there is systemic vasculitis 
with dermal and epidermal necrosis and necrotizing and fibrinous glomerulonephritis. The 
microscopic hallmark lesions of PDNS, generalized vasculitis and glomerulonephritis, are 
suggestive of a type III hypersensitivity reaction which is characterized by deposition of 
antigen-antibody aggregates or immune complexes at certain tissue sites. Many pathogens 
including viruses (PRRSV; Choi and Chae, 2001; Thibault et al., 1998) and bacteria such as 
Pasteurella multocida, Streptococcus suis type 1 and 2, E. coli, Proteus sp., Haemophilus 
parasuis, APP, Bordetella bronchiseptica, Arcanobacterium pyogenes, Staphyloccoccus 
aureus, or Salmonella sp. (Thomson et al., 2002) have been implicated in the etiology of 
PDNS. Lainson et al. (2002) further differentiated Pasteurella multocida isolates from PDNS 
cases and from cases without PDNS by pulsed-field gel electrophoresis and found a single 
Pasteurella multocida variant associated with PDNS. PDNS was first associated with PCV2 
in 2000 (Rosell et al., 2000). Allan et al. (2000d) investigated PDNS cases submitted in 
Northern Ireland in 1990 when PRRSV had not been introduced into the area and found 
granulomatous lymphadenitis associated with PCV2 antigen in affected pigs. 
There are two forms of PDNS described: the sporadic form and the epizootic form. 
With the sporadic form the mortality is rarely above 0.5%. The epizootic form was first 
observed in 1999 in England, when there was a sudden, marked increase of PDNS cases 
(Thomson et al., 2000, 2002). The within-herd mortality was reported to range from 0.25-
20% and similar observations were made in the Netherlands (Elbers et al., 2000; Wellenberg 
et al., 2004b). Investigations into this “outbreak” found that there was a clear temporal 
association of PMWS and PDNS; PDNS cases usually followed PMWS cases on the same 
farms. Studies have determined that the mean age of pigs affected by PMWS ranges from 6 
to 14 weeks whereas the mean age of pigs affected by PDNS ranges from 12 to 16 weeks 
 
 32
(Gresham et al., 2000). Similar observations were made in Korea and these authors 
speculated that the presence of both PMWS and PDNS in the same herd but in different age 
groups was probably due to different strains of PCV2 or varying susceptibility of the pigs 
(Choi et al., 2002a). A recent case-control study investigating PDNS in the Netherlands 
found that there was a significant association of high antibody titers to PCV2 and the 
development of PDNS (Wellenberg et al., 2004b). The authors were not able to show PCV2-
antigen by IHC in all of the PDNS cases but they were able to confirm the presence of PCV2 
by PCR in all cases of PDNS. Importantly, the authors were able to show that porcine 
parvovirus or PRRSV nucleic acids were not present in many of the PDNS cases as 
determined by PCR (Wellenberg et al., 2004b). A study comparing PCV2 serum load in 
PMWS and PDNS cases found that PDNS cases had significantly lower numbers of PCV2 in 
serum compared to healthy, subclinical PCV2-infected pigs (Olvera et al., 2004). This study 
further confirms that PDNS pigs are infected with PCV2. Mauch et al. (2004) observed 
abortions and death loss in dams after 94 gilts in mid-pregnancy and seronegative for PCV2-
antibodies were transported to four PCV2 positive farms. Within 2 months of entry, 34 of the 
94 gilts showed typical PDNS like lesions, 8 of 34 gilts aborted, and 4 of 34 gilts died. The 
gilts had necrotizing vasculitis in skin, renal cortex, lymph nodes, spleen ileum, and in the 
uterus wall (Mauch et al. 2004).  
 
PCV2-associated enteritis 
Cases of PCV2-associated enteritis are relatively uncommon. Most of the PCV2-
associated enteritis cases are from grow-finish pigs. PCV2-associated enteritis cases often 
clinically and grossly resemble subacute or chronic ileitis. The intestinal mucosa is grossly 
thickened and mesenteric lymph nodes are enlarged. Microscopic examination confirms the 
presence of ganulomatous enteritis which can be associated with abundant PCV2-antigen by 
IHC (Halbur and Opriessnig, 2004). Kim et al. (2004a) diagnosed PCV2-associated enteritis 
in six weanling pigs. PMWS or PDNS were not seen in the herd of origin and the six pigs 
had no lymphoid depletion or histiocytic replacement of follicles in lympoid tissues. The 
authors proposed that diagnosis PCV2-associated enteritis occur only (1) if diarrhea is 
present, (2) if characteristic lesions are present in Peyer’s patches but not in other lymph 
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nodes, and (3) if PCV2-antigen or nucleic acids are present within the lesions (Kim et al., 
2004a). 
There are many reports of concurrent infections with PCV2-associated enteritis. 
Cryptosporidium parvum and PCV2 were demonstrated in a 3-month-old Iberian pig (Núňez 
et al., 2003). Since Cryptosporidium parvum is a rare primary intestinal pathogen in post-
weaning and growing pigs, the authors speculated that concurrent PCV2 infection caused 
immunosuppression (Núňez et al., 2003). Granulomatous enteritis was observed in Iberian 
pigs naturally infected with PCV2 and Lawsonia intracelllularis (Segalés et al., 2001b). 
Intestinal chlamydial infection concurrent with PMWS was observed in a 12-week-old 
Spanish pig (Carrasco et al., 2000). Finally, Jung et al. (2006) identified PCV2 in pig 
naturally infected with porcine epidemic diarrhea virus (PEDV). The authors found 32.7% 
(35/107) small intestinal samples from 87 pig herds diagnosed with PEDV-infection positive 
for PCV2 nucleic acids by PCR and 29.9% (32/107) PCV2 positive by ISH. Since most of 
the pigs in this study were less than 3 days old, it was concluded that prenatal in utero PCV2 
infection may be common (Jung et al., 2006). 
 
PCV2-associated hepatitis 
Hepatic lesions have been described as lymphohistiocytic inflammatory infiltration in 
portal zones, single cell necrosis of hepatocytes, swelling and vacuolation of hepatocyte 
cytoplasm and karyomegaly (Clark, 1997). PCV2 associated hepatitis has been reported in 
experimentally infected pigs coinfected with PCV2 and PPV (Allan et al., 1999a; Kennedy et 
al., 2000). Harms et al. (2001) observed severe necrotizing hepatitis lesions in CDCD pigs 
inoculated with PCV2 or concurrently inoculated with PCV2 and PRRSV, whereas hepatitis 
was not observed in pigs singularly infected with PRRSV. The authors concluded that 
hepatitis observed in field cases of atypical PRRSV likely results from concurrent 
PRRSV/PCV2 infection (Harms et al., 2001). Moderate-to-severe necrotizing and 
granulomatous hepatitis was observed in PCV2 and PCV2/PPV coinfected gnotobiotic 
piglets (Krakowka et al., 2000). Acute hepatitis with centrilobular necrosis of hepatocytes 
was observed in a 24-day-old CD pig experimentally infected with a tissue homogenate from 
a pig with naturally-acquired PMWS (Hirai et al., 2003). Ladekjær-Mikkelsen (2002) 
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observed moderate to severe hepatic atrophy associated with nonsuppurative 
cholangiohepatitis in experimentally-PCV2-infected pigs. In field cases, hepatic disease is a 
common clinical and pathological feature in pigs with PMWS and has been associated with 
concurrent PPV infection (Ellis et al., 2000a). Coinfection with Aujezsky’s disease virus and 
PCV2 has been reported in pigs with severe PMWS and hepatic lesions (Rodríguez-Arrioja 
et al., 1999). 
 
PCV2-associated CNS disease 
Congenital tremors in pigs are associated with demyelination of brain and spinal cord. 
The most common form in North America is transmissible and classified as type A2. This 
form is characterized by clonic contractions of skeletal muscles of varying severity that 
decrease with time and usually resolves by 4 weeks of age. Hines and Lukert (1994) were the 
first to report on a potential association between PCV and congenital tremors. Four PCV 
seronegative sows were experimentally infected with PCV obtained from a piglet with 
congenital tremor. The sows didn’t develop any clinical signs, but all of the piglets had 
congential tremors of varying degrees. Stevenson et al. (2001) demonstrated PCV2-antigen 
(IFA) and nucleic acids (ISH and PCR) intralesional in affected neonatal pigs from four 
different farms in the Midwestern US.  
In contrast to this, Kennedy et al. (2003) investigated central nervous system and 
nonneural tissue of 40 pigs affected by congenital tremor from Spain, the United Kingdom, 
Ireland, and Sweden by IHC, ISH, and PCR (Spanish cases only). PCV1 or PCV2 nucleic 
acids or antigen were not found in any of the pigs (Kennedy et al., 2003). 
 
PCV2-associated exudative epidermitis 
Wattrang et al. (2002) described an outbreak of exudative epidermitis in a Swedish 
SPF herd associated with PCV2. At the time of the outbreak, seroconversion to PCV2 was 
observed. Staphylococcus hyicus was isolated from skin swabs from affected pigs and PCV2 
nucleic acids were demonstrated by PCR in lymphoid tissues from affected pigs (Wattrang et 
al., 2002). Harms et al. (2001) observed severe, diffuse exudative dermatitis in 42% (8 of 19 
pigs) of CDCD pigs experimentally infected with PCV2 and the presence of Staphylococcus 
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hyicus was confirmed by bacterial culture. The dermatitis lesions appeared at 3 to 7 DPI and 
progressed to a severe and diffuse form between 10 to 21 DPI. In addition, mild exudative 
dermatitis was observed in 6/18 PCV2 infected pigs and in 2/10 control pigs. Exudative 
dermatitis was not observed in PRRSV and PRRSV/PCV2 coinfected pigs (Harms et al., 
2001). Kim and Chae (2004b) investigated 142 tissues from pigs diagnosed with exudative 
epidermitis on the basis of bacterial isolation and microscopic lesions. The cases had been 
submitted between 1997 and 2002. Sections of skin and lymph node were tested by ISH for 
the presence of PPV and PCV2. PCV2 was found in 12 of 142 (8.5%) cases, PPV was found 
in 16 of 142 (11.3%) cases, and both, PCV2 and PPV were found in 60 of 142 (42.3%) cases. 
Distinct positive labeling was found throughout the inflammatory area in the dermoepidermal 
junction and superficial dermis. PCV2 and PPV DNA were detected occasionally in 
macrophages in lymphoid tissues. The authors concluded that PCV2 and PPV are highly 
prevalent in pigs with exudative epidermitis (Kim and Chae, 2004b). 
 
Factors that play a Role in PCV2-associated Diseases 
Coinfections 
a. Porcine parvovirus (PPV)  
Ellis et al. (1999) reproduced most of the lesions typical of PMWS in gnotobiotic pigs 
inoculated with filtered cell culture material and filtered lymphoid tissues from pigs with 
naturally acquired PMWS. Both PCV2 and PPV and antibodies to these viruses were 
detected in the experimentally-inoculated pigs. Since then, several groups have demonstrated 
that CD pigs dually-inoculated with PCV2 and PPV develop more severe disease and lesions 
than pigs with singular PCV2 infection (Allan et al., 1999a; Kennedy et al., 2000). Krakowka 
et al. (2000) further confirmed the synergistic effect of PCV2 and PPV in gnotobiotic pigs by 
reproducing clinical disease and lesions typical of PMWS in coinfected pigs but not in pigs 
infected with PCV2 or PPV alone. Kim et al. (2003a) coinfected twenty-four 28-day-old CD 
pigs with a Korean PCV2 isolate and PPV and observed clinical PMWS in all pigs. 
Opriessnig et al. (2004a) were able to demonstrate the development of PMWS in 
conventional SEW pigs coinfected with PCV2 and PPV. The mortality in PCV2/PPV-
infected pigs was 6.7%, which is similar to PMWS-associated mortality in affected herds in 
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the US. Hasslung et al. (2005) reproduced PMWS in Swedish and Danish CD pigs 
concurrently infected with PCV2 and PPV at 3 days of age. Ostanello et al. (2005) coinfected 
eight 3-week-old conventional pigs confirmed to have passively acquired antibodies to PPV 
and PCV2 oronasally and intramuscularly with PPV and PCV2. Half of the pigs (4/8) were 
vaccinated with a commercial APP vaccine at 3 DPI. None or the pigs developed clinical 
disease and all pigs were necropsied at 42 DPI. It was found that passive immunity against 
PCV2 can prevent PMWS but it can not prevent subclinical PCV2 infection (Ostanello et al., 
2005). 
b. Porcine reproductive and respiratory syndrome virus (PRRSV) 
Allan et al. (2000a) inoculated 1- to 2-day-old CD pigs with PCV2 and PRRSV and 
observed upregulation of PCV2 replication in coinfected pigs. However, the replication and 
distribution of PRRSV in concurrently infected pigs was not enhanced compared to that 
observed in single PRRSV infected pigs (Allan et al., 2000a). Harms et al. ( 2001) coinfected 
3-week-old CDCD pigs at three weeks of age with PCV2 and PRRSV and showed that 
PCV2-infection increased the severity of PRRSV-induced interstitial pneumonia in CDCD 
pigs. Rovira et al. (2002) inoculated 5-week-old conventional pigs with PRRSV and seven 
days later with PCV2 and confirmed that PRRSV infection enhances PCV2 replication. A 
longer duration of PRRSV viremia and a higher proportion of viremic pigs were observed in 
the coinfected pigs compared to singular PRRSV infected pigs (Rovira et al., 2002). Chung 
et al. (2005) coinfected 10-week-old conventional pigs with PRRSV and PCV2 and injected 
a portion of the pigs with formalin-inactivated Salmonella choleraesuis and complete 
Freund’s adjuvant one week before inoculation. It was found that PRRSV was significantly 
upregulated by the Salmonella treatment whereas PCV2 was not (Chung et al., 2005). A 
recent in vitro study using swine alveolar macrophages found that PCV2-induced interferon-
alpha reduced PRRSV infection and PRRSV-associated cytopathic effect (Chang et al., 
2005). Subclinical infection of SPF pigs with PCV2 14 days before modified live PRRSV 
vaccination resulted in significantly (P > 0.05) increased PRRSV-induced macroscopic lung 
lesions after PRRSV challenge (Opriessnig and Halbur, 2005b). Evidence of interaction of 
PCV2 with the attenuated vaccine strain of PRRSV was lacking (Opriessnig and Halbur, 
2005b).   
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c. Mycoplasma hyopneumoniae 
Conventional pigs were inoculated intratracheally with M. hyopneumoniae at 4 weeks of age 
followed by intranasal inoculation with PCV2 at 6 weeks of age (Opriessnig et al., 2004c). 
Four of 17 (23.5%) dual-infected pigs had decreased growth rate and severe lymphoid 
depletion and granulomatous lymphadenitis associated with high amounts of PCV2-antigen 
consistent with PMWS. M. hyopneumoniae potentiated the severity of PCV2-associated lung 
and lymphoid lesions, increased the amount and prolonged the presence of PCV2-antigen, 
and increased the incidence of PMWS in pigs (Opriessnig et al., 2004c). 
 
Immunostimmulation 
Studies have demonstrated that immune stimulation may trigger progression of PCV2 
infection to disease and lesions characteristic of PMWS. Krakowka et al. (2001) reproduced 
PMWS in gnotobiotic pigs stimulated with KLH/ICFA and infected with PCV2. Allan et al. 
(2000c) observed PMWS in 21% of PCV2-infected and vaccinated (M. hyopneumoniae at 13 
and 31 days of age, and APP at 47 days of age) colostrum-fed pigs. Opriessnig et al., (2003) 
demonstrated enhanced PCV2 replication manifest as significantly longer PCV2 viremia, a 
higher copy number of PCV2 genome in serum, a wider range of tissue distribution of PCV2 
antigen, and an increased severity of lymphoid depletion in conventional pigs vaccinated 
with commercial APP and M. hyopneumoniae vaccines compared to PCV2-inoculated, 
unvaccinated pigs. A study testing the effect of different adjuvants on PCV2-associated 
lesions found that oil-in-water adjutants increased the length of PCV2-viremia, increased the 
amount of PCV2 in serum and tissue, and increased the severity of lymphoid depletion 
compared to aqueous and aluminum hydroxide adjuvanted products (Hoogland et al., 2006). 
These experimental models suggest that immune stimulation in the form of adjuvanted 
vaccines may in some cases increase the incidence and severity of PMWS in PCV2-infected 
pigs. Field trials also support this hypothesis. Vaccination of piglets with a M. 
hyopneumoniae bacterin at 1 and 4 weeks of age resulted in a significant increase in losses 
associated with PMWS in the vaccinated pigs in two of five batches (Allan et al., 2001). 
Kyriakis et al. (2002) vaccinated a portion of the pigs in a herd experiencing a PMWS 
outbreak with a M. hyopneumoniae vaccine and observed PMWS in 43% of the vaccinated 
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pigs compared with 11% of the non-vaccinated pigs. Vanderstichel et al. (2003) conducted a 
field trial in herds affected by PMWS. The authors used different adjuvanted M. 
hyopneumoniae products (two oil-in-water adjuvanted M. hyopneumoniae bacterins and one 
aluminum hydroxide adjuvanted bacterin). It was found that a higher number of the pigs 
treated with aluminum hydroxide developed PMWS compared to pigs treated with saline or 
with the oil-in-water adjuvant. It was concluded that the immunostimulation from the 
aluminum hydroxide adjuvant may have facilitated the development of clinical disease 
(Vanderstichel et al., 2003). 
In contrast, another recent study using conventional pigs failed to demonstrate an 
immune-stimulation dependent difference in pigs inoculated with PCV2 and stimulated with 
KLH/ICFA (Ladekjær-Mikkelsen, 2002). Resendes et al. (2004) used a control group, a 
vaccine adjuvant group, a PCV2-infected group, and a group infected with PCV2 and 
injected with a vaccine adjuvant. The authors found no differences between groups 
(Resendes et al., 2004). Harvey (2003) reported on observational studies on two farms known 
to be infected by PMWS and found no significant difference between vaccinated and 
unvaccinated groups in terms of overall mortality rates or development of clinical PMWS.  
 
Immunosuppression 
Krakowka et al. (2002) infected 12 gnotobiotic pigs with PCV2 at one day of age. In 
addition, 4 pigs received cyclosporine orally on a daily basis, and 4 pigs received 
corticosteroid (triamcinolone aceonide suspension) intramuscularly twice a week. The 
cyclosporine treatment but not the corticosteroid treatment resulted in increased PCV2 
replication in tissues and promoted spread of PCV2 to hepatocytes. Inflammatory reactions 
typically of PMWS were absent although tissues contained high titer of virus (Krakowka et 
al. 2002). Kawashima et al. (2003) inoculated CDCD pigs intransally and intraperitoneally 
with PCV2 (n = 7) and treated 3 of 7 PCV2-infected pigs with dexamethasone at 8 days of 
age. The authors were able to produce granulomatous lyamphadentits in PCV2 and 
dexamethasone treated pigs but not in pigs infected with PCV2 alone suggesting that 
immunosuppression of the host has an effect on development of PMWS (Kawashima et al., 
2003). 
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Age 
PMWS is observed most often in pigs between 5 and 18 weeks of age with most cases 
occurring between 6 and 10 weeks of age. Reports of PMWS in adult pigs are rare. PCV2-
associated lesions are typically observed from 14 to 35 days post PCV2 inoculation in 
experimental studies. This suggests that pigs in the field are most likely infected between 1 
and 10 weeks of age. Studies investigating the influence of age on PCV2-infection are 
lacking. In experimental models described to date in the literature, pigs that were singularly-
infected with PCV2 (no coinfection or immune stimulation) and developed clinical PMWS 
were between 1-21 days of age when inoculated. PMWS in older pigs was observed only in 
purebred Landrace pigs (35-39 days of age) (Opriessnig et al., 2006a) or with additional 
coinfections or immune stimulation (i.e. vaccination).  
 
Gender 
Corrégé et al. (2001) collected data on PMWS over a 1-year period on a French pig 
farm and found that castrated male pigs were more susceptible to PMWS than females (38% 
versus 29%). In this study, the prevalence of PMWS was estimated by evaluating all dead 
pigs, recording clinical signs, and by regularly weighing the pigs (15-day-intervals during the 
first two month). Rodríguez-Arrioja et al. (2002) followed 250 3-week-old piglets (121 
females, 106 castrated male, and 23 intact males) from a PMWS-affected farm up to 28 
weeks of age and observed a difference in mortality between males and females. Males 
appeared to be at a higher risk of dying and it was concluded that this was likely due to an 
effect of castration associated with secondary infections. 
 
Host susceptibility 
Madec et al. (2000) found that 42% of the litters in PMWS herds were not affected 
but 16% of the litters accounted for 54% of the losses. This is indicative of a litter effect and 
increased susceptibility to PCV2-associated PMWS in some pigs.  
A cohort study was conducted to investigate a suspected decreased susceptibility to 
PCV2-associated disease in Pietrain pigs by manipulating the genetics via artificial 
insemination on 4 PMWS-affected farms (Rose et al., 2004). Half of the sows were 
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inseminated with Pietrain semen whereas the remaining sows received the semen that was 
typically used on these farms. The PCV2-associated disease in the Pietrain-offspring did not 
differ from that observed in other pigs on these farms in terms of PCV2-seroconversion, 
morbidity, and mortality (Rose et al., 2004).  
Allan et al. (2002a, 2003) reproduced PMWS in Northern Irish Large White/Landrace 
pigs experimentally infected with a porcine PCV2 isolate recovered from a clinically normal 
Swedish Yorkshire pig in 1993. The authors concluded that there is disease potential of 
PCV2 isolated from regions free of PMWS and that the status of the host and its environment 
may be an important factor in the development of PMWS (Allan et al., 2002a, 2003).  
Duroc, Landrace, and Large White pigs were infected intranasally and 
intramuscularly at 5 to 7 weeks of age with PCV2 (Opriessnig et al., 2006a). Clinical disease 
compatible with PMWS was observed only in the Landrace pigs. Three of 19 Landrace pigs 
and none of the Duroc or Large White pigs developed severe lymphoid lesions associated 
with large amounts of intralesional PCV2-antigen typical of PMWS. In this experiment, 23 
Duroc pigs (4 sires, 8 dams), 19 Landrace pigs (4 sires, 6 dams), and 21 Large White pigs (4 
sires, 6 dams) were inoculated with PCV2. The results suggest a predisposition of the 
Landrace pigs used in this study to PCV2-induced disease and lesions (Opriessnig et al., 
2006a).  
McIntosh et al. (2005) tested 43 boars for presence of PCV2 DNA in semen. Duroc 
and Landrace boars were found to be positive for PCV2-DNA in semen whereas Large White 
and Meishan synthetic breeds were not observed to shed PCV2 DNA.  
Zhou et al. (2006) looked at seroprevalence of PCV2 in 46 swine farms in Zhejian, 
China, and found that 44.83% of all Landrace sows and 64.28% of all Landrace piglets were 
positive for PCV2-antibodies. The seroprevalence of Landrace sows was higher than that of 
Yorkshire and Duroc sows. 
López-Soria et al. (2004) compared the effect of 3 different genetic boar lines on 2 
different Spanish farms on the outcome of general and PCV2-associated postweaning 
mortality. There was a significant effect of genetics on the expression of PCV2-associated 
diseases observed on both farms. Pigs with the paternal genetic backgrounds “A” (100% 
Pietrain) and “B” (50% Large White x 50% Pietrain) showed lower percentages of PCV2-
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associated disease than those with the paternal genetic background “C” (25% Large White x 
75% Duroc). However, due to the limited size of the study, it could not be concluded that the 
observed effect was due to a particular breed or line, or a particular boar (López-Soria et al., 
2004).  
Sibila et al. (2005) quantified and compared the PCV2 load in serum of naturally-
infected pigs at different ages in two Spanish farms affected by PMWS with three different 
paternal genetic backgrounds (A=100% Pietrain; B=50% Large White x 50% Pietrain, and 
C=25% Large White x 75% Duroc). PMWS-associated mortality occurred mainly between 9-
15 weeks of age and was related with the highest viral loads. A significant relationship 
between the paternal genetic background C and higher PCV2 viral loads in serum was 
observed in one farm (Sibila et al., 2005).   
 
Antibody levels 
In a field trial on a farm with a severe PMWS problem, the piglets of 8 sows were 
followed until 12 weeks of age. None of the piglets derived from the dams with highest 
PCV2-antibodies developed PMWS, and 60% of the piglets that did develop PMWS were 
derived from the dams with the lowest PCV2 serum antibody levels (Allan et al., 2002b). 
Another European field study investigated the effect of the sow on PMWS in a cohort study 
in 3 sow herds with a high postweaning mortality due to PMWS (Hassing et al, 2003). A 
total of 1,183 piglets derived from 125 sows were included in this study. It was found that the 
offspring from sows with high antibody levels against PCV2 at farrowing had a higher risk of 
dying after weaning. The risk of dying was also dependent on increasing IPMA titers against 
PCV2 from weaning until 4 weeks after weaning (Hassing et al., 2003).  
Harms et al. (2002b) used a total of 124 pigs with highly variable PCV2-antibody 
titers and inoculated 51/124 with PCV2 and coinfected 47/124 with PRRSV and PCV2 at 
different ages (3, 6 and 11 weeks of age). Piglets with a PCV2 ELISA S/P ratio of 0.6 were 
protected by PCV2 replication and development of PMWS (Harms et al., 2002b).  
Allan et al. (2002b) published an experimental study in which ten piglets derived 
from 2 dams with high PCV2 titers (determined by IFA) and ten piglets derived from 2 dams 
with low PCV2 titers were weaned at 2 days of age and infected with PCV2 at 3 weeks of 
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age. Piglets derived from the low PCV2 titer dams had significantly reduced daily weight 
gain and a higher incidence of PCV2 antigen in lymphoid tissues as determined by IHC 
(Allan et al., 2002b).  
Fenaux et al. (2004a) demonstrated that pigs vaccinated with PCV2 and challenged 
with the same strain were protected. McKeown et al. (2005) determined the effects of PCV2 
maternal antibodies on the immune response to experimental PCV2 infection. Twenty-four 
piglets were divided into 4 groups on the basis of the ELISA titers of PCV2 maternal 
antibodies: group A (n = 6; negative), group B (n = 5; low antibody levels), group C (n = 8; 
high antibody levels), and group D (n = 5; high antibody levels). Piglets in groups A, B, and 
C were inoculated with PCV2 at 0 DPI and challenged with PCV2 at 42 DPI. Group D pigs 
were not exposed to PCV2 at 0 DPI but were challenged at 42 DPI. The authors concluded 
that protection against PCV2 infection conferred by maternal antibodies is titer dependent: 
higher titers are generally protective, but low titers are not (McKeown et al., 2005). 
Pigs that have a lower birth and weaning weight are more frequently affected by 
PMWS (Corrégé et al., 2001) and 7 of 10 pigs in a PMWS affected herd with insufficient 
colostral transfer as defined by refractometer reading did not survive to weaning (Moll 2004). 
Unfortunately, PCV2 antibodies in the piglets or dams were not determined in those studies. 
By using the gnotobiotic pig model, Meerts et al. (2005c) found that variation in the 
onset of adaptive immunity may account for variation in PCV2 replication in pigs. In 
particular, absence of PCV2 neutralizing antibodies may be an important factor in the 
development of a increased virus replication (Meerts et al., 2005c). 
 
PCV2 isolates 
Molecular studies to determine the genetic variation of PCV2 found that minor 
branches of PCV2 were associated with geographic origin rather than with differences in 
viruelence (Fenaux et al., 2000; Mankertz et al., 2000). Meehan et al. (2001) investigated 
PCV2 isolates from cases of PDNS and abortions and found the isolates being closely related 
to a PMWS-associated PCV2 further establishing the apparent genetic stability of PCV2. 
Mahé et al. (2000) identified four dominant immunoreactive areas by PEPSCAN analysis 
within ORF2. Larochelle et al. (2002) sequenced 34 Eastern Canadian PCV2 isolates 
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recovered from 5- to 20-week-old pigs with various clinical conditions such as PMWS (15 
isolates), PRRS (8 isolates), generalized tremors (5 isolates), erysipelas (1 isolate), gastric 
ulcer (1 isolate), nervous signs (1 isolate), arthritis (1 isolate), and no clinical signs (1 isolate) 
and compared the obtained sequences to 36 published sequences. Sequence analysis 
indicated that all the isolates were closely related. Three major regions of amino acid 
heterogeneity were identified among PCV2 isolates, and two of the regions corresponded to 
two of the immunoreactive areas described by Mahé et al. (2000). Comparison of three 
immunodominant regions however, revealed no link between capsid protein variation and 
pathogenicity of isolates (Larochelle et al., 2002).  
Larochelle et al. (2003) compared PCV2 from PMWS-affected herds to PCV2 from 
healthy pigs from herds non-affected by PMWS and found closely related strains in 6 
different herds (4 with PMWS and 2 without) sharing at least 99.4% of their nucleotide-
sequence identity and more than 98.7% of their amino-acid identity for the capsid protein. 
One strain identified in a herd without PMWS was found to be 100.0% homologous to a 
PCV2 from a PMWS herd (Larochelle et al., 2003). De Boisséson et al. (2004) used 31 pigs 
originating from 13 PMWS-affected herds and 25 pigs from 10 PMWS fee herds and 
sequenced 38 PCV2 isolates. All the isolates shared 94.2-100% nucleotide identity. A wider 
nucleotide diversity was observed in the PCV2 isolates originating from PMWS free herds 
compared with isolates from PMWS herds; however, residues found to be specific to non-
PMWS strains were also found in PMWS strains and no molecular marker of virulence in 
PMWS strains could be identified (de Boisséson et al., 2004). Sequence analysis of a PCV1 
associated with congenital tremor in 1960 and two PCV2 isolates associated with recent 
cases of congenital tremors demonstrated that the PCV2 isolates showed 99% sequence 
identity with each other and also with other PMWS-isolates (Choi et al., 2002b). No 
consistent genomic differences between PMWS and recent congenital tremor isolates were 
found. The 1960 PCV1 isolate showed 98% similarity to other PCV1 isolates (Choi et al., 
2002b). In a case control study done by Pogranichniy et al. (2002) PCV2 was not only found 
in PMWS cases but also in 62.5% of the control cases. Sequencing and genetic comparison 
revealed no differences between 5 PMWS-associated PCV2 isolates and 4 PCV2 isolates 
recovered from cases not associated with PMWS (Pogranichniy et al., 2002).  
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In contrast, Wang et al. (2004) comparing the ORF2 of Taiwanese PCV2 isolates 
associated with PMWS (4 isolates), PDNS (2 isolates), nervous signs (1 isolate), abortion (1 
isolate) found a small number of residue difference associated with the different clinical 
conditions. Farnham et al. (2003) further characterized 2 PCV2 isolates associated with 
abortions by ORF2 sequencing and found that the isolates were almost identical to each other 
and to other isolates associated with reproductive failure whereas there were at least 2 amino 
acid differences to PCV2 isolates associated with PMWS. Recently it has been demonstrated 
that two amino acid changes in the PCV2 capsid protein that occurred during serial in vitro 
passage enhanced the ability of PCV2 to grow in vitro and attenuated the virus in vivo 
(Fenaux et al., 2004b). Furthermore, we recently compared field isolates of PCV2 recovered 
from a case with moderate-to-severe PCV2-associated lesions to a PCV2 isolate from a case 
with no PCV2-associated lesions and demonstrated significant differences in incidence and 
severity of PCV2-induced lesions and in amount of PCV2 virus in the serum and tissues of 
experimentally-inoculated SPF pigs (Opriessnig and Halbur, 2005).  
Delay et al. (2005) reported on markedly increased incidence and severity of porcine 
circovirus type 2 (PCV2)-associated disease in eastern Canada since January 2005. PCV2 
strains isolated from these outbreaks appear to be different from the resident PCV2 strains 
that have been in the region for the last 10-15 years. There is a dramatic increase of 
restriction fragment length polymorphism (RFLP) type 321 strains, whereas the most 
common PCV2 strain had been type 422. Sequencing and comparison of the ORF2 gene of 
the recent 321 strains showed high homology with French isolates (99%) but only 95% 
sequence identity with pre-2005 strains from eastern Canada.  
  
Diagnosis 
Detection of anti-PCV2 antibodies 
a. Indirect immunofluorscence assay (IFA)
This assay detects the ability of the antibody in the serum to bind to a fixed 
monolayer of virus-infected cells. The specific antibodies are labeled with fluorescein-
conjugated anti-swine-IgG. IFA assays for PCV2 have been described in the literature (Allan 
et al., 1998b; Pogranichnyy et al., 2000; Tischer et al, 1995a). Recently, an IFA assay based 
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on an ORF2 protein has been described (Racine et al., 2004) and it was found that the regular 
whole PCV2-based IFA had only a 57.1% relative sensitivity compared to the ORF-2 protein 
based IFA. IFAs have also been described for antibodies against non-pathogenic PCV1 
(Fenaux et al., 2003) and appear to be specific. Studies have shown that there is a low level 
of cross-reactivity between PCV1 and PCV2 on IFA test (Allan et al., 1998b, Pogranichnyy 
et al., 2000).
b. Indirect immunoperoxidase monolayer assay (IPMA)
The IPMA is similar to the IFA with the exception that the antibody used is a 
peroxidase-conjugated anti-swine IgG. IPMA for PCV2 is widely used (Ellis et al., 1998; 
Balasch et al., 1999). An interlaboratory testing comparing IFA and IPMA results on the 
same 20 serum samples performed in different laboratories in Europe and Canada found a 
wide variation in detected titers between laboratories (NcNair et al., 2004). In general, IPMA 
gave higher titers than IFA, and paraformaldehyde used as fixative gave higher titers than did 
acetone or ethyl alcohol (McNair et al., 2004). 
c. Enzyme-linked immunosorbent assay (ELISA)
There are several peer-reviewed articles describing PCV2 ELISA assays (Blanchard 
et al., 2003b; Liu et al., 2004; Nawagitgul et al., 2002). Recently, commercially available 
IgG and IgM PCV2-ELISA assays have been introduced in Europe (Ingezim PCV IgG® and 
Ingezim PCV IgM®, Ingenasa, Madrid, Spain). Combined IgG and IgM values might be 
useful to determine the timing of PCV2-infection: IgM values ≥ IgG values: early active 
infection (within the first 21 DPI); IgM values < IgG values: active infection (approximately 
between 20 to 50 DPI); High IgG values and negative IgM values: late or resolving infection 
of convalescent (approximately 2 months after infection) (Segalés et al., 2005b). A variant of 
the regular ELISA assay is the competitive (blocking) ELISA (Walker et al., 2000). A 
competitive ELISA specific for PCV2-antibodies is available in Europe (Synbiotics, Europe, 
Lyon, France). An antibody-detection blocking ELISA to detect PCV2-specific antibodies on 
feces is also described (Lopez et al., 2005) and is commercially available in Europe 
(Synbiotics Europe, Lyon, France). 
d. Serum-virus neutralization (SVN) assay
The basis of the SVN assay is that it detects the presence of antibodies that have the 
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ability to prevent virus from attaching to and/or infecting cells. Neutralizing antibody assays 
for PCV2 have been described in the literature (Meerts et al., 2006, 2005c; Pogranichnyy et 
al., 2000). Neutralizing antibodies were detected between 15 (Meerts et al., 2005c) and 28 
(Pogranichnyy et al., 2000) days post PCV2-infection and were correlated with protection or 
clearance of PCV2 infection in gnotobiotic pigs (Meerts et al., 2005c).  
 
Detection of PCV2 nucleic acids  
a. Polymerase chain reaction (PCR) 
There are several PCR assays for the detection of PCV2-specific nucleic acids 
described in the literature (Choi et al., 2000; Grierson et al., 2004b; Hamel et al., 2000; 
Morozov et al., 1998; Shibata et al., 2003). Variants of the regular PCR assay include the 
following:  
Multiplex PCR. More than one target sequence is detected in a single PCR step. The 
following multiplex PCR assays have been described in the literature: PCV2/PCV1 
(Pogranichnyy et al. 2000; Ouardani et al., 1999), PCV2/PPV (Kim et al., 2001a), and 
PCV2/pseudorabies virus/PPV (Huang et al., 2004).  
Nested PCR. To increase the ability to detect very small amounts of the target 
sequence the PCR assay is done in two steps. The first step generates a product that serves as 
template for the second step (Kim and Chae, 2001b; Kim and Chae, 2004a, Larochelle et al., 
2000). 
Multiplex-nested PCR. This assay combines multiplex and nested PCR and is 
designed to detect very small amounts of several target sequences. Assays have been 
described for the simultaneous detection of PCV1/PCV2/PPV Kim et al., 2003c; Kim and 
Chae, 2003a) and PCV1/PCV2 (Kim et al., 2001b). 
Quantitative real time PCR. Quantitative real-time PCR-assays have been developed 
and these assays allow for determination of the amount of PCV2 genomic copy numbers in 
the serum or tissues. PCR reaction and detection are combined in one step which decreases 
the turn-around time (Brunborg et al., 2004; Chung et al., 2005, Ladekjær-Mikkelsen, 2002; 
Liu et al., 2000; Olvera et al., 2004; Opriessnig et al., 2003; Rovira et al., 2002)  
Reverse transcriptase (RT-) PCR. This is used to detect PCV2 RNA which is only 
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present if PCV2 replicates (Yu et al., 2005). Reverse transcription of RNA is required to 
make a complementary DNA for further amplification.  
Most pigs in the field (healthy or diseased pigs) are infected with PCV2 at some point 
in their lives. Therefore the use of PCR, which theoretically can detect one genomic copy, is 
considered by many to be too sensitive for most applications. One notable exception may be 
the detection of PCV2-nucleic acids in semen. PCR assays to detect PCV2 in semen have 
been described (Larochelle et al., 2000; Kim et al., 2003c; Kim et al., 2001b); however, the 
infection dose required to transmit PCV2 infection via semen is unknown.  
The amount of PCV2 nucleic acids in serum and tissues has been demonstrated to be 
predictive of the clinical outcome which might be an application for quantitative real-time 
PCR on individual pigs (Brunborg et al., 2004; Olvera et al., 2004). Those pigs with 107 or 
greater PCV2 genomic copies per milliliter of serum likely have PCV2-associated lymphoid 
lesions and disease (Brunborg et al., 2004).
b. In-situ-hybridization (ISH)
ISH for PCV2 uses a labeled DNA probe that corresponds to a specific portion of the 
PCV2-genome (Kim and Chae, 2003b; McNeilly et al., 1999; Rosell et al., 1999; 
Sirinarumitr et al., 2000). Hybridization is usually done over night and followed by a color 
reaction. This method allows localization of PCV2 but the method in general is time 
consuming (over night hybridization step) and the reagents are expensive. Several ISH 
assays that detect multiple viruses within the same tissue section have been described: 
PCV1/PCV2 (Kim and Chae, 2001a; Nawagitgul et al., 2000b) PCV2/PRRSV (Choi and 
Chae, 2001; Sirinarumitr et al., 2001), and PCV2/PPV (Choi and Chae, 2000; Kim and Chae, 
2002). 
 
Detection of PCV2 virus or viral antigen 
a. Immunohistochemistry (IHC)
IHC uses polyclonal antibody to detect PCV2 antigen in formalin-fixed, paraffin-
embedded tissue sections (McNeilly et al., 1999; Sorden et al., 1999). This method allows 
localization of the antigen within a tissue section. It has been determined that an estimated 
minimum viral load of 108 PCV2 genomes per 500 ng DNA was required to give visible 
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staining in IHC (Brunborg et al., 2004). A comparison of ISH and IHC on tissues from 
diseased pigs that were stored for up to 6 month in 10% neutral buffered formalin before 
being embedded in paraffin found that both techniques were able to detect antigen or nucleic 
acids in all tissues examined (McNeilly et al., 1999). ISH was found to be more specific than 
IHC especially when compared to IHC performed with polyclonal antibodies (Kim and 
Chae, 2004a).  
b. Virus isolation (VI)
PK-15 cells support PCV2-replication in vitro and these cells can be inoculated with 
body fluids or homogenate from pigs suspected to be infected with PCV2 (Pogranichnyy et 
al., 2000). Glucosamine treatment of the cells has shown to be effective in increasing PCV2-
replication (Tischer et al., 1987). A PCV2-induced cytopathic effect is typically not observed 
and in order to determine viral replication, immunofluorescent or immunoperoxidase staining 
has to be performed. VI is not routinely done for PCV2 because it is time consuming and not 
always efficient since viable virus is required and prolonged transit time and autolysis can 
have negative effects. Applications may include determining if PCV2 shed in semen is 
infectious. Another version of virus isolation is the quantitative virus isolation (McNeilly et 
al., 1999). For this assay, 10-fold dilutions of clinical specimens (serum, tissue homogenates) 
are inoculated on PK-15 cells. This test has been found useful in discriminating subclinical 
PCV2-infection from clinical PCV2-infection (McNeilly et al., 1999).
c. Indirect and direct fluorescent antibody assays (IFA/FA) on tissue sections
IFA/FA uses a monoclonal antibody or polyclonal antiserum to detect antigen(s) in 
frozen tissue sections (McNeilly et al., 2002). The assay is fast but antigen can not be 
confidently associated with lesions and the assay is relatively subjective. Studies using 
polyclonal antisera and monoclonal antibodies against PCV1 and PCV2 isolates on cells 
infected with either PCV1 or PCV2 have shown that there was no cross-reaction (Allan et al., 
1999b).   
d. Antigen-capture ELISA
Antigen-capture ELISA on tissue homogenates has been described and the results 
were found to be comparable to quantitative virus isolation and IHC (Allan et al., 2000b). An 
antigen detection capture ELISA optimized for fecal samples was also developed (Synbiotics 
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Europe, Lyon, France) and tested on samples with and without a history of PMWS (Lopez et 
al., 2005). The main advantage of this kit is that fecal samples are readily available. In 
contrast, PCV2 is not always detected in serum, bleeding pigs might be inconvenient, and 
PCR on large numbers of samples is expensive. 
e. Electron microscopy (EM)
This method is used to demonstrate circovirus-like particles directly within a cell and 
to study the virus structure and size. Intracytoplasmic inclusions in macrophages in affected 
lymph nodes have been shown to be electron dense, round to ovoid bodies with sharp 
margins. The matrix was described as being heterogenous, with different areas being 
granular, crystalline in a herringbone pattern or crystalline in cross-sectional arrays on non-
enveloped, small, icosahedral-viral particles (Kiupel et al., 1998). EM is not routinely done 
in diagnostic labs because it is time consuming and expensive. The overall sensitivity is low 
and there has to be an abundance of virus present in the tissue in order to be detectable by 
EM. 
 
PCV2-associated microscopic lesions 
PCV2-associated disease diagnosis can not be done without evaluation of 
microscopic lesions. The hallmark lesions in growing pigs are lymphoid depletion and 
histiocytic replacement of follicles in lymphoid tissues and granulomatous inflammation in a 
variety of organs such as liver, kidney, lungs, heart and intestines (Sorden, 2000). Chianini et 
al. (2003) described three stages in pigs with naturally occurring PMWS. Stage I is 
characterized by mild lymphoid depletion and mild histiocytic infiltration with few 
multinucleated giant cells mainly in germinal centers of follicular areas of lymphoid tissues. 
Stage II is characterized by moderate lymphoid depletion of follicles in lymphoid tissues 
with moderate histiocytic infiltration. Stage III is characterized by loss of follicles in 
lymphoid tissues and by marked histiocytic replacement of such areas (Chianini et al., 2003). 
Sarli et al. (2001) described the (1) initial stage: remnants of lymphoid follicles are present, 
(2) intermediate stage: absence of lymphoid follicles and a more extensive depletion of 
interfollicular tissue, and (3) end stage: absence of follicles, lymphoid cell depletion and 
medulla-like tissue prevalence over the lymphoid tissue. In aborted fetuses, the hallmark 
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lesion is necrotizing to necrotizing and lymphohistiocytic myocarditis. Determining if PCV2-
associated microscopic lesions are present or not is critical for the diagnosis of PMWS 
(Sorden, 2000). 
 
Further characterization of the PCV2 isolate 
a. Sequencing 
With sequence analysis it is possible to characterize the genetic information and 
compare isolates to each other (Choi et al., 2002b; De Boisséson et al., 2004; Fenaux et al., 
2000; Grierson et al., 2004; Kim and Lyoo, 2002; Mankertz et al., 2000). To further 
investigate possible differences among PCV2 isolates it is possible to sequence the entire 
PCV2 genome or to sequence only ORF2. At this point in time, sequencing results may be a 
useful epidemiological tool but the knowledge to determine virulence based on sequence 
information is not yet available.  
b. Restriction fragment length polymorphism (RFLP)
RFLP uses enzyme digestion of viral nucleic acid (partial or whole) which results in a 
specific cutting pattern that is visualized on a gel. If there are differences between viruses at 
the site of enzyme cutting, different patterns can be observed. This fingerprinting technique 
has been commonly used for DNA viruses. An ORF2 based PCR-RFLP assay described in 
2000 using HinfI, HinP1I, KpnI, MseI, and RsaI enzymes is able to distinguish among PCV2 
isolates (PCV2A, B, C, D, and E) (Hamel et al., 2000). A PCR-RFLP assay using NcoI 
enzyme that differentiates between PCV1 and PCV2 was described in 2000 (Fenaux et al., 
2000). An ORF2 based PCR-RFLP assay using Sau3AI, BanII, NspI, XbaI, and CfrI 
enzymes has been described recently and is able to distinguish 9 different PCV2 genotypes 
(Wen et al., 2005). PCV2 RFLP analysis showed that there was a significant change from 
RFLP type 422 to type 321 in 2005 in Ontario, Canada (Delay et al., 2005). 
 
Control of PCV2-associated Diseases 
Good management practices 
Successful treatment and control of PMWS has primarily focused on assuring good 
production practices that minimize stress, eliminating coinfections or minimizing their effect 
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and eliminating potential triggering factors that induce immune stimulation. Madec et al. 
(2000) emphasized the role of the environment on development of PMWS within a herd. The 
focus on control of PCV2-associated diseases remains on improving pig comfort and 
minimizing the effect of those coinfections or other circumstances that trigger PCV2 
infection to progress to PCV2-associated disease. Madec et al. (1999) proposed a 20-point 
plan against PMWS in severely affected farms. This plan includes recommendations for the 
farrowing units (1) application of strict all-in and all-out rules with thorough cleaning and 
disinfecting between batches, (2) sows should be washed and treated for parasites before 
farrowing, (3) cross-fostering should be limited; (4) post-weaning pens should be small and 
separated by solid partitions, (5) pits should be emptied, cleaned and disinfected on a regular 
basis, (6) the stock density should be lowered to 0.33 m2 per pig, (7) the feeder space should 
be increased to more than 7 cm per pigs, (8) the air quality should be improved so that NH3 < 
10 ppm, CCO < 0.1%, and RH < 85%, (9) the temperature should be controlled, (10) there 
shouldn’t be any mixing of batches; (11) grow/finish pens should be small and separated by  
solid partitions, (12) the pigs should be emptied, cleaned and disinfected on a regular basis 
and strict all-in, all-out rules should be applied, (13) there should be no mixing of pigs from 
the post-weaning pens, (14) there should be no remixing between finishing pens, (15) the 
stock density should be lowered to > 0.75 m2 per pig, (16) the air quality and temperature 
should be improved. In addition, the following should be considered: (17) the vaccination 
program should be appropriate, (18) the air and animal flow within buildings should be 
carefully controlled, (19) strict hygiene should be applied (tail and teeth clipping, injections); 
and (20) sick pigs should be removed as soon as possible to a hospital room or should be 
euthanized. It is recommended that at least 16 of the points should be adopted in order for the 
plan to be effective (Madec et al., 1999). Usage of disinfectants in buildings and transport 
vehicles that have been demonstrated to be efficacious against PCV2 (Royer et al., 2001) is 
also recommended. 
Rose et al. (2003) reported on the risk factors for PMWS in French farrow-to-finish 
herds and found that things such as PPV or PRRSV coinfection of finishers, large pen size 
versus small pen size for weaners, and increased levels of cross-fostering increased the risk 
for PMWS; whereas long empty periods in the pig flow, regular treatment against external 
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parasites, pen versus crated gestation, and internal versus external gilt replacement decreased 
the risk for PMWS. López-Soria et al. (2005) did an exploratory study on risk factors for 
PMWS involving 62 Spanish farms and found that vaccination of gilts against PRRSV 
increased the odds of PMWS expression and vaccination of sows against atrophic rhinitis 
decreased odds of the disease.  
 
Control of coinfections 
a. M. hyopneumoniae
Chlortetracycline (CTC)-treatment used in the M. hyo-PCV2-coinfection model provided 
evidence that the CTC treatment is highly efficacious in reducing lesions associated with 
PCV2 and M. hyo coinfection (Halbur et al., 2005). At 6 weeks of age, pigs were inoculated 
intratracheally with M. hyopneumoniae, followed by intranasal inoculation with PCV2 at 8 
weeks of age. At 8 weeks of age, half of the pigs received a CTC feed additive at an 
approximate dose of 22 mg/kg. The CTC-treated and coinfected pigs had significantly less 
severe clinical disease, macroscopic and microscopic lung lesions compared to the non-
treated coinfected pigs.  
A recent study evaluated the losses or gains associated with the use of three different 
commercially available M. hyopneumoniae bacterins in pigs experimentally co-infected with 
M. hyopneumoniae and PCV2. Two hundred ninety-six M. hyopneumoniae-negative pigs 
were randomly assigned to one of four treatment groups. Three commercial vaccines, 
administered as per label direction, were tested: two bacterins containing an oil-based 
adjuvant and one bacterin containing an aqueous-based adjuvant. The M. hyopneumoniae 
challenge resulted in severe macroscopic and microscopic lesions in the non-vaccinated pigs. 
Pigs in all vaccine treatment groups had significantly higher mean body weight and average 
daily gain on 100 and 131 DPI, compared to the unvaccinated controls (Halbur et al., 2005).  
Furthermore, to minimize the enhancing effect of adjuvanted M. hyopneumoniae vaccine 
products on PCV2-replication and PCV2-assoicated lesions it has been shown that pigs 
should be vaccinated two to four weeks prior to expected PCV2 exposure (Opriessnig et al., 
2006b). 
b. Porcine parvovirus
 
 53
Rodibaugh (2002) described changing a lepto-parvo-erysipleas program from 
weaning to pre-farrowing in a herd with approximately 7-8% mortality due to PMWS. After 
intervention, the mortality rate declined to 2-3% (Rodibaugh, 2002).  
Conventional pigs were coinfected with PCV2 and PPV and the effect of PPV 
vaccination in reducing disease and lesions associated with PCV2/PPV coinfection was 
investigated (Opriessnig et al., 2004a). PPV vaccination was done 24 and 10 days before 
PCV2/PPV virus challenge with a killed PPV vaccine. Clinical signs consistent with PMWS 
(fever, respiratory disease, jaundice, weight loss) were seen in vaccinated and non-vaccinated 
PCV2/PPV coinfected pigs (Opriessnig et al., 2004a). 
 
PCV2-vaccines 
Vaccination of sows with an inactivated oil-adjuvanted PCV2-vaccine 
(CIRCOVAC®; Merial Inc.) in field conditions in Europe was beneficial in reducing the 
PCV2 circulation and shedding in the first weeks of life, but also in improving the pig health 
after an additional experimental PCV2 challenge at 3- 4 weeks of age (Charreyre et al., 
2005). Eleven gilts free of PCV2-antibodies were vaccinated with the PCV2-vaccine 
intramuscularly at 5 and 2 weeks before breeding and again at 2 weeks before farrowing. A 
group of 22 piglets born to 4 vaccinated gilts and a group of 22 piglets born to unvaccinated 
control gilts were inoculated with PCV2 intranasally at 3-4 weeks of age. Seroconversion 
was observed in piglets born to seronegative dams. PCV2 DNA in serum and mesenteric 
lymph nodes was significantly (P = 0.00002) lower in piglets born not vaccinated dams. In a 
field efficacy study, 3 groups of piglets were selected on farm and brought to the research 
facility. Group 1 pigs (n = 12) were born to unvaccinated sows, group 2 pigs (n = 10) were 
born to sows that had been vaccinated once with the PCV2-vaccine 2 weeks before 
farrwowing, and group 3 pigs (n = 11) were from a different farm and free of antibodies to 
PCV2. All piglets were infected intranasally with PCV2 at 25-47 days of age. Piglets born to 
non-vaccinated sows had a rise in PCV2 antibodies, whereas the PCV2-antibodies decayed in 
the pigs born to vaccinated sows. Lymph nodes were grossly unremarkable in this group 
whereas the lymph nodes were enlarged in the two other groups. During field efficacy studies 
of the PCV2 vaccine conducted in Germany and France it was found that there was a rise in 
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PCV2 antibody level in the breeder herds concurrently with a decrease in PMWS rates in the 
pigs originating from the farms (Charreyre et al., 2005). 
Pogranichniy et al. (2004) tested two inactivated US-PCV2 isolate preparations 
(ultraviolet irradiation or chemical inactivation) in the CDCD PCV2 PRRSV coinfection 
model and in the CDCD PCV2 KLH model using 57 piglets randomly assigned to 6 groups. 
Vaccination was done at 7 days of age and again 2 weeks later. PRRSV inoculation was done 
at 7 days of age. KLH with incomplete Freund’s adjuvant was infected at 21 and 27 days of 
age. At 24 days of age, the pigs were inoculated with PCV2. After PCV2 inoculation, the 
mortality in the vaccinated pigs was 20% whereas it was 70% in the non-vaccinated pigs 
implying that vaccination against PCV2 can be effective (Pogranichniy et al., 2004).    
It has been demonstrated that a chimeric PCV1-2 virus (with the immunogenic capsid 
gene of PCV2 cloned into the backbone of PCV1) induces an antibody response to PCV2 
capsid protein and is attenuated in pigs (Fenaux et al., 2003). The attenuated chimeric PCV1-
2 induced protective immunity to wild-type PCV2 challenge in pigs (Fenaux et al., 2004a). A 
total of 48 SPF pigs were randomly and equally assigned to 4 groups of 12 pigs each. Pigs in 
group 1-3 were vaccinated with the chimeric PCV1-2 and pigs in group 4 were not 
vaccinated and served as controls. At 42 days post vaccination, all pigs were challenged 
intranasally and intramuscularly with wild-type pathogenic PCV2. Mild-to-severe lymphoid 
depletion and histiocytic replacement were detected in lymphoid tissues in the majority of 
nonvaccinated group 4 pigs but in only a few vaccinated group 1-3 pigs (Fenaux et al., 
2004a) 
Blanchard et al. (2003a) found the ORF2 protein to be a major immunogen, inducing 
protection in a prime-boost protocol. Thirty-five, 25-day-old SPF pigs were divided into 5 
groups of seven piglets. Groups 1-4 piglets received an intramuscular injectin of DNA 
plamid preparation followed by a second injection 2 weeks later. Pigs were challenged 
intratracheally and intramuscularly with PCV2 10 days after the second injection. As 
evaluated by growth parameters, clinical signs and seroconversion, the pigs were protected 
against a PCV2 challenge after vaccination. In a second trial, sixty-four 4-week-old SPF pigs 
were divided into eight groups with eight pigs in each group. Piglets received either in 
intramuscular DNA injection or a intramuscular infection of baculovirus-expressed protein 
 
 55
followed by a booster injection 2 weeks later. The piglets were inoculated with PCV2 11 
days after second injection. The results indicated that protection induced by a subunit vaccine 
was even better than the one induced by a DNA vaccine, since PCV2 replication was 
completely inhibited (Blanchard et al. 2003a). 
Seven week old femal Balb/c mice were DNA vaccinated three times on the against 
PCV2 structural protein on 0, 30, and 52 days and seroconverted to PCV2 (Kamstrup et al., 
2004). The authors cloned a 768 bp fragment of the capsid protein of a Danish PCV2 isolate 
into the vector pcDNA1.1/V5-His/TOPO. The plasmid DNA was coated onto gold particles 
and used for particle mediated DNA vaccination. After 2 vaccinations, alls mice had 
seroconverted to PCV2. A PCV2 challenge was not done in this study (Kamstrup et al., 
2004). 
 
Serotherapy 
“Serotherapy” has been utilized extensively by some European practitioners to 
control and prevent PMWS; however, the literature reports of this technique are limited to 
abstracts describing uncontrolled field studies. In those trials, serum is obtained from healthy 
pigs from a group of pigs on the farm that went through PMWS 2-3 months prior. Recipient 
pigs are treated by subcutaneous (Ferreira et al., 2001) or intraperitoneal (Waddilove and 
Marco, 2002) injection of convalescent serum. With both protocols, a significant reduction of 
clinical disease and mortality was observed. Sick animals treated with serum had a 
significantly increased survival rate in Spain (48%) and in England (58%) compared with 
normal survival of below 10% on both farms (Waddilove and Marco, 2002). The overall herd 
mortality rate of growing pigs in three trials was reduced from 15-18% in untreated pigs to 2-
5% in treated pigs (Ferreira et al., 2001).  
A controlled study tested efficacy of serotherapy at minimizing PCV2-associated 
disease and lesions (Halbur et al., 2005). Serum from experimentally-infected pigs in the 
acute and convalescent stages of infection was used. In addition, serum from pigs with high 
levels of anti-PCV2 maternal antibodies was also used. These three serotherapy treatments 
were compared to a group that was vaccinated with an experimental PCV1-2 chimeric 
vaccine. All pigs were necropsied at 21 DPI. The group vaccinated with the chimeric vaccine 
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had significantly (P < 0.05) lower levels of viremia than all other groups and four of the 
seven pigs in this group remained PCV2 negative by PCR for the duration of the project. 
Under the conditions of this study, neither the acute- or convalescent-serotherapy were 
effective practices for preventing PCV2 infection and PCV2-associated lesions. The apparent 
success of serotherapy reported in European field trials remains unexplained. The 
experimental PCV1-2 chimeric vaccine appears to be effective, safe, and superior to 
serotherapy in reducing PCV2 infection and viremia (Halbur et al., 2005). 
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Summary 
Objective: To summarize procedures utilized to derive piglets negative both for porcine 
circovirus type 2 (PCV2) and for antibody to PCV2, from PCV2-positive breeding herds. 
Methods: Sow herds were screened for antibodies to PCV2 by ELISA, with sample-to-
positive (S:P) ratios ≥ 0.2 considered positive. Piglets were obtained by segregated early 
weaning (SEW) at 10 to 12 days of age. Maternal anti-PCV2 antibody was determined by 
testing weekly blood samples by ELISA and indirect immunoflorescence assay. Absence of 
PCV2 was determined by polymerase chain reaction (PCR) on weekly serum samples and by 
PCR and immunohistochemistry assays on lymphoid tissues collected at necropsy (8 to 15 
weeks of age). 
Results: Piglets negative for PCV2 by PCR and for anti-PCV2 antibody were derived from 
PCV2-positive breeding herds. Mean PCV2-antibody half-life in weanling piglets was 
estimated to be 19.0 days (95% confidence intervals, 17.6 and 20.3 days). Passively acquired 
PCV2-antibody present at 10 to 12 days of age declined to S:P ratios < 0.2  by 4.9 ± 1.2 
weeks of age in piglets with S:P ratios   0.2 and < 0.6; by 8.1 ± 1.9 weeks in piglets with S:P 
ratios ≥ 0.6 and < 1.0; and by 11.1 ± 2.5 weeks in piglets with S:P ratios   1.0. Pigs kept in 
isolation remained PCV2-negative by PCR and ELISA through 8 to 15 weeks of age.   
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Implications: SEW may be an effective technique to derive PCV2-negative piglets from 
positive breeding herds. 
Introduction 
Postweaning multisystemic wasting syndrome (PMWS) is a disease complex 
characterized by wasting and pneumonia in pigs 5 to 12 weeks old.1 The hallmark lesions of 
PMWS are lymphoid depletion and histiocytic replacement of follicles associated with 
porcine circovirus type 2 (PCV2) antigen.2 Transmission of PCV2 is thought to occur 
through direct contact via oronasal, fecal and urinary routes.3,4 Vertical transmission has been 
demonstrated in individual sows in the field5,6 and experimentally7. There is experimental3 
and field8,9 evidence that PCV2 may establish persistent infection in pigs.  
Serological surveys in England10 and North America11 found that nearly all swine 
herds are infected with PCV2. However, detection of antibodies to PCV2 is not necessarily 
indicative of disease prevalence. Diseases associated with PCV2, such as PMWS, are seen in 
a relatively low percentage of herds infected with PCV2.1 It has been reported that pigs with 
sample-to-positive (S:P) ratios of at least 0.6 in an ELISA, using as antigen an open reading 
frame 2 (ORF2) PCV2 capsid protein, are protected against infection by PCV2 and 
development of PMWS.12,13  
The study described here indicates that, under research conditions, pigs negative both 
for PCV2 and antibodies against ORF2 of the virus can be derived from PCV2-positive 
breeding herds. This information may be extrapolated to the field for purposes of 
establishment of PCV2-free herds.  
 
Materials and Methods 
Screening of breeding herds for PCV2 by ORF2 ELISA 
Screening of blood samples for PCV2-specific antibodies was performed using an 
ELISA based on a recombinant ORF2 capsid protein as previously described.13 An S:P ratio 
of   0.2 was considered positive (sensitivity = 78.2%; specificity = 99.6%), and an S:P ratio 
of <0.12 was considered negative (sensitivity = 90.7%; specificity = 93.2%).13 Values 
between these S:P ratios were considered suspect for PCV2 antibody. For simplification, the 
0.2 cutoff was used to separate seronegative and seropositive piglets in this study. 
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Six US breeding herds, designated as Herds A to F, were screened by testing the 
dams (sows and gilts) approximately 7 to 10 days prior to farrowing, except in the case of 
Herd B. In Herd B, only gilts were tested, and samples were collected 5 months prior to 
farrowing. None of the herds tested had a history of PMWS or PCV2-associated disease.  
The number of sows on each farm randomly selected for screening ranged from 12 to 43, 
depending on how many piglets were needed for our experiments and how many sows were 
in the batch ready to farrow at the time piglets were needed.   
Selection of dams for derivation of piglets 
Where parity information on the dams was available (Herds A, C, D, E, and F), ORF2 
ELISA S:P ratios of the dams were compared by parity. Sows within herds were divided into 
three categories on the basis of prefarrrowing ORF2 ELISA results. Category 1 included 
negative sows (S:P ratio <0.2), Category 2 included sows with S:P ratios   0.2 and < 0.6, and 
Category 3 included sows with S:P ratios   0.6. Dams were selected for derivation of piglets 
from either Category 1 or 2. No cross-fostering of piglets was allowed. 
Segregated early weaning 
The selected piglets were weaned at 10 to 12 days of age and moved to the Livestock 
Infectious Disease Isolation Facility at Iowa State University (Ames, Iowa) where they were 
housed. On the day of weaning, blood samples were collected from the anterior vena cava, 
using a single-use blood collection system (Vacutainer; Becton Dickinson, Franklin Lakes, 
New Jersey), and tested by ORF2 ELISA. Piglets were randomly assigned to groups and 
rooms independent of ORF2 ELISA S:P ratios. Handling and housing of the piglets was the 
same for all piglet groups. All people entering rooms were required to shower in, put on 
laundered coveralls, and wear latex gloves when touching piglets. The piglets were kept on 
raised wire decks, with feed and drinking water provided ad libitum. Airflow was 
unidirectional (positive pressure), with 10 to 15 air changes per hour.  
Monitoring PCV2 status through 15 weeks of age 
Randomly selected ELISA-negative samples from 10- to 12-day-old piglets were 
tested by indirect fluorescent antibody (IFA) assay14 to confirm results. Sera were tested at 
weekly intervals for PCV2-specific nucleic acids by regular polymerase chain reaction (PCR) 
and quantitative real-time PCR, using different primer annealing sites as described 
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previously.15,16 At the time of necropsy, performed when pigs were 8 to 15 weeks of age 
depending on experiment, lymphoid tissues (lymph nodes, spleen, tonsil, and thymus) were 
collected in 10% formalin, routinely processed, and tested for PCV2-antigen by 
immunohistochemistry (IHC) as previously described.17 In addition, blood was collected for 
ORF2 ELISA testing, and selected lymph nodes were collected, stored at -80ºC, and tested 
by PCR for PCV2-specific nucleic acids.  
PCV2-antibody half-life calculation and monitoring of passive antibody decay  
The rate of maternal PCV2-antibody decay was determined as previously described.18 
A linear regression curve was fitted to the natural logarithms (ln) of the ORF2 ELISA data of 
199 randomly selected piglets.  The equation h = -(ln 2) ÷ b was used to estimate the 
antibody half-life, where h is the estimated half-life of antibody and b is the slope of the 
regression line. Antibody half-life for PCV2 antibodies was determined separately for each 
piglet, and the mean half-life was used as a point source estimate. The 95% confidence 
interval was calculated on the mean half-life. 
For the purpose of following the passive antibody decay, the ELISA S:P ratios of the 
piglets at 10 to 12 days of age were separated into four categories.  Category 1 included 
seronegative piglets (S:P ratio < 0.2), Category 2 included piglets with low levels of PCV2 
antibodies (S:P ratio   0.2 and < 0.6), Category 3 included piglets with moderate levels of 
PCV2 antibodies (S:P ratio   0.6 and < 1.0), and Category 4 included piglets with high levels 
of PCV2 antibodies (S:P ratio   1.0). The mean category values were calculated, and passive 
PCV2-antibody levels were followed over time to determine antibody decay.   
Animals and experimental groups 
Individual groups of piglets were obtained from Herds A to F for use in several 
experimental PCV2-inoculation trials performed over a 2-year period. Details of the studies 
have been described previously.16,19-21 From the time of PCV2 inoculation until necropsy, 
this report focuses only on the non-infected negative control piglets in these experiments.   
Herd A: A total of 98 piglets were obtained from Herd A and brought to the research 
facility in two batches 3 weeks apart. All piglets were serologically monitored until 6 weeks 
of age. Negative controls were monitored serologically each week until necropsy: 61 pigs 
were monitored to 10 weeks of age, 40 pigs to 12 weeks of age, and nine pigs to 15 weeks of 
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age.   
Herd B. Seventy-one piglets were obtained from Herd B. All piglets were 
serologically monitored until 6 weeks of age. Negative controls were monitored serologically 
each week until necropsy: 28 pigs were monitored to 10 weeks of age, and 14 pigs were 
monitored to 13 weeks of age.
Herd C. Seventy-eight piglets were obtained from Herd C. All piglets were 
serologically monitored until 8 weeks of age. Negative controls were monitored serologically 
each week until necropsy at 14 weeks of age (n=10). 
Herd D. One hundred twenty-six piglets were obtained from Herd D. All piglets were 
serologically monitored until 9 weeks of age. Negative controls were monitored serologically 
each week until necropsy: 34 pigs were monitored to 9 weeks of age, and 16 pigs to 11 
weeks of age.   
Herd E. Ninety piglets were obtained from Herd E. All piglets were serologically 
monitored until 6 weeks of age. Necropsies were not performed on pigs of this group. 
Herd F. Forty-one piglets were purchased from Herd F. All piglets were serologically 
monitored until 5 weeks of age. Negative controls were monitored serologically each week 
until necropsy: 16 pigs were monitored to 8 weeks of age, and 11 pigs to 11 weeks of age. 
Statistical analysis 
Summary statistics were calculated to assess the overall quality of the ORF2 ELISA 
S:P ratios. Welch analysis of variance (ANOVA) was used for parity comparison and for 
continuous data with unequal standard deviation. The rejection level for the null hypothesis 
was .05. The R-squared statistic was used to determine what proportions of the total S:P ratio 
variation of the piglets was explained by the S:P ratio of the dams with S:P ratios < 0.6. 
 
Results 
Sow herd PCV2 antibody profiles 
Most breeding herds and most sows across parities within herds were seropositive for 
PCV2 antibodies by ORF2 ELISA (Table 1). There was no difference between high and low 
parity sows in terms of S:P ratios. The incidence of PCV2 ORF2 antibodies and the within-
herd antibody distribution of S:P ratios in the six sow herds are summarized in Figure 1. In 
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the selected herds, 50 to 85% of dams had S:P ratios ≥ 0.6, 15 to 42% had S:P ratios  0.2 and 
< 0.6, and 0 to 8% were seronegative. Among all breeding herds screened, only one herd 
(Herd B) was seronegative by ORF2 ELISA. In this case, all animals tested were gilts, and 
they were tested prior to breeding and not retested 7 to 10 days before farrowing as for sows 
from the other five herds. 
Transfer of passive antibodies from the dams to their offspring 
Similar passive antibody transfer data were obtained from all sow herds. Results for 
sows and piglets are summarized in Table 1. Within the same litter, some individual piglets 
had up to two to three times higher S:P ratios than their dams, whereas others were 
seronegative (Figure 2). The r2 for sow S:P ratios and piglets S:P ratios was 0.13, ie, 13% of 
the variation in the piglets’ S:P ratios was explained by the sow S:P ratios (P < .001). 
Overall, there was limited predictability of passive PCV2 antibody levels in piglets obtained 
from sows with S:P ratios < 0.6. 
Maternal antibody decay in piglets and PCV2 antibody half-life 
A total of 504 piglets were derived from herds A to F. Among all piglets, the PCV2 
antibody levels at weaning (10 to 12 days of age) were below the ELISA cutoff in 175 piglets 
(34.7 %); within the lower S:P range (  0.2 and < 0.6) in 202 piglets (40.1%); moderate (  
0.6 and < 1.0) in 93 piglets (18.5%); and high (  1.0) in 34 piglets (6.7%). The individual 
distributions of S:P ratios of the piglets in each herd at weaning are summarized in Figure 3.  
Within the observation periods, titers of passively acquired PCV2 antibodies declined 
in all piglets, and none of them seroconverted. The mean antibody half-life, based on 
declining ELISA S:P ratios in 199 pigs from Herds A to F, was 19.0 days. The 95% 
confidence intervals for the mean half-life were 17.6 and 20.3 days. In the group with S:P 
ratios   0.2 and < 0.6 at weaning (n=202), pigs became seronegative at 3 (n=7), 4 (n=96), 5 
(n=33), 6 (n=44), 7 (n=13), and 8 weeks of age (n=9), respectively. Piglets with S:P ratios   
0.6 and < 1.0 (n=93) became seronegative at 4 (n=9), 5 (n=2), 6 (n=9), 7 (n=1), 8 (n=32), 9 
(n=18), 10 (n=13), and 11 weeks of age (n=9), respectively. Piglets with S:P ratios   1.0 
(n=34) became seronegative at 5 (n=2), 9 (n=7), 10 (n=6), 11 (n=1), 12 (n=8), 13 (n=4), 14 
(n=3), and 15 weeks of age (n=3), respectively. Antibody levels waned below cutoff levels 
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by 4.9 weeks of age for piglets with low levels of passive antibodies at weaning (95% 
confidence intervals, 4.8 and 5.1 weeks), at 8.1 weeks of age for piglets with moderate levels 
of passive antibodies at weaning (95% confidence intervals, 7.7 and 8.5 weeks), and at 11.1 
weeks of age for piglets with high levels of passive antibodies at weaning (95% confidence 
intervals, 10.3 and 12.0 weeks). The antibody decay of 113 pigs is summarized in Figure 4 
and represents a typical passive antibody decay curve.  
A total of 149 piglets remained segregated and experimentally uninfected, and were 
necropsied at 8 (n=5), 9 (n=18), 10 (n=35), 11 (n=27), 12 (n=31), 13 (n=14), 14 (n=10), and 
15 (n=9) weeks of age, respectively. All pigs were free of PCV2 antibody and virus on the 
basis of ELISA and IFA serologically testing, PCR on serum and selected lymph nodes, and 
IHC on lymphoid tissues. 
Piglets that were experimentally infected with PCV2 (n=355) seroconverted within 2-
4 weeks post challenge and developed PCV2-associated lymphoid depletion and histiocytic 
replacement of follicles characteristic of PMWS as previously described.16,19-22 PCV2-
antigen was detected by IHC in lymphoid tissues associated with lesions, and PCV2-nucleic 
acids were detected by PCR on serum samples (data not shown). 
 
Discussion 
The objective of this report was to summarize the evidence from several experiments 
that piglets free of PCV2 and antibody to PCV2 can be derived from PCV2-positive breeding 
herds representative of US swine production. Recently, it has been demonstrated that PCV2-
free pigs can be derived by cesarean-section and colostrum deprivation.23 The results of the 
study summarized here confirm that segregated early weaning (SEW) techniques may also be 
used for derivation of PCV2-free pigs. 
In this study, for the purpose of deriving PCV2-free piglets for research trials, several 
breeding herds were screened for PCV2-antibodies, and most were positive. Only one 
breeding herd was seronegative, and these results were based on testing 12 gilts in one 
farrowing batch. 
The use of SEW allowed us to obtain 504 PCV2-free piglets from six seropositive 
breeding herds with no history of PMWS or PCV2-associated disease. Passive PCV2 
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antibodies in the piglets, detected by the ORF2 ELISA, decayed to negative levels. The 
PCV2-negative status of 149 of these pigs was confirmed by PCR on serum and selected 
lymphoid tissues, as well as by IHC on lymphoid tissues. Most of the pigs were kept until 10 
to 15 weeks of age, and none seroconverted during the observation period.   
In contrast to reports of vertical intrauterine transfer of PCV2 resulting in viremic or 
persistently infected piglets at birth,24 viremia was not detected in these piglets, which were 
tested weekly by PCR on sera. It has been suggested that piglets can be infected in utero or 
during the first days after birth.5,6 Vertical PCV2 infection may not always cause fetal death, 
and virus, antibody, or both were detected in clinically normal piglets.25 It is possible that the 
passively acquired antibody may suppress the PCV2 replication until maternal antibody 
levels wane and the pigs become viremic. The data obtained in our repeated experiments do 
not support this hypothesis, since all pigs remained seronegative after waning of maternal 
antibodies.  
Transmission routes for PCV2 have not yet been fully investigated. The absence of 
virus in our pigs may have been due to the carefully controlled environment of the pigs, ie, 
we can rule out possible transmission by means of semen, equipment, clothing, birds, or 
rodents in these pigs.   
We observed differences in the  passive antibody levels within litters. These 
differences may account for the temporal variability of onset and endemic manifestation of 
PCV2-associated diseases in many herds. Direct comparison of dam and piglet PCV2 ORF2 
ELISA results (Figure 2) suggested that sows with higher S:P ratios tended to have piglets 
with higher passive antibody levels, and sows with lower S:P ratios tended to have piglets 
with lower S:P ratios. However, testing was limited to selected dams in the categories with 
lower S:P ratios. Besides the effect of the sow on the passively transferred antibodies, there 
might also be a piglet effect, such as failure of colostrum uptake. This might in part explain 
the lack of maternal antibodies in some piglets derived from seropositive dams (14.1% 
derived from Herd C, and 8.7% derived from Herd D).   
In the United States, clinical PMWS is most often observed in pigs that are 8 to 12 
weeks of age, and, on the basis of experimental models,16,19-22 the piglets are probably 
infected 7 to 21 days prior to this time. Our results indicate that in piglets weaned at 2 weeks 
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of age, PCV2 maternal antibody decays below ORF2 ELISA cutoff values by approximately 
4.9 ± 1.2 weeks of age in piglets with low levels of antibody at weaning (S:P ratio < 0.6), by 
approximately 8.1 ± 1.9 weeks of age in piglets with moderate levels of antibody at weaning 
(S:P ratio   0.6 and < 1.0), and by approximately 11.1 ± 2.5 weeks of age in piglets with high 
levels of antibody at weaning (S:P ratio > 1.0).  
It has been demonstrated that pigs with ELISA S:P ratios > 0.6 are protected from 
developing PMWS.12,26 Piglets with lower S:P ratios are therefore at a higher risk for PCV2 
infection at an early age. In herds with PMWS, dams with high S:P ratios could be selected 
to obtain piglets passively protected for a longer time period. However, lack of maternal 
antibodies is certainly not the only important factor in the pathogenesis of PMWS. 
Colostrum-deprived, gnotobiotic pigs experimentally inoculated with PCV2 alone did not 
develop clinical disease.27,28 Other factors, such as coinfections20,29 or certain vaccination 
protocols,16 may enhance PCV2 infection and must also be considered. 
The results of this study may be useful to veterinarians and producers planning to 
establish a PCV2-free herd. A uniform within-herd distribution of PCV2 antibody in dams 
might be achieved in the future with PCV2 vaccines, resulting in more uniform antibody 
levels in piglets and appropriate timing of vaccination in growing piglets.  
 
Implications 
  Under the conditions of this study, in six breeding herds with no history of PCV2 
infection or clinical PMWS, 50% or more of sows randomly tested by serum ELISA had 
moderate-to-high levels of antibody to PCV2. 
  Individual sows with PCV2 ELISA S:P ratios close to the positive cutoff (< 0.2) were 
identified in every herd tested. 
  Differences in amount of transfer of maternal anti-PCV2 antibody were observed among 
piglets within litter. 
  Under the conditions of this study, the higher the PCV2 ELISA S:P ratio at weaning, the 
older the pig when the S:P ratio declined below the positive cutoff value.  
  Under the conditions of this study, SEW-derived pigs remained free of PCV2-specific 
antigen and nucleic acids until at least 15 weeks of age. 
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  SEW may be an effective technique to derive PCV2-free piglets from positive breeding 
herds for research or commercial production. 
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Table 1: Mean sample-to-positive (S:P) ratios ± SD of selected dams 7 to 10 days 
prefarrowing1 and their piglets at 10 to 12 days of age, tested by ELISA2 for porcine 
circovirus type 2 (PCV2) 
Total dams tested  Selected dams Piglets Herd 
n Mean S:P ratio  N Mean S:P ratio n Mean S:P ratio 
A 26 0.784 ± 0.57  13 0.286±0.13 98 0.381±0.41 
B 12 0.016 ± 0.03  12 0.016±0.03 71 0.202±0.30 
C 33 0.917 ± 0.28  8 0.525±0.19 78 0.638±0.33 
D 40 1.001 ± 0.57  19 0.516±0.20 126 0.634±0.36 
E 43 0.739 ± 0.34  12 0.352±0.14 90 0.361±0.31 
F 43 0.939 ± 0.39  5 0.437±0.20 41 0.335±0.22 
1 In Herd B, all dams tested were gilts that were tested 5 month prior to farrowing. 
2 ELISA using as antigen open reading frame 2 PCV2 capsid protein. An S:P ratio of ≥ 0.2 
was considered positive. 
 
 
 72
0
20
40
60
80
100
Herd A Herd B Herd C Herd D Herd E Herd F
D
is
tr
ib
ut
io
n 
of
 s
ow
s 
(%
)
S:P ratio <0.2 S:P ratio >0.2  <0.6 S:P ratio >0.6
 
Figure 1: Distribution of sample-to-positive (S:P) ratios in randomly selected sows tested by 
ELISA for porcine circovirus type 2 (PCV2) in six US swine breeding herds. Numbers of 
sows: Herd A, n=26; Herd B, n=12; Herd C, n=33; Herd D, n=40; Herd E, n=43; and Herd F, 
n=43. The ELISA used as antigen open reading frame 2 PCV2 capsid protein. An S:P ratio of 
≥ 0.2 was considered positive. Dams in each herd were divided into three categories on the 
basis of the ELISA results: those with S:P ratios < 0.2, those with S:P ratios   0.2 and <0.6, 
and those with S:P ratios  0.6.  
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Figure 2: Sample-to-positive (S:P) ratios in 11 Herd E sows (shaded bars) tested 10 days 
postpartum and their piglets (unshaded bars) tested at 10 to 12 days of age by ELISA for 
porcine circovirus type 2 (PCV2). The ELISA used as antigen open reading frame 2 PCV2 
capsid protein. An S:P ratio of   0.2 was considered positive. 
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Figure 3: Distribution of sample-to-positive (S:P) ratios in piglets derived from six different 
breeding herds, tested at weaning (10-12 days of age) by ELISA for porcine circovirus type 2 
(PCV2). The ELISA used as antigen open reading frame 2 PCV2 capsid protein. An S:P ratio 
of ≥ 0.2 was considered positive. Numbers of piglets: Herd A, n=98; Herd B, n=71; Herd C, 
n=78; Herd D, n=126; Herd E, n=90; and Herd F, n=41. Piglets in each herd were divided 
into four categories on the basis of the ELISA results: those with S:P ratios < 0.2, those with 
S:P ratio   0.2 and < 0.6, those with S:P ratios   0.6 and < 1.0, and those with S:P ratios   
1.0.  
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Figure 4. Decay of maternal porcine circovirus type 2 (PCV2) antibody in piglets tested 
weekly by ELISA, which used as antigen open reading frame 2 PCV2 capsid protein. A 
sample-to-positive ratio of ≥ 0.2 was considered positive. Pigs were divided into four 
categories on the basis of ELISA results on samples collected at weaning (10-12 days of 
age). Group 1, S:P ratio < 0.2 (n=25); Group 2, S:P ratio   0.2 and < 0.6 (n=48), Group 3, 
S:P ratio   0.6 and < 1.0 (n=38); and Group 4, S:P ratio   1.0 (n=9).
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CHAPTER 4.  EFFECT OF VACCINATION WITH SELECTIVE BACTERINS ON 
CONVENTIONAL PIGS INFECTED WITH TYPE 2 PORCINE CIRCOVIRUS 
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Abstract. The objective of this study was to determine whether vaccination with bacterins 
commonly used in the USA, when administered at a time typical of US protocol, enhances 
porcine circovirus type 2 (PCV2) replication and the incidence and severity of clinical signs 
and lesions characteristic of postweaning multisystemic wasting syndrome (PMWS) in 
conventional pigs. Sixty-one pigs free of PCV2 were randomly assigned to four groups. 
Group 1 (n = 15) and group 2 (n = 15) pigs served as sham-inoculated negative controls. 
Groups 3 (n = 14) and 4 (n = 17) pigs were inoculated intralymphoid with PCV2 field isolate 
ISU-40895. Pigs in groups 2 and 4 were vaccinated with Actinobacillus pleuropneumoniae 
(APP) and Mycoplasma hyopneumoniae (M. hyopneumoniae) bacterins 21 days before and 
again 1 day before inoculation with PCV2. Mild transient respiratory disease and diarrhea 
were observed from 13 to 34 days postinoculation (DPI) in pigs in groups 3 and 4. Half the 
pigs from each group were necropsied at 22 and 34 DPI, respectively. Moderately enlarged, 
tan-colored lymph nodes were observed in the majority of pigs in groups 3 and 4. There was 
a significantly (P < 0.05) longer length of viremia (2.14 ± 0.26 versus 4.44 ± 0.23 weeks), a 
higher copy number of PCV2 genome in serum, a wider range of tissue distribution of PCV2 
antigen, and an increased severity of lymphoid depletion in pigs vaccinated with commercial 
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APP and M. hyopneumoniae vaccines and inoculated with PCV2 compared with PCV2-
inoculated unvaccinated pigs. Swine producers and veterinarians may need to consider 
changes in vaccination protocols in herds with recurrent PCV2-associated PMWS. 
 
Introduction 
Two types of porcine circovirus (PCV), referred to as type 1 PCV (PCV1) and type 2 
PCV (PCV2), have been characterized in pigs.5,24 PCV is a very small, nonenveloped, single 
stranded DNA virus with a circular genome33 and belongs to the Circoviridae family.23 
PCV1 was first recognized in 1974 as a cell culture contaminant.35 Experimental PCV1 
infections have demonstrated no effect in pigs; thus, PCV1 is considered to be 
nonpathogenic.3,34 PCV2 was first recognized to be associated with postweaning 
multisystemic wasting syndrome (PMWS) in 1996.12 PMWS is characterized clinically by 
enlargement of the lymph nodes, chronic pneumonia, progressive weight loss, and less 
commonly by icterus, pallor, or diarrhea. Characteristic microscopic lesions include 
lymphoid depletion and histiocytic replacement of follicles in lymphoid tissues. Mild-to-
severe granulomatous inflammation in lymphoid and other tissues also is commonly 
observed. Macrophages in affected lymphoid tissues may contain basophilic inclusion 
bodies.1,31 
Serological studies demonstrate that PCV2 is ubiquitous in the swine population, and 
essentially all herds are infected.22,36 In contrast, PMWS is manifested in a relatively low 
percentage of pigs in PCV2-infected herds.1 It has been demonstrated that other coinfections 
such as porcine reproductive and respiratory disease virus (PRRSV)4,14,30 or porcine 
parvovirus (PPV)2,16,18 may potentiate the development of PMWS in PCV2-infected pigs. 
Recent studies have demonstrated that immune stimulation may trigger progression of 
PCV2 infection to disease and lesions characteristic of PMWS. Krakowka et al.17 reproduced 
PMWS in gnotobiotic pigs stimulated with keyhole limpet hemocyanin in Freund’s 
incomplete adjuvant (KLH-ICFA) and infected with PCV2. Allan et al.6 observed PMWS in 
21% of PCV2-infected and vaccinated (Mycoplasma hyopneumoniae [M. hyopneumoniae] at 
13 and 31 days of age, and Actinobacillus pleuropneumoniae [APP] at 47 days of age) 
colostrum-fed pigs. In contrast, another recent study using conventional pigs failed to 
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demonstrate an immune-stimulation-dependent difference in pigs inoculated with PCV2 and 
stimulated with KLH-ICFA.20 These experimental models suggest that immune stimulation 
may in some cases increase the incidence and severity of PMWS in PCV2-infected pigs.  
Field trials further supported this hypothesis. Vaccination of piglets with a M. 
hyopneumoniae bacterin at 1 and 4 weeks of age resulted in a significant increase in losses 
associated with PMWS in the vaccinated pigs in two of five batches.7 Kyriakis et al.19 
vaccinated a portion of the pigs in a herd experiencing a PMWS outbreak with a M. 
hyopneumoniae vaccine and observed PMWS in 43% of the vaccinated pigs compared with 
11% of the non-vaccinated pigs.  
The objective of this study was to determine whether vaccination with bacterins (APP 
and M. hyopneumoniae) commonly used in the USA enhances the incidence and severity of 
PCV2-associated PMWS lesions in conventional pigs.  
 
Materials and Methods 
Animal source 
Sixty-one pigs were weaned at 12-14 days of age and brought to the livestock 
infectious disease isolation facility at Iowa State University. All pigs were tested by enzyme 
linked immunosorbent assay (ELISA) and confirmed to be negative for antibodies to 
PCV2.28 The pigs were assigned randomly to rooms and pens and were housed in two rooms, 
with four pens in each room.  
Experiment design 
The experimental design is shown in Table 1. Pigs were 7-10 weeks of age when 
inoculated with PCV2. For the sham-inoculation, the pigs in groups 1 and 2 received a 
similar volume of a 0.9% sodium chloride solution (Lot 65-181-DK; Abbot Laboratories, 
North Chicago, Illinois). Half of the pigs were necropsied at 22 days post-inoculation (DPI) 
and the remaining pigs at 34 DPI. 
Vaccines 
A Mycoplasma hyopneumoniae (M. hyopneumoniae) bacterin (M+PAC®, Schering-
Plough Animal Health, Omaha, Nebraska; Lot EX-0061-1108-01) and an APP bacterin 
(Serotypes 1, 5 and 7, PNEU PAC®, Schering-Plough Animal Health, Lot NDC-0061-0260-
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01) were used for immune stimulation. The APP vaccine was adjuvanted with emulsified 
paraffin and the M. hyopneumoniae bacterin contained Emunade®, a combination of 
aluminium hydroxide with oil-in-water dual-action adjuvant. The first dose of each vaccine 
was given 21 days before and the second dose was given 1 day before PCV2 inoculation. 
Each pig was vaccinated intramuscularly in the right neck with 2 ml of the APP and in the 
left neck with 1 ml of the M. hyopneumoniae bacterins according to the manufacturer’s 
directions. 
Virus inoculum 
The PCV2 isolate used in this study, field isolate ISU-40895, was originally obtained 
from a pig with PMWS in a herd in western Iowa with mild-to-moderate losses associated 
with PMWS.9 The virus preparation was performed on PK-15 cells free of PCV1 and PCV2, 
as previously described.10 Briefly, PK-15 cells were cultivated in T-25 culture flasks and 
transfected with the PCV2-infectious DNA clone.10 The transfected cells were harvested at 3 
days posttransfection by freezing and thawing at -80°C three times. The infectious titer of the 
inoculum was determined by immunofluorescence assay as described previously.10 The virus 
inoculum was stored at -80°C until use. Each pig in groups 3 and 4 received 8 ml of isolate 
ISU-40895 with a titer of about 103.5 tissue culture infective dose50 intralymphoid. One half 
of the inoculum was injected in the right and the other half in the left superficial inguinal 
lymph node.10
Clinical evaluation 
The pigs were evaluated daily for clinical signs, including respiratory disease (score 
ranging from 0 [normal breathing] to 6 [severe dyspnea and abdominal breathing]).11 Nasal 
discharges and coughing were recorded by observers along with other changes such as 
lethargy. Rectal temperatures were recorded daily. The pigs were weighed at 20 and 3 days 
before inoculation and at 22 and 34 DPI. 
Serology 
Serum samples were taken before inoculation and at 7, 13, 21, 28, and 33 DPI. A 
PCV2-ELISA based on the recombinant open reading frame 2-capsid protein of PCV2 was 
performed on serum samples of all pigs as described previously.28 Samples with a sample-to-
positive (S : P) ratio ≥ 0.2 were considered to be positive for antibodies to PCV2. 
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In addition, serum of all pigs was tested for the presence of specific antibodies to porcine 
parvovirus by hemagglutination inhibition (HI),25 and for the presence of PRRSV-specific 
antibodies by PRRSV ELISA (IDEXX Laboratories, Inc. Westbrook, MA) on 33 DPI. 
Gross pathology and histopathology 
At necropsy, macroscopic lung lesions (0-100% of the lung affected) and size of 
lymph nodes (score ranging from 0 [normal] to 3 [three times the normal size]) were 
determined. Bronchoalveolar lavage (BAL) for bacterial and virological examinations was 
collected as described previously.26 
Tissue samples from lymph nodes (superficial inguinal, mediastinal, tracheobronchial, and 
mesenteric), lung, tonsil, thymus, ileum, kidney, colon, skin, spleen, liver, stomach, bone 
marrow, and ribs were collected during necropsy and fixed in 10% formalin, and routinely 
processed for histologic examination. Microscopic lesions were evaluated blindly by a 
veterinary pathologist.  
Immunohistochemistry 
Immunohistochemistry (IHC) for detection of PCV2-specific antigen was performed 
on sections of paraffin blocks of selected tissue samples (lymph nodes, including superficial 
inguinal, mediastinal, tracheobronichal, and mesenteric, tonsil, and spleen) using a rabbit 
polyclonal antiserum as described previously.32 The amount and distribution of PCV2 
antigen was compared by evaluation of IHC signals of each tissue section ranging from 0 (= 
no signal) to 3 (= strong positive signals) in a blinded fashion. The mean group score was 
determined for each lymphoid tissue and compared between groups. 
Polymerase chain reaction 
To confirm the presence of PCV2 infection and for the assessment of the length of 
PCV2 viremia, polymerase chain reaction (PCR) was performed on serum samples collected 
at different DPIs. Deoxyribonucleic acid (DNA) from weekly serum samples was extracted 
using a commercial DNA isolation kit (QIAamp® DNA Blood Mini Kit, Qiagen, Valencia, 
California). PCR was performed as described previously.9 As a positive control for DNA 
extraction and PCR, PCV2 isolate ISU-98-15237 was used. 
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Quantitative PCR 
Sequence-specific oligonucleotide primers and a fluorescent probe for detection and 
relative quantification of PCV2 genomic DNA were designed using computer software (ABI 
Prism Primer Express, Version 1.5, PE Applied Biosystems, Foster City, California) 
according to the manufacturer’s suggestions and were engineered to be within a highly 
conserved region of the viral genome (Table 2). The PCR reaction consisted of 50 µl PCR 
mixtures that contained 25 µl of the commercially available master mix (TaqMan Universal 
PCR Master Mix, PE Applied Biosystems), 5 µl DNA extract from each pig serum, forward 
and reverse primers, and detection probe with concentrations of 400, 400, and 200 nM, 
respectively. All reactions were carried out in triplicate. In addition, each reaction included 
three replicates for each of the five progressive 1:10 dilutions of a known copy number of 
PCV2 genomic DNA excised from a purified PCV2 DNA clone that served to generate a 
standard curve. Each plate was run in the sequence detection system (GeneAmp 5700 
Sequence Detection System, Applied Biosystems) under company-specified conditions that 
were optimal (2 minutes at 50 C, 10 minutes at 95 C followed by 45 cycles of 15 seconds at 
95 C and 1 minute at 60 C) for the Taq Master Mix used. 
Bone marrow analysis 
On both necropsy days, 22 and 34 DPI, bone marrow specimens were collected from 
the distal femur and were placed immediately into an ethylenediaminetetraacetic acid tube 
containing 0.5 ml sterile normal saline and 0.1 ml albumin and mixed to disperse cells. Two 
to three slides per animal were then prepared by cytospin preparation, and three 500 cell-
count differentials were performed on each animal. 
Statistic analyses 
Chi-square test was used to analyze the clinical scores. Daily rectal temperatures were 
analyzed with multiple analysis of covariance (MANCOVA), which accounts for the 
repeated measures on each pig and for baseline temperature. For the pigs that were 
necropsied at 22 DPI, all the data were analyzed from 0 to 21 DPI. For the remaining pigs, 
the data were analyzed from 0 to 31 DPI. If the time-by-group interaction was not significant, 
then the group effect was assessed. Otherwise, the data were analyzed cross-sectionally to 
determine at which time points the group means are different. MANCOVA also was chosen 
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for analyzing the weight data, which accounted for the repeated measurements of each pig 
and for baseline weight at 20 days before inoculation. Analysis of ELISA results was done by 
using cross-sectional analysis (analysis of variance [ANOVA]), and differences between 
groups were evaluated with Tukey’s test. Non-repeated measures of necropsy and 
histopathology data were assessed using analysis of covariance (ANCOVA) or 
nonparametric ANOVA. If a nonparametric ANCOVA test was significant (P < 0.5), then 
Wilcoxon tests (with the Bonferroni correction) were used to assess the differences of pairs 
of groups. Fisher’s exact test was used to compare the incidence between groups. 
Statistical analysis for real-time PCR was performed using the means of three 
replicate wells for each sample as compared to a standard curve generated with a purified 
known genome copy number of PCV2 genomic DNA ranging from 103 to 107 genomic 
copies per PCR plate well. Serial dilutions (1 : 10) between each standard resulted in a 5-
point standard curve with a correlation of >0.992. The threshold cycle (threshold cycle CT, is 
the cycle number at which a statistically significant increase in amplification above the 
threshold line [0.1 in all cases] is first detected) of triplicate unknowns were compared to CTs 
of triplicate standards on a standard curve to determine the absolute number of viral genomes 
per ml of pig serum. 
 
Results 
Clinical signs 
Pigs in the sham-inoculated control groups 1 and 2 showed no clinical signs of 
disease throughout the study. Pigs in PCV2-infected groups 3 and 4 exhibited intermittent 
diarrhea and mild respiratory disease from 13 DPI until the end of the study at 34 DPI. The 
respiratory disease was characterized by sneezing, clear nasal discharge, and occasionally 
coughing. Statistical analysis of the clinical scores (chi-square test) revealed that the clinical 
respiratory disease scores in pigs of groups 3 and 4 were statistically more severe than those 
of groups 1 and 2 pigs (P < 0.0001). There was no difference in clinical scores between pigs 
of groups 3 and 4 (P = 0.6). Statistical analysis of the daily rectal temperatures (0 to 33 DPI) 
showed neither a significant group-by-time interaction (P = 0.14) nor a significant group 
effect (P = 0.08). Statistical analysis of the weight data showed no statistically significant 
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difference in time-by-group effect (P = 0.8) or group effect (P = 0.6). At 34 DPI, the average 
weights appeared to differ (49.1 kg [± 5.4] in group 1 pigs, 47.9 kg [± 4.2] in group 2 pigs, 
48.6 kg [± 7.5] in group 3 pigs, and 45.6 kg [± 4.7] in group 4 pigs) but there was substantial 
variability within each group. The average daily weight gain was 0.70 kg (± 0.05) for group 1 
pigs, 0.67 kg (± 0.05) for group 2 pigs, 0.70 kg (± 0.08) for group 3 pigs, and 0.63 kg (± 
0.09) for group 4 pigs. 
Gross lesions 
In sham-inoculated control groups 1 and 2, only 4 of the 30 pigs had visible gross 
lesions. The four pigs with lesions were necropsied at 34 DPI and had lymph node 
enlargement of approximately two times the normal size. There were significantly more pigs 
in groups 3 and 4 (P < 0.05) with enlarged lymph nodes (Table 3) compared with groups 1 
and 2. In group 3, 12 of 14 pigs had enlargement of all lymph nodes from two to three times 
the normal size. In group 4, 15 of 17 pigs had lymph node enlargement of two to three times 
the normal size. The macroscopic evaluation of the lymph nodes sizes showed no statistical 
difference between groups 3 and 4 at the first (P = 0.33) or second (P = 0.3) necropsy.  
Microscopic lesions and IHC 
There were no microscopic lesions in the lymph nodes of pigs in groups 1 and 2. In 
groups 3 and 4, microscopic lesions characterized by lymphoid depletion of follicles and 
granulomatous lymphadenitis were observed in nearly all pigs: 12 of 14 in group 3 pigs, and 
16 of 17 in group 4 pigs. At 34 DPI, there was a significant difference (P = 0.02) in severity 
of lymphoid depletion between groups 3 (mean = 0.86) and 4 (mean = 1.56). Mild to 
moderate lymphoplasmacytic interstitial nephritis was observed in 1 of 15 pigs in group 1 
pigs, in 4 of 14 group 3 pigs, and in 5 of 17 group 4 pigs. Mild lymphohistiocytic hepatitis 
was observed in 7 of 14 pigs in group 3, and in 11 of 17 pigs in group 4. Mild to moderate 
lymphohistiocytic enteritis was observed in 6 of 14 pigs in group 3, and in 7 of 17 pigs in 
group 4 (Table 3).  
PCV2 antigen was detected by IHC in a variety of tissues (lymph nodes, spleen, and 
tonsil) in groups 3 and 4. At 22 DPI, PCV2 antigen was detected in all pigs examined. There 
was no difference between the amount and distribution of PCV2 antigen between groups 3 
and 4 at 22 DPI. At 34 DPI, PCV2 antigen was only detected in the lymph nodes in 4 of 7 
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group 3 pigs. In contrast, at DPI 34, PCV2 antigen was still detectable in the lymph nodes of 
all group 4 pigs (9 of 9) and the amount of PCV2 antigen in the lymph nodes was 
significantly (P < 0.05) higher in group 4 than in group 3 pigs at 34 DPI (Table 4).  
Antibody response 
Pigs in groups 1 and 2 remained seronegative for PCV2 antibody throughout the 
study. Pigs in groups 3 and 4 seroconverted to PCV2 between 21 and 28 DPI. Cross-sectional 
analysis (using ANOVA) indicated that there were statistically different group means (P < 
0.0001) at 21, 28, and 33 DPI. A Tukey’s test showed that for each day neither were groups 1 
and 2 statistically different from each other nor were groups 3 and 4 different from each 
other. All serum samples tested were negative for presence of PRRSV- and PPV-specific 
antibodies at 33 DPI. 
PCV2 viremia 
In groups 1 and 2, all serum samples collected at different DPIs were negative for 
PCV2 DNA by PCR. Viremia in groups 3 and 4 pigs was detected at as early as 7 DPI in 24 
of 31 pigs. All pigs in groups 3 and 4 were viremic at 13 DPI. By DPI 21, 11 of 14 pigs in 
group 3 and 16 of 17 pigs in group 4 remained positive with PCV2 DNA. By 28 DPI, 1 of 7 
pigs in group 3 was positive for PCV2 DNA in sera, while 7 of 9 pigs in group 4 were 
positive. At 33 DPI, the day before necropsy, 7 of 9 pigs in group 4 were still positive for 
PCV2 DNA, wheras none of the pigs (0 of 7) in group 3 were positive. The PCR data were 
analyzed using nonparametric ANOVA as an omnibus test and Wilcoxon pairwise post hoc 
tests. The overall test was significant (P < 0.001), and post hoc tests indicated that groups 3 
and 4 were different (P = 0.03) from each other and from groups 1 and 2 (P < 0.0001). To 
determine the length of viremia, only the animals that were alive at the end of study were 
analyzed. Pigs necropsied at 22 DPI were not included. The mean viremia length observed in 
group 3 pigs (n = 7) was 2.14 (±0.26) weeks, compared with 4.44 (±0.23) weeks in group 4 
pigs (n = 9). The length of viremia in group 4 pigs was determined by the end of the study at 
34 DPI. At this time point, 7 of 9 group 4 pigs were still viremic, whereas none of the 
nonvaccinated group 3 pigs were viremic. The difference in viremia length between groups 3 
and 4 was highly significant (P = 0.0003). 
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PCV2 genome titer in sera 
Analysis of the amount of PCV2 genomic DNA per milliliter of serum revealed major 
differences between groups 3 and 4 pigs. The mean copy number of PCV2 genomic DNA 
measured in nonvaccinated group 3 pigs was 1.3 × 105 genomic copies per milliliter serum at 
7 DPI. On the following testing dates (13-33 DPI), the PCV2 genomic titer decreased in all 
pigs to 6.1 × 103 PCV2-copies per milliliter serum at 33 DPI. In contrast, the mean copy 
number of PCV2 genome in sera measured in vaccinated group 4 pigs was 2.7 × 107 copies 
per milliliter serum at 7 DPI. Furthermore, in the majority of group 4 pigs (7 of 9), the PCV2 
genomic titer remained at a relatively high level (mean copy number per milliliter serum 
between 2.3 × 106 at 14 DPI and 1.7 × 106 at 33 DPI) compared with nonvaccinated group 3 
pigs during the entire experiment. Instead of decreasing, PCV2 genomic titer continued to 
increase over time in some pigs. Figure 1 illustrates the comparison of group mean PCV2 
genome titer. Differences in the amount of PCV2 genome copy number between both groups 
were significant (P < 0.05) on 13, 21, 28, and 32 DPI. 
Bacteriology 
There was no growth on cultures of the BAL-fluid in any of the pigs from groups 1 to 
4. 
Bone marrow analysis 
All the variables were analyzed by using nonparametric ANOVA. There were no 
significant differences between the groups. Erythroid and myeloid cell series were present 
and followed a normal maturation sequence. M : E ratios were within reference intervals for 
this species. Megakaryocytes were observed in all specimens. One interesting feature was the 
presence of many eosinophils on marrow cytospin preparations; eosinophils are rarely 
observed on peripheral complete blood count differentials. 
 
Discussion 
The objective of this study was to determine whether M. hyopneumoniae and APP 
vaccination enhanced the incidence and severity of PMWS disease and lesions associated 
with PCV2 infection of conventional pigs. At least three European studies, one using an 
experimental model6 and two recent field studies,7,19 provide evidence that vaccine-induced 
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immune stimulation enhances PCV2 replication and increases the incidence of clinical 
PMWS. The results of these European studies are not ideally suited for application to the US 
field situation, where M. hyopneumoniae vaccines are typically used on older pigs. In the 
USA, PCV2-associated PMWS is most commonly seen in pigs aged 8-20 weeks,13,15 whereas 
in Europe it is observed in pigs aged 3-10 weeks.1 M. hyopneumoniae vaccination in the 
USA is typically done in nursery-age pigs from 3 to 10 weeks, whereas in Europe it is more 
commonly done on suckling pigs or on pigs in early nursery phase at 1-4 weeks of age. We 
attempted to mimic the immune stimulation approach of the European studies by vaccinating 
pigs with M. hyopneumoniae and APP; however, we vaccinated at 5 and 7 weeks of age 
using segregated early-weaned (12-14 days) pigs, consistent with current US production 
systems. 
Diagnostic criteria of PMWS include clinical evidence of wasting, histological 
evidence of lymphoid depletion or granulomatous lymphadenitis, and the presence of PCV2 
antigen or nucleic acids associated with the characteristic lymphoid lesions.31 PCV2-
associated microscopic lesions consistent with PMWS were observed in both PCV2-
inoculated groups in this study; however, we failed to reproduce clinical manifestation of 
PMWS. This might be due to removal of other key stressors not present in the clean 
experimental environment. Unlike most field situations, our pigs had no known concurrent 
viral or bacterial coinfections, which have been shown to increase the incidence and severity 
of PMWS in PCV2-infected pigs.2,4,14,16,18,30 The PCV2 inoculum was a pure and 
homogeneous infectious stock derived from an infectious DNA clone of PCV2 isolate ISU-
40895, which was originally isolated from a pig with PMWS.9,10 Therefore, the disease and 
lesions reproduced in this study perhaps are more definitive than those using tissue 
homogenate or cell culture-propagated PCV2 inoculum, which might contain other common 
swine agents. The differences in environment and coinfection may at least partly explain the 
differences in results of different experiment models and differences in severity of PCV2-
associated disease from farm to farm.  
Pigs in the vaccinated and non-vaccinated PCV2-infected groups developed 
microscopic lesions consistent with PMWS. This observation in the nonvaccinated group 3 is 
in contrast to many PCV2 experimental models, where no or mild microscopic lesions typical 
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of PCV2-associated disease were observed.4,17,18,29,30 There are only a few reports to date 
which describe reproduction of severe microscopic lesions characteristic of PMWS with 
singular PCV2 inoculation.8,20,21 Differences in experimental results could be explained by 
PCV2 strain variation, individual pig susceptibility differences, differences in age of 
inoculation, or type of animal housing. Typically, more severe lesions were observed in 
young gnotiobiotic pigs,17,18 cesarean-derived-colostrum-deprived pigs,8,14 and colostrums-
deprived pigs,2,4,16 compared with “conventional pigs”.30 The definition of conventional pigs 
also may vary. In our case, these are genetics typical of the current US swine industry; pigs 
free of several major pathogens (PRRSV, SIV, PCV2, APP, M. hyopneumoniae) and early 
weaned to a distant site where they are reared in all-in-all-out fashion.  
The length of PCV2 viremia in the unvaccinated group 3 pigs (2.14 ± 0.26 weeks) 
was consistent with observations of other research groups.10,29 PCV2-associated lymphoid 
lesions peaked around 22 DPI and were minimal or absent in the nonvaccinated pigs at the 
end of the study at 34 DPI. In contrast, pigs in the vaccinated group 4 had significantly 
longer length of PCV2 viremia (4.44 ± 0.23 weeks) and a longer duration of PCV2 antigen 
detection in various lymphoid tissues. Quantitative PCR results further confirmed the 
significantly (P < 0.05) higher amount of PCV2 genome titers in sera of vaccinated pigs 
compared with that of nonvaccinated pigs. However, this did not influence the clinical 
appearance of the pigs in this study. Only mild respiratory disease and mild diarrhea were 
observed. Nevertheless, the increased length of viremia may increase the window of 
opportunity for coinfecting agents or other cofactors to trigger progression of PCV2 infection 
to PMWS. 
Most modern pig production systems utilize some types of vaccines, particularly in 2-
to 12-weeks-old pigs. It has been speculated that both the use of vaccines and the type of 
vaccine may play an important role in the manifestation of clinical PMWS.6,19 In addition to 
the type of vaccine used, the timing of vaccination may also be important. This difference 
might be reflected in this current study, where none of the pigs vaccinated between 5 and 10 
weeks of age developed clinical PMWS, whereas in a previous study6 with an earlier onset of 
vaccination (2 weeks of age), PMWS was developed in 21% of the pigs. Early vaccination, 
high virus prevalence in the environment, and low maternal antibody status may lead to 
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increased incidence and severity of PMWS typical of what is occurring in the UK, where the 
postweaning mortalities have increased by 5-40% in many affected herds.27  
PMWS is a disease complex influenced by many factors. One of these factors may be 
commonly used vaccines. However, on a herd basis, the risk of elimination of effective 
vaccines may be greater than the risk of inducing PMWS in a low percentage of the 
population. Further work is warranted to determine whether there is an optimal time for 
vaccination and if certain types of adjuvants or antigens play a role in vaccine-induced 
enhancement of PMWS. Swine producers may need to consider changing vaccine products 
or regimens to minimize PCV2 replication and PCV2-associated diseases in affected herds. 
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Table 1. Experimental design. 
Vaccination*  
Group 
 
Pigs -21 DPI† -1 DPI 
Inoculation with PCV2 
(0 DPI) 
1 15 - - - 
2 15 + + - 
3 14 - - + 
4 17 + + + 
*Vaccination with Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae 
bacterins. 
†Days post inoculation. 
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Table 2. Sequences of the primer and TaqMan fluorescent probe used in fluorogenic real-
time PCR for absolute quantification of PCV2 genomic DNA in serum samples. 6FAM = 
fluorescent reporter dye. TAMRA = fluorescent quencher dye.  
Name Sequence 
P1570 (forward primer) 5’-TGGCCCGCAGTATTCTGATT-3’ 
P1642 (reverse primer)  5’-CAGCTGGGACAGCAGTTGAG-3’ 
P1591 (TaqMan probe) 5’-6FAM-CCAGCAATCAGACCCCGTTGGAATG-TAMRA-3’ 
 
 Table 3. Gross and microscopic lesions in control and PCV2-inoculated 7- to-10-week-old conventional pigs at 22 and 34 DPI* 
Gross Lymphadenopathy 
0-3)† 
Lymphoid Depletion 
(0-3)† 
Lymphohistiocytic Interstitial  
Nephritis (0-3)† 
 
 
Group No. 22 DPI 34 DPI 22 DPI 34 DPI 22 DPI 34 DPI 
Sham inoculated       
1 (Nonvaccinated) 0/7 (0.0[0])§A║ 3/8 (2.0[2])A 0/7 (0.0[0])A 0/8 (0.0[0])A 0/7 (0.0[0])A 1/8 (1.0[1])A
2 (Vaccinated) 0/7 (0.0[0])A 1/8 (2.0[2])A 0/7 (0.0[0])A 0/8 (0.0[0])A 0/7 (0.0[0])A 0/8 (0.0[0])A
PCV2 inoculated       
3 (Nonvaccinated) 6/7 (2.0[1-3])B 6/7 (2.3[2-3])B 6/7 (1.3[1-2])B 6/7 (1.0[1])B 2/7 (2.0[1-3])A 2/7 (1.5[1-2])A
4 (Vaccinated) 6/8 (2.5[2-3])B 9/9 (2.6[2-3])B 7/8 (1.4[1-2])B 9/9 (1.6[1-2])C 2/8 (2.0[1-3])A 3/9 (2.0[1-3])A
95
*Days postinoculation 
†Score range (0 = normal; 1 = mild; 2 = moderate; 3 = severe). 
‡Interstitial pneumonia score (0 = normal; 1 = mild multifocal; 2 = mild diffuse; 3 = moderate multifocal; 4 = moderate diffuse; 5 
= severe multifocal; 6 = severe diffuse interstitial pneumonia). 
§Incidence (mean severity for affected animals [range of severity for affected animals]). 
║Groups 1-4 were evaluated against each other in each column. Different superscripts (A-C) within each column indicate 
significantly (P < 0.05) different values in the overall mean group scores. 
 
 
 Table 3. (Continued). 
Lymphohistiocytic Hepatitis 
(0-3)† 
Lymphohistiocytic Enteritis  
(0-3)† 
Interstitial Pneumonia 
(0-6) ‡ 
 
 
Group No. 22 DPI 34 DPI 22 DPI 34 DPI 22 DPI 34 DPI 
Sham inoculated       
1 (Nonvaccinated) 0/7 (0.0[0])A 0/8 (0.0[0])A 0/7 (0.0[0])A 0/8 (0.0[0])A 5/7 (1.0[1])A 4/8 (1.0[1])A
2 (Vaccinated) 0/7 (0.0[0])A 0/8 (0.0[0])A 0/7 (0.0[0])A 0/8 (0.0[0])A 6/7 (1.2[1-2])A 6/8 (1.0[1])A
PCV2 inoculated       
3 (Nonvaccinated) 3/7 (1.0[1])B 4/7 (1.3[1-2])B 0/7 (0.0[0])A 6/7 (1.0[1])B 7/7 (1.4[1-2])A 7/7 (1.0[1])A
4 (Vaccinated) 4/8 (1.0[1])B 7/9 (1.3[1-2])B 0/8 (0.0[0])A 7/9 (1.0[1])B 8/8 (1.6[1-3])A 8/9 (1.1[1-2])A
96
*Days postinoculation 
†Score range (0 = normal; 1 = mild; 2 = moderate; 3 = severe). 
‡Interstitial pneumonia score (0 = normal; 1 = mild multifocal; 2 = mild diffuse; 3 = moderate multifocal; 4 = moderate diffuse; 5 
= severe multifocal; 6 = severe diffuse interstitial pneumonia). 
§Incidence (mean severity for affected animals [range of severity for affected animals]). 
║Groups 1-4 were evaluated against each other in each column. Different superscripts (A-C) within each column indicate 
significantly (P < 0.05) different values in the overall mean group scores. 
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Table 4. Comparison of estimated amount of PCV2 antigen (ranging from 0 = not detectable to 3 = strong signal) in lymphoid 
tissues between groups 3 (PCV2 infected) and 4 pigs (PCV2 infected and vaccinated).  
Lymph nodes Tonsil Spleen
 22 DPI* 34 DPI 22 DPI 34 DPI 22 DPI 34 DPI 
Group 3 7/7A‡ (1.7[1-3])C† 4/7A (1.0[1])C   5/7A (1.2[1-2])C 0/7A (0.0[0])C 5/7A (1.4[1-2])C 0/7A (0.0[0]C
Group 4 7/8A (1.1[1-2])C 9/9A (1.4[1-2])D   4/8A (1.0[1])C 7/9B (1.0[1])D 4/8A (1.0[1])C 6/9B (1.0[1])D
‡Different superscripts within each column indicate significantly (P < 0.05) different values in incidence (A and B), or 
significantly (P < 0.05) different values in estimated overall mean group amount of PCV2 antigen (C and D). 
†Incidence (mean estimated amount for affected animals [estimated range]). 
*Days postinoculation. 
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Fig. 1. PCV2 genomic titers in sera measured by quantitative real-time PCR. The values are 
the mean group results for group 3 (nonvaccinated, n = 7) and group 4 (vaccinated, n = 9) 
pigs. Pigs that were necropsied at 22 DPI are not included. Error bars represent standard 
errors. 
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Abstract 
To determine whether there is an effect of the timing of vaccination on porcine 
circovirus type 2 (PCV-2) replication and PCV-2-associated lesions, 78 pigs were randomly 
assigned to eight groups: group 1 (10 pigs) was vaccinated with a commercial Mycoplasma 
hyopneumoniae vaccine at two and four weeks of age, group 2 (nine pigs) was vaccinated at 
four and six weeks of age, group 3 (10 pigs) at six and eight weeks of age and group 4 (10 
pigs) at eight and 10 weeks of age; group 5 (nine pigs) was vaccinated once with a double 
dose at four weeks of age, and group 6 (10 pigs) was vaccinated once with a double dose at 
eight weeks of age. Groups 7 and 8, both of 10 pigs, were not vaccinated. At eight weeks of 
age, pigs in group 1 to 7 were inoculated with PCV-2. Fourteen days after they had been 
inoculated, the pigs in groups 1, 4 and 5 had significantly (P<0.05) more copies of the PCV-2 
genome in their serum than the unvaccinated pigs. Microscopically, 14 of the 68 inoculated 
pigs had normal lymphoid tissues, 40 had mild PCV-2-associated lymphoid lesions and 14 
had moderate lesions. The mean overall lymphoid lesions (lymphoid depletion, 
granulomatous inflammation, and quantity of PCV-2 antigen in spleen, tonsil, and five lymph 
nodes) were significantly (P<0.05) more severe in groups 4 and 5 than in groups 2, 3, 7 and 
8. 
 
 100
Introduction 
Porcine circovirus type 2 (PCV-2) was first described in association with postweaning 
multisystemic wasting syndrome (PMWS) in pigs in the mid-1990s (Harding and Clark 
1997). The syndrome is characterised clinically by enlargement of the lymph nodes, chronic 
pneumonia and progressive weight loss, and less often by icterus, pallor or diarrhoea. The 
characteristic microscopic lesions include lymphoid depletion and histiocytic replacement of 
follicles in lymphoid tissues; mild to severe granulomatous inflammation in lymphoid and 
other tissues is also commonly observed (Allan and Ellis 2000, Sorden 2000). The virus is 
now associated with several other disease manifestations in pigs, including reproductive 
failure (abortion), myocarditis, enteritis, and as a component of the porcine respiratory 
disease complex (PRDC) (Allan and Ellis 2000, Harms and others 2002, Opriessnig and 
others 2004b).
Immune stimulation by commonly used vaccines has been shown to enhance the 
replication of PCV-2 and increase the severity of PCV-2-associated lesions both 
experimentally (Allan and others 2000b) and in the field (Allan and others 2001, Kyriakis 
and others 2002). In a recent study, it was shown that the enhanced replication of PCV-2 
manifests as significantly longer periods of PCV-2 viraemia, more copies of the PCV-2 
genome in serum, a wider tissue distribution of PCV-2 antigen, and more severe lymphoid 
depletion in segregated early weaned pigs vaccinated with commercial Actinobacillus 
pleuropneumoniae and Mycoplasma hyopneumoniae vaccines than in unvaccinated, 
segregated early weaned pigs inoculated with PCV-2 (Opriessnig and others 2003). 
The objective of this study was to investigate whether the timing of M 
hyopneumoniae vaccination in relation to infection with PCV-2 has an effect on the 
replication of the virus and the severity of the associated lesions. 
  
Material and Methods 
On the day they were weaned, 78 segregated early weaned, 10-to 12-day-old, crossbred pigs 
were randomly assigned to rooms and pens and housed in four equally lighted and power-
ventilated rooms with two to eight pens in each room and four to five pigs in each pen.  
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Vaccination 
The pigs were divided into eight groups (Table 1), six of which were vaccinated with 
M+PAC® (Schering-Plough Animal Health), a commercially available M hyopneumoniae 
bacterin. The vaccine is adjuvanted with Emunade(Schering-Plough Animal Health), a 
combination of aluminum hydroxide with an oil-in water, dual-action adjuvant. According to 
the manufacturer’s directions, each pig in groups 1 to 4 was vaccinated intramuscularly in the 
right side of the neck with 1 ml of the bacterin and boosted two weeks later with a second 1 
ml dose; the pigs in groups 5 and 6 each received a single injection in the form of 2 ml of the 
bacterin according to label directions for the single-dose regimen, and the pigs in groups 7 
and 8 were not vaccinated. The pigs in each group were vaccinated at different intervals 
before all of them were inoculated with PCV-2 when they were eight weeks old (Table 1). 
Inoculum  
The PCV-2 inoculum was prepared on PK-15 cells free of porcine circovirus type 1 
(PCV-1) and PCV-2 as described by Fenaux and others (2002). Before it was used, the 
inoculum was tested and shown to be negative for porcine parvovirus and PCV-1 by PCR. A 
dose of 105.1 50 per cent tissue culture infective doses (TCID50) of PCV-2 field isolate ISU-
40895 (Fenaux and others 2000), passage 6, in a 5 ml volume was administered to each pig 
intranasally by slowly dripping 2.5 ml of the inoculum into each nostril.  
Clinical evaluation 
The pigs were scored daily for clinical signs including sneezing (score range 0 No 
sneezing to 3 Severe sneezing), coughing (score range from 0 No coughing to 3 Severe 
coughing), and increased respiratory rate (score range from 0 Normal breathing to 6 Severe 
dyspnoea and abdominal breathing) as described by Halbur and others (1995) and Opriessnig 
and others (2003). Other clinical signs such as nasal discharge, lethargy, jaundice and rectal 
temperatures were recorded daily. The pigs were weighed at 42, 28, and 16 before they were 
inoculated, on the day they were inoculated, and seven, 14 and 42 days after they were 
inoculated. 
Serology 
Samples of blood were collected at weekly intervals, starting when the pigs were 10 
to 12 days of age. The sera were tested for PCV-2-specific antibodies by ELISA (Nawagitgul 
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and others 2002); they were considered positive if the calculated sample-to-positive (S/P) 
ratio was 0.2 or more.  
In addition, serum samples collected from the pigs at 42 days after they were inoculated were 
tested for the presence of antibodies to porcine parvovirus by haemagglutination inhibition 
(Mengeling and others 1988), and by ELISA for the presence of antibodies specific to 
porcine reproductive and respiratory syndrome virus (PRRSV) (IDEXX Laboratories) and M 
hyopneumoniae (DAKO). 
Detection and quantification of PCV-2 genomic DNA 
Real-time PCR was used to detect and measure PCV-2 genomic DNA in serum 
samples collected seven, 14, 21, 28, 35 and 42 days after the pigs were inoculated 
(Opriessnig and others 2003). The DNA was extracted by using the QIAamp DNA Mini Kit 
(Qiagen).  
Gross pathology and histopathology 
All pigs were euthanased with an overdose of phenobarbital (Beuthanasia-D; 
Schering Plough Animal Health) at 14 weeks of age, 42 days after they had been inoculated. 
The gross lesions in the lungs and lymph nodes were scored at postmortem examination as 
described by Halbur and others (1995) and Opriessnig and others (2003). Samples of the 
lymph nodes, spleen, kidney, liver, tonsil, lung, thymus, heart, colon and ileum were 
collected in 10 per cent neutral-buffered formalin and processed for microscopic evaluation. 
The microscopic examination and scoring was performed in a blinded fashion. For the lungs 
the scoring system ranged from 0 for normal to 6 for severe diffuse for interstitial 
pneumonia; for the other organs the scores ranged from 0 for normal to 3 for severe lesions 
(Halbur and others 1995). Lymphoid tissues such as lymph nodes, tonsil, and spleen were 
evaluated for lymphoid depletion with scores ranging from 0 for normal to 3 for severe, and 
for the loss of lymphoid follicle structure and presence of inflammation with scores ranging 
from 0 for normal to 3 for severe histiocytic to granulomatous inflammation with 
replacement of follicles (Opriessnig and others 2004b). 
Immunohistochemistry 
Immunohistochemistry was used to detect PCV-2 antigen in lymph nodes, thymus, 
spleen, and tonsil as described by Sorden and others (1999). The amount and distribution of 
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PCV-2 antigen was scored blind, 0 for undetectable, 1 when less than 10 per cent of the 
lymphoid follicles contained cells with PCV-2 antigen staining, 2 for 10 to 50 per cent of the 
lymphoid follicles contained cells with PCV-2 antigen staining, and 3 when more than 50 per 
cent of the lymphoid follicles contain cells with PCV-2 antigen staining) in a blinded fashion 
(Opriessnig and others 2004b).  
Mean score for lymphoid lesions 
To evaluate the PCV-2-associated lesions for individual pigs, a combined scoring 
system was used for each lymphoid tissue that ranged from 0 to 9, with a lymphoid depletion 
score from 0 to 3, granulomatous inflammation score from 0 to 3 and an 
immunohistochemistry score from 0 to 3 (Opriessnig and others 2004b). The scores for the 
seven lymphoid tissues (five lymph nodes, spleen and tonsil) were added together and 
divided by 7. The lymph node pool consisted of tracheobronchial, superficial inguinal, 
external iliac, mediastinal and mesenteric lymph nodes. The mean lymphoid score of each 
treatment group was calculated and compared with the scores of the other groups. The pigs 
were grouped into four categories on the basis on the basis of their overall lymphoid lesion 
scores: I (normal; score 0), II (mild; score 1 to 3), III (moderate; score 4 to 6) and IV (severe; 
score 7 to 9). A pig was diagnosed with PMWS if it had a lower rate of weight gain or had 
lost weight, and if its mean lymphoid lesion score was in category IV.  
Bacteriology 
Selected lymphoid tissues were cultured for bacteria by routine methods, and selected 
formalin-fixed, paraffin embedded lymph nodes were stained for acid-fast bacteria. 
Statistical analysis 
Summary statistics were calculated for each group cross-sectionally to assess the 
overall quality of the data. The clinical scores were analyzed by response feature analysis 
followed by non-parametric Kruskal-Wallis analysis of variance (ANOVA) with a rejection 
level for the null hypothesis of P<0.05. If this non-parametric ANOVA test was significant 
(P<0.05), then Wilcoxon tests were used to assess the differences between pairs of groups. 
The repeated measurements of rectal temperature were analyzed by a multivariate ANOVA, 
and the continuous non-repeated measurements among the different treatment groups were 
also assessed using ANOVA. Non-repeated measurements from postmortem and the 
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histopathology data were assessed by non-parametric Kruskal-Wallis ANOVA followed by 
Wilcoxon tests. Differences in incidence were evaluated by Fisher’s exact test. 
 
Results 
Clinical disease 
Some of the inoculated pigs in each of groups 1 to 7 showed signs of mild respiratory 
disease, characterised by sporadic sneezing, a clear nasal discharge, and mild dyspnoea, 
between six and 22 days after they had been inoculated; some of them had high temperatures 
between eight and 34 days, were lethargic and had a rough haircoat. There were no 
significant differences in the mean rectal temperatures or the mean respiratory scores 
between the groups. There were no significant differences between the average daily weight 
gains of the groups of pigs up to six weeks after they had been inoculated. 
Antibody response 
All pigs were negative for PCV-2-specific antibodies when they were inoculated at eight 
weeks of age, and the uninfected pigs in group 8 remained seronegative for PCV-2 antibodies 
throughout the study. All the pigs in groups 1 to 7 seroconverted to PCV-2 between 14 and 
28 days after inoculation, and six weeks after inoculation there were no significant 
differences between the PCV-2 S/P ratios of the groups. Six weeks after they were 
inoculated, M hyopneumoniae-specific antibodies were detected in six of the 10 pigs in group 
1, six of the nine pigs in group 2, nine of the 10 pigs in group 3, nine of the 10 pigs in group 
4, four of the nine pigs in group 5, and eight of the 10 pigs in group 6. None of the 
unvaccinated pigs in groups 7 and 8 seroconverted to M hyopneumoniae. The average M 
hyopneumoniae S/P ratios were significantly (P<0.05) lower in groups 1 and 5 than in groups 
2, 3, 4 and 6 pigs. Six weeks after the pigs had been inoculated, all serum samples were 
tested negative for PRRSV- and porcine parvovirus-specific antibodies. 
PCV2 genomic titers 
The mean numbers of copies of the PCV-2 genome and the mean viraemia recorded 
in the infected groups are summarized in Table 2. The mean period of viraemia did not differ 
significantly the groups. Fourteen days after they had been inoculated, there were 
significantly (P<0.05) more PCV2 copies of the PCV-2 genome in the sera of the pigs in 
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groups 1, 4 and 5 than in the unvaccinated pigs of group 7 pigs; at the other times there was a 
trend towards higher numbers of copies PCV2 in the pigs in groups 1, 4 and 5 but the 
increases were not significant. 
Macroscopic and microscopic lesions 
The gross lesions were limited to mildly to moderately enlarged lymph nodes in the 
PCV-2-inoculated pigs, but there were no significant differences between the vaccinated or 
unvaccinated inoculated pigs and the uninfected control pigs.  
The microscopic lesions are summarized in Tables 3 and 4. The lesions in the lymph 
nodes were characterised by mild to severe lymphoid depletion with loss of follicle definition 
in the affected pigs in groups 1 and 5, and by mild to moderate lymphoid depletion in groups 
2, 3, 4, 6 and 7. The overall mean (se) severity of the lymphoid depletion, including the 
affected and unaffected pigs within the groups, was significantly (P<0.05) greater in groups 4 
(1.5 [0.2]) 5 (1.6 [0.4]), and 6 (1.3 [0.2]) than in groups 7 (0.6 [0.2]) and 8 (0.0 [0.0]). There 
was mild to moderate histiocytic to granulomatous infiltration of lymphoid tissues (Figs 1, 2) 
and histiocytic replacement of follicles (Fig 3). Small numbers of macrophages and 
multinucleated giant cells contained spherical, basophil, intracytoplamic inclusion bodies. No 
bacteria were isolated by routine culture, and acid-fast stains were negative. 
There was mild to moderate depletion and mild to moderate histiocytic inflammation 
in tonsils and spleen in the vaccinated and inoculated pigs in groups 1 to 6, and mild 
lymphoid depletion and mild histiocytic inflammation in the unvaccinated, PCV-2-inoculated 
group 7. Among the 68 inoculated pigs, PCV-2 antigen was detected by 
immunohistochemistry in the lymph nodes of 32 (47.1 per cent), in the spleens of 12 (17.6 
per cent) and in the tonsils of 16 (23.5 per cent). 
The overall mean severity of the lymphoid lesions is summarised in Fig 4. Fourteen 
of the 68 inoculated pigs (20.6 per cent) had no evidence of lymphoid lesions, 40 (58.8 per 
cent) had mild lymphoid lesions, and 14 (20.6 per cent) had moderate PCV2-associated 
lymphoid lesions; none of the pigs had the severe lymphoid lesions characteristic of PMWS 
when they were examined postmortem, six weeks after they had been inoculated. None of the 
unvaccinated, PCV-2-inoculated pigs in group 7 had more than mild lesions (Fig 4). The 
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group mean (se) lesion scores were significantly (P<0.05) higher in groups 4 (3.1 [0.4]) and 5 
(3.3 [0.6]) than in groups 2 (1.7 [0.6]), 3 (1.5 [0.6]), and 7 (1.3 [0.3]) (Table 3).  
The lung lesions were characterised by mild to moderate, multifocal peribronchial 
lymphoid hyperplasia and mild, focal to diffuse alveolar wall thickening by macrophages and 
lymphocytes. The mean (se) severity of interstitial pneumonia was significantly (P<0.05) 
higher in groups 1 (0.9 [0.2]), 4 (1.2 [0.1]), 5 (0.9 [0.1]) and 6 (1.2 [0.2]) than in groups 7 
(0.3 [0.2]) and 8 (0.3 [0.2]).  
Among the 68 PCV-2-infected pigs, 39 (57.4 per cent) had mild to moderate 
lymphohistioctytic hepatitis, 31 (45.6 per cent) had mild to moderate lymphohistiocytic 
interstitial nephritis, and 21 (30.9 per cent)had mild to moderate lymphohistiocytic 
myocarditis. The pigs in groups 5 and 6 had a significantly (P<0.05) higher incidence of 
lymphohistiocytic interstitial nephritis compared to group 8 pigs (Table 4). The pigs in group 
4 pigs had a significantly (P<0.05) higher incidence of lymphohistiocytic myocarditis than 
the pigs in groups 3, 7 and 8 pigs (Table 4). The mean (se) severity of the lymphohistiocytic 
mycocarditis was significantly (P<0.05) higher in the pigs in groups 4 (0.6 [0.2]), 5 (0.6 
[0.2]), and 6 (0.5 [0.2]) than in the pigs in groups 7 (0.0 [0.0]) and 8 (0.0 [0.0]). The pigs in 
groups 1 and 4 had a significantly (P<0.05) higher incidence of lymphohistiocytic hepatitis 
than the pigs in group 8 (Table 4). The mean (se) severity of the lymphohistiocytic hepatitis 
was significantly (P<0.05) higher in groups 4 (0.9 [0.2]) and 5 (0.9 [0.2]) than in groups 7 
(0.3 [0.2]) and 8 (0.0 [0.0]). Mild enteritis characterised by lymphohistiocytic infiltration of 
the lamina propria was observed in a few of the pigs in groups 1 to 6, but no group-specific 
differences or trends were observed. 
 
Discussion 
The experimental reproduction of PMWS in PCV-2-infected gnotobiotic pigs treated 
with keyhole limpet hemocyanin in incomplete Freund’s adjuvant (KLH/ICFA) suggested 
that activation of the immune system is a key component in the pathogenesis of PCV-2-
induced disease (Krakowka and others 2001). Follow up studies using either KLH/ICFA 
(Ladekjær-Mikkelsen and others 2002), commercial vaccine adjuvants (Resendes and others 
2004), or complete commercial vaccines (Allan and others 2001, Kyriakis and others 2002, 
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Opriessnig and others 2003) in experimentally PCV-2-infected conventional pigs or field 
studies have given inconsistent results: PMWS in the stimulated and non-stimulated groups 
(Ladekjær-Mikkelsen and others 2002), no PCV2-associated lesions and no differences 
between the stimulated and unstimulated groups (Resendes and others 2004), and increased 
incidence of lesions and/or PMWS in the immunostimulated groups (Allan and others 2001, 
Kyriakis and others 2002, Opriessnig and others 2003). Although there have been field 
studies in which M hyopneumoniae vaccine has been used as the only source of immune 
stimulation (Allan and others 2001, Kyriakis and others 2002), the present paper describes 
the first controlled study in which one commercially available product has been administered 
at different times relative to a challenge. In contrast with the vaccinated pigs, none of the 
unvaccinated pigs in group 7 had more than mild PCV-2-associated lesions. The study of the 
study show that vaccination with a commercial M hyopneumoniae vaccine increases the 
severity of the lymphoid lesions and the quantity of PCV-2 genome in the serum of pigs 
vaccinated with two 1 ml doses of the vaccine at the time of, and two weeks after, the PCV-
2-challenge (group 4), and in pigs vaccinated with a single 2 ml dose at four weeks of age 
(group 5).  
At present, there are no commercially available PCV-2 vaccines and the 
recommendations for minimising losses associated with PMWS and other PCV-2-associated 
diseases are limited to the control of secondary infections and minimising stress by 
improving animal husbandry practices. M hyopneumoniae vaccination has been shown to be 
economically beneficial by reducing the losses associated with respiratory disease (Maes and 
others 1996, Thacker and others 2000). Coinfections with M hyopneumoniae and PCV-2 are 
commonly associated with the PRDC (Harms and others 2002). The experimental infection 
of pigs with both PCV-2 and M hyopneumoniae results in significantly more severe lesions 
and an increased incidence of PMWS (Opriessnig and others 2004b). Evidence from this 
work and others (Allan and others 2000b, Allan and others 2001, Kyriakis and others 2002, 
Opriessnig and others 2003) suggests that the use of adjuvanted vaccines such as M 
hyopneumoniae vaccines may be one of the triggers for the development of PMWS from an 
infection with PCV-2. It may be more appropriate to adjust the timing of vaccination rather 
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than to eliminate M hyopneumoniae vaccines and risk re-emergence in many herds of disease 
complexes associated with M hyopneumoniae. 
The objective of the present study was to investigate the effect of timing of a 
commercial M hyopneumoniae vaccine on the replication of PCV-2 and the development of 
associated lesions. The experiment was designed to mimic some of the one- and two-dose M 
hyopneumoniae vaccination protocols that are used by pig producers. In a previous study, the 
authors observed that the PCV-2-associated lesions in vaccinated and unvaccinated pigs were 
essentially the same 21 days after inoculation, but were significantly different after 35 days 
(Opriessnig and others 2003). In the present experiment it was decided to euthanase all pigs 
at 42 days after inoculation in order to evaluate whether the lesions had resolved or 
progressed between 35 and 42 days after inoculation. At 42 days there were no lymphoid 
lesions in 20.6 per cent of the inoculated pigs, only minimal lesions in 58.8 per cent of the 
pigs and moderate lesions in the remaining 20.6 per cent. In general, the lesions appeared to 
be in the process of resolving because there was either no PCV-2 antigen, or only small 
amounts, associated with areas of inflammation in the lymphoid tissues, mainly restricted to 
a few macrophage-like or multinucleated giant cells in the centre of the lymphoid follicles 
(Figs 2, 3).  
Vaccination of the pigs in group 4 at the time of, and two weeks after, PCV-2 
challenge significantly (P<0.05) increased the severity of the lesions in lymphoid tissues, the 
numbers of copies of the PCV-2 genome in serum at 14 days after inoculation, the incidence 
of lymphohistiocytic myocarditis, and the severity of lymphohistiocytic myocarditis, 
lymphohistiocytic hepatitis, and interstitial pneumonia in comparison with the PCV-2-
inoculated, unvaccinated pigs in group 7. Vaccination of the pigs in group 1 at two and four 
weeks of age also induced significantly (P<0.05) more copies of the PCV-2 genome in their 
serum at 14 days after inoculation and more severe interstitial pneumonia than in the pigs in 
group 7, even though the interval between their vaccination and challenge was longer than in 
the other groups. It is uncertain whether the lesions would have been even more severe if the 
pigs had been vaccinated at one and three weeks of age, as is commonly done in Europe, or if 
they had been challenged earlier.  
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Vaccination of the pigs in group 2 at four an six weeks of age (four an dtwo weeks 
before they were challenged), and of the pigs in group 3 at six and eight weeks of age, had 
little influence on the PCV-2-associated lesions 42 days after they were challenged. The 
incidence and severity of the microscopic lesions in these groups were not different from 
those in the unvaccinated, PCV-2-inoculated group 7 or in the uninfected group 8. The 
results in group 3 differ from those observed in a previous study in which the same protocol 
induced significantly more severe lesions than were observed in unvaccinated pigs 
(Opriessnig and others 2003). One explanation for this difference might be that in the 
precious study two vaccines (against A pleuropneumoniae and M hyopneumoniae) were 
administered simultaneously. The products and adjuvant used in both studies were from the 
same manufacturer, but the A pleuropneumoniae vaccine contained a different adjuvant 
(paraffin) and probably other immune-modulating substances such as lipopolysaccharide. 
Acting together, the two vaccines might have provided a stronger immune stimulus than the 
M hyopneumoniae product alone.  
Whether the single-dose (2 ml) regimens were administered at four weeks of age 
(group 5) or at eight weeks of age (group 6) made no difference to the severity of the lesions. 
Both single-dose regimens induced significantly (P<0.05) more severe lymphoid depletion, 
interstitial pneumonia and myocarditis, and a higher incidence of lymphohistiocytic nephritis 
than was observed in the unvaccinated pigs in group 7.The pigs in group 5 had significantly 
(P<0.05) more copies of the PCV-2 genome in serum 14 days after being challenged, and the 
lesions of lymphohistiocytic hepatitis and the overall PCV-2-associated lymphoid lesions 
were more severe compared to the unvaccinated pigs in group 7.  
The control of PCV-2-associated disease remains a challenge for veterinarians. 
Several factors, including immune stimulation in the form of commonly used vaccines, or 
coinfections with porcine parvovirus (Allan and others 1999, Kennedy and others 2000, 
Krakowka and others 2000, Opriessnig and others 2004a), PRRSV (Allan and others 2000a, 
Harms and others 2001, Rovira and others 2002), or M hyopneumoniae (Opriessnig and 
others 2004b) have been shown to increase disease associated with PCV-2. Other factors, 
including the infectious dose, the type of vaccine adjuvant, the age of the pigs when they are 
infected and their genetic susceptibility, require further investigation. No clinical signs of 
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PMWS were reproduced during this study, suggesting that the M hyopneumoniae bacterin 
used probably plays a relatively minor role in the pathogenesis of PCV-2-associated disease. 
However, the experiment used healthy, early-weaned pigs housed under strictly-controlled 
environment conditions without additional stressors or other infections, conditions that are 
quite different from those of field-based experiments. Nevertheless, most of the pigs 
developed the characteristic microscopic lesions of PMWS. Pig producers with herds that 
have suffered recurrent outbreaks of disease associated with PCV-2 should consider 
determining approximately when the pigs in the herd typically become infected with PCV-2, 
so that the effect of the timing of vaccination can be taken into account in trying to minimize 
the effects of PCV-2associated disease. However, this study was carried out using only one 
commercial M hyopneumoniae vaccine, and any inferences on the optimal timing of vaccine 
administration may be applicable to this vaccine only.  
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TABLE 1. Age in weeks at which the pigs in each group were vaccinated with a 
Mycoplasma hyopneumoniae bacterin and inoculated with porcine circovirus type 2 (PCV-2) 
Vaccination  
 
Group 
 
Number 
of pigs 
Age at  
first dose 
 
Volume (ml)
Age at  
second dosee 
 
Volume (ml) 
Age at  
inoculation 
with PCV-2*
1 10 2 1 4 1 8 
2 9 4 1 6 1 8 
3 10 6 1 8 1 8 
4 10 8 1 10 1 8 
5 9 4 2 - - 8 
6 10 8 2 - - 8 
7 10 - - - - 8 
8 10 - - - - - 
* 105.1 TCID50 of field isolate ISU-40895 
- None 
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TABLE 2. Mean (se) log porcine circovirus type 2 genome copy numbers/ml serum in the 
pigs of groups 1 to 7 at seven, 14, 21, 28, 35 and 42 days afer they were inoculated, and the 
mean (se) period of viraemia 
Days after inoculation  
Group 7 14 21 28 35 42 
Period of  
viraemia (weeks)
1 5.0±0.3 6.0±0.2a 5.3±0.3 5.6±0.3 4.9±0.2 4.7±0.2 5.6±0.22 
2 3.8±0.8 5.4±0.3a,b 4.6±0.3 4.9±0.5 4.4±0.4 3.7±0.5 4.0±0.71 
3 4.2±0.7 5.3±0.3a,b 4.6±0.4 4.7±0.5 4.8±0.4 3.7±0.6 4.2±0.63 
4 4.9±0.3 6.1±0.3a 5.2±0.3 5.7±0.4 5.4±0.4 4.4±0.3 5.3±0.40 
5 4.3±0.7 6.2±0.3a 5.2±0.4 5.4±0.5 5.4±0.5 4.3±0.4 4.8±0.64 
6 4.9±0.6 5.6±0.3a,b 5.0±0.3 5.5±0.3 4.8±0.3 4.7±0.3 5.1±0.50 
7 3.4±0.7 5.0±0.3b 4.5±0.4 4.5±0.3 4.7±0.3 4.0±0.4 4.0±0.77 
a, b Different superscripts within each column indicate significant (P<0.05) differences 
between groups  
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TABLE 3. Incidence (number affected/number examined) and mean severity of microscopic lesions in the lymphoid tissues of the 
pigs in groups 1 to 8, 42 days after they were inoculated with porcine circovirus type 2 (PCV-2)  
Lymph nodes Tonsil Spleen  
Group          Depletion Inflammation IHC Depletion Inflammation IHC Depletion Inflammation IHC
Mean (se) lymphoid 
Score (0 to 9)* 
1 7/10 (1.0) 6/10 (0.9) 4/10 (0.4) 3/10 (0.4) 3/10 (0.3) 3/10 (0.3) 6/10 (0.6) 6/10 (0.8) 2/10 (0.2) 2.0±0.5a,b
2 
 
 
 
 
 
6/9 (0.9) 3/9 (0.4) 4/9 (0.7) 1/9 (0.1) 2/9 (0.2) 2/9 (0.4) 5/9 (0.7) 3/9 (0.3) 2/9 (0.2) 1.7±0.6b
3 5/10 (0.7) 5/10 (0.6) 2/10 (0.3) 1/10 (0.2) 3/10 (0.4) 2/10 (0.3) 6/10 (0.6) 5/10 (0.7) 2/10 (0.2) 1.5±0.6b
4 10/10 (1.5) 10/10 (1.2) 5/10 (0.9) 5/10 (0.5) 4/10 (0.4) 3/10 (0.5) 8/10 (1.2) 6/10 (0.7) 3/10 (0.4) 3.1±0.4a
5 7/9 (1.6) 8/9 (1.3) 5/9 (1.0) 4/9 (0.4) 4/9 (0.6) 4/9 (0.6) 8/9 (1.1) 6/9 (0.8) 2/9 (0.2) 3.3±0.6a
6 9/10 (1.3) 6/10 (0.8) 6/10 (0.7) 2/10 (0.2) 1/10 (0.1) 1/10 (0.1) 4/10 (0.5) 2/10 (0.2) 1/10 (0.1) 2.1±0.5a,b
7 5/10 (0.6) 4/10 (0.5) 6/10 (0.6) 0/10 (0.0) 1/10 (0.1) 1/10 (0.1) 5/10 (0.5) 1/10 (0.1) 0/10 (0.0) 1.3±0.3b
8 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 0.0±0.0c
*Mean (se) group score for depletion, histiocytic inflammation and PCV-2-antigen associated with the lesions as determined by immunohistochemistry 
(IHC) 0 Normal, 1 to 3 Mild, 4 to 6 Moderate, 7-9 Severe  
a, b, c, Groups with different superscripts are significantly different
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TABLE 4. Incidence (number affected/number examined) and mean severity of microscopic 
lesions in the lungs, heart, kidney and liver of the pigs in groups 1 to 8, 42 days after they 
were inoculated with porcine circovirus type 2 
 
Group 
Interstitial 
pneumonia 
Lymphohistiocytic 
Myocarditis 
Lymphohistiocytic 
interstitial nephritis
Lymphohistiocytic 
Hepatitis 
1 8/10 (0.9) 2/10 (0.2) 6/10 (1.1) 7/10 (0.7) 
2 4/9 (0.4) 2/9 (0.2) 3/9 (0.6) 4/9 (0.4) 
3 5/10 (0.7) 1/10 (0.2) 2/10 (0.3) 5/10 (0.5) 
4 10/10 (1.2) 7/10 (0.6) 4/10 (0.6) 8/10 (0.9) 
5 8/9 (0.9) 4/9 (0.6) 7/9 (1.1) 7/9 (0.9) 
6 9/10 (1.2) 5/10 (0.5) 7/10 (0.8) 5/10 (0.7) 
7 3/10 (0.3) 0/10 (0.0) 2/10 (0.2) 2/10 (0.3) 
8 3/10 (0.3) 0/10 (0.0) 0/10 (0.0) 0/10 (0.0) 
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FIG 1: Mild histiocytic infiltration in a lymph node follicle of a pig from group 4. 
Haematoxylin and eosin. × 200. Inset: Moderate to large numbers of porcine circovirus type 
2 (PCV-2) antigen-positive cells resemble macrophage-like cells. Immunohistochemical 
staining with anti-PCV-2 polyclonal antibody; streptavidin-biotin-peroxidase method 
counterstained with haematoxylin. × 500. 
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FIG 2: Mild lymphoid depletion and moderate histiocytic and granulomatous inflammation 
in a lymph node follicle of a pig from group 5. Haematoxylin and eosin.  
× 200. Inset: Weak porcine circovirus type 2 (PCV-2)-antigen-positive cytoplasm (arrow) of 
a multinucleated giant cell. Immunohistochemical staining with anti-PCV-2 polyclonal 
antibody; streptavidin-biotin-peroxidase method counterstained with haematoxylin.  
× 500. 
 
  
FIG 3: Histiocytic and granulomatous replacement of a lymph node follicle in pig from 
group 5. Haematoxylin and eosin × 200. Inset: No detectable porcine circovirus type 2 (PCV-
2) antigen. Immunohistochemical staining with anti-PCV-2 polyclonal antibody; 
streptavidin-biotin-peroxidase method counterstained with haematoxylin. × 500. 
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FIG 4: Percentages of the pigs in groups 1 to 7 that had zero lesion scores (normal), or mild, moderate or severe lesion scores for 
lymphoid depletion, histiocytic inflammation and porcine circovirus type 2 (PCV-2) antigen, 42 days after they had been 
inoculated with PCV-2 
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CHAPTER 6.  PORCINE CIRCOVIRUS TYPE 2-INFECTION DECREASES THE 
EFFICACY OF A MODIFIED LIVE PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS VACCINE 
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ABSTRACT 
Porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia is 
a major problem and vaccination is used to reduce losses associated with PRRSV. Porcine 
circovirus type 2 (PCV2) causes lymphoid depletion and there is concern this adversely 
affects the immune response. The objective of this study was to investigate the effect of 
PCV2 infection on efficacy of modified live virus (MLV) PRRSV vaccine. Sixty-nine, 2-
week-old pigs were randomly assigned to one of seven groups of 9-10 pigs each. At 6 weeks 
of age, pigs in groups 4, 5 and 6 were inoculated intranasally with PCV2 ISU-40895. At 8 
weeks of age, groups 3, 4, 6, and 7 were vaccinated with a MLV PRRSV vaccine. At 12 
weeks of age, groups 2, 3, and 4 were challenged with PRRSV-SDSU73. All pigs were 
necropsied 14 days post PRRSV challenge. PCV2-infected, PRRSV-vaccinated and PRRSV-
challenged pigs had significantly (P < 0.05) more severe macroscopic lung lesions compared 
to the PRRSV-vaccinated and PRRSV-challenged pigs that were not exposed to PCV2 prior 
to PRRSV vaccination. Non-vaccinated-PRRSV-infected pigs had significantly (P < 0.001) 
higher incidence of PRRSV-antigen in lungs compared to all other groups except the group 
infected with PCV2 prior to PRRSV vaccination and challenge. The nonvaccinated-PRRSV-
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challenged group and the group challenged with PCV2 prior to PRRSV vaccination and 
challenge had significantly (P < 0.001) lower average daily weight gain compared to controls 
and the vaccinated groups. This work suggests that PCV2-infection has an adverse effect on 
development of protective immunity induced by PRRSV vaccine.   
 
INTRODUCTION 
Porcine circovirus type 2 (PCV2), a small, nonenveloped, single-stranded DNA virus 
with a circular genome (48), is ubiquitous in the global swine population (2). The hallmark 
microscopic lesions of PCV2-infection are lymphoid depletion and histiocytic replacement of 
lymphoid follicles in the lymphoid tissues and variable degrees of lymphohistiocytic 
inflammation in a variety of organs (45). PCV2 is associated with postweaning multisystemic 
wasting syndrome (PMWS) (1, 12) which is characterized by moderate to excessive loss of 
body condition often accompanied by respiratory disease in nursery and grow-to-finish pigs 
(17). The incidence of PCV2-associated disease in affected herds generally varies from 4% to 
up to 30% in individual farms (2, 17, 23). On most farms, PCV2-infection is widespread and 
subclinical. 
Studies on pigs with naturally-acquired PMWS and PCV2-infection showed 
leukopenia characterized by decreased lymphocyte counts compared to healthy control pigs 
(10, 42, 43). Segalés et al. (42) found a significant decrease in the number of CD3+ and 
CD4+ cells in PMWS-affected pigs compared to clinically healthy pigs whereas no 
difference was found in the numbers of CD8+ cells. Darwich et al. (10) compared clinically 
PMWS-affected pigs that were infected by PCV2, wasted pigs that were not infected by 
PCV2, and healthy control pigs and found that, regardless of PCV2 infection status, wasted 
pigs in general had decreased CD4+ cells. However, only PMWS-affected and PCV2-
infected pigs had decreased numbers of CD8+ and double–positive cells. The amount of 
PCV2 in lymphoid tissues was correlated to the degree of lymphoid depletion and to the 
decrease in IgM+ and CD8+ cells in peripheral blood (10). Further detailed assessment of 
PCV2-induced alteration of cells of the immune system in pigs experimentally-infected with 
PCV2 demonstrated a PCV2-induced lymphopenia present only in pigs that developed 
clinical PMWS but not in those that were subclinically-infected (29). The mean lymphocyte 
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levels of PCV2-infected pigs decreased below that of the control pigs which was most 
evident at 10 days post inoculation (DPI). A prominent lymphopenia was present in PMWS-
affected pigs starting from DPI 14 until death of the pigs. All T-cell subpopulations were 
found to be susceptible to PCV2-induced lymphopenia (29).  
Lymphoid depletion is a necessary and hallmark lesion of PCV2-associated PMWS 
(45); however, lymphoid depletion, to some degree, can also be observed in subclinically 
infected pigs (38). Studies on pigs with naturally acquired PMWS revealed that there was a 
reduction in number of interfollicular dendritic cells and a reduction or absence of B cells 
and CD4+ cells (40). Chianini et al. (8) graded lymphoid lesions in pigs with natural PMWS 
as mild, moderate, and severe and showed a reduction or loss of B and T lymphocytes. It has 
been suggested that PCV2-associated lymphoid depletion compromises the immune system 
of the pig. This is supported by case reports describing PCV2-infection associated with 
coinfecting pathogens that are typically indicative of an immunosuppressed stage of the host 
such as Pneumocystitis carinii (9), Chlamydia spp, (6), pulmonary aspergillosis (44); and 
Cryptosporidium parvum (30). 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the major 
contributor to the porcine respiratory disease syndrome complex (PRDC) in the US (18) and 
is estimated to cost the US swine industry $560 million annually (28). PRRSV is an 
enveloped, positive sense, single-stranded RNA virus classified in the order Nidovirales, 
family Arteriviridae, genus Arterivirus (7). Clinical signs of PRRSV-infection in growing 
pigs include fever, sneezing, dyspnea, tachypnea, anorexia, and decreased weight gain. 
Vaccination is a common procedure to minimize economic losses associated with this 
pathogen and vaccines have proven to be effective in experimental trials (33) and field 
studies (24, 47). However, PRRSV vaccine failures are not uncommon in the field and 
PRRSV continues to be the most common primary pathogen in cases of PRDC (18). PRRSV 
vaccine failure may be due to lack of cross-protection between the vaccine and field strain or 
failure of the pig to mount an effective response to PRRSV vaccine.  
The effect of PCV2 infection on PRRSV vaccine efficacy has, to our knowledge, not 
been reported in the literature and the objective of this study was to investigate the effects of 
PCV2-infection on the efficacy of a modified-live-PRRSV (PRRS-MLV)-vaccine.  
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MATERIALS AND METHODS 
Animals. Sixty-nine, segregated early weaned, specific-pathogen-free (SPF), 
crossbred pigs were brought to the research facility at Iowa State University at approximately 
12-14 days of age. The pigs were purchased from a herd free of PRRSV based on regular 
serological testing. PCV2-associated disease was not observed in the source herd or the 
offspring of this herd.  
Housing and feeding. On the day of arrival at the research facility, the pigs were 
randomly assigned to 7 groups and rooms with 9-10 pigs in each room. The pen size was 3 × 
3.6 m and each pen contained a nipple waterer and one self feeder. The rooms were identical 
in size and environmental controls. The pigs were fed a complete, phased, corn- and 
soybean-based ration.  
Experimental design, inoculations and vaccination. The experimental design is 
summarized in Table 1. Pigs were vaccinated with MLV-PRRSV vaccine at 14 days post 
PCV2-infection when PCV2-associated lymphoid depletion is typically most severe and the 
amount of PCV2 genomic copy numbers in serum is typically highest in this experimental 
SPF pig model (32, 34, 36).  
The experimental protocols were approved by the Iowa State University Committee 
on Animal Care. After waning of the passively acquired antibodies to PCV2 at 6 weeks of 
age, pigs in groups 4, 5, and 6 were inoculated intranasally with 3 ml of the PCV2 ISU-
40895. At 8 weeks of age, pigs in groups 3, 4, 6, and 7 were vaccinated intramuscularly in 
the right neck with 2 ml of the Ingelvac® PRRS ATP MLV vaccine (Boehringer Ingelheim 
Vetmedica, Inc., St. Joseph, MO, USA) according to the manufacturer’s recommendations. 
At 12 weeks of age, each pig in groups 2, 3, and 4 received 2 ml of PRRSV-SDSU73 
intranasally.  
PCV2 inoculum. The PCV2-virus stock was generated through direct transfection of 
PK-15 cells with an infectious DNA clone of PCV2 ISU-40895 as previously described (13). 
PCV2 isolate ISU-40895 was isolated in 1998 from a wasting pig with respiratory disease in 
Iowa. The pig came from a group of 300 pigs with the history of increased respiratory 
disease and lethargy with approximately 50% of the pigs affected (14). Inoculation was done 
with the PCV2-virus stock at a dose of 105.2 50% tissue culture infective dose (TCID50) per 
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ml. 
PRRSV inoculum. High virulent PRRSV-isolate SDSU73 was isolated from a sow 
herd with a high prevalence of abortions and higher than usual sow mortality in 1996 (26). 
Passage 2 of PRRSV-SDSU73 (Courtesy of Dr. M. Roof, BIVI) at a titer of 105 TCID50 per 
ml was used for inoculation of the pigs. 
Serology. Blood samples were collected on arrival of the pigs followed by weekly 
blood collections. Sera collected at 2 (arrival), 8 (PRRSV-vaccination), 9, 10, 11, 12 
(PRRSV-inoculation), 13, and during necropsy at 14 weeks of age were tested for the 
presence of PRRSV-specific antibodies by a commercial PRRSV ELISA (HerdChek PRRS 
virus antibody test kit; Idexx Laboratories Inc., Westbrook, MA, USA). The optical density 
at 405 nm greater or equal to 0.4 was set as the ELISA cut-off value. A fluorescent focus 
neutralization (FFN) assay to determine the amount of PRRSV-SDSU73 neutralizing 
antibodies was done on sera from all PRRSV vaccinated groups (3, 4, 6, and 7) collected on 
the day of vaccination, and at 7, 14, 21, and 28 days post vaccination according to protocols 
used at the Iowa State University Veterinary Diagnostic Laboratory.   
Sera collected at 2 (arrival of the pigs), 6 (PCV2-inoculation), and at 14 weeks of age 
(necropsy) were tested for the presence of PCV2-specific antibodies by a PCV2-enzyme 
linked immunosorbent assay (ELISA) based on the recombinant ORF2 capsid protein of 
PCV2 (27). Samples were considered positive if the calculated sample-to-positive (S/P) ratio 
was 0.2 or greater. 
Clinical evaluation. The pigs were monitored daily and scored for severity of clinical 
respiratory disease ranging from 0 = normal to 6= severe dyspnea and abdominal breathing 
(16). In addition, pigs were evaluated daily for clinical signs including sneezing and jaundice. 
Rectal temperatures, wasting, and behavioral changes such as lethargy were recorded daily. 
The pigs were weighed at weekly intervals. 
PCV2 DNA quantification. DNA-extraction on sera collected at the day of PRRSV 
challenge and at 14 days post PRRSV challenge, and on bronchoalveolar lavage fluid 
collected during necropsy was performed using the QIAamp® DNA Mini Kit (Qiagen, 
Valencia, CA). DNA-extracts were used for quantification of the amount of PCV2 genomic 
DNA by real-time PCR as previously described (36).
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PRRSV RNA quantification. RNA-extraction on sera collected 7 and 14 days post 
PRRSV challenge and on bronchoalveolar lung lavage fluid collected during necropsy was 
performed using the QIAamp® Viral RNA Mini Kit (Qiagen). Primer-probe combinations 
specific for the North American PRRSV [PRRSORF7F (TGTCAGATTCAGGGAGRA-
TAAGTTAC), PRRSORF7R (ATCARGCGCACAGTRTGATGC), and PRRSORF7P 
(6FAM-TGTGGAGTTYAGTYTGCC)] and the European PRRSV [LELYRTF (GCTGA-
AGATGACRTYCGGCA), LELYRTR (GCAGTYCCTGCGCCTTGAT), and LELYRTP 
(VIC-TGCAATCGATYCAGAC LELYRTP)] were used for the real time reverse-
transcriptase PCR. Each PCR reaction consisted of 2.5µl of the RNA template and 22.5µl 
PCR master mix. The PCR master mix contained 0.35µl QuantiTect® Probe RT-PCR kit 
(Qiagen) with the magnesium chloride concentration adjusted to 6 mM. Forward and reverse 
primers and detection probes were used at concentrations of 800, 800 and 275 nM, and 400, 
400, and 100 nM for the North American and European PRRSV, respectively. An additional 
0.25 µl (1.25U) of HotStarTaq (Qiagen) was added to each reaction. Each reaction included 
five progressive 1:10 dilutions of a known copy number of PRRSV that served to generate a 
standard curve. Each plate was run in a sequence detection system (GeneAmp 7900, Applied 
Biosystem) under company-specific conditions (30 min at 50°C, 15 min at 95°C, followed by 
35 cycles of 15 seconds at 94°C and 60 seconds at 60°C).  
Necropsy. Necropsy was performed at 14 days post PRRSV challenge when the pigs 
were 14 weeks old. Pathologists were blinded to treatment group for evaluation of gross 
lesions. The total amount of lung affected by pneumonia (0-100% of the lung affected by 
grossly visible pneumonia) was recorded for each pig at necropsy in a blinded fashion as 
described (16). The scoring system is based on the approximate volume that each lung lobe 
contributes to the entire lung: the right cranial lobe, right middle lobe, cranial part of the left 
cranial lobe, and the caudal part of the left cranial lobe contribute 10% each to the total lung 
volume, the accessory lobe contributes 5%, and the right and left caudal lobes contribute 
27.5% each (16). The size of lymph nodes [score range from 0-3; 0 (normal), 1 (two times 
the normal size), 2 (three times the normal size), 3 (four times the normal size)] was 
estimated and recorded for each pig (36). Bronchoalveolar lavage (BAL) for bacterial and 
virologic examinations was collected as previously described using fifty milliliters of sterile 
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phosphate-buffered saline for each lung (25). Sections of lungs, lymph nodes (superficial 
inguinal, mediastinal, tracheobronchial, mesenteric), tonsil, thymus, ileum, kidney, colon, 
spleen, and liver were collected at necropsy and fixed in 10% neutral-buffered formalin and 
routinely processed for histological examination.  
Histopathology. Microscopic lesions were evaluated in a blinded fashion. Lung 
sections were scored for presence and severity of interstitial pneumonia ranging from 0 to 6 
(0=normal; 1=mild multifocal; 2=mild diffuse; 3=moderate multifocal; 4=moderate diffuse; 
5=severe multifocal; 6=severe diffuse) (16). Sections of heart, liver, kidney, ileum, and colon 
were evaluated for the presence of lymphohistiocytic inflammation and scored from 0=none 
to 3=severe (32). Lymphoid tissues including lymph nodes, tonsil, and spleen were evaluated 
for the presence of lymphoid depletion ranging from 0=normal to 3=severe and histiocytic 
inflammation and replacement of follicles ranging from 0=normal to 3=severe (32).
Immunohistochemistry (IHC) for detection of PRRSV and for PCV2 antigens. 
IHC for detection of PRRSV specific antigen was performed on formalin-fixed and paraffin-
embedded lung tissue sections as previously described (15). Similarly, IHC for detection of 
PCV2 specific antigen was performed on formalin-fixed and paraffin-embedded lung tissue 
sections using a rabbit polyclonal antiserum as previously described (46). 
Statistical analysis. Prior to data analysis, descriptive statistics were performed to 
assess the overall quality of the data. Continuous data (weight, rectal temperature, 
macroscopic lung lesions and S:P ratios) were analyzed with a one-way analysis of variance 
(ANOVA). If a one-way ANOVA was significant (P < 0.05), pairwise testing using the 
Tukey’s adjustment was performed. Discrete data (microscopic lesions, clinical observations) 
were analyzed by the nonparametric Kruskal-Wallis one-way ANOVA. If the nonparametric 
ANOVA was significant (P < 0.05), Wilcoxon tests were used for pairwise testing. Response 
feature analysis was performed to account for clinical observations. The observations 
obtained after PRRSV-challenge were combined and average for each pig, and differences 
among groups were compared by using a nonparametric Kruskal-Wallis ANOVA. Fisher’s 
exact test was used to evaluate differences in incidence. 
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RESULTS 
Clinical disease. Clinical disease was characterized by increased rectal temperatures, 
by respiratory disease with labored breathing and sneezing, and by reduced average daily 
weight gain after PRRSV challenge. The NV-PRRSV, the PCV2-V-PRRSV, and V-PRRSV 
groups had increased rectal temperatures after PRRSV challenge. The temperatures ranged 
from 40.1 to 41.8ºC with peak temperatures at 5 to 7 days post PRRSV challenge with 80% 
of the pigs febrile. After challenge there were significant (P < 0.001) differences in mean 
rectal temperatures between groups. The NV-PRRSV pigs had highest rectal temperatures, 
and all PRRSV challenged groups had significantly higher rectal temperatures compared to 
non-PRRSV inoculated groups.  
After PRRSV challenge, the highest average group respiratory scores were observed 
in the NV-PRRSV pigs (mean score 1.6), in the PCV2-V-PRRSV pigs (mean score 1.2) and 
in the V-PRRSV pigs (mean score 1.1) which were all significantly (P < 0.0001) higher 
compared to the other groups but not different from each other (Data not shown).  
The average daily weight gain is summarized in Table 2. From the day of PRRSV 
vaccination to the day of PRRSV-challenge, the average daily gain was not significantly (P = 
0.24) different between the groups. From the day of PRRSV challenge to the day of 
necropsy, NV-PRRSV pigs had significantly (P < 0.0001) lower average daily gain 
compared to all other groups. The average weight gain in the V-PRRSV and the PCV2-V-
PRRSV pigs was not different from each other but were significantly (P < 0.001) lower 
compared to the CONTROLS, PCV2, PCV2-V, and V groups. When the total average 
weight gain for the period from the day of PRRSV vaccination until necropsy was evaluated, 
the NV-PRRSV and PCV2-V-PRRSV pigs had significantly (P < 0.001) lower average daily 
gain compared to CONTROLS and the V groups.  
Antibody response. All pigs were free of PRRSV-specific antibodies at arrival in the 
research facility.  The V-PRRSV, PCV2-V-PRRSV, and PCV2-V pigs seroconverted to 
PRRSV between 7 to 21 days post vaccination. The mean group S/P ratios were numerically 
but not significantly lower in the PCV2-V-PRRSV group and in the V-PCV2 group 
compared to the V-PRRSV group. The non-vaccinated and non-PRRSV challenged groups 
(CONTROLS, PCV2) remained seronegative until the termination of the experiment. The 
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NV-PRRSV pigs seroconverted within 2 weeks post PRRSV challenge. Neutralizing 
antibodies to SDSU-73 were not detected in any of the vaccinated pigs prior to PRRSV 
challenge. 
At arrival, the majority of the pigs had maternal antibodies to PCV2, which waned 
over the following weeks. On the day of PCV2 inoculation, all pigs were negative for PCV2-
specific antibodies. Seroconversion to PCV2 was observed at the termination of the study in 
10/10 PCV2-V-PRRSV pigs, 9/10 PCV2-V pigs, and 7/10 PCV2 pigs. The mean S/P ratios 
were significantly (P < 0.001) higher in the PCV2-V-PRRSV (0.87 ± 0.08) group compared 
to PCV2 (0.41 ± 0.09) and PCV2-V (0.49 ± 0.05) groups.  
Amount and incidence of PRRSV-RNA detection. The CONTROLS and PCV2 
groups were negative for PRRSV-RNA in serum and lung lavage fluid (Table 3). The 
incidence of PRRSV-viremic pigs was 9/9 for NV-PRRSV, 9/10 for V-PRRSV, 10/10 for 
PCV2-V-PRRSV, 3/10 for PCV2-V, and 2/10 for the V group on DPI 7. The incidence of 
PRRSV-RNA-positive pigs was 8/9 for NV-PRRSV, 6/10 for V-PRRSV, 5/10 for PCV2-V-
PRRSV, 0/10 for PCV2-V, and was 0/10 for V group on DPI 14. The amount of PRRSV-
RNA in serum was significantly (P < 0.001) higher in the NV-PRRSV group compared to 
that of the V-PRRSV and PCV2-V-PRRSV groups at 7 and at 14 days post PRRSV-infection 
(Figure 1). The incidence of PRRSV-RNA-positive lavage fluids is summarized in Table 3. 
There was a significantly (P < 0.05) higher incidence of PRRSV-RNA positive BAL in the 
NV-PRRSV, V-PRRSV, PCV2-V-PRRSV, and PCV2-V pigs compared to the V pigs. There 
was no significant (P > 0.05) difference in group mean amount of PRRSV-RNA in BAL 
fluids between NV-PRRSV, V-PRRSV, and PCV2-V-PRRSV pigs.  
Amount and incidence of PCV2-DNA detection. At the day of PRRSV challenge, 
PCV2-DNA were detected in 8/10 PCV2-V-PRRSV pigs, in 7/10 PCV2-V pigs, and in 6/10 
PCV2 pigs. At the day of necropsy, PCV2-DNA were detected in 9/10 PCV2-V-PRRSV 
pigs, in 7/10 PCV2-V pigs, and in 5/10 PCV2 pigs. All PCV2-infected pigs were positive for 
PCV2-DNA on BAL (Table 3). The amount of PCV2-antigen was not different (P > 0.05) 
among the three groups.  
Macroscopic lesions. PRRSV-induced macroscopic lung lesions were characterized 
by failure of the lungs to collapse and by focal-to-diffuse, mottled-tan, well-to-poorly 
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demarcated areas of pneumonia. There were significant differences among groups in the 
mean percentage of lung macroscopically affected by pneumonia as summarized in Table 3.  
Microscopic lesions. PRRSV challenge induced moderate-to-severe lung lesions 
characterized by type 2 pneumocyte hypertrophy and hyperplasia, septal infiltration with 
mononuclear cells and increased amounts of necrotic alveolar exudate. No or mild lung 
lesions characterized by septal infiltration with mononuclear cells and mild peribronchiolar 
fibroplasia and histiocytic infiltrates were observed in singular PCV2-inoculated pigs in this 
study consistent with our previous studies (32, 36).  
PRRSV and PCV2-antigen in lungs. The incidence of PRRSV and PCV2-antigen 
detection in lungs as determined by IHC stains is summarized in Table 3. NV-PRRSV pigs 
had a significantly (P < 0.001) higher incidence of PRRSV-antigen detection compared to all 
other groups except PCV2-V-PRRSV. 
 
DISCUSSION 
PCV2 infection is widespread and PCV2 is now commonly associated with varying 
conditions in pigs such as PMWS, enteritis, abortion, and respiratory disease. Another 
important impact of PCV2 may actually be its adverse effect on the immune system in the 
form of compromising the development of a protective immune response to commercial 
vaccines commonly used on pigs around the time of PCV2 infection. PCV2 infection 
commonly occurs in pigs at 6 to 12 weeks of age in the US (37). Vaccines commonly used at 
that time include Mycoplasma hyopneumoniae, swine influenza virus, and PRRSV. Porcine 
respiratory disease complex (PRDC) is a major problem in the pig industry and PRRSV is 
the most commonly associated primary pathogen in PRDC. Coinfections with PRRSV and 
PCV2 are commonly observed in the field (37, 49). 
The overall goal of this study was to investigate the effect of PCV2 infection on the 
efficacy of the PRRS MLV vaccine to protect pigs against PRRSV-induced clinical disease 
and lesions. The vaccination protocol used in this study has been shown previously to be 
effective in reducing clinical disease and lesions associated with PRRSV SDSU73-infection 
(33).  
The effect of other immunomodulating pathogens such as PRRSV (11, 22) or 
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Trypanosma evansi (T. evansi) (20) on vaccine efficacy has been investigated. Pigs were 
inoculated with a European PRRSV strain, vaccinated with a pseudorabies virus (PRV) 
vaccine 2 weeks later, and challenged with PRV 10 weeks after PRRSV-inoculation. The 
results of that study indicated that the lymphoproliferative response was quicker and longer 
in pigs that were not previously infected by PRRSV. However, PRRSV infection did not 
inhibit the vaccine efficacy (11). Another study investigated the effect of PRRSV infection 
on the antibody response to classical swine fever virus (CSFV) vaccination (22). In that 
study, pigs were vaccinated 2 days after PRRSV inoculation and it was found that the 
PRRSV-inoculated pigs had significantly lower levels of anti-CSFV-antibodies compared to 
non-PRRSV-inoculated pigs within 3-5 weeks after vaccination. Pigs infected with T. evansi 
and vaccinated four weeks later against CSFV and challenged 12 weeks after T. evansi 
infection with CSFV had significantly reduced antibody response compared to non-infected 
control pigs. However, there was no effect on growth performance or feed conversion. (20).  
In this study, differences in IgG antibody response or in presence of neutralizing 
antibodies against PRRSV were not observed between V-PRRSV and PCV2-V-PRRSV pigs. 
However, we did observe a significant (P < 0.05) increase in PRRSV-associated macroscopic 
lung lesions, a higher incidence of PRRSV-antigen in lung sections, and more severe 
microscopic PRRSV-associated lung lesions in pigs that were subclinically infected by PCV2 
at the time of PRRSV-vaccination compared to pigs that were not infected with PCV2.  
Previous studies have investigated the interaction of PCV2 and PRRSV in 
experimental models using colostrum-deprived pigs, cesarean-derived/colostrum-deprived 
(CDCD) pigs, or conventional pigs. In all these models, PCV2 and PRRSV inoculations were 
done within a narrow time window (same day, or within one week). Allan et al. (4) 
inoculated 1-2 day old colostrum-deprived pigs with PCV2 and PRRSV and observed 
upregulation of PCV2 in coinfected pigs. The replication and distribution of PRRSV in 
concurrently infected pigs was not enhanced compared to single PRRSV infected pigs (4). 
Harms et al. (19) coinfected 3-week-old CDCD pigs with PCV2 and PRRSV and showed 
that PCV2-infection increased the severity of PRRSV-induced interstitial pneumonia in 
CDCD pigs. Rovira et al. (39) inoculated 5-week-old conventional pigs with PRRSV and 
seven days later with PCV2 and confirmed that PRRSV infection enhances PCV2 
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replication. A longer duration of PRRSV viremia and a higher proportion of viremic pigs 
were observed in the coinfected pigs compared to singular PRRSV infected pigs (39). In the 
current study, PCV2 infection and PRRSV challenge were done 6 weeks apart since we were 
most interested in the PCV2-PRRSV MLV-vaccine interaction. We did not expect to observe 
a PRRSV-PCV2 interaction since we know from past PCV2 studies that PCV2-associated 
lesions typically peak at 2-3 weeks post inoculation and usually become minimal or resolved 
by 4-6 weeks post inoculation (34, 35).  
The interval of 2 weeks between PCV2 inoculation and PRRSV MLV vaccination 
was chosen because at this time we frequently observe high amounts of PCV2-genomic 
copies in serum in our pig model. A relation between PCV2 DNA load and amount of PCV2 
antigen in lymphoid lesions has been demonstrated (31). In addition, Nielsen et al. (29) found 
that the white blood cell count and the mean lymphocyte counts were significantly decreased 
at 10 DPI following experimental PCV2 infection compared to uninfected controls. Rovira et 
al. (39) found maximal PCV2 DNA loads in serum of experimentally PCV2-infected pigs at 
21 DPI. In contrast, Allan et al. (3) observed minimal amounts of PCV2 antigen in 
mesenteric lymph nodes starting at 10 DPI with increasing density and distribution of PCV2 
antigen at 14, 17, 21, and 26 DPI. 
Krakowka et al. (21) reported evidence that strong immunostimulation can upregulate 
PCV2 infection towards manifestation of clinical PMWS in the gnotobiotic pig model. 
Similar results were observed in the conventional pig model using commercially available 
adjuvanted, killed vaccines (5, 36). To our knowledge, PRRSV MLV vaccines have not yet 
been tested for possible interaction with PCV2 infection. In the current study we found no 
evidence of vaccine-induced enhancement of PCV2-associated disease. None of the PCV2-V 
pigs developed clinical disease and lungs sections were negative for the presence of PCV2-
antigen by IHC. Mild interstitial pneumonia lesions were present in a portion of the PCV2-V 
pigs; however, this was not different from CONTROLS, PCV2, or V pigs. Interestingly, 
there was a significantly (P < 0.05) higher incidence of PRRSV-RNA positive 
bronchoalveolar lavage samples in PCV2-V compared to V. However, PRRSV-antigen as 
determined by IHC was not detected in any of the PCV2-V or V pigs. We concluded that the 
use of PRRSV MLV-vaccines in subclinically PCV2-infected pigs appeared to be safe under 
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the conditions of this study. This is in contrast to the findings that PRRSV MLV vaccine 
predisposed pigs to disease associated with Streptococcus suis infection (41)  
In this study, we found that subclinical infection of SPF pigs with PCV2 prior to 
PRRSV MLV vaccination and subsequent PRRSV challenge resulted in increased PRRSV-
induced macroscopic and microscopic lung lesions. The adverse effect of PCV2 infection on 
the development of protective immunity against PRRSV and other respiratory pathogen 
vaccines may be an important factor in controlling PRDC and other diseases in growing pigs. 
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TABLE 1. Experimental design to determine the effect of porcine circovirus type 2 (PCV2) 
infection on the efficacy of porcine reproductive and respiratory syndrome virus (PRRSV) 
vaccine 
Groupa  6 weeks of age 8 weeks of age 12 weeks of age 
1 (n = 10) CONTROL - - - 
2 (n = 9) NV-PRRSV - - PRRSV 
3 (n = 10) V-PRRSV - Vaccinationb PRRSV 
4 (n = 10) PCV2-V-PRRSV PCV2 Vaccinationb PRRSV 
5 (n = 10) PCV2 PCV2 - - 
6 (n = 10) PCV2-V PCV2 Vaccinationb - 
7 (n = 10) V - Vaccinationb - 
a NV, non-vaccinated; V, vaccinated. 
b Ingelvac PRRS ATP (Boehringer Ingelheim Vetmedica Inc, St. Joseph, Missouri, USA. 
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TABLE 2. Average daily weight gain (ADG) (group mean ± SE) for the period from 
vaccination to prior to inoculation with porcine reproductive and respiratory syndrome virus 
(PRRSV) (ADG 1), post PRRSV challenge (ADG 2), and the entire period from vaccination 
to necropsy (AGD 3) 
Group ADG 1 (g) ADG 2 (g) ADG 3 (g) 
CONTROL 774.9 ± 28.8 1277.4 ± 33.3Aa 875.4 ± 29.1A
NV-PRRSV 793.2 ± 36.1 388.2 ± 108.0B 694.9 ± 36.1B
V-PRRSVb 813.5 ± 23.6 783.3 ± 47.9C 807.5 ± 20.8A,B
PCV2-V-PRRSVb 715.0 ± 34.0 711.0 ± 37.2C 714.2 ± 31.0B
PCV2 732.2 ± 38.8 1099.3 ± 32.3A,D 805.6 ± 33.1A,B
PCV2-Vb 739.6 ± 26.8 1044.3 ± 41.1D 800.6 ± 22.5A,B
Vb 797.3 ± 36.5 1138.2 ± 46.8A,D 865.5 ± 35.2A
a Values within a column with no common superscript are significantly (P < 0.0001) 
different. 
b Groups vaccinated with Ingelvac PRRS ATP modified live virus vaccine (Boehringer 
Ingelheim Vetmedica Inc, St. Joseph, Missouri). 
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Table 3: Incidence and severity of macroscopic and microscopic lung lesions and presence of porcine reproductive and respiratory 
syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) nucleic acids and antigens in lungs detected by PCR on 
bronchoalveolar lavage (BAL) and immunohistochemistry (IHC) at 14 days post PRRSV challenge. Data presented as incidence 
and group mean ± SE 
e Groups vaccinated with Ingelvac PRRS ATP modified live virus vaccine (Boehringer Ingelheim Vetmedica Inc, St. Joseph, 
Missouri). 
c Values within a column with no common superscript represent significantly (P < 0.05) different group means. 
PRRSV PCV2  
Group 
Macroscopic  
lung lesionsa
Microscopic  
lung lesionsb BAL PCR IHC 
 
BAL PCR IHC
CONTROL     1/10 (0.3±0.3)Ac 10/10 (1.2±0.1)A 0/10 NAd NA NA
NV-PRRSV     
    
   
    
   
    
9/9 (50.1±3.1)B 9/9 (4.6±0.4)B 9/9 8/9 NA NA
V-PRRSVe 10/10 (13.2±2.6)C 10/10 (2.5±0.3)A,C 10/10 0/10 NA NA
PCV2-V-PRRSVe 10/10 (31.7±5.0)D 10/10 (3.3±0.5)B,C 10/10 4/10 10/10 0/10
PCV2 4/10 (1.0±0.6)A 10/10 (1.2±0.1)A 0/10 NA 10/10 0/10
PCV2-Ve 3/10 (2.2±1.3)A,C 10/10 (1.8±0.2)A 8/10 0/10 10/10 0/10
Ve 0/10 (0.0±0.0)A 8/10 (1.2±0.3)A 2/10 0/10 NA NA
b Interstitial pneumonia score ranging from 0 (normal) to 6 (severe, diffuse). 
a Percentage of lung grossly affected by lesions ranging from 0 to 100%. 
d Not applicable. 
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FIG 1: Mean log transformed group porcine reproductive and respiratory syndrome virus 
(PRRSV) genomic copies. Error bars represent standard errors. * = significant (P < 0.001) 
differences between groups. 
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Abstract 
The objectives of this study were to determine if coinfection of segregated early 
weaned (SEW) pigs with porcine circovirus type 2 (PCV2) and porcine parvovirus (PPV) 
induces an increase in the incidence of postweaning multisystemic wasting syndrome 
(PMWS) compared to singular PCV2 infection, and to determine if vaccination against PPV 
protects pigs against PMWS associated with PCV2/PPV coinfection in SEW pigs. Seventy, 
3-week-old, SEW pigs were randomly assigned to one of five groups. Pigs in group 1 (n = 
14) served as the negative controls, group 2 pigs (n = 14) were inoculated with PCV2, group 
3 pigs (n = 12) were inoculated with PPV, group 4 (n = 16) and 5 (n = 14) pigs were 
inoculated with both PCV2 and PPV. Pigs in groups 1-3 and 5 were vaccinated with two 
doses of a killed parvovirus-leptospira-erysipelothrix (PLE) vaccine prior to inoculation. The 
PCV2/PPV-coinfected pigs (groups 4 and 5) had significantly (P < 0.05) higher and more 
persistent fevers than the singular PCV2-infected pigs. One pig in each of the coinfected 
groups developed clinical disease (fever, respiratory disease, jaundice, weight loss) 
consistent with PMWS. Lymphoid depletion was significantly (P < 0.05) more severe in the 
 
 147
dually-infected pigs at 42 days post inoculation (DPI). Vaccinated, coinfected pigs (group 5) 
remained viremic significantly (P < 0.05) longer and had higher copy numbers of genomic 
PCV2 DNA in sera at 28, 35, and 42 DPI compared to the unvaccinated coinfected pigs 
(group 4). PPV-viremia was detected only in the unvaccinated group 4 pigs. PLE-vaccination 
prevented PPV-viremia but did not prevent clinical PMWS or reduce the severity of 
lymphoid depletion in PCV2/PPV-coinfected pigs. Evidence of increased incidence of 
clinical PMWS due to vaccination was not observed in this model. 
  
1. Introduction 
Post-weaning multisystemic wasting syndrome (PMWS) is an emerging disease 
associated with porcine circovirus type 2 (PCV2). Mortality associated with PMWS ranges 
from 2 to 30% or more (Harding and Clark, 1997; Allan and Ellis, 2000). Typical clinical 
signs of PMWS are progressive weight loss, enlarged lymph nodes, and pneumonia. Less 
common signs of PMWS include diarrhea, icterus, and pallor. Characteristic microscopic 
lesions include lymphoid depletion, histiocytic replacement of follicles in lymphoid tissues, 
and mild-to-severe granulomatous inflammation in lymphoid and other organs (Allan and 
Ellis, 2000; Sorden, 2000).  
Single PCV2 infection is generally not associated with clinical disease in pigs and 
causes only mild microscopic lesions (Allan et al., 2000b; Krakowka et al., 2000, 2001; 
Rovira et al., 2002), whereas a high percentage of PCV2 inoculated pigs coinfected with 
other swine pathogens developed more severe disease (Allan et al., 1999, 2000b; Ellis et al., 
1999; Kennedy et al., 2000; Krakowka et al., 2000; Harms et al., 2001; Rovira et al., 2002; 
Kim et al., 2003). Several groups have investigated the interaction of PCV2 and porcine 
reproductive and respiratory syndrome virus (PRRSV) in experimental models. Harms et al. 
(2001) induced significantly more severe disease and higher mortality in colostrum-deprived, 
caesarean-derived (CDCD) pigs coinfected with PRRSV and PCV2 compared to singular 
infection. Experimental dual infection of colostrum-deprived (CD) pigs (Allan et al., 2000b) 
or conventional pigs (Rovira et al., 2002) with PCV2 and PRRSV potentiated the replication 
and distribution of PCV2.  
Porcine parvovirus (PPV) has also been shown to enhance disease associated with 
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PCV2. Ellis et al. (1999) reproduced most of the lesions typical of PMWS in gnotobiotic pigs 
inoculated with filtered cell culture material and filtered lymphoid tissues from pigs with 
naturally acquired PMWS. Both PCV2 and PPV and antibodies to these viruses were 
detected in the experimentally inoculated pigs. Since then, several groups have demonstrated 
that CD pigs dually-inoculated with PCV2 and PPV develop more severe disease and lesions 
than pigs with singular PCV2 infection (Allan et al., 1999; Kennedy et al., 2000). Krakowka 
et al. (2000) further confirmed the synergistic effect of PCV2 and PPV in gnotobiotic pigs by 
reproducing clinical disease and lesions typical of PMWS in coinfected pigs but not in pigs 
infected with PCV2 or PPV alone. To our knowledge, this synergistic effect has not been 
demonstrated in segregated early weaned (SEW) pigs which are typical of current US 
production techniques. 
PPV is widespread in the swine population. Incoming gilts and less often sows are 
routinely vaccinated to protect against PPV-associated reproductive losses. There is evidence 
that different PPV-isolates vary in pathogenicity (Mengeling and Cutlip, 1976; Oraveerakul 
et al., 1993). PPV-isolates have been classified as non-pathogenic (Cutlip and Mengeling, 
1975; Paul and Mengeling, 1980), pathogenic to non-immunocompetent fetuses leading to 
death (Mengling et al., 1979), pathogenic to immunocompetent fetuses and inducing 
dermatitis (Choi et al., 1987; Kresse et al., 1985; Lager et al., 1992; Lager and Mengeling, 
1994), and enteric PPV-strains (Dea et al., 1985, Duhamel et al., 1991). In general, infection 
of growing pigs with PPV alone is not associated with clinical disease (Brown et al., 1980; 
Allan et al., 1999; Kennedy et al., 2000; Krakowka et al., 2000).  
PPV is similar to PCV in many ways. Both viruses are small, non-enveloped DNA 
viruses. Both have a strong cellular tropism for mitotically active tissues like lymph nodes or 
heart muscle (Oraveerakul et al., 1993; Allan and Ellis, 2000). It is thought that stimulation 
of host DNA to enter the S-phase of the cell cycle by PPV promotes PCV2-replication 
(Krakowka et al., 2000). One potential way to minimize the effect of PPV-associated 
enhancement of replication of PCV2 and induction of PMWS may be by PPV-vaccination of 
growing pigs in PCV2/PPV-coinfected herds. Attempts to control PMWS with PPV vaccine 
on finishing sites with confirmed PPV circulation have been repeatedly successful (Halbur, 
2000, 2001).  
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The objectives of this study were to determine if coinfection of SEW pigs with PCV2 
and PPV induces an increase in the incidence of PMWS compared to singular PCV2 
infection, and to determine if vaccination against PPV protects pigs against PMWS 
associated with PCV2/PPV coinfection in SEW pigs. 
 
2. Materials and methods 
2.1. Animal source 
Seventy, 12-14 day-old pigs were transported to the livestock infectious disease 
isolation facility (LIDIF) at Iowa State University, Ames, IA. Prior to purchase, sera from the 
dams were tested and confirmed to be negative for the presence of antibodies to PPV and 
PCV2 by hemagglutination inhibition (HI) (Mengeling et al., 1988) and ELISA (Nawagitgul 
et al., 2002), respectively.  
2.2. Experimental design 
The experimental design is summarized in Table 1. All groups were housed in one 
room until 1 day prior to inoculation at which time pigs from groups 1-3 were removed and 
housed separately. Pigs in groups 4 and 5 remained in one room together. Necropsy was 
performed on half of the pigs at 21 days post-inoculation (DPI), and the remaining pigs at 
DPI 42. 
2.3. Virus inocula 
PCV2 isolate ISU-40895 was obtained via direct transfection of PK-15 cells with an 
infectious clone of PCV2 (Fenaux et al., 2002). Passage number 4 of the virus at a titer of 104 
TCID50 was used for inoculation of the pigs. Each pig received 2 ml of the PCV2-inoculum 
intranasally, and 0.5 ml intralymphoid into left and 0.5 ml into the right superficial inguinal 
lymph node (Fenaux et al., 2002). PPV-strain NADL-8 was isolated from fetal porcine 
kidney cells from a naturally infected pig in 1977 in Perry, Iowa (Mengeling et al, 1979). In 
this study, PPV-passage 4 (10% tissue homogenate suspension containing lungs of aborted 
fetuses and minimal essential medium) from the year 1982 was used. Each pig received 2 ml 
of the PPV-inoculum with a titer of about 104.9TCID50 intranasally. Prior to inoculation, the 
PPV-inoculum was tested and confirmed to be negative for the presence of viable PCV2 or 
PCV2-specific nucleic acids by virus isolation on PK-15 cells and by PCR (Fenaux et al., 
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2000). Sham inoculation for pigs in groups 1 and 3 was done with sterile water (Abbott 
Laboratories, North Chicago, IL). The pigs were 6-7 weeks old at the time of inoculation. 
2.4. Vaccine 
The vaccine used in this study was a commercial parvovirus-leptospira-erysipelothrix 
(PLE) vaccine (FarrowSure® Plus; Pfizer Animal Health, Inc.; Lot# A133712), which 
contained killed PPV, Leptospira (serovar bratislava, canicola, grippotyphosa, leptospira, 
hardjo, icterohaemorrhagiae, and pomona) antigens, and Erysipelothrix rhusiopathiae, and 
was adjuvanted with Amphigen®. Fifty-five pigs (groups 1, 2, 3, and 5) were vaccinated 
with the PLE-vaccine at three weeks of age. A booster dose was given two weeks later at -10 
days prior to inoculation. Each pig was vaccinated intramuscularly in the left neck with 5 ml 
of the vaccine according to the manufacturer’s instructions. 
2.5. Clinical evaluation 
Following challenge, the pigs were monitored daily and scored for severity of clinical 
respiratory disease ranging from 0 to 6 (0 = normal; 6 = severe) as previously described 
(Halbur et al., 1995). Rectal temperatures were recorded daily. One day prior to inoculation, 
and at 14, 21, 28, 35, and 42 DPI the pigs were weighed. 
2.6. Serology 
Blood samples were taken -30 and -4 days prior to, on the day of inoculation, and at 
7, 14, 21, 28, 35, and 42 DPI. A PCV2-ELISA based on the recombinant ORF2 capsid 
protein of PCV2 was performed on all serum samples as previously described (Nawagitgul et 
al., 2002). A hemagglutination inhibition (HI) assay for detection of PPV-specific antibodies 
was performed on all serum samples as previously described (Mengeling et al., 1988). In 
addition, 42 DPI sera of all pigs were tested for the presence of specific antibodies to PRRSV 
by PRRSV-ELISA (IDEXX Laboratories, Inc. Westbrook, MA). 
2.7. Polymerase chain reaction (PCR) and quantification of PCV2 genomic DNA 
Sera collected on DPI 0, 7, 14, 21, 28, 35, and 42 were tested by PCR for PCV2 and 
PPV-specific nucleic acids by PCR. DNA-extraction was performed using the QIAamp® 
DNA Mini Kit (Qiagen, Valencia, CA). A multiplex assay for both viruses was performed 
simultaneously as previously described (Kim et al., 2001). DNA-extracts were also used for 
quantification of the amount of PCV2 genomic DNA by real-time PCR as previously 
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described (Opriessnig et al., 2003). 
2.8. Gross pathology and histopathology 
At necropsy, the lungs were given a score for the estimated percentage of lung 
affected by pneumonia (0-100%) (Halbur et al., 1995). The size of five lymph nodes 
(tracheobronchial, external inguinal, internal iliac, mediastinal, and mesenteric lymph nodes) 
from each pig were scored individually (0 = normal to 3 = three times the normal size). 
Tissue samples (lymph nodes, spleen, kidney, liver, brain, tonsil, pancreas, lung, thymus, 
heart, stomach, colon, and ileum) were collected in 10% neutral buffered formalin, and 
processed for microscopic evaluation. The microscopic examination and scoring was 
performed in a blinded fashion. The scoring system used values ranging from 0 to 6 (0 = 
normal; 6 = severe diffuse interstitial pneumonia) for lung sections and values of 0 to 3 (0 = 
normal; 3 = severe inflammation) for all other organs (Halbur et al., 1995). 
2.9. Immunohistochemistry (IHC) for PCV2 and PPV 
Immunohistochemistry for PCV2 was performed on selected lymphoid tissues (lymph 
nodes, thymus, spleen, and tonsil) as previously described (Sorden et al., 1999). The amount 
and distribution of PCV2 was scored ranging from 0 (=undetectable) to 3 (=large amount of 
antigen) in a blinded fashion. To evaluate the amount of PPV in lymphoid tissues, an IHC 
method for PPV was developed by using monoclonal PPV-antibodies (VMRD, Pullman, 
WA) at a dilution of 1:300. The amount of PPV was scored from 0 to 3 as was done for 
PCV2. 
2.10. Statistical Analysis 
Descriptive statistics for all variables were computed to assess the distributions of the 
data and identify potential spurious observations. For the different types of data, several 
inferential methods were used to assess experimental group differences. Continuous repeated 
measured data were assessed with the conservative multivariate analysis of variance method 
(MANOVA). In each MANOVA analysis, the group by time interaction had to be non-
significant (P > 0.05) before the group effect was considered. If the group by time interaction 
was significant, then cross sectional analysis was used to determine the significant time 
points. Ordinal repeated measures data were assessed with response feature analysis (Everitt, 
1995). Non-repeated measures were assessed using analysis of covariance (ANOVA) or non-
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parametric ANOVA. If an ANOVA test was significant (P < 0.05), then pair wise tests with 
Tukey adjustment were used to assess specific group differences. If a non-parametric 
ANOVA test was significant, then Wilcoxon tests with Bonferroni correction were used to 
assess the differences of pairs of groups. 
 
3. Results 
3.1. Clinical signs 
Pigs in the sham-inoculated control group 1 had no signs of clinical disease at any 
time during the experiment. Three of 12 pigs in the PPV-inoculated group 3 had fevers 
ranging from 40.4ºC to 40.7ºC at 1 DPI, and were clinically normal thereafter.  
The PCV2-infected group 2 pigs and the PCV2/PPV-coinfected group 4 and 5 pigs 
showed intermittent fevers between 1 and 21 DPI (Fig. 1). On DPI 6, 10 and 13, the mean 
daily rectal temperatures in group 4 pigs were significantly (P < 0.05) higher compared to 
those in group 5 pigs. Group 4 pigs had significantly (P < 0.05) higher mean temperatures 
compared to those in group 2 pigs from 8 to 21 DPI. Group 5 pigs had significantly (P < 
0.05) higher mean temperatures than group 2 pigs on DPI 8, 9, 12, 13, and 17-19.  
The clinical manifestation in the coinfected group 4 and 5 pigs was further 
characterized by sneezing starting from 2 DPI through 21 DPI. Beginning at 13 DPI, sporadic 
coughing was also observed. Based on the assessment of the weekly body weight data, two 
wasting pigs were identified in the coinfected groups. One group 4 pig lost 2.7 kg between 
DPI 14 to DPI 20, and one group 5 pig lost 1.4 kg between 14 and 21 DPI. Both pigs 
developed severe respiratory disease, jaundice, and depression and had to be euthanized at 
DPI 20 and DPI 21, respectively. After 21 DPI, clinical disease began to resolve in the 
coinfected groups and most pigs returned to normal by 28 DPI. 
The mean daily weight gain for group 1 pigs was 0.77 kg, for group 2 pigs was 0.70 
kg, for group 3 pigs was 0.74 kg, for group 4 pigs was 0.71 kg, and for group 5 pigs was 0.74 
kg. Statistically, there was no difference in daily weight gain between the groups (P = 
0.4335). 
3.2. Serology 
Prior to PPV-vaccination, 9/14 group 1 pigs, 8/14 group 2 pigs, and 3/12 group 3 pigs 
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had residual passive antibody titers to PPV ranging from 1:32 to 1:256. Group specific PPV-
antibody titer trends are summarized in Fig. 2. There was a group by time trend at 7, 14, 21, 
28, 35, and 42 DPI. PPV-titers in group 1 and 2 (PPV-vaccinated, non-PPV-infected) were 
not different from each other at any time of the experiment. This was also the case for PPV-
titers in groups 3 and 5 (PPV-vaccinated, PPV-infected), which were not different from each 
other during the experiment. Groups 1 and 2 pigs (PPV-vaccinated) had significantly (P < 
0.05) lower PPV-titers compared to groups 3 and 5 pigs (PPV-vaccinated, PPV-infected). 
PPV-titers in group 4 pigs (non PPV-vaccinated, PPV-infected) were significantly (P < 0.05) 
higher than those in all other groups at 7, 14, 35, and 42 DPI.  
Pigs in groups 1 and 3 remained free of PCV2-specific antibodies at the end of the 
experiment at DPI 42 whereas pigs in groups 2, 4, and 5 seroconverted to PCV2 between 21 
and 42 DPI. There was no significant difference in serum PCV2-antibody levels in groups 2, 
4, and 5. At 42 DPI, all pigs were free of antibodies to PRRSV. 
3.3 PCR 
All pigs in groups 1-3, and 5 were negative by PCR for PPV-nucleic acids in serum. 
In group 4, 9/16 pigs were PPV-PCR positive at 7 DPI, and 3/16 pigs were PPV-PCR 
positive at 14 DPI. The mean PPV-viremia length was determined to be 0.75 (±0.11) weeks. 
PCR testing for the presence of PCV2-specific nucleic acids in serum revealed no 
PCR-positive pigs in groups 1 and 3. The majority of the PCV2-infected group 2, 4 and 5 
pigs (40/44) were positive for PCV2-specific nucleic acids in sera starting at 7 DPI. The 
mean PCV2-viremia length was determined by PCV2-PCR results of the pigs that remained 
until the end of the study. Viremia length was 4.9 ± 0.63 weeks for group 2 pigs, 4.0 ± 0.69 
weeks for group 4 pigs, and 6.0 ± 0.00 weeks for group 5 pigs. Groups 2 and 4 (P = 0.45), 
and groups 2 and 5 (P = 0.06) were not significantly different from each other, but there was 
a significant difference in mean PCV2-viremia length between groups 4 and 5 (P = 0.025). 
3.4. PCV2 genome titer in sera 
The mean PCV2 genome copy numbers in sera measured at 7, 14, 21, 28, 35, and 42 
DPI were not different between group 2 and 4 pigs, nor was there a difference between group 
2 and 5 pigs. Group 5 pigs had significantly (P < 0.05) higher PCV2 genome copy numbers 
in sera at 28, 35, and 42 DPI compared to group 4 pigs (Fig. 3). The highest genomic copy 
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levels measured in the entire experiment (1.53 × 109 and 5.07 × 109 PCV2 copies/ml serum) 
were found in sera obtained from the two PMWS-affected pigs from group 4 and 5 at 20 and 
21 DPI, respectively. In addition, another pig in group 5 had relatively high PCV2 titers at 14 
DPI (1.06 × 109 PCV2 copies/ml serum), but the titer decreased over time to 3.8×105 PCV2 
copies/ml of serum at DPI 42.  
3.5. Macroscopic lesions 
At 21 and 42 DPI necropsies, group 1 and 3 pigs had no remarkable gross lesions. In 
contrast, most of the pigs in groups 2, 4, and 5 had enlargement of all lymph nodes evaluated 
(Table 2). 
At 21 DPI, the two wasting pigs (one in group 4 and one in group 5) were also icteric, 
and had severe chronic bleeding gastric ulcers of the pars esophagea. In addition, the group 4 
wasting pig had moderate edema of the gastric wall, a pneumonia score of 21%, and serous 
atrophy of fat on the heart. The group 5 wasting pig had a pneumonia score of 15% and had 
well demarcated, purple lesions especially in the cranioventral part of the lung. This pig also 
had approximately 200 ml icteric fluid in the abdomen.  
At 42 DPI necropsy, three pigs (one group 4 pig and two group 5 pigs) had enlarged 
tan kidneys with multifocal white spots and streaks.  
3.6 Microscopic lesions 
Microscopic lesions are summarized in Tables 2 and 3. Mild-to-severe interstitial 
pneumonia and lymphoplasmacytic hepatitis were observed in pigs in groups 2, 4 and 5 
(Table 2). At 21 DPI, there were significantly more severe lymphoplasmacytic interstitial 
nephritis (P < 0.05) and lymphoplasmacytic interstitial hepatitis (P < 0.05) lesions in group 4 
pigs than in group 2 pigs. Also, the incidence of interstitial nephritis was significantly (P < 
0.05) higher in group 4 pigs compared to that of group 2 pigs (Table 2). Pigs in groups 2, 4 
and 5 had lymphoplasmacytic myocarditis and lymphoplasmacytic meningoencephalitis 
lesions but there were no differences between the groups in incidence or severity (data not 
shown). Mild lymphocytic depletion of thymus was observed in one group 5 pig (data not 
shown). At 42 DPI, the lymphoid depletion in lymph nodes was significantly (P < 0.05) more 
severe in groups 4 and 5 compared to group 2 pigs (Table 3). There was no difference in 
severity of lymphoid depletion between group 4 and 5. 
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3.7 Immunohistochemistry for PCV2 and PPV 
The immunohistochemical distribution of PCV2 and PPV-antigen in lymph nodes, 
spleens, and tonsils of all pigs is summarized in Table 3. Between groups there was no 
difference in amount or incidence of PCV2 antigen in thymus. Individual pigs in groups 2, 4 
and 5 pigs had a few PCV2 antigen positive cells at 21 DPI (data not shown). 
 
4. Discussion 
Current recommendations for minimizing losses from PCV2-associated PMWS 
include identifying and minimizing the effect of concurrent infections. In addition to more 
well established pathogens such as PRRSV, swine influenza virus, and Mycoplasma 
hyopneumoniae, there is now interest in eliminating or minimizing the potential effect of 
PPV on triggering PCV2 infection to progress to clinical PMWS manifest as progressive 
wasting, pallor and/or jaundice, and respiratory disease. This is largely based on literature 
suggesting that characteristic PMWS disease and lesions can be induced in CD or gnotobiotic 
pigs by PCV2/PPV-coinfection (Allan et al., 1999, 2000c; Kennedy et al., 2000; Krakowka et 
al., 2000; Kim and Chae, 2002; Kim et al., 2003). We attempted to mimic the field situation 
in the U.S. by coinfection of conventional 6-7-week-old SEW pigs with PCV2 and PPV. 
Furthermore, we attempted to decrease the synergistic effect between these two viruses by 
vaccinating pigs against PPV prior to coinfection. 
In this study, we were able to demonstrate the development of PMWS in conventional 
SEW pigs coinfected with PCV2 and PPV. The combined mortality in both PCV2/PPV-
infected groups was 6.7%, which is similar to PMWS-associated mortality in affected herds 
in the US. One of the two PMWS-affected pigs in the current experiment was PPV-
vaccinated prior to PPV/PCV2 inoculation, while the other pig was not. PCV2 infection, 
either as single infection or in combination with PPV-infection, induced typical PCV2-
associated macroscopic and microscopic lesions. The most obvious difference between the 
PCV2-single-infected pigs compared to the pigs in both of the PCV2/PPV-coinfected groups 
was the clinical manifestation of disease. The coinfected pigs had a mild-to-severe clinical 
disease characterized by fevers, sneezing, coughing, and wasting, whereas the singular 
PCV2-infected pigs remained clinically normal throughout the study. Despite their 
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vaccination status, the two coinfected groups (PPV-vaccinated as well as non-vaccinated) 
were similar in terms of clinical presentation, macroscopic, and microscopic lesions.  
The PPV-vaccine regime used in this study was not able to reduce clinical PMWS or 
lymphoid lesions characteristic of PMWS in PCV2/PPV-coinfected pigs. Although there was 
no measurable PPV-viremia by PCR in the PPV-vaccinated and PPV-infected pigs, the IHC 
and the anamnestic serological response suggested that PPV-replication in tissues was not 
completely inhibited by vaccine-induced PPV-antibodies. Low-to-high amounts of PPV were 
detected by IHC in lymphoid tissues of the majority of PPV-infected pigs, whether or not 
they were PPV-vaccinated. PPV-infection in pigs other than fetuses is usually not associated 
with disease. There are some exceptions such as the sporadic observations of dermatitis 
(Kresse et al., 1985), non-suppurative myocarditis (Bolt et al., 1997), and enteritis (Dea et al., 
1985; Duhamel et al., 1991) in young pigs. Brown et al., (1980) experimentally inoculated 6-
week-old conventional pigs with PPV and demonstrated PPV-distribution mainly in 
lymphoid tissues without observation of clinical signs, macroscopic or microscopic lesions. 
Nevertheless, PPV has been identified as an important potential trigger for PCV2 infections 
to progress to PMWS in CD and gnotobiotic pigs. Our work further supports that synergism 
occurs in SEW pigs typical of the current US field production. However, the particular PPV 
vaccine used in this study did not fully inhibit PPV-replication and did not decrease the 
incidence of PMWS- or PCV2-associated lesions. 
It is difficult to measure the efficacy of PPV vaccine in growing pigs since the strain 
used in this study by itself does not appear to induce disease or lesions. Explanations for the 
failure of the vaccine to completely prevent PPV-infection in this study could include 
inappropriate timing of the PPV-vaccination in terms of age of the pigs at vaccination time, 
and timing of PPV-vaccination in relation to PPV-infection. Although the presence of 
passively acquired PPV-antibodies in pigs at the time of vaccination may also play a role, a 
negative influence on vaccine efficacy in the current study can be excluded. None of the 
PPV-vaccinated and coinfected group 5 pigs had passively acquired PPV-antibodies prior to 
vaccination. Investigations carried out in gilts suggested that low PPV-titers at the time of 
PPV-vaccination did not interfere with immunization, whereas high PPV-titers blocked the 
response to vaccination; however, after a second dose there was an anamnestic response 
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(Paul and Mengeling, 1986). Effective control of acute PPV infection is believed to depend 
on humoral immunity (Ladekjær-Mikkelsen and Nielsen, 2002). All PPV-vaccinated pigs in 
this study reached PPV-antibody levels higher than 1:128 by the time of PPV-challenge. 
There are different opinions as to how high the PPV-titers need to be for protection since the 
definition of “protection” varies. Some groups evaluated the efficacy of the PPV-vaccine 
based on reduction or prevention of transplacental transfer of PPV (Mengeling et al., 1979), 
while others define protection as lack of any evidence of PPV-replication in the dam (Suzuki 
and Fujisaki, 1976). In the current study, there was no detectable PPV-viremia in the PPV-
vaccinated and PPV-inoculated pigs; however, four-fold increasing HI-titers and 
demonstration of PPV-antigen by IHC staining in lymphoid tissues suggests that PPV-
replication occurred in the PPV-vaccinated pigs. At DPI 21 and 42, moderate-to-large 
amounts of PPV antigen were not only present in pigs with “low” serum antibody titers 
(1:256) at inoculation time, but also in pigs with vaccination titers between 1:512 and 1:1024. 
There may also be some degree of antigenic variation between the vaccine strain and the 
challenge strain, though previous studies have failed to confirm antigenic differences among 
PPV-isolates based on hemagglutination (Molitor and Joo, 1990).  
It is not known if different strains of PPV vary in their synergistic effect with PCV2. 
From the four PCV2/PPV coinfection studies published to date, all the PPV-isolates were 
from recent field-cases of PMWS. Three of the studies were done with the same Canadian 
PPV-isolate (Allan et al., 1999; Kennedy et al., 2000; Krakowka et al., 2000) on the basis of 
an 800-bp sequence described as similar to the NADL and the Kresse strain of PPV (Allan et 
al., 2000a,b), and one with a Korean PPV-isolate (Kim et al., 2003). The isolate we used is 
over 25 years old and has been well characterized (Mengeling et al., 1979). 
Recent studies suggest that the immunostimulatory effects of bacterins increase PCV2 
replication (Allan et al., 2000a, 2001; Kyriakis et al., 2002; Opriessnig et al., 2003). Based on 
the level of mortality and morbidity in the current study, the PLE-vaccine regime did not 
increase the severity or incidence of PMWS in the coinfected groups. There was a 
significantly longer length of PCV2-viremia and higher numbers of PCV2-genomic copies in 
sera of vaccinated coinfected pigs compared to non-vaccinated coinfected pigs.  
Although we were not able to experimentally prove a positive effect of PPV-
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vaccination in reducing the incidence of clinical PMWS in PCV2/PPV-coinfected pigs, 
reduction in morbidity and mortality of grow-finish pigs affected by PMWS and respiratory 
disease has been repeatedly achieved in the field with the use of PPV vaccines (Halbur, 2000, 
2001). Another approach to reduce the losses in weaning pigs due to coinfection with PCV2 
and PPV could be through hyperimmunization of the breeding herd against PPV. A direct 
correlation between the antibody titer of the sow’s colostrum and her litter’s average 
antibody titer has been demonstrated (Paul and Mengeling, 1982; Damm et al., 2002). Sows 
with higher PPV-antibodies in sera have piglets with higher maternal PPV-antibody titers 
that decay over a longer period of time. As supported by a recent study (Rodibaugh, 2002), 
vaccination of sows may even be more practical than vaccinating growing pigs, and the 
potential adverse vaccine dependent-effect on PCV2 replication in growing pigs could be 
avoided. 
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Table 1 
Experimental design 
Group number Number of pigs Vaccinationa Inoculation 
1 14 + - - 
2 14 + - PCV2 
3 12 + PPV - 
4 16 - PPV PCV2 
5 14 + PPV PCV2 
aParvovirus-leptospira-erysipelothrix vaccine. 
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Table 2. Macroscopic and microscopic lesions in group 1 (sham-inoculated, PPV-
vaccinated), 2 (PCV2-inoculated, PPV-vaccinated), 3 (PPV-inoculated, PPV-vaccinated), 4 
(PCV2/PPV-inoculated, non-vaccinated), and 5 (PCV2/PPV-inoculated, PPV-vaccinated) 
pigs at 21 and 42 days post inoculation  
Group     
  
Lymphadenopathy 
 
(0-3a) 
 
Interstitial 
pneumonia 
(0-6b) 
 
Lymphoplasmacytic  
interstitial nephritis 
(0-3c) 
 
Lymphoplasmacytic 
hepatitis 
(0-3c) 
21 DPI 
1  2/7 (0.2[0.6])d Ae  4/7 (0.6[1.0]) A  0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A 
2  6/7 (1.2[1.4]) B  7/7 (1.1[1.1) B  1/7 (0.1[1.0]) BC  4/7 (0.6[1.0]) B 
3  0/6 (0.0[0.0]) A  3/6 (0.4[1.0]) A  0/6 (0.0[0.0]) AB  0/6 (0.0[0.0]) A 
4  8/8 (2.3[2.3]) C  8/8 (1.6[1.6]) B  6/8 (0.9[1.2]) D  8/8 (1.3[1.3]) C 
5  7/7 (2.1[2.1]) C  7/7 (2.0[2.0]) B  4/7 (0.6[1.0]) CD  6/7 (1.3[1.5]) BC 
42 DPI 
1  0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A 
2  7/7 (0.4[0.4]) B  5/7 (0.9[1.2]) BC  4/7 (0.9[1.5]) B  5/7 (0.7[1.0]) B 
3  0/6 (0.0[0.0]) A  1/6 (0.1[1]) AB  0/6 (0.0[0.0]) AC  0/6 (0.0[0.0]) A 
4  8/8 (2.1[2.1]) C  8/8 (1.5[1.5]) C  4/8 (0.8[1.5]) BC  7/8 (0.9[1.0]) B 
5  7/7 (1.8[1.8]) C  7/7 (1.1[1.5]) C  3/7 (0.7[1.7]) AB  7/7 (1.0[1.0]) B 
aScore range (0 = normal; 3 = three times the normal gross size). 
bMicroscopic interstitial pneumonia score (0 = normal; 6 = severe diffuse interstitial pneumonia). 
cScore range (0 = normal; 3 = severe). 
dIncidence (mean group score [mean severity for affected animals]).  
eDifferent letters indicate significantly (P < 0.05) different mean group values within columns for 21 
or 42 DPI.
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Table 3 
Lymphoid depletion and amount of PCV2 and PPV-specific antigen demonstrated by immunohistochemistry in lymphoid tissues 
in group 1 (sham-inoculated, PPV-vaccinated), 2 (PCV2-inoculated, PPV-vaccinated), 3 (PPV-inoculated, PPV-vaccinated), 4 
(PCV2/PPV-inoculated, non-vaccinated), and 5 (PCV2/PPV-inoculated, PPV-vaccinated) pigs at 21 and 42 days post-inoculation 
Group       Lymph nodes Spleen Tonsil
 
 
  Depletiona IHCb PCV2 IHC PPV  Depletion IHC PCV2  Depletion IHC PCV2 
21 DPI 
1  0/7 (0.0[0.0])cAd 0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A 
2  7/7 [1.0(1.0)] B 7/7 (1.4[1.4]) B 0/7 (0.0[0.0]) A  7/7 (1.0[1.0]) B 5/7 (0.7[1.0]) B  6/7 (0.9[1.0]) B 6/7 (1.1[1.3]) B 
3  0/6 (0.0[0.0]) A 0/6 (0.0[0.0]) A 3/6 (0.5[1.0]) A  0/6 (0.0[0.0]) A 0/6 (0.0[0.0]) A  0/6 (0.0[0.0]) A 0/6 (0.0[0.0]) A 
4  8/8 (1.5[1.5]) B 7/8 (1.8[2.0]) B 7/8 (2.0[2.3]) B  8/8 (1.3[1.3]) B 7/8 (1.4[1.6] BC  8/8 (1.3[1.3]) B 7/8 (1.4[1.6]) B 
5  7/7 (1.7[1.7]) B 7/7 (2.0[2.0]) B 6/7 (2.0[2.3]) B  7/7 (1.3[1.3]) B 7/7 (1.6[1.6]) C  7/7 (1.4[1.4]) B 7/7 (1.9[1.9]) B 
42 DPI 
1  0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A  0/7 (0.0[0.0]) A 0/7 (0.0[0.0]) A 
2  6/7 (0.86[1.0]) B 5/7 (0.7[1.0]) B 0/7 (0.0[0.0]) A  5/7 (0.7[1.0]) BC 4/7 (0.6[1.0]) BC  6/7 (0.9[1.0]) B 4/7 (0.6[1.0]) B 
3  0/6 (0.0[0.0]) A 0/6 (0.0[0.0]) A 5/6 (1.0[1.2]) BC  0/6 (0.0[0.0]) A 0/6 (0.0[0.0]) A  0/6 (0.0[0.0]) A 0/6 (0.0[0.0]) A 
4  8/8 (1.6[1.6]) C 7/8 (1.0[1.1]) BC 5/8 (0.8[1.2]) B  5/8 (0.6[1.0]) B 1/8 (0.1[1.0]) AB  7/8 (0.9[1.0]) B 2/8 (0.3[1.0]) AB 
5  7/7 (1.8[1.8]) C 6/7 (1.6[1.8]) C 6/7 (1.4[1.6]) C  7/7 (1.3[1.3]) C 5/7 (0.7[1.0]) C  7/7 (1.0[1.0]) B 5/7 (0.9[1.2]) B 
dDifferent letters within columns represent significantly (P < 0.05) different mean group values within columns for each DPI. 
cIncidence (average value within group [mean severity for affected animals]). 
aScore range (0 = normal; 3 = severe lymphoid depletion of follicles). 
bScore range (0 = undetectable; 3 = large amount of antigen). 
 
 167
0
10
20
30
40
50
60
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Days post inoculation
Pe
rc
en
ta
ge
 o
f p
ig
s/g
ro
up
 w
ith
 r
ec
ta
l
 te
m
pe
ra
tu
re
s h
ig
he
r 
th
an
 4
0.
2º
C
Group 2 Group 4 Group 5
 
Fig. 1. Percentage of pigs in groups 2 (PCV2-inoculated, PPV-vaccinated), 4 (PCV2/PPV-
inoculated, non-vaccinated), and 5 (PCV2/PPV-inoculated, PPV-vaccinated) with rectal 
temperatures higher than 40.2ºC from 1 to 21 days post-inoculation. 
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Fig. 2. Mean group PPV-antibody titers in serum of pigs in groups 1 (sham-inoculated, PPV-
vaccinated), 2 (PCV2-inoculated, PPV-vaccinated), 3 (PPV-inoculated, PPV-vaccinated), 4 
(PCV2/PPV-inoculated, non-vaccinated), and 5 (PCV2/PPV-inoculated, PPV-vaccinated). 
Error bars represent standard errors. 
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Fig. 3. Mean group PCV2 genomic copy numbers in sera obtained from groups 2 (PPV-
vaccinated, PCV2-infected, n = 7), 4 (non-vaccinated, PCV2/PPV-coinfected, n = 8), and 5 
pigs (PPV-vaccinated, PCV2/PPV-coinfected, n = 7). Error bars represent standard errors. 
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Abstract. The objectives of this study were to investigate the interactions between 
Mycoplasma hyopneumoniae and porcine circovirus type 2 (PCV2) and to establish a model 
for studying the pathogenesis of and testing intervention strategies for the control of PCV2-
associated porcine respiratory disease complex (PRDC). Sixty-seven pigs were randomly 
assigned to four groups. Group 1 (n = 17) pigs served as controls, group 2 (n = 17) pigs were 
inoculated with M. hyopneumoniae, group 3 (n = 17) pigs were dual infected with M. 
hyopneumoniae and PCV2, and group 4 (n = 16) pigs were inoculated with PCV2. Pigs were 
inoculated intratracheally with M. hyopneumoniae at 4 weeks of age followed by intranasal 
inoculation with PCV2 at 6 weeks of age. Dual-infected pigs had moderate dyspnea, 
lethargy, and reduced weight gain. The overall severity of macroscopic lung lesions, PCV2-
associated microscopic lesions in lung and lymphoid tissues, and the amount of PCV2-
antigen associated with these lesions were significantly (P < 0.05) higher in dual-infected 
pigs compared with all other groups. Four of 17 (23.5%) dual-infected pigs had decreased 
growth rate and severe lymphoid depletion and granulomatous lymphadenitis associated with 
high amounts of PCV2-antigen consistent with postweaning multisystemic wasting syndrome 
(PMWS). PCV2-antigen in lung tissue was most often associated with M. hyopneumoniae 
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induced peribronchial lymphoid hyperplasia suggesting that this is an important site for 
PCV2 replication in the lung. This study indicates that M. hyopneumoniae potentiates the 
severity of PCV2-associated lung and lymphoid lesions, increases the amount and prolongs 
the presence of PCV2-antigen, and increases the incidence of PMWS in pigs. 
 
Introduction 
Porcine circovirus type 2 (PCV2) is associated with several disease manifestations in 
swine including postweaning multisystemic wasting syndrome (PMWS).1,20,21,33 PMWS is 
characterized clinically by wasting, decreased weight gain, enlarged lymph nodes and 
dyspnea.20,49 The hallmark microscopic lesions of PMWS are lymphoid depletion or 
granulomatous lymphadenitis (or both) and the presence of PCV2 antigen or nucleic acids 
associated with the lymphoid lesions.49  
PCV2 alone is limited in its ability to induce the full spectrum of disease and lesions 
associated with PMWS in pigs3,14,30,41,42,47 and is considered by some to be a ubiquitous 
opportunist.49 Porcine reproductive and respiratory syndrome virus (PRRSV)-induced 
potentiation of PCV2-associated PMWS has been experimentally confirmed.3,24,47 Porcine 
parvovirus (PPV) has also been found to potentiate the progression of PCV2-infection to 
clinical PMWS.2,25,26,30,41 The authors are not aware of previous reports of bacterial 
potentiation of PCV2 infection. 
Investigations carried out in the field further support the important role of 
coinfections in the pathogenesis of PCV2-associated disease. A retrospective analysis of 
PMWS cases in the Midwest United States revealed that PCV2 alone was found in only 1.9% 
of all cases investigated.44 Mycoplasma hyopneumoniae was found in combination with 
PCV2 in 35.5% of the cases, second only to PRRSV/PCV2 coinfection in 51.9% of the 
cases.44  
M. hyopneumoniae is associated with porcine enzootic pneumonia,18,36 a disease 
characterized by high morbidity but low mortality in affected herds. In the early stages of 
infection, M. hyopneumoniae colonizes the luminal surface of bronchial and bronchiolar 
epithelial cells without invading epithelial cells.5,31,48 Attachment to the cilia leads to 
progressive loss of cilia, exfoliation of epithelial cells, and accumulation of inflammatory 
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cells in airway lumina and around airways.9 The hallmark lesion associated with M. 
hyopneumoniae is hyperplasia of the bronchus-associated lymphoid tissue (BALT); however, 
M. hyopneumoniae antigen/nucleic acids are not detectable within the hyperplasic BALT.31,48 
Lymphoid hyperplasia of BALT may lead to obliteration of bronchioles and atelectasis of 
surrounding alveoli.12 The authors have commonly observed the presence of abundant PCV2 
antigen in the hyperplasic BALT of lungs from field cases confirmed to have M. 
hyopneumoniae/PCV2 coinfection by immunohistochemistry (IHC). 
Porcine respiratory disease complex (PRDC) is a condition observed mainly in 8-26-
week-old pigs and associated with multiple respiratory pathogens including PRRSV, swine 
influenza virus (SIV), and M. hyopneumoniae. PRDC is characterized by decreased rate of 
growth, decreased feed efficiency, anorexia, fever, cough, and dyspnea. Recent field 
investigations suggest that PCV2 may be playing an important role in some cases of 
PRDC.23,28 Studies investigating the relationship of PCV2/M. hyopneumoniae coinfection are 
lacking in the literature. The objectives of this study were to investigate the interactions 
between M. hyopneumoniae and PCV2 and to establish a model for studying the 
pathogenesis of and testing intervention strategies for the control of PCV2-associated PRDC. 
 
Materials and Methods 
Animals 
Sixty-seven colostrum-fed, crossbred piglets were purchased from a herd with no 
history of PCV2-associated diseases, free of M. hyopneumoniae and PRRSV based on 
monthly serological testing of the breeding herd, and routinely using PPV and SIV 
vaccination of the breeding animals. The pigs were early-weaned at 12 days of age and 
transported to the livestock infectious disease isolation facility at Iowa State University, 
Ames, Iowa. The pigs were randomly assigned to four groups of 16-17 pigs each and 
separated into 4 rooms with 3 pens each and 5-6 pigs per pen. 
Experimental design, Mycoplasma hyopneumoniae, and PCV2 inocula 
The experimental design is summarized in Table 1. At 4 weeks of age, a tissue 
homogenate containing strain 232, a derivative of M. hyopneumoniae strain 11 challenge 
inoculum (105 color changing units/ml), was administered intratracheally to each pig in 
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groups 2 and 3 in a dilution of 1 : 100 in 10 ml Friis medium.46 Before inoculation, the Friis 
medium and M. hyopneumoniae inoculum were tested and confirmed negative for the 
presence of PCV2-, PCV1-, and PPV-specific nucleic acids by polymerase chain reaction 
(PCR).13,27  
PCV2 isolate ISU-40895 was obtained through direct transfection of PK-15 cells with 
an infectious clone of PCV2.14 Passage four of the virus at a titer of 104.8 50% tissue culture 
infective dose (TCID50) was used for inoculation of the pigs. Each pig in groups 3 and 4 
received 6 ml of the PCV2-inoculum intranasally at 6 weeks of age. In addition, each pig in 
groups 1 and 2 was sham inoculated at 6 weeks of age by administration of 6 ml PK15-cell-
supernatant intranasally.  
Clinical evaluation 
Following PCV2 challenge, the pigs were monitored daily and scored for severity of 
clinical respiratory disease ranging from 0 to 6 (0 = normal; 1 = mild dyspnea or tachypnea 
or both when stressed; 2 = mild dyspnea or tachypnea or both when at rest; 3 = moderate 
dyspnea or tachypnea or both when stressed; 4 = moderate dyspnea or tachypnea or both 
when at rest; 5 = severe dyspnea or tachypnea or both when stressed; 6 = severe dyspnea or 
tachypnea or both when at rest).19 In addition, pigs were evaluated daily for clinical signs 
including sneezing (score range from 0 [no sneezing] to 3 [severe persistent sneezing]), 
coughing (score range from 0 [no coughing] to 3 [severe persistent coughing]), and jaundice 
(score range from 0 [normal] to 3 [severe icterus]). Rectal temperatures, wasting, and 
behavioral changes such as lethargy were recorded daily. The pigs were weighed on the day 
of arrival, -14 days before PCV2 inoculation, at the day of PCV2 inoculation and at 7, 14, 21, 
and 35 days postinoculation (DPI).  
Serology 
Blood samples were collected at -24 and -14 days before, on the day of PCV2 
inoculation, and at 7, 14, 21, 28, and 35 DPI. A PCV2-enzyme linked immunosorbent assay 
(ELISA) based on the recombinant ORF2 capsid protein of PCV2 was performed on -24, -14, 
0, 21, and 35 DPI sera samples.40 Samples were considered positive if the calculated sample-
to-positive (S/P) ratio was 0.2 or greater.  
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M. hyopneumoniae titers were determined by ELISA on -14, 21, and 35 DPI sera.8 
Known positive and negative sera were included on every plate. Readings more than 2 
standard deviations above the mean value of the negative control were considered positive. 
In addition, -14, 0, and 35 DPI sera from 8 pigs in each group were tested for the 
presence of antibodies to PRRSV by PRRSV-ELISA (IDEXX Laboratories, Inc. Westbrook, 
MA), antibodies to SIV subtypes H1N1 and H3N2 by hemagglutination inhibition (HI) assay 
(protocol used at the Iowa State University Veterinary Diagnostic Laboratory), and for the 
presence of antibodies to PPV by HI assay.38 
PCV2 quantification 
DNA extraction on sera collected on the day of PCV2 inoculation and at 7, 14, 21, 28, 
and 35 DPI was performed using the QIAamp® DNA Mini Kit (Qiagen, Valencia, CA). 
DNA-extracts were used for quantification of the amount of PCV2 genomic DNA by real-
time PCR.42 
Necropsy and histopathology 
Necropsies were performed on half of the pigs in each group at 21 DPI and the 
remainder at 35 DPI. Lung lesions consistent with mycoplasmal pneumonia (well 
demarcated, dark red-to-purple consolidated areas in the cranioventral regions) were 
sketched on a standard diagram and assessed for the proportion of lung surface with lesions 
using a Zeiss SEM-IPS image analyzing system.46 In addition, the total amount of 
macroscopic lung lesions (0-100% of the lung affected by grossly visible pneumonia) was 
estimated and recorded for each pig.19 The scoring system is based on the approximate 
volume that each lung lobe contributes to the entire lung: the right cranial lobe, right middle 
lobe, cranial part of the left cranial lobe, and the caudal part of the left cranial lobe contribute 
10% each to the total lung volume, the accessory lobe contributes 5%, and the right and left 
caudal lobes contribute 27.5% each.19 The mean size of several lymph nodes (superficial 
inguinal, external iliac, mediastinal, tracheobronchial, mesenteric) was estimated (score 
range from 0 [normal] to 3 [three times the normal size]) and recorded for each pig.42 
Tracheobronchiolar swabs and bronchoalveolar lavage for bacterial and virologic 
examinations were collected at 21 and 35 DPI.37 Fifty milliliters of sterile phosphate-buffered 
saline (PBS) was used to lavage each lung. Lungs collected at 21 DPI were insufflated with 
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fixative until the natural contour of the lung was reestablished, and then the right bronchus 
was clamped off and the right lung was submerged in fixative.19 Sections of lung from each 
lobe were collected at 35 DPI and submerged in 10% neutral-buffered formalin. Sections of 
lymph nodes (superficial inguinal, mediastinal, tracheobronchial, mesenteric), tonsil, thymus, 
ileum, kidney, colon, spleen, and liver were collected at necropsy and fixed in 10% neutral 
buffered formalin and routinely processed for histologic examination. Microscopic lesions 
were evaluated in a blinded fashion by two veterinary pathologists (T. Opriessnig and P.G. 
Halbur). Lung sections were scored for presence and severity of type 2 pneumocyte 
hypertrophy and hyperplasia, alveolar septal infiltration with inflammatory cells, 
peribronchial lymphoid hyperplasia , amount of alveolar exudate, and amount of 
inflammation in the lamina propria of bronchi and bronchioles ranging from 0 to 6 (0, 
normal; 1, mild multifocal; 2, mild diffuse; 3, moderate multifocal; 4, moderate diffuse; 5, 
severe multifocal; 6, severe diffuse).  
Sections of heart, liver, kidney, ileum, and colon were evaluated for the presence of 
lymphohistiocytic inflammation and scored from 0 (none) to 3 (severe). Lymphoid tissues 
including lymph nodes, tonsil, and spleen were evaluated for the presence of lymphoid 
depletion ranging from 0 to 3 (0, normal; 1, mild lymphoid depletion with loss of overall 
cellularity; 2, moderate lymphoid depletion; 3, severe lymphoid depletion with loss of 
lymphoid follicle structure) and presence of inflammation ranging from 0 to 3 (0, normal; 1, 
mild histiocytic-to-granulomatous inflammation, 2, moderate histiocytic-to-granulomatous 
inflammation, 3, severe histiocytic-to-granulomatous inflammation with replacement of 
follicles).  
In addition, Warthin-Starry (WS) silver staining for the identification of cilia-
associated respiratory bacillus was done on lung tissues (three sections for each pig) on all 
pigs necropsied at 21 DPI (n = 35). 
IHC for detection of PCV2 and image analysis for quantification of PCV2-specific 
staining  
Immunohistochemical detection of PCV2-specific antigen was performed on sections 
of formalin-fixed, paraffin-embedded blocks of selected tissue samples (lungs [three 
sections], lymph nodes [one section each of superficial inguinal, external iliac, mediastinal, 
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tracheobronchial, and mesenteric], tonsil [one section], thymus [one section] and spleen [one 
section]) using a streptavidin-biotin-peroxidase complex method (DAKO, Carpinteria, CA). 
The fixed sections were pretreated with 0.05% protease (Sigma, St. Louis, MO), and a rabbit 
polyclonal antiserum (Identification number ISU-31) was used in a dilution of 1:1000.50 
Assessment of staining for PCV2 antigen was done in a blinded fashion and scores ranged 
from 0 to 3 (0, negative; 1, less than 10% of the lymphoid follicles have cells with PCV2 
antigen staining; 2, 10-50% of the lymphoid follicles contain cells with PCV2 antigen 
staining; 3, more than 50% of the lymphoid follicles contain cells with PCV2 antigen 
staining).42 The mean group score was determined for each tissue and compared among 
groups. 
Image analysis was done on ten randomly selected fields of tracheobronchial lymph 
node (one section per pig) labeled with anti-PCV2 antibody by IHC from all singular PCV2 
and dual-infected pigs. Images were captured with a Sony DXC-S500 color digital camera 
(Sony Electronics, Inc., Park Ridge, NJ) mounted on a Zeiss Axiophot microscope (Carl 
Zeiss, Inc., Thornwood, NY) and processed using KS400 image analysis software (Carl 
Zeiss). A 20× objective and a 1.25× optivar were used, resulting in a final magnification of 
25×. The images were converted from RGB to HLS mode and the red and green color planes 
added together to isolate stained areas. The areas were then interactively discriminated from 
the surrounding tissue and measured. The software was calibrated to measure in microns. 
The total area for each field was 227,319.2 square microns, and the percentage of the mean 
PCV2-specific stained area compared to the total area was calculated for each pig. 
IHC for detection of M. hyopneumoniae 
Immunohistochemical detection of M. hyopneumoniae-specific antigen on selected 
lung tissues (three sections for each pig) was done using the heat-induced epitope retrieval 
(HIER) technique. Paraffin-embedded tissue sections were dewaxed and rehydrated, covered 
with 1 : 10 ethylenediaminetetraacetic acid butter solution, pH 6.0 (Richard Allan Scientific, 
Kalamazoo, MI), placed in a microwave and boiled for 5 minutes. After cooling for 20 
minutes, the slides were rinsed, and M. hyopneumoniae monoclonal antibody (Identification 
number D79DI-7; Dr. Richard Ross, Iowa State University) was applied in a 1 : 500 dilution 
for 2 hours at room temperature and further processed by using a labeled streptavidin-biotin 
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detection kit (DAKO). Specificity of the M. hyopneumoniae IHC procedure was evaluated by 
testing sections from formalin-fixed paraffin-embedded blocks from pigs known positive for 
other pathogens (SIV, PRRSV, PCV2, Mycoplasma flocculare). Specificity was determined 
to be 100%. There was no evidence of cross-reaction with any of the pathogens tested. 
Sensitivity was evaluated by comparing the IHC results to those obtained with M. 
hyopneumoniae culture, which is considered the gold standard for M. hyopneumoniae 
detection. The sensitivity of the IHC procedure was determined to be 71% (24/34). Known 
M. hyopneumoniae-positive tissue sections as well as known M. hyopneumoniae-negative 
tissue sections were used as controls for each IHC run. Slides were scored ranging from 0 to 
3 (0, no signal detectable; 1, weak labeling lining the ciliated epithelium of at least one 
airway; 2, weak-to-moderate labeling on the surface of a low number of airways; 3, intense 
labeling on the surface of several airways). 
Isolation of M. hyopneumoniae and other bacteria from lungs 
Isolation of M. hyopneumoniae was performed on tracheobronchial swabs that were 
inoculated into Friis medium.46 Tracheobronchial and lung airway swabs were also used for 
routine bacterial culture on MacConkey and sheep blood agar plates. 
Definition and diagnosis of PMWS in this study 
Criteria required for the diagnosis of PMWS in this experiment include weight loss or 
decreased average daily weight gain compared to negative controls, severe lymphoid 
depletion and histiocytic inflammation in the majority of lymphoid tissues evaluated, and 
association of the lymphoid lesions with PCV2-antigen. To evaluate pigs in our experiment 
we used a scoring system for each lymphoid tissue ranged from 0 to 9 (lymphoid depletion 
score 0-3; granulomatous inflammation score 0-3; PCV2-IHC score 0-3). The scores (lesions 
and PCV2-IHC) of the seven lymphoid tissues ([lymph node pool] × 4, tracheobronchial 
lymph node, spleen, and tonsil) were added together and divided by 7. The lymph node pool 
consisted of superficial inguinal, external iliac, mediastinal, and mesenteric lymph nodes. 
The mean treatment group lymphoid score was calculated and compared between groups. 
Pigs were grouped into four categories on the basis of overall microscopic lymphoid lesion 
scores: I (normal; score = 0), II (mild; score = 1-3), III (moderate; score = 4-6) and IV 
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(severe; score = 7-9). A pig was diagnosed with PMWS if it had decreased weight gain or 
weight loss and if the mean lymphoid microscopic lesion severity score was in category IV.  
Statistical analysis 
Summary statistics were calculated for each group cross-sectionally to assess the 
overall quality of the data. Analysis of variance (ANOVA) was used for cross sectional 
assessment of the average daily weight gain and non-repeated continuous measures. The 
rejection level for the null hypothesis was 0.05 followed by pairwise testing using the Tukey 
Kramer adjustment to identify the groups that were different. The chi-square test was used to 
analyze clinical scores and daily rectal temperature data were analyzed with multivariate 
ANOVA. Nonrepeated measures of necropsy and histopathology data were assessed using 
nonparametric Kruskal-Wallis ANOVA. If a nonparametric ANOVA test was significant (P 
< 0.05), then Wilcoxon tests were used to assess the differences of pairs of groups. 
Differences in incidence were evaluated by using Fisher’s exact test. Kendall’s tau was used 
for nonparametric correlations. 
 
Results 
Clinical disease 
Singular M. hyopneumoniae- and dual-infected pigs exhibited respiratory disease 
which was mild-to-moderate in the singular M. hyopneumoniae-infected pigs and mild-to-
severe in the dual-infected pigs and was characterized mainly by increased respiratory rates, 
lethargy, coughing, and occasionally sneezing. Coughing in dual-infected pigs was 
significantly (P = 0.01) more severe compared to pigs infected singularly with M. 
hyopneumoniae. Coughing was not observed in control pigs or singular PCV2-infected pigs. 
Sneezing was occasionally observed in singular PCV2-infected pigs. Singular M. 
hyopneumoniae- and dual-infected pigs had significantly (P < 0.05) higher respiratory 
disease scores compared to all other groups. Dual-infected pigs had significantly (P < 0.05) 
higher respiratory scores compared to singular M. hyopneumoniae-infected pigs except in the 
1st week after PCV2-inoculation, when the two groups were not different from each other. 
The majority of the dual-infected pigs had rough hair coats and appeared to be falling behind 
their cohorts in the other treatment groups.  
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Individual pigs within all groups had periodically elevated temperatures. None of the 
pigs developed persistent fever. Assessment of the mean rectal temperatures showed no 
significant (P = 0.06) differences between groups. 
There was no difference in mean group weight on the day of M. hyopneumoniae 
inoculation (P = 0.318) or at the day of PCV2 inoculation (P = 0.207), and there was no 
difference (P = 0.162) in average daily weight gain in the 2 weeks before PCV2 inoculation. 
The average daily weight gain in the 1st 3 weeks after PCV2 inoculation was 721.7 ± 16.4 
grams for the control pigs, 662.2 ± 23.8 grams for the singular M. hyopneumoniae-infected 
pigs, 576.6 ± 26.2 grams for the dual-infected pigs, and 678.8 ± 32.5 grams for the singular 
PCV2-infected pigs. During this time period, the average daily weight gain was significantly 
(P < 0.02) decreased in the dual-infected pigs compared to all other groups. The average 
daily weight gain from 21 to 35 DPI was not different (P = 0.605) among the groups. 
Serology 
All pigs were serologically negative for M. hyopneumoniae-specific antibodies before 
M. hyopneumoniae challenge. Singular M. hyopneumoniae- and dual-infected pigs 
seroconverted to M. hyopneumoniae between 21 and 35 DPI. At 21 DPI, 12/17 dual-infected 
pigs were positive, 1/17 dual-infected pigs were in the suspect positive category, and 4/17 
dual-infected pigs were negative for M. hyopneumoniae-specific antibodies. There were 5/17 
singular M. hyopneumoniae-infected pigs that were positive, 7/17 singular M. 
hyopneumoniae-infected pigs were suspect, and 5/17 singular M. hyopneumoniae-infected 
pigs were negative for M. hyopneumoniae specific antibodies at 21 DPI. By 35 DPI, 8/8 dual-
infected and 7/8 singular M. hyopneumoniae-infected pigs had seroconverted to M. 
hyopneumoniae. Dual-infected pigs had significantly (P < 0.05) higher M. hyopneumoniae 
S/P ratios compared to singular M. hyopneumoniae-infected pigs at 21 and at 35 DPI. Control 
and singular PCV2-infected pigs remained negative for M. hyopneumoniae-specific 
antibodies 
At arrival, the pigs had maternal antibodies to PCV2, which decayed below ELISA 
cutoff levels (S/P ratio < 0.2) before PCV2 inoculation. Control and singular M. 
hyopneumoniae-infected pigs remained PCV2 antibody negative. Singular PCV2 and dual-
infected pigs seroconverted to PCV2 between 21 and 35 DPI. There were 11/17 dual-infected 
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pigs and 6/16 singular PCV2-infected pigs positive for PCV2-specific antibodies by 21 DPI. 
By 35 DPI, all singular PCV2- and dual-infected pigs had seroconverted to PCV2. At 21 and 
at 35 DPI, S/P ratios were not different between the two PCV2-infected groups.  
All pigs tested were negative for PRRSV as determined by ELISA at -14, 0, and 35 
DPI. Some pigs had low maternal antibody titers to SIV and PPV which decreased over time 
as expected in pigs from a vaccinated breeding herd. 
PCV2 viremia length and genomic copy numbers 
Control and singular M. hyopneumoniae-infected pigs were negative by PCR for the 
presence of PCV2 nucleic acids in sera throughout the study. At 7 DPI, PCV2 viremia was 
detected in 11/17 dual-infected pigs and in 4/16 singular PCV2-infected pigs. All dual and 
singular PCV2-infected pigs were viremic by 14 DPI. The duration of the PCV2-viremia was 
based on results from the eight dual-infected and eight singular PCV2-infected pigs that 
remained in the study for the entire 35 days. PCV2-viremia was determined to be 4.6 ± 0.26 
weeks in the dual-infected pigs compared with 3.9 ± 0.40 weeks in the singular PCV2-
infected group (P = 0.138). The mean copy number of PCV2 genomic DNA in the dual-
infected pigs was significantly higher at 14 (P < 0.01) and 21 (P < 0.05) DPI compared to the 
singular PCV2-infected pigs (Fig. 1). At 7, 28, and 35 DPI, there was no significant 
difference in the amount of PCV2 genomic DNA in the sera, although dual-infected pigs had 
higher values. 
Macroscopic lesions 
Macroscopic lesions are summarized in Table 2. Mean percentages of the lung tissue 
with grossly visible pneumonia in singular M. hyopneumoniae-infected pigs and dual-
infected pigs were most severe at 21 DPI and generally appeared to be resolving by 35 DPI. 
The severity (%) of M. hyopneumoniae-associated lung lesions did not differ between 
singular M. hyopneumoniae- and dual-infected pigs, although the total gross lung lesion 
scores were significantly (P < 0.05) more severe in dual-infected pigs at 21 DPI compared 
with all other groups and at 35 DPI compared to singular PCV2-infected pigs and controls 
(Fig. 2-5). Lymph nodes in dual- and singular PCV2-infected pigs were two to three times 
normal size on both necropsy days, whereas control and singular M. hyopneumoniae-infected 
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pigs had essentially normal-sized lymph nodes. 
Microscopic lesions 
Microscopic lesions are summarized in Tables 3-5. All treatment groups except 
controls (Fig. 6) had interstitial pneumonia characterized by type 2 pneumocyte hypertrophy 
and hyperplasia and alveolar wall thickening by macrophages and lymphocytes (Table 3). If 
present, these lesions were mild in the singular M. hyopneumoniae-infected pigs, mild-to-
moderate in the singular PCV2-infected pigs and mild-to-severe in the dual-infected pigs 
(Fig. 7). Lungs from singular M. hyopneumoniae- and dual-infected pigs also had moderate-
to-severe peribronchiolar and perivascular lymphohistiocytic cuffing and nodule formation, 
moderate-to-severe increase in alveolar exudate and eosinophilic fluid, lymphohistiocytic 
inflammation in the lamina propria of airways, and mixed inflammation in the lumina of the 
airways (Fig. 8, 9). There was clumping and loss of cilia, sloughing of epithelial cells into the 
airway lumina, mild necrosis and ulceration of epithelium over hyperplastic peribronchiolar 
lymphoid nodules, and infiltration of mononuclear cells in the lamina propria in the M. 
hyopneumoniae-infected groups. In addition, some PCV2- and dual-infected pigs had mild 
peribronchial fibroplasia. Multinucleated giant cells were infrequently observed in 
peribronchial areas of lymphoid hyperplasia. 
Lesions in the lymphoid tissues are summarized in Tables 4 and 5. Control and 
singular M. hyopneumoniae-infected pigs had essentially normal lymphoid tissues. PCV2-
associated lesions in lymphoid tissues were characterized by mild-to-severe lymphoid 
depletion and mild-to-severe histiocytic-to-granulomatous inflammation with low-to-
moderate numbers of multinucleated giant cells. Low-to-moderate numbers of macrophages 
and multinucleated giant cells contained several, variable-sized, spherical, basophilic 
intracytoplasmic inclusion bodies. If present (31/34 singular PCV2- and dual-infected pigs), 
the lymphoid lesions were restricted to one or two of the seven lymphoid tissues examined in 
16/31 (51.8%) of the pigs. Two of the singular PCV2-infected pigs had severe lymphoid 
depletion and moderate histiocytic inflammation; however, this was restricted to individual 
lymph nodes, was not associated with high amounts of PCV2 antigen (PCV2 IHC score 0 
and 1, respectively), and was not observed in tonsil or spleen. The individual scores for 
overall severity of microscopic lymphoid lesions associated with PCV2 antigen in dual and 
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singular PCV2-infected pigs are summarized in Fig. 10. The mean group severity score for 
lymphoid lesions was 4.8 ± 0.8 for the dual-infected pigs and 2.1 ± 0.6 for the singular 
PCV2-infected pigs at 21 DPI, 3.1 ± 0.7 for the dual-infected pigs and 1.8 ± 0.5 for the 
singular PCV2-infected pigs at 35 DPI. Four dual-infected pigs were in category IV (three 
were necropsied at 21 DPI, and one was necropsied at 35 DPI) and had decreased rate of 
weight gain and moderate respiratory disease and fulfilled our definition for PMWS. 
Individual pigs in all groups had mild-to-moderate lymphohistiocytic mycocarditis, 
mild-to-moderate lymphohistiocytic hepatitis, mild-to-moderate lymphohistiocytic interstitial 
nephritis, and mild lymphohistiocytic enteritis. Dual-infected pigs had significantly (P < 
0.05) more severe lymphohistiocytic myocarditis compared with control pigs and M. 
hyopneumoniae-infected pigs but not compared with the singular PCV2-infected group at 
DPI 21 and 35. The four pigs that were diagnosed with PMWS had moderate 
lymphohistiocytic mycarditis and hepatitis, moderate lymphohistiocytic-to-granulomatous 
nephritis, and mild-to-moderate histiocytic-to-granulomatous inflammation of Peyer’s 
patches.  
IHC, image analysis, and M. hyopneumoniae isolation 
The estimated mean amount of PCV2 antigen in lung and lymphoid tissues by groups 
as determined by IHC is summarized in Tables 3-5. PCV2-antigen in lung tissue was most 
often associated with cells that had morphological features consistent with macrophages or 
dendritic cells in areas of M. hyopneumoniae-induced peribronchial lymphoid hyperplasia 
(Fig. 11), within the expanded lamina propria beneath areas of M. hyopneumoniae 
colonization and damage to epithelial cells (Fig. 12), within alveolar macrophages and in 
cells morphologically consistent with septal fibroblasts. In these cells, abundant staining was 
observed mainly in the cytoplasm but also in few nuclei (Fig. 7 inset). Compared with 
singular PCV2-infected pigs, dual-infected pigs had significantly (P < 0.05) more PCV2 
antigen in lymph nodes at 21 (Fig. 13) and 35 DPI, in spleen at 21 DPI, and in the lung at 35 
DPI. Two dual-infected pigs and one PCV2-infected pig had a few PCV2 positive cells in the 
thymus (data not shown). 
Image analysis on tracheobronchial lymph nodes demonstrated a significant (P < 
0.05) difference between the singular PCV2- and the dual-infected pigs at both 21 and 35 
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DPI. Because of their distribution, the data are presented as medians with a 2.5% to 97.5% 
interval that contains 95% of the data. There was a median stained area of 1,173.1 (0.0; 
15,883.2) square microns (0.516% of the total area) in the dual-infected pigs and 20.9 (0.0; 
732.8) square microns (0.009% of the total area) in the singular PCV2-infected pigs at 21 
DPI. There was a median stained area of 238.6 (2.1; 2,241.4) square microns (0.105% of the 
total area) in the dual-infected pigs and 5.5 (0.0; 174.2) square microns (0.002% of the total 
area) in the singular PCV2-infected pigs at 35 DPI. The correlation between IHC scoring and 
image analysis data was high (0.78) and statistically significant (P < 0.0001). Those pigs 
with IHC sores of 0 (n = 13), 1 (n = 10), 2 (n = 7), and 3 (n = 3) had mean stained areas of 
11.8 ± 7.2 (0.01% of the total area), 122.0 ± 69.5 (0.05% of the total area), 1,207.3 ± 342.5 
(0.53% of the total area), and 9,638.1 ± 3,368.3 (4.24% of the total area) square microns, 
respectively. 
The IHC results for M. hyopneumoniae are summarized in Table 3. M. 
hyopneumoniae antigen was associated with the surface of epithelial cells of bronchi and 
bronchioli (Fig. 14). At 35 DPI, there was significantly (P < 0.05) more M. hyopneumoniae 
antigen in dual-infected pigs compared with singular M. hyopneumoniae-infected pigs, but 
there was no difference (P = 0.315) in incidence between the two groups. M. hyopneumoniae 
was isolated from 0/17 control pigs, from 17/17 singular M. hyopneumoniae-infected pigs, 
and from 17/17 dual-infected pigs. M. hyopneumoniae was also isolated from 1/16 singular 
PCV2-infected pigs. This pig was necropsied at 35 DPI and had no lesions characteristic for 
M. hyopneumoniae infection (peribronchial lymphoid hyperplasia score = 0). IHC staining 
for M. hyopneumoniae on this pig was negative and the pig was seronegative for antibodies 
to M. hyopneumoniae at necropsy. Therefore, this likely is a case of contamination at some 
point in sample handling and processing. 
Bacteriology 
Cultures of tracheobronchial and lung swabs of all pigs were negative for common 
swine respiratory pathogens including Pasteurella multocida, Bordetella bronchiseptica, 
Haemophilus parasuis, Streptococcus suis, Salmonella sp., Actinobacillus sp., and others. 
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Organisms morphologically consistent with cilia-associated respiratory bacillus were 
not detected in any of the lung sections of the 35 pigs tested as determined by WS silver 
staining. 
 
Discussion 
PCV2 is now considered an important contributor to the PRDC.23,28,44 The overall 
goal of this study was to investigate the potential interaction between PCV2 and M. 
hyopneumoniae. We demonstrated that dual-infection of pigs with M. hyopneumoniae and 
PCV2 results in increased severity of pneumonia and increased incidence of PMWS. Four of 
17 (23.5%) of the dual-infected pigs had clinical signs and microscopic lesions consistent 
with PMWS, whereas none of the singular PCV2-infected pigs developed PMWS. This is to 
our knowledge the first report of bacterial potentiation of PCV2-infection resulting in PMWS 
in experimentally infected pigs. As in the results reported here, M. hyopneumoniae 
significantly prolonged and increased the severity of PRRSV-induced pneumonia;52,55 
however, M. hyopneumoniae had no effect on concurrent SIV infection.53 Neither those 
studies nor the work described here demonstrated a virus-dependent enhancement of 
mycoplasmal pneumonia.  
M. hyopneumoniae infection increased the amount of PCV2 genomic copy numbers 
in the sera, prolonged the presence of PCV2 antigen in lymphoid and lung tissues and 
increased the amount of PCV2 antigen in lung tissues in dual-infected pigs. PCV2-associated 
lesions and the amount of PCV2 antigen associated with the lesions were enhanced by 
concurrent infection by viruses (PRRSV, PPV) that replicate in cells of the 
monocyte/macrophage lineage.2,3,24,25,26,30,41,47 Two recent in vitro studies reported that 
monocytes, macrophages, and dendritic cells were successfully infected with PCV2; 
however, PCV2 was not found to replicate in vitro in these cell types under culture 
conditions.17,58 PCV2 replication depends on the availability of host cell polymerase which is 
active in regularly dividing cells.57 Although tissue macrophages are capable of cell division, 
usually less than 5% of the resident macrophage population arise de novo.34 Unlike PCV2, 
PPV and PRRSV both readily replicate in the monocyte lineage in vitro.11,22 Because both 
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PPV and PRRSV have been shown to enhance PCV2 replication in vivo, it is possible that 
these viruses activate the macrophages in a way that supports PCV2 replication.  
M. hyopneumoniae infection induces an infiltration of inflammatory cells in BALT 
areas,48 and PCV2 antigen in dual-infected pigs was demonstrated mainly in the cytoplasm 
and also in a few nuclei of cells with morphologic features consistent with macrophages, 
dentritic-like cells, and fibroblasts in areas associated with M. hyopneumoniae colonization. 
In situ hybridization and IHC have failed to demonstrate M. hyopneumoniae in these 
cells;31,48 however, the immune response induced by M. hyopneumoniae is complex with 
reports of both immunostimulation and immunosuppression,29,35,39 nonspecific mitogenic 
effects on swine lymphocytes,39 immunogenic mycoplasmal proteins,51 or cytokines secreted 
by activated macrophages.6,7,54,56 Hence, the mitogenic activity of M. hyopneumoniae could 
upregulate the macrophage proliferation in the lung, thereby supporting PCV2 replication at 
the site of infection.  
It has been shown that PCV2 is not degraded upon uptake by bone marrow- or blood 
monocyte-derived dendritic cells in vitro, suggesting that these cells provide potentially 
important vehicle for transport of the virus throughout the body and tissues.58 Macrophages 
and dendritic cells are upregulated by M. hyopneumoniae,48 and thus M. hyopneumoniae 
coinfection might promote systemic distribution of PCV2. This could explain how localized 
M. hyopneumoniae infection could trigger systemic PCV2-infection to progress to PMWS as 
shown in this model.  
It has been proposed that the diagnosis of PMWS requires a pig to exhibit 
characteristic clinical signs (wasting), histological lesions (lymphoid depletion and 
granulomatous inflammation), and PCV2 antigen associated with these lesions.49 Under field 
conditions, many other factors in addition to PCV2 infection can cause a pig to exhibit signs 
of wasting as described in the context of the current definition of PMWS. It is also not clear 
whether wasting actually means weight loss or decrease in rate of average daily gain (and the 
appearance of wasting) compared to healthy cohorts. Furthermore, the current PMWS 
definition49 neither accounts for distribution or severity of lesions nor for relative amount of 
PCV2 antigen in association with the lesions. Lymphoid depletion and granulomatous 
inflammation can be present in various degrees and diffusely distributed throughout all 
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lymphoid tissues or restricted to one or two lymph nodes in individual pigs. It is unknown 
what consequences these variable manifestations of lymphoid lesions have for individual 
pigs. It seems likely that even the pigs with mild lymphoid depletion may be 
immunologically compromised to some degree and perhaps more susceptible to secondary 
infections and more at risk for vaccination failures. To address this problem, and to properly 
distinguish between PCV2 infection (subclinically or associated with other diseases) and 
PMWS, an overall severity score for microscopic lymphoid lesions that accounted equally 
for distribution (lymph nodes, spleen, and tonsil), severity of lymphoid depletion, severity of 
inflammation, and amount of PCV2 antigen was calculated. Microscopic lesions (mild, 
moderate, and severe PCV2-associated lymphoid depletion and granulomatous 
inflammation) have been staged on cases of naturally occurring PMWS.10,45 We believe that 
the mean group severity score for lymphoid lesions as developed and used in this model 
allows for a more uniform understanding and interpretation of PCV2-associated lesions. 
Some dual-infected pigs in this study had severe dyspnea (persistent coughing and 
moderate-to-severe respiratory score) in combination with decreased weight gain and 
macroscopic (more than 40% of the lung affected by lesions) and microscopic lung lesions 
(moderate-to-severe bronchointerstitial pneumonia) consistent with PRDC. The macroscopic 
and microscopic lung lesions of these pigs were remarkably similar to those observed with 
PRRSV/PCV2 coinfection.24 These pigs also had lymphoid depletion, histiocytic 
inflammation of lymph nodes, and PCV2 antigen associated with the lesions. However, we 
found that the lymphoid lesions lacked the overall severity and distribution to clearly classify 
them as cases of PMWS. We believe that PCV2-associated pneumonia and PCV2-associated 
lymphoid depletion are more descriptive terms in such cases.  
It is of interest that at 21 and at 35 DPI, the dual-infected pigs had a significantly (P < 
0.05) higher serum antibody response to M. hyopneumoniae compared with the singular M. 
hyopneumoniae-infected pigs. There was also a trend to a higher antibody response to PCV2 
in dual-infected pigs compared to the singular PCV2-infected pigs at 35 DPI (P = 0.055). 
Similar results have been reported with PPV antibody response in PCV2/PPV dual-infected 
pigs.41 The three pigs that were diagnosed with PMWS in the current study did not 
seroconvert to M. hyopneumoniae by 21 DPI. The one PMWS pig that remained in the study 
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through 35 DPI was negative at 21 DPI and had a weak positive antibody response (near 
ELISA cutoff value) to M. hyopneumoniae by 35 DPI. Three of the four PMWS pigs 
seroconverted to PCV2 at 21 DPI but had lower S/P ratios than the other pigs in this group. 
Similarly, the antibody response in PCV2-infected, immunostimulated, PMWS-affected pigs 
was markedly reduced.33 The dual-infected pigs in this study certainly had more stimulus in 
the form of inflammation than did the singular-infected pigs. Thus, in the context of 
additional stimulation (coinfection or nonspecific immunostimulation), the B-cell response in 
PCV2-infected non-PMWS pigs appeared to be enhanced due to PCV2 infection, whereas it 
is severely diminished in pigs that progressed to PMWS. Up-regulation of certain cytokines 
during the course of inflammation can lead to enhanced proliferation of T lymphocytes and B 
lymphocytes inducing B cell- and plasma cell-dependent antibody production which could 
explain the better response in the non-PMWS pigs. It appears that if the inflammatory 
stimulation reaches a certain level, it has more of a counterproductive effect subsequently 
leading to PMWS. However, the quality of the enhanced B-cell response, the presence of an 
enhanced T-cell response, and inflammatory aspects in the dual-infected pigs were not 
evaluated in this study, thus, making any conclusions about possible alterations of the 
immune system speculative. This coinfection model should allow us to further explore those 
questions.  
The PCV2/M. hyopneumoniae coinfection model presented here demonstrated that, 
by themselves, PCV2 and M. hyopneumoniae induce mild transient respiratory disease and 
lesions but in concurrent infection induce severe respiratory disease and lesions consistent 
with PMWS as well as PRDC. The sequence of infection (M. hyopneumoniae followed 2 
weeks later by PCV2) of this dual-infection model was designed to address our hypothesis 
that M. hyopneumoniae lesions are present first and create an ideal environment and cell-type 
accumulation in the lung for PCV2 replication. This may or may not be typical of the 
sequence of infection in the field. After weaning and mixing of pigs at 2-4 weeks of age, M. 
hyopneumoniae is commonly spread slowly throughout the population. PCV2 infection likely 
coincides with waning of maternal antibodies over a large window of time from 5-11 weeks 
of age43. The exact timing and sequence of infection of pigs with these two pathogens likely 
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differs from pig to pig and from herd to herd and these different scenarios should be further 
explored to see if there are similar effects as observed in this model.  
This dual-infection model will be very useful for testing vaccine and antimicrobial 
intervention strategies. Experimental PCV2 vaccines have been shown to protect PCV2-
infected pigs from developing the characteristic PCV2-associated lymphoid lesions.15,16 M. 
hyopneumoniae vaccines are well established in the field and have been shown to be 
economically beneficial in reducing losses associated with respiratory disease.35 However, 
recent field studies have indicated that M. hyopneumoniae vaccination in PMWS-affected 
herds actually increased the incidence of PMWS.4,32 This information has led some 
practitioners to discontinue the use of M. hyopneumoniae vaccination programs in affected 
herds. Based on the PCV2/M. hyopneumoniae model, the detrimental effects from lack of M. 
hyopneumoniae control may be more costly than the detrimental effects of vaccine induced 
enhancement of PCV2 replication. This risk and benefit associated with M. hyopneumoniae 
vaccination should be thoroughly assessed. It also needs to be determined what vaccine 
regimen (singular PCV2 or M. hyopneumoniae or a combination of both) is most efficient in 
reducing PRDC and PMWS in pigs from herds that are at a high risk of dual-infection by M. 
hyopneumoniae and PCV2.  
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Table 1. Experimental design. 
Inoculation No. of Pigs Necropsied at: 
 
Group 
4 Weeks* 
-14 Days before PCV2 inoculation
6 Weeks
DPI 0† 
9 Weeks 
DPI 21 
11 Weeks 
DPI 35 
1 (n=17) None None 
2 (n=17) Mycoplasma hyopneumoniae None 
3 (n=17) Mycoplasma hyopneumoniae PCV2 
4 (n=16) None PCV2 
9 
9 
9 
8 
8 
8 
8 
8 
*Age of the pigs. 
†Days post inoculation (DPI) with porcine circovirus type 2 (PCV2). 
 
 
 
 
 Table 2. Macroscopic lesions at 21 and 35 days after PCV2 inoculation. Data presented as group mean ± SE. 
Percentage of Lung with Pneumonia  
 
Group 
  
 
Inoculation  
Total† M. hyopneumoniae  
Lesions‡ 
Gross  
Lymphadenopathy* 
21 after PCV2 inoculation 
1 (n = 9) Sham inoculation 0.00±0.00A§ 0.07±0.03A 0.00±0.00A
2 (n = 9) M. hyopneumoniae 16.55±3.18B 12.60±3.43B 0.00±0.00A
3 (n = 9) M. hyopneumoniae and PCV2 33.22±6.64C 22.53±6.35B 2.72±0.15B
4 (n = 8) PCV2 0.63±0.50A 0.45±0.29A 2.21±0.21B
35 days after PCV2 inoculation 
1 (n = 8) Sham inoculation 0.00±0.00A 0.12±0.07A 0.00±0.00A
2 (n = 8) M. hyopneumoniae 10.50±3.27B 6.05±1.68B 0.00±0.00A
3 (n = 8) M. hyopneumoniae and PCV2 23.88±5.91B 6.60±1.85B 3.00±0.00B
4 (n = 8) PCV2 1.00±0.87A 0.67±0.43A 2.19±0.13C
197
*Score range from 0 (normal) to 3 (three times the normal size). 
†Total amount (0-100%) of the entire lung affected by any type of pneumonia lesion. 
‡Well-demarcated cranioventral purple-tan lesions suggestive of M. hyopneumoniae infection. 
§Different superscripts (A, B, C) within each column indicate significantly (P < 0.001) different values in mean score among 
treatment groups at 21 or 35 DPI.
 
 Table 3. Microscopic lung lesions in pigs in group 1 (sham-inoculated), 2 (singular Mycoplasma hyopneumoniae-infected), 3 (M. 
hyopneumoniae and PCV2 dual infected), and 4 (singular PCV2 infected) at 21 and 35 days after PCV2 inoculation. Data 
presented as incidence (group mean [mean severity score for affected animals]). 
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Group 
Type 2 Pneumocyte  
Hypertrophy 
Septal Infiltration Peribronchiolar 
Lymphoid Hyperplasia 
 Alveolar Exudate
       0-6* 0-6* 0-6* 0-6*
21 days after PCV2 inoculation 
1 (n = 9) 1/9 (0.1[1.0])A‡   
  
  
  
  
  
  
  
4/9 (0.4[1.0])A 1/9 (0.1[1.0])A 2/9 (0.2[1.0])A
2 (n = 9) 9/9 (1.9[1.9])B 9/9 (1.3[1.3])B 9/9 (3.7[3.7])B 8/9 (3.7[4.1])B
3 (n = 9) 9/9 (3.0[3.0])C 8/8 (2.6[2.6])C 9/9 (2.9[2.9])B 9/9 (4.1[4.1])B
4 (n = 8) 8/8 (1.4[1.4])B 8/8 (1.4[1.4])B 4/8 (0.6[1.3])A 8/8 (1.6[1.6])C
35 days after PCV2 inoculation 
1 (n = 8) 0/8 (0.0[0.0])A 8/8 (1.1[1.1])A 3/8 (0.4[1.0])A 3/8 (0.4[1.0])A
2 (n = 8) 6/8 (1.0[1.3])B 8/8 (1.4[1.4])B 8/8 (4.3[4.3])B 6/8 (2.9[3.8])B
3 (n = 8) 8/8 (2.4[2.4])C 8/8 (3.2[3.2])C 8/8 (4.5[4.5])B 8/8 (3.5[3.5])B
4 (n = 8) 7/8 (1.3[1.4])B 8/8 (2.0[2.0])B 5/8 (1.1[1.8])A 7/8 (1.4[1.6])C
*Score range from 0 (normal) to 6 (severe diffuse). 
†Score range as determined by immunohistochemistry (0 = undetectable; 3 = large amount of antigen). 
‡Different superscripts (A, B, C) indicate significantly (P < 0.05) different mean group severity scores within columns for each 
DPI. 
 
 Table 3. (Continued). 
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Group 
 Inflammation of  
Lamina Propria 
Necrotizing
Bronchiolitis 
Amount of PCV2 
Antigen  
in Lung Tissue 
Amount of  
M. hyopneumoniae 
Antigen  
       0-6* 0-6* 0-3† 0-3†
21 days after PCV2 inoculation 
1 (n = 9)  0/9 (0.0[0.0])A  
 
 
 
 
 
 
 
0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 0.0[0.0])A
2 (n = 9)  9/9 (2.6[2.6])B 1/9 (0.1[1.0])A 0/9 (0.0[0.0])A 8/9 1.7[1.9])B
3 (n = 9)  9/9 (3.0[3.0])B 7/9 (1.0[1.2])B 6/9 (0.8[1.2])B 7/9 1.4[1.9])B
4 (n = 8)  5/8 (0.9[1.4])C 2/8 (0.6[2.5])A,B 2/8 (0.3[1.0])A,B 0/8 0.0[0.0])A
35 days after PCV2 inoculation 
1 (n = 8)  2/8 (0.3[1.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 0.0[0.0])A
2 (n = 8)  7/8 (1.4[1.6])B 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 3/8 0.4[1.0])A
3 (n = 8)  8/8 (2.8[2.8])C 6/8 (1.3[1.7])B 6/8 (0.8[1.0])B 6/8 1.4[1.8])B
4 (n = 8)  5/8 (0.8[1.2])B 2/8 (0.3[1.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Score range from 0 (normal) to 6 (severe diffuse). 
†Score range as determined by immunohistochemistry (0 = undetectable; 3 = large amount of antigen). 
‡Different superscripts (A, B, C) indicate significantly (P < 0.05) different mean group severity scores within columns for each 
DPI. 
 
 
 Table 4. Microscopic lesions (lymphoid depletion and inflammation) and amount of PCV2-specific antigen demonstrated by 
immunohistochemistry (IHC) in lymph nodes at 21 and 35 days after PCV2 inoculation. Data presented as incidence (mean group 
severity score [mean severity for affected animals]). 
  Lymph node pool*  Tracheobronchial lymph nodes  
Group  
 
Inoculation        Depletion† Inflammation‡ PCV2 Antigen§ Depletion† Inflammation‡ PCV2 Antigen§
21 days after PCV2 inoculation 
1 (n = 9)  Sham inoculation  0/9 (0.0[0.0])A║  0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A
2 (n = 9)  Mycoplasma hyopneumoniae   
 
 
0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 1/9 (0.1[1.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A
3 (n = 9)  M. hyopneumoniae and PCV2  9/9 (2.3[2.3])B 9/9 (1.8[1.8])B 9/9 (1.9[1.9])B 9/9 (2.0[2.0])B 8/9 (1.4[1.6])B 9/9 (2.2[2.2])B
4 (n = 8)  PCV2  6/8 (1.4[1.8])C 5/8 (1.0[1.6])B 3/8 (0.4[1.0])C 8/8 (1.5[1.5])B 6/8 (1.0[1.3])B 5/8 (0.8[1.2])C
35 days after PCV2 inoculation 
1 (n = 8)  Sham inoculation  0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A  1/9 (0.1[1.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A
2 (n = 8)  M. hyopneumoniae   
 
 
2/8 (0.3[1.0])A 1/8 (0.1[1.0])A,B 0/8 (0.0[0.0])A 1/9 (0.1[1.0])A 2/8 (0.0[0.0])A 0/8 (0.0[0.0])A
3 (n = 8)  M. hyopneumoniae and PCV2  8/8 (1.9[1.9])B 5/8 (0.9[1.4])C 7/8 (1.6[1.9])B 8/8 (1.3[1.3])B 3/8 (0.5[1.3])A 8/8 (1.8[1.8])B
4 (n = 8)  PCV2  7/8 (1.3[1.4])B 4/8 (0.6[1.3])B,C 3/8 (0.5[1.3])C 6/8 (1.0[1.3])B 3/8 (0.5[1.3])A 4/8 (0.6[1.3])C
200
*Superficial inguinal, external iliac, mediastinal, and mesenteric lymph nodes. 
†Score range 0 (normal) to 3 (severe lymphoid depletion). 
‡Score range 0 (normal) to 3 (severe histiocytic-to-granulomatous inflammation with replacement of follicles) 
§Score range 0 (undetectable) to 3 (large amount of PCV2 antigen). 
║Different superscripts within columns (A, B, C) represent significantly (P < 0.05) different mean group severity scores within columns for each DPI. 
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Spleen TonsilGroup 
  
Inoculation 
        Depletion* Inflammation† PCV2-antigen‡ Depletion* Inflammation† PCV2-antigen‡
 
21 days after PCV2-inoculation 
1 (n = 9)  Sham-inoculation  0/9 (0.0[0.0])A§  0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A
2 (n = 9)  M. hyopneumoniae   
 
 
0/9 (0.0[0.0])A 1/9 (0.1[1.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A 0/9 (0.0[0.0])A
3 (n = 9)  M. hyopneumoniae and PCV2  7/9 (1.1[1.4])B 5/9 (1.0[1.8])B 6/9 (1.2[1.8])B 6/9 (0.9[1.3])B 4/9 (0.4[1.3])A 6/9 (1.2[1.8])B
4 (n = 8)  PCV2  4/8 (0.5[1.0])B 2/8 (0.4[1.5])A,B 1/8 (0.1[1.0])A 2/8 (0.3[1.0])A,B 1/8 (0.3[2.0])A 2/8 (0.3[1.0])A,B
35 days after PCV2-inoculation 
1 (n = 8)  Sham-inoculation  0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A  0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A
2 (n = 8)  M. hyopneumoniae   
 
 
0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A 0/8 (0.0[0.0])A
3 (n = 8)  M. hyopneumoniae and PCV2  4/8 (0.5[1.0])B 2/8 (0.4[1.5])A 4/8 (0.5[1.0])B 2/8 (0.3[1.0])A 1/8 (0.3[2.0])A 3/8 (0.5[1.3])A
4 (n = 8)  PCV2  2/8 (0.4[1.5])A,B 2/8 (0.3[1.0])A 1/8 (0.1[1.0])A,B 2/8 (0.4[1.5])A 1/8 (0.1[1.0])A 3/8 (0.4[1.0])A
Table 5. Microscopic lesions (lymphoid depletion and inflammation) and amount of PCV2-specific antigen demonstrated by 
immunohistochemistry (IHC) in tonsil and spleen at 21 and 35 days after PCV2 inoculation. Data presented as incidence (mean 
group severity score [mean severity for affected animals]). 
§Different superscripts within columns (A, B, C) represent significantly (P < 0.05) different mean group severity scores within columns for each DPI.
†Score range 0 (normal) to 3 (severe histiocytic-to-granulomatous inflammation with replacement of follicles). 
‡Score range 0 (undetectable) to 3 (large amount of PCV2 antigen). 
*Score range 0 (normal) to 3 (severe lymphoid depletion). 
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Fig. 1. Mean group PCV2-genomic copy numbers obtained from singular PCV2 and dual 
Mycoplasma hyopneumoniae/PCV2-infected pigs. Error bars represent standard errors. 
* = significant (P < 0.05) differences between groups. 
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Fig. 2. Lung; pig, 35 days after inoculation with PCV2. No gross lesions were observed. 
 
Fig. 3. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae. The lung has 
well-demarcated, dark red areas of pneumonia in the cranioventral region. 
 
Fig. 4. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae and 21 days 
after inoculation with PCV2. The lung failed to collapse, has a diffuse mottled-tan 
appearance and severe multifocal dark-purple-to-tan consolidation. 
 
Fig. 5. Lung; pig, 49 days after inoculation with Mycoplasma hyopneumoniae and 35 days 
after inoculation with PCV2. The lung is diffusely mottled-tan and has well-demarcated, 
dark-red tan areas of consolidation.  
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Fig. 6. Lung; control pig. Normal. HE. Bar = 250 µm. 
 
Fig. 7. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae and 21 days 
after inoculation with PCV2. There is thickening of the alveolar septa by marked type 2 
pneumocyte hypertrophy and hyperplasia and infiltration of alveolar space by moderate 
numbers of macrophages and low numbers of neutrophils. HE. Bar =  75 µm. Inset: Intense 
nuclear and cytoplasmic staining for PCV2 antigen in a macrophage-like cell. 
Immunohistochemical staining with anti-PCV2 polyclonal antibody. Streptavidin-biotin-
peroxidase complex method counterstained with hematoxylin. Bar = 20 µm. 
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Fig. 8. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae. There is 
peribronchiolar lymphoid hyperplasia typical of M. hyopneumoniae infection. HE. Bar = 250 
µm. 
 
Fig. 9. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae and 21 days 
after inoculation with PCV2. There is peribronchiolar lymphoid hyperplasia typical of M. 
hyopneumoniae infection. The interstitial pneumonia, peribronchial fibroplasia, and 
infiltration of the lamina propria with macrophages and lymphocytes (arrows) is typical of 
PCV2-infection. HE. Bar = 250 µm. 
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Fig 10. Distribution of individual pig lymphoid lesion (lymphoid depletion and inflammation 
and PCV2-antigen) scores in pigs in singular PCV2 (n = 16) and dual M. 
hyopneumoniae/PCV2 (n = 17) infected groups. Score ranges from 0 to 9. 
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Fig 11. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae and 21 days 
after inoculation with PCV2. PCV2 antigen-positive cells (arrows) are associated with the 
peribronchial lymphoid hyperplasia. Immunohistochemical staining with anti-PCV2 
polyclonal antibody. Streptavidin-biotin-peroxidase complex method counterstained with 
hematoxylin. Bar = 120 µm. Inset: Detail of the area of follicular lymphoid hyperplasia with 
several PCV2 antigen-labeled macrophage- and dendritic-like cells. Bar = 35 µm. 
 
Fig 12. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae and 21 days 
after inoculation with PCV2. PCV2 antigen-positive cells (arrows) in the lamina propria and 
submucosa of a bronchus. Immunohistochemical staining with anti-PCV2 polyclonal 
antibody. Streptavidin-biotin-peroxidase complex method counterstained with hematoxylin. 
Bar = 80 µm. Inset: Detail of the area with macrophage-like cells with numerous variable-
sized PCV2 antigen-positive intracytoplasmic spherical bodies as well as nuclear staining. 
Bar = 30 µm. 
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Fig 13. Tracheobronchial lymph node; pig, Fig. 13A. small amount of PCV2 antigen 
(arrows) in the follicle of a singular PCV2-infected pig 21 days after inoculation with PCV2, 
Fig. 13B. large amount of PCV2 antigen (arrows) in a follicle of a dual-infected pig 35 days 
after inoculation with M. hyopneumoniae and 21 days after inoculation with PCV2. These 
pigs were the individual pigs with the highest amount of PCV2 antigen in each treatment 
group based on scoring and image analysis results. Immunohistochemical staining with anti-
PCV2 polyclonal antibody. Streptavidin-biotin-peroxidase complex method counterstained 
with hematoxylin. Bar = 30 µm. 
 
Fig 14. Lung; pig, 35 days after inoculation with Mycoplasma hyopneumoniae and 21 days 
after inoculation with PCV2. M. hyopneumoniae-specific staining (arrow) at the luminal 
surface of the bronchus epithelial cells. Immunohistochemical staining with anti-M. 
hyopneumoniae monoclonal antibody. Streptavidin-biotin complex method counterstained 
with hematoxylin. Bar = 200 µm. Inset: The epithelial cell layer has intense staining for M. 
hyopneumoniae antigen on the surface. Bar = 30 µm.
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CHAPTER 9.  EVIDENCE OF BREED-DEPENDENT DIFFERENCES IN 
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Abstract. Porcine circovirus type 2 (PCV2) has been confirmed as the primary cause of 
postweaning multisystemic wasting syndrome (PMWS). However, in the field, PMWS is 
seen only in a small percentage of pigs infected with PCV2. The overall objective of this 
study reported here was to determine whether host genetic differences in the susceptibility to 
PCV2-associated disease exist among selected breeds of pigs. This study included Duroc (n = 
23), Landrace (n = 19), and Large White (n = 21) pigs. The pigs were infected intranasally 
and intramuscularly at 5-7 weeks of age with PCV2. A portion of the pigs (31/63; 30.2%) 
had low passively acquired PCV2 antibodies at the time of infection. There were no 
differences in mean weight gain, rectal temperature, or respiratory score. Clinical disease 
compatible with PMWS was observed only in the Landrace pigs. Most of the PCV2-infected 
pigs had enlarged lymph nodes, and individual Duroc and Landrace pigs had mottled tan 
lungs. PCV2-associated lymphoid depletion and granulomatous inflammation were observed 
in pigs of all breeds. Three of 19 Landrace pigs and none of the Duroc or Large White pigs 
developed severe lymphoid lesions associated with large amounts of intralesional PCV2-
antigen typical of PMWS. Compared with seronegative Landrace pigs, Landrace pigs that 
had low maternal antibodies at the time of PCV2 inoculation had significantly (P < 0.05) 
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less-severe PCV2-associated lesions. The results suggest a predisposition of the Landrace 
pigs used in this study to PCV2-induced disease and lesions, and that low levels of passively 
acquired antibodies are protective.  
 
Introduction 
Porcine circovirus (PCV) was first detected as a contaminant of a continuous porcine 
kidney cell line in 197470 and was further described in 1982.69 In the late 1990s, PCV was 
associated with postweaning multisystemic wasting syndrome (PMWS).18 Further analysis of 
the virus documented two distinct types of PCV: nonpathogenic type 1 (PCV1) and 
pathogenic and PMWS-associated type 2 (PCV2).6,46,50 Subsequently, PCV2 has been 
associated with several other swine diseases including porcine respiratory disease complex,31 
reproductive disorders characterized by abortions with mummified fetuses,73 enteritis,38 and 
porcine dermatitis and nephropathy syndrome.63 PMWS was first observed in a Canadian 
herd in 1991,28 and is now recognized worldwide.1 The syndrome is characterized by a 
clinical history of wasting or poor performance in weaned pigs and by severe lymphoid 
depletion and histiocytic replacement of follicles in lymphoid tissues.66 Detection of PCV2 
antigen or nucleic acids within characteristic microscopic lesions is required for the diagnosis 
of PMWS.66  
Serological surveys indicate a high prevalence of PCV2 in the swine 
population16,17,34,44,72; however, the prevalence of PCV2-associated disease seems to vary 
considerably from farm to farm and country to country. Morbidity attributable to PMWS 
reportedly varies from as little as 4% to as high as 30%, and mortality in affected pigs is 
typically 70-80%.1,28,43,61 However, most reports to date lack important additional 
information regarding breed, production style, and environment of the farm, or description of 
other diseases present in the pigs that may have influenced expression and outcome of PCV2-
associated diseases. Genetic analyses to date have not been able to document major 
differences between PCV2 isolates recovered from affected pigs and those from nonaffected 
pigs.12,42 Analysis and comparison of PCV2 isolates from severely affected countries like 
Spain or France with those from countries that are less affected like the United States20,45 
have failed to explain differences in clinical manifestations of PCV2-associated diseases. All 
 
 211
isolates sequenced and compared so far indicated a nucleic acid sequence homology 
>94%.20,45  
Experimental PCV2 infection models indicate that PCV2 is an opportunist, depending 
on immunostimulation3,39 or coinfecting agents like porcine parvovirus (PPV),7,36,40,52 porcine 
reproductive and respiratory syndrome virus (PRRSV),2,32,64 or Mycoplasma 
hyopneumoniae54 for PCV2 infection to progress to clinical PMWS. Although most research 
groups where not able to induce clinical disease in pigs inoculated singularly with PCV2, 
some groups have succeeded in this regard.8,32 PMWS was recently induced in conventional 
colostrum-fed pigs singularly-infected with PCV2.41 The exact reasons for the different 
outcomes in experimental PCV2 infection models are not known, but there are several 
possible explanations including differences in environmental conditions and stressors, age of 
the pigs at infection, or differences in type and dose and routes of the PCV2-inoculation.  
One other aspect that, to the authors’ knowledge, has not been investigated is the 
influence of host genetics on PCV2 infection. Differences in genetic susceptibility of 
populations or breeds to parasites, bacteria, and viruses have been reported.9,10,30,68 Evidence 
exists for pig breed-dependent differences in disease resistance for a variety of pathogens 
including pseudorabies virus,59 PRRSV,27 Escherichia coli,15,49 and Sarcocystis 
miescheriana.60 Pigs of all breeds seem to be susceptible to PCV2 infection, and PMWS has 
been observed within a large variety of purebred and crossbred pigs submitted to a US 
diagnostic laboratory (P.G. Halbur, unpublished data). Recently, PMWS has been reported in 
Eurasian wild boars in Canada19 and Spain.71 Retrospective studies indicate that naturally 
acquired PCV2-infections in pig herds date back for at least 20 years prior to the first 
observation of PMWS25,44,65,72; however, PCV2-associated diseases emerged in the late 
1990s. Allan et al.5 reported experimental induction of PMWS in colostrum-deprived 
Northern Ireland Landrace/Large White crossbred pigs inoculated with a PCV2 isolate 
recovered in 1993 from a subclinically infected Swedish Yorkshire pig, implying host and/or 
environmental dependant factors associated with the development of PMWS. A recent in 
vitro study investigating the replication patterns of PCV2 in pulmonary alveolar 
macrophages indicated clear differences among macrophages derived from different 
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conventional crossbred pigs that were suggestive of differences in susceptibility to PCV2-
associated disease.47  
The overall objective of the study reported here was to determine whether there is 
evidence for host genetic differences in susceptibility to PCV2-associated disease among 
selected breeds including Duroc, Landrace, and Large White. These breeds were selected 
because they could be purchased from a single source. 
 
Materials and Methods 
Animal source 
Seventy-five purebred (n = 26 Duroc; n = 25 Landrace; and n = 24 Large White), 
colostrum-fed, female pigs raised under identical conditions on the same farm and in the 
same barn were purchased from a herd that is routinely tested for major swine pathogens and 
is free of PRRSV and M. hyopneumoniae. There was no evidence of PCV2-associated 
disease in the source herd or in the multiplier herds supplied by this source. The source herd 
is routinely vaccinated against PPV infection and leptospirosis. The pigs were born within a 
range of 23 days, randomly selected on farm after blocking by sire and litter, weaned at 10-
12 days of age, and transported in two groups of 39 (n = 12 Duroc; n = 14 Landrace; and n = 
13 Large White) and 36 (n = 14 Duroc; n = 11 Landrace; and n = 11 Large White) pigs 2 
weeks apart to the Livestock Infectious Disease Isolation Facility at Iowa State University, 
Ames, Iowa. The pigs from the various breeds were housed in two rooms until inoculation.   
Serologic testing 
Blood samples were collected at arrival of the pigs, followed by blood collections at 
2-week intervals until the day of PCV2 inoculation. Thereafter, blood was collected on 
postinoculation day (PID) 7, 14, 21, 28, and 35. Preinoculation sera (from arrival up to PID 
0) and serum samples obtained on PID 21 and 35 were tested by a PCV2-enzyme linked 
immunosorbent assay (ELISA) that is based on the recombinant ORF2 capsid protein of 
PCV2.51 Results were considered positive if the calculated sample-to-positive ratio (S : P) 
ratio was ≥0.2.  
The serum samples obtained on arrival of the pigs at the research facility and the 
serum samples obtained at necropsy from 11 randomly selected PCV2-infected pigs of each 
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of the three breeds were tested for the presence of antibodies to PRRSV by use of a PRRSV-
ELISA (IDEXX Laboratories, Inc. Westbrook, MA), and for the presence of antibodies to 
PPV by hemagglutination-inhibition assay48. 
Experimental design and PCV2 inoculation 
Twelve pigs (three Duroc, six Landrace, and three Large White pigs) were kept as 
sham-inoculated control pigs and housed together in a separate room. These pigs were 
procedural controls, selected on the basis of presence of maternal antibodies to PCV2. 
Experimentally induced PCV2 in the remaining 63 pigs (23 Duroc, 19 Landrace, and 21 
Large White pigs) was initiated after waning of the PCV2 maternal antibody levels below the 
negative cutoff (S : P ratio <0.2). All of the PCV2-infected pigs were housed in three rooms 
and randomly distributed into two to seven pens of five to six pigs per pen. The procedural 
controls were housed separately in a fourth room. To account for and minimize sire and litter 
effects, a minimum of four sires were represented within each breed and two to five piglets 
were chosen from each dam. The sire and dam distribution in the PCV2-inoculated pigs was 
as follows: Duroc pigs (n = 23) represented four sires and eight dams, and the Landrace (n = 
19) and the Large White (n = 21) pigs represented four sires and six dams, respectively.  
PCV2 isolate ISU-4089520 was obtained via direct transfection of PK-15 cells with an 
infectious clone of PCV2 as previously described.21 Passage 4 of the virus at a titer of 104.2 
50% tissue culture infective doses was used for inoculation of the pigs. The inoculum tested 
negative for the presence of porcine parvovirus and PCV1 nucleic acids on the basis of 
results of polymerase chain reaction (PCR) analysis.20,37 After production, the PCV2 
inoculum was stored in individual 50-ml tubes at -80ºC and thawed only once immediately 
prior to inoculation. To better ensure infection of all pigs at the time of inoculation, each pig 
received 1 ml of the PCV2 inoculum intranasally and 0.5 ml intramuscularly in the right side 
of the neck as described.22,23 On the day of PCV2 inoculation, the pigs were 5-8 weeks old. 
Mean ± SE age was 43.5 ± 1.8 days for the Duroc, 48.6 ± 2.0 days for the Landrace, and 46.0 
± 2.0 days for the Large White pigs. 
Clinical evaluation 
After PCV2 inoculation, the pigs were monitored daily and scored for severity of 
clinical respiratory disease ranging from 0 to 6 (0 = normal and 6 = severe dyspnea and 
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abdominal breathing).26 In addition, pigs were evaluated daily for clinical signs including 
sneezing (score range from 0 [no sneezing] to 3 [severe persistent sneezing]), and jaundice. 
Rectal temperatures, wasting, and behavioral changes such as lethargy were recorded daily. 
The pigs were weighed on the day of PCV2 inoculation and on PID 7, 14, 21, 28, and 35. 
Quantification of PCV2 
Extraction of DNA from sera obtained on the day of PCV2 inoculation and on PID 7, 
14, 21, 28, and 35 was performed using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA). 
The DNA extracts were used for quantification of the amount of PCV2 genomic DNA by 
real-time PCR analysis.55 
Necropsy 
Necropsies were performed on half of the PCV2-infected pigs of each breed at PID 
21 (n = 12 Duroc, n = 11 Landrace, and n = 11 Large White) and on the remaining pigs at 
PID 35 (n = 11 Duroc, n = 8 Landrace, n = 10 Large White). In addition, 7 of 12 control pigs 
(two Duroc, three Landrace, and two Large White pigs) were necropsied on PID 21, and 5 of 
12 (one Duroc, three Landrace, and one Large White pig) were necropsied on PID 35. The 
total amount of macroscopic lung lesions (0-100% of the lung affected),26 and size of lymph 
nodes (score range from 0-3; 0 [normal], 1 [two times the normal size], 2 [three times the 
normal size], 3 [four times the normal size]) were estimated.
Lungs were insufflated with fixative as described.26 Sections of lymph nodes 
(superficial inguinal, external iliac, mediastinal, tracheobronchial, mesenteric), tonsil, 
thymus, ileum, kidney, colon, spleen, and liver were collected at necropsy and fixed in 10% 
neutral-buffered formalin and processed in routine manner for histologic examination.  
Histologic examination and immunohistochemical analysis 
Microscopic lesions were evaluated in a blinded manner. Lung sections were scored 
for presence and severity of interstitial pneumonia ranging from 0 to 6 (0=normal; 6=severe 
diffuse).26 Sections of heart, liver, kidney, ileum, and colon were evaluated for the presence 
of lymphohistiocytic inflammation and were scored from 0 = none to 3 = severe. Lymphoid 
tissues including lymph nodes, tonsil, and spleen were evaluated for the presence of 
lymphoid depletion ranging from 0 = normal to 3 = severe histiocytic inflammation and 
replacement of follicles ranging from 0 = normal to 3 = severe.54 
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Immunohistochemical detection of PCV2-specific antigen was performed on 
formalin-fixed and paraffin-embedded lymphoid tissue sections (lymph nodes [superficial 
inguinal, external iliac, mediastinal, tracheobronchial, and mesenteric], tonsil, spleen, and 
thymus) of all pigs and sections of intestine from selected pigs using a rabbit polyclonal 
antiserum.67 Scoring for PCV2 antigen was done in blinded manner, and scores ranged from 
0 = no signal to 3 = >50% of the lymphoid follicles containing cells with PCV2 antigen 
staining.54 Mean group score was determined for each tissue and compared among groups.  
The overall PCV2-associated lesions were evaluated as described.54 A combined 
scoring system for each lymphoid tissue that ranged from 0 to 9 (lymphoid depletion score 0-
3; granulomatous inflammation score 0-3; PCV2-IHC score 0-3) was used. The scores 
(lesions and PCV2-IHC) of the seven lymphoid tissues ([lymph node pool multiplied by five] 
+ [spleen] + [tonsil]) were added together and divided by seven. The lymph node pool 
consisted of one section each of tracheobronchial, superficial inguinal, external iliac, 
mediastinal, and mesenteric lymph nodes. Pigs were grouped into four categories on the basis 
of overall microscopic lymphoid lesion scores: normal (score = 0), mild (score = 1-3), 
moderate (score = 4-6) and severe (score = 7-9). The mean treatment group lymphoid score 
was calculated and compared among groups. A pig was diagnosed as having microscopic 
lesions typical of PMWS if the mean lymphoid microscopic lesion severity score was severe 
(score of 7-9) and if there was evidence of lymphohistiocytic inflammation in other organ 
systems.  
Statistical analysis 
The main outcome of interest in this study was evaluation differences in PCV2 
susceptibilty among breeds. Therefore, owing to the low number of sham-inoculated control 
pigs, statistical analyses were limited to PCV2-infected pigs. Summary statistics were 
calculated for all PCV2-infected pigs within each breed to assess the overall quality of the 
data. Analysis of variance (ANOVA) was used for cross-sectional assessment of the average 
daily weight gain and nonrepeated continuous measures. The significance level was P < 0.05 
followed by pairwise testing using the Tukey-Kramer adjustment to identify the groups that 
were different. Effect of sire or dam on the outcome was tested by using the model y = 
breeds + sires (breeds) + dams (sires, breeds). In order to summarize and simplify the clinical 
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observations, response feature analysis and chi-square testing was used. The clinical scores 
for each pig were reduced to one weekly mean score, and the resulting values were subject to 
statistical analysis. Daily rectal temperature data were analyzed with multivariate ANOVA. 
Nonrepeated measures of necropsy and histopathology data were assessed using 
nonparametric Kruskal-Wallis ANOVA. If a nonparametric ANOVA results was significant 
(P < 0.05), Wilcoxon tests were used to assess the differences of pairs of groups. Differences 
in incidence were evaluated by using Fisher’s exact test. 
A portion of the pigs within each breed had low maternal antibodies at the time of 
PCV2 infection. To evaluate influence of the antibody status on the results regarding PCV2-
associated lesions, maternal-antibody-negative and maternal-antibody-positive pigs were 
compared separately among breeds, and pairwise Wilcoxon tests on outcomes of antibody 
negative (S : P ratio<0.2) and antibody positive pigs (S : P ratio≥0.2) within each breed were 
done. 
 
Results 
Clinical disease 
From PID 7 to 14, PCV2 infection was clinically characterized by mild respiratory 
distress and, occasionally, by sneezing. Mean respiratory scores were higher in the Landrace 
pigs for PID 7-14, but were not significantly different (P > 0.05) among breeds. Individual 
pigs of all three breeds had periodically increased temperatures; however, there was no 
difference during the 21 days (P = 0.189) or from PID 21 to PID 35 (P = 0.372) in mean 
body temperature between breeds nor was there a time-by-group interaction.  
From the day of PCV2 inoculation onwards to PID 35, mean ± SE weight gain was 
633.7 ± 32.8 g for Duroc pigs, 763.8 ± 49.5 g for Landrace pigs, and 746.4 ± 36.8 g for Large 
White pigs. The weekly weight gain (data not shown) was not significantly different (P > 
0.05) among the breeds.  
One Landrace pig developed persistent fever >41.1 C from PID 14 onwards and had 
to be euthanized at PID 21, although it had been randomly selected for the PID 35 necropsy 
group. This pig gained only 6 g between PID 14 and 21, which is consistent with wasting and 
clinical PMWS in a growing pig. One other Landrace pig had decreased average daily weight 
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gain, compared with the other Landrace pigs. 
Serologic test results 
At arrival, the majority of the pigs (65/75) had maternal antibodies to PCV2, with 
mean PCV2-ELISA S : P ratios of 0.46 ± 0.08 for Duroc pigs, 0.57 ± 0.08 for Landrace pigs, 
and 0.43 ± 0.07 for Large White pigs. In the majority of the pigs (18/23 Duroc, 10/19 
Landrace, 16/21 Large White), maternal antibodies waned below the ELISA cutoff (S : P 
ratio <0.2) prior to PCV2-inoculation (PID-0 seronegative pigs). At the time of PCV2 
inoculation, 5 of 23 Duroc, 9 of 19 Landrace, and 5 of 21 Large White pigs had low maternal 
antibody levels (PID-0 seropositive pigs) with mean S : P ratios of 0.22 ± 0.00 for Duroc, 
0.23 ± 0.01 for Landrace, and 0.24 ± 0.01 for Large White pigs. As expected,56 the passively 
acquired antibodies in the noninfected control pigs decayed over time. None of the control 
pigs seroconverted to PCV2 during the study. Most of the PCV2-infected pigs seroconverted 
to PCV2 between PID 21 and PID 35I. At PID 35, 7 of 11 Duroc, 6 of 8 Landrace, and 6 of 
10 Large White pigs were positive for PCV2-specific antibodies.  
All pigs tested negative for PRRSV-specific antibodies. The pigs had maternal 
antibodies to PPV that decayed over time as expected.58 Indications of seroconversion to 
PRRSV or PPV were lacking. 
PCV2 viremia duration and genomic copy numbers 
All serum samples obtained from the noninfected control pigs were negative for 
PCV2-specific nucleic acids, as tested by real-time PCR analysis. In the PCV2-infected pigs, 
PCV2 viremia was detected first at PID 7 in 13 of 23 Duroc, 14 of 19 Landrace, and in 9 of 
21 Large White pigs. Landrace pigs had significantly (P < 0.05) higher incidence of viremic 
pigs at PID 7, compared with that for the Large White pigs. The majority of the PCV2-
infected pigs were viremic by PID 14 (21/23 Duroc, 17/19 Landrace, and 21/21 Large 
White). The duration of the PCV2 viremia was based on results from the PCV2-infected pigs 
(n = 11 Duroc, n = 8 Landrace, and n = 10 Large White) that remained in the study for the 
entire 35 days. PCV2 viremia was determined to be 4.6 ± 0.2 weeks in Duroc pigs (n = 11), 
4.3 ± 0.6 weeks in Landrace pigs (n = 8), and 4.2 ± 0.4 weeks in Large White pigs (n = 10), 
and was not significantly different (P = 0.669) among breeds. Mean copy number of PCV2 
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genomic DNA in serum was not different (P > 0.05) among the breeds at PID 7, 14, 21, 28, 
and 35. 
Macroscopic lesions 
There were no gross lesions in the noninfected control pigs at the PID-21 or the PID-
35 necropsy dates. At PID 21, 9 of 12 PCV2-inoculated Duroc, 10 of 11 PCV2-inoculated 
Landrace, and 11 of 11 PCV2-inoculated Large White pigs had gross lymph node 
enlargement scores of 1.4 ± 0.3, 2.0 ± 0.3, and 1.6 ± 0.2, respectively. In addition, three 
Landrace pigs and one Duroc pig had mottled-tan lungs that failed to collapse. The Landrace 
pig that had to be euthanized at PID 21 (prior to scheduled necropsy at PID 35) was 
emaciated, had a pale liver, and had moderate edema throughout the stomach wall. At PID 
35, gross lesions in the PCV2-inoculated pigs were limited to enlargement of lymph nodes in 
9 of 11 Duroc (mean 1.8 ± 0.3), 5 of 8 Landrace (mean 1.4 ± 0.4), and 5 of 10 Large White 
(mean 0.9 ± 0.3) pigs. 
Microscopic lesions and amount of PCV2-antigen 
There were no microscopic lesions in any of the control pigs (data not shown). A total 
of 7 of 63 PCV2-infected pigs had no PCV2-associated lymphoid lesions (overall score, 0) 
and 35 of 63 had mild PCV2-associated lymphoid lesions (overall score, 1-3). In 18 of 63 
PCV2-infected pigs, lymphoid lesions were moderate (overall score, 4-6), and 3 of 63 pigs 
had severe lymphoid lesions consistent with PMWS (overall score, 7-9) (Table 1). If present, 
PCV2-associated lesions were characterized by mild-to-severe lymphoid depletion and mild-
to-severe granulomatous inflammation in lymphoid tissues associated with low to high 
amounts of PCV2-antigen (Tables 2,3). Landrace pigs had significantly (P < 0.05) more 
severe lymphoid depletion scores in tonsil at PID 21 (Table 2) and in the lymph node pool at 
PID 35 compared with those for Duroc and Large White pigs (Table 3). 
At PID 21, lymphohistiocytic hepatitis was mild to moderate in 3 of 12 Duroc and 6of 
11 Landrace pigs, and mild in 6 of 11 Large White pigs. Lymphohistiocytic myocarditis was 
moderate in 1 of 12 Duroc, mild to moderate in 4 of 11 Landrace, and mild in 2 of 11 Large 
White pigs. Lymphohistiocytic nephritis was mild in 3 of 12 Duroc, mild to moderate in 3 of 
11 Landrace and  3 of 11 Large White pigs.  
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At PID 35, lymphohistiocytic hepatitis was mild to moderate in 4 of 11 Duroc pigs, 
and was mild in 4 of 8 Landrace pigs and 1 of 10 Large White pigs. Lymphohistiocytic 
myocarditis was mild in 1 of 11 Duroc, 2 of 8 Landrace, and 0 of 10 Large White pigs. Mild 
lymphohistiocytic nephritis was observed in 5 of 11 Duroc, in three of eight Landrace, and 3 
of 10 Large White pigs.  
Lung lesions were characterized by mild, focal-to-diffuse, lymphohistiocytic 
interstitial pneumonia with type-2 pneumocyte hypertrophy and hyperplasia in 5 of 12 Duroc 
and 4 of 11 Large White pigs. Lymphohistiocytic interstitial pneumonia was mild to 
moderate, focal to diffuse in 8 of 11 Landrace pigs at PID 21. At PID 35, mild, focal-to-
diffuse, lymphohistiocytic interstitial pneumonia was present in 6 of 11 Duroc, 5 of 8 
Landrace, and 5 of 10 Large White pigs.   
Three Landrace pigs had microscopic lesions consistent with PMWS, with severe 
lymphoid depletion characterized by complete loss of the follicular structure of all lymphoid 
tissues evaluated, severe histiocytic replacement of lymphoid follicles, and high amounts of 
PCV2 antigen associated with the lesions. These pigs also had mild to moderate 
lymphohistiocytic inflammation in other organ systems including heart, kidney, liver, and 
thymus. There also was moderate to severe granulomatous enteritis with moderate numbers 
of multinucleated giant cells present in Peyer’s patches of the ileum associated with moderate 
to high amounts of PCV2-antigen.  
Evaluation of the influence of passively acquired antibodies on PCV2-associated lesions 
and viremia among breeds 
There was a total of 5 of 23 PID-0 seropositive Duroc, 9 of 19 PID 0 seropositive 
Landrace, and 5 of 21 PID 0 seropositive Large White pigs on the day of PCV2-inoculation. 
To delineate any possible influence of low amounts of passively acquired anti-PCV2-
antibodies, the outcomes of the PID-0 seronegative pigs of all breeds were compared with 
each other. Similarly, the outcomes of the PID-0 seropositive pigs among all breeds were 
compared with each other. Separation of the weekly weight gain data into PID-0 serongetive 
and PID-0 seropositive pigs did not result in major changes, compared with the weight gain 
data that included PID-0 seronegative and PID-0 seropositive pigs and was not significantly 
different (P > 0.05) among the breeds (data not shown). Mean PCV2-genomic copy numbers 
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for the PID-0 seronegative pigs was not significantly (P > 0.5) different among the breeds at 
PID 7, 14, 21, 28, and 35. Likewise, no significant difference (P > 0.05) was observed among 
breeds in mean PCV2 copy number for the PID-0 seropositive pigs. At PID 21, PID-0 
seronegative Landrace pigs had a significantly (P = 0.01) higher mean group overall 
lymphoid severity score compared with PID-0 seronegative Duroc pigs (Table 1). The PID-0 
seronegative Landrace pigs had significantly (P < 0.05) more severe depletion of the lymph 
nodes at PID 21 and 35 (Table 3), and significantly (P < 0.05) more severe lymphoid 
depletion, inflammation, and PCV2 antigen associated with these lesions in tonsils at PID 21, 
compared with that in PID-0 seronegative Duroc and Large White pigs (Table 2). There was 
a higher incidence of microscopic lung, liver, heart and kidney lesions in PID-0 seronegative 
pigs compared with PID-0 seropositve pigs across breeds (data not shown), but this 
difference was not significant (P > 0.5). 
In this study, the total incidence of microscopic lesions consistent with PMWS was 
15.8% (3 of 19) for Landrace pigs, whereas none of the Duroc and Large White pigs 
developed lesions consistent with PMWS. When separated into PID-0 seronegative and PID-
0 seropositive, the PMWS incidence increased to 30% (3 of 10) in PID-0 seronegative 
Landrace pigs. 
Within breed influence of passively acquired antibodies on PCV2-associated lesions and 
viremia 
To further explore the possible influence of the presence of the amounts of passively 
acquired PCV2 antibodies at the time of PCV2 inoculation on PCV2 infection, outcomes of 
PID-0 seropositive and PID-0 seronegative pigs within each breed were compared with each 
other. At PID 14 and 21, PID-0 seronegative Landrace pigs (n = 10) had significantly (P < 
0.01) higher amounts of PCV2 nucleic acids in serum compared with those in PID-0 
seropositive Landrace pigs (n = 9). At PID-21 necropsy, mean overall lymphoid severity 
score was significantly (P < 0.002) higher in PID-0 seronegative Landrace, compared with 
PID-0 seropositive Landrace pigs (mean score 6.2 ± 1.0 in PID-0 seronegative pigs [n = 6] 
versus 1.1 ± 0.3 in PID-0 seropositve pigs [n = 5]) (Table 1). There were no significant 
differences in Duroc or Large White pigs between PID-0 seronegative and PID-0 
seropositive pigs, although PID-0 seronegative pigs had higher values (Table 1).  
 
 221
Evaluation of the littermates of the PMWS affected pigs 
There was no litter or sire effect on the development of PCV2-associated lesions. The 
three Landrace pigs with microscopic lesions typical of PMWS were from three litters, and 
two sires and were housed in two rooms and three pens. Comparison of data (serologic, 
overall lymphoid lesions score) among the three Landrace pigs with lesions consistent with 
PMWS and their littermates is summarized in Table 4. 
 
Discussion 
The overall goal of this study was to conduct a controlled experiment to investigate 
the influence of host genetics on susceptibility to PCV2. We utilized Duroc, Landrace, and 
Large White pigs because they were available from a single source. Today, all three of these 
breeds are used extensively worldwide in purebred and crossbred breeding programs.  
A limited number of peer-reviewed manuscripts have compared disease susceptibility 
in various pig breeds. The muscle load of Sarcocystis miescheriana bradyzoites after oral 
exposure was found to be 20 times higher in Pietrain, compared with Meishan pigs.60 
Compared with Meishan pigs, Large White pigs were found to be more susceptible to 
infection with pseudorabies virus59 or K88+ Escherichia coli.15  Compared with Duroc and 
Meishan pigs, Hampshire pigs developed significantly less severe macroscopic lung lesions 
after experimental PRRSV-inoculation.27 Meishan pigs were found to be highly resistant to 
K88ac+ E. coli-induced disease, whereas there were both susceptible and disease-resistant 
pigs within the Fengjjing and Minzhu breeds.49 
A cohort study was conducted on four PMWS-affected farms to investigate a 
suspected decreased susceptibility to PCV2-associated disease in Pietrain pigs by 
manipulating the genetics via artificial insemination. Half of the sows were inseminated with 
Pietrain semen, whereas the remaining sows received the semen that was typically used on 
these farms.62 The PCV2-associated disease in the Pietrain offspring did not differ from that 
observed in other pigs on these farms in terms of PCV2 seroconversion, morbidity, and 
mortality. We did not include Pietrain pigs in the study reported here because the farm from 
which we purchased our purebred pigs did not raise Pietrain and we believed it important to 
minimize confounding factors (differences in environment, production style, coinfection 
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status) typical in pigs derived from various sources.  
All breeds in the current study appeared to be equally susceptible to PCV2 infection. 
There were no significant differences in viremia duration, amount of PCV2 genomic DNA 
copies, or anti-PCV2-antibody production among the breeds. However, clinical disease and 
microscopic lesions consistent with PMWS were only observed in the Landrace pigs. The 
results indicate that the Landrace pigs of this study were predisposed to progress from 
subclinical PCV2-infection to clinical PMWS.  
To the best of our knowledge, all other confounding factors were similar across 
breeds in this study. In the field, PMWS often resembles an end-stage disease complex and 
multiple pathogens in addition to PCV2 are often detected.57 Experimental coinfection of 
pigs with PCV2 and other viruses such as PPV7,36,40,52 or PRRSV,2,32,64 or bacteria such as M. 
hyopneumoniae54 has been documented to enhance the amount of PCV2 genomic copies and 
PCV2-associated lesions and to increase the incidence of PMWS. There may be a variety of 
other known and unknown pathogenic and non-pathogenic organisms that are able to trigger 
progression of PCV2 infection to PMWS. To account for this, we believed it important that 
all pigs came from the same farm and, farrowed in the same barn, and were transported 
together to our research facilities, thereby equalizing the microbiological flora across breeds 
as much as possible.  
Sex can be a confounding factor as well. There are at least two studies that concluded 
male pigs were more susceptible to development of PMWS than were female pigs, and the 
authors thought this might be attributable to castration and associated secondary 
infections.11,61 Thus, in our study, we used only female pigs to control for sex.  
To our knowledge, all breeding herds are infected with PCV2. We usually derive 
PCV2-negative crossbred pigs for our experimental PCV2-inoculation trials by screening the 
entire batch of dams scheduled to farrow during the desired timeframe. We then select piglets 
from those sows in the batch that have the lowest anti-PCV2-antibody titers.56 Due to litter 
and sire restrictions and to the low number of purebred sows within the same farrowing 
batch, such was not possible in this study. We, therefore, did not screen sows prior to 
purchase of the pigs, and a portion of the pigs had high levels of maternal antibodies at time 
of arrival. Compared with that in the other two breeds, the Landrace pigs of this study had 
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higher levels of PCV2-antibodies at weaning and at the time of PCV2 inoculation, but the 
difference was not statistically significant (P > 0.5). Because of the higher incidence and titer 
of maternal PCV2 antibodies, we increased the number of procedural control Landrace pigs 
(six rather than three), which decreased the number of experimentally infected pigs within 
this breed. Because of budget and room restrictions, experimental infection of the pigs was 
started prior to complete waning of the maternal antibody titers in these pigs.  
We were also concerned about a possible but unknown host age effect on PCV2-
infection. At 5 to 8 weeks of age, 19 of 63 pigs (30.1%) still had low titer of passively 
aquired antibodies to PCV2 at the time of PCV2 inoculation. There were 47.4% (9 of 19) of 
the experimentally infected Landrace pigs that had low levels of PCV2-specific antibodies at 
the time of PCV2-inoculation, compared with 21.8% (5 of 23) of the Duroc and 23.8% (5 of 
19) of the Large White pigs. Landrace piglets that had low but measurable maternal 
antibodies at the time of PCV2-inoculation had significantly (P < 0.05) reduced overall 
PCV2-associated lesions, compared with Landrace piglets that were seronegative at the time 
of PCV2-inoculation. All three Landrace pigs that developed lesions consistent with PMWS 
were seronegative at the time of PCV2 inoculation, as were the 18 Duroc, 16 Large White, 
and seven additional Landrace pigs that did not develop PMWS. The presence of anti-PCV2-
antibodies has been documented to protect pigs from developing severe PCV2-associated 
lesions.4,22 Our experimental results support this conclusion and indicate further that only a 
portion of the anti-PCV2-negative pigs are susceptible to PCV2-associated diseases. It has 
been suggested, that a PCV2-ELISA S : P of 0.6 prevents PCV2 replication and development 
of PMWS.33 On the basis of the results of our study, even lower levels of passively acquired 
antibodies are protective against development of severe PCV2-associated lesions. This 
suggests that PCV2 vaccination of breeding herds resulting in high passively transferred 
antibody levels may be one way to control PCV2-associated disease in growing pigs. 
We were able to induce lesions consistent with PMWS in 3 of 19 (15.8%) Landrace 
pigs, whereas we were not able to induce PMWS in any of the Duroc or Large White pigs. 
This is comparable to what is seen in commercial crossbred swine production in the field 
where the incidence of PMWS in affected herds usually peaks with around 10% of the herd 
affected, but may vary from as little as 4% to as high as 30% in individual farms.1,28,43,61  
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In the current study we used a genetically-well-characterized PCV2-isolate20 that has 
been used extensively in pig models. Previously, singular PCV2 infection with the same 
isolate at a similar cell culture passage and in approximately the same dose as used in the 
purebred pigs in the current study did not result in expression of clinical disease or presence 
of microscopic lesions consistent with PMWS in 264 crossbreed pigs that were part of nine 
different studies.21-24,35,52-55 This further supports our conclusion that the purebred Landrace 
pigs used in this experiment were more susceptible to PCV2-associated diseases. 
It appears to be a common belief among some producers and veterinarians that 
Landrace pigs are more susceptible to infectious diseases in general; however, publications 
describing experimental results that substantiate this clinical impression are lacking to our 
knowledge. On the basis of field observations, it has been suggested that Landrace pigs in the 
UK appeared to be less affected by progressive atrophic rhinitis than are Large White pigs.13 
Landrace pigs are known to be predisposed to type III congenital tremor, which is 
attributable to a monogenic sex-linked factor resulting in a deficiency of oligodendrocytes in 
the spinal cord in male Landrace pigs.29 Danish Landrace pigs are thought to be the origin of 
dermatosis vegetans which is caused by a semilethal autosomal recessive factor.14 
More studies including larger numbers of Landrace pigs from several different lines 
and different geographic locations are warranted to further investigate a possible 
predisposition to PCV2-associated PMWS within this breed. Genetic resistance may be 
associated with a single gene, but is usually associated with multiple genes. Another 
approach may be to further study PMWS-affected pigs and non-affected littermates (who 
share at least 50% of their genes in common) by gene array analysis to possibly identify gene 
loci with differences in expression that may be responsible for increased susceptibility to 
PCV2-associated diseases. In conclusion, despite its limited size, this work adds to the body 
of evidence to explain differences in clinical expression of PCV2-associated diseases from 
farm to farm. 
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 Table 1. Comparison of mean group lymphoid lesions (lymphoid depletion, inflammation, and porcine circovirus type 2 [PCV2] 
antigen) in PCV2-inoculated pigs at postinoculation day (PID) 21 and 35 in pigs of various breeds and with various antibody status 
at the time of PCV2 infection. Score ranges from 0 to 9. 
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    Duroc Landrace Large White 
 
PID 
All  
Pigs 
SERONEG* 
Pigs 
SEROPOS†
Pigs 
All  
Pigs 
SERONEG*
Pigs 
SEROPOS† 
Pigs 
All  
Pigs 
SERONEG*
Pigs 
SEROPOS†
Pigs 
21 2.2±0.6‡
(n = 12) 
2.5±0.7 
(n = 9) 
1.1±0.6 
(n = 3) 
3.9±1.0 
(n = 11)
6.2±1.0 
(n = 6) 
1.1±0.3 
(n = 5) 
2.8±0.5 
(n = 11)
3.7±0.7 
(n = 6) 
1.8±0.7 
(n = 5) 
35  2.1±0.5
(n = 11) 
2.0±0.5 
(n = 9) 
2.9±1.2 
(n = 2) 
3.0±0.3 
(n = 8) 
3.2±0.7 
(n = 4) 
2.8±0.6 
(n = 4) 
1.6±0.4 
(n = 10)
1.6±0.4 
(n = 10) 
NA§ 
(n = 0) 
* Seronegative pigs based on ELISA sample-to-positive ratio <0.2 on the day of PCV2-inoculation. 
† Seropositive pigs based on ELISA sample-to-positive ratio ranging from 0.2 to 0.3 on the day of PCV2-inoculation. 
‡ Mean group score ± SE. 
§ NA = not applicable. 
 
 Table 2. Microscopic lesions (lymphoid depletion and granulomatous inflammation) and amount of PCV2-antigen as determined 
by immunohistochemistry (IHC) in tonsil of PCV2-infected Duroc, Landrace, and Large White pigs with different antibody status 
at the time of PCV2 inoculation. Data presented as incidence (mean group severity score [mean severity for affected animals]). 
Depletion (0=normal, 3=severe)  Inflammation (0=normal, 3=severe)  PCV2-antigen (0=undetectable, 3=large amount)  
Breed All pigs SERONEG* SEROPOS†  All pigs SERONEG* SEROPOS†  All pigs SERONEG* SEROPOS† 
 21 days post PCV2 inoculation 
Duroc    3/12 (0.3[1.0])I‡ 2/9 (0.2[1.0])I 1/3 (0.3[1.0])I 1/12 (0.1[1.0])I 1/9 (0.1[1.0])I 0/3 (0.0[0.0])I 4/12 (0.3[1.0])I 3/9 (0.3[1.0])I 1/3 (0.3[1.0])I
Landrace   
  
8/11 (1.2[1.6])II 6/6 (1.8[1.8])II 2/5 (0.4[1.0])I 4/11 (0.8[2.2])I 4/6 (1.5[2.3])II 0/5 (0.0[0.0])I 7/11 (1.2[1.9])I 6/6 (2.0[2.0])II 1/5 (0.2[1.0])I
Large White 3/11 (0.3[1.0])I 3/6 (0.5[1.0])I 0/5 (0.0[0.0])I 1/11 (0.1[1.0])I 1/6 (0.2[1.0])I 0/5 (0.0[0.0])I 6/11 (0.7[1.3])I 4/6 (0.8[1.5])I 2/5 (0.6[1.5])I
 35 days post PCV2 inoculation 
Duroc   4/11 (0.4[1.0])I 3/9 (0.3[1.0])I 1/2 (0.5[1.0])I 1/11 (0.9[1.0])I 1/9 (0.1[1.0])I 0/2 (0.0[0.0])I 5/11 (0.6[1.4])I 4/9 (0.7[1.5])I 1/2 (0.5[1.0])I
Landrace   
  
4/8 (0.5[1.0])I 1/4 (0.3[1.0])I 3/4 (0.8[1.0])I 0/8 (0.0[0.0])I 0/4 (0.0[0.0])I 0/4 (0.0[0.0])I 1/8 (0.1[1.0])I 1/4 (0.3[1.0])I 0/4 (0.0[0.0])I
Large White 1/10 (0.1[1.0])I 1/10 (0.1[1.0])I NA§  0/10 (0.0[0.0])I 0/10 (0.0[0.0])I NA  4/10 (0.5[1.2])I 4/10 (0.5[1.5])I NA 
* Seronegative pigs based on ELISA sample-to-positive ratio <0.2 on the day of PCV2-inoculation. 234
† Seropositive pigs based on ELISA sample-to-positive ratio ranging from 0.2 to 0.3 on the day of PCV2-inoculation. 
‡ Different superscripts (I and II) within columns represent significantly (P < 0.05) different mean group severity scores within columns for each day after inoculation. 
§ NA=not applicable. 
 
 Table 3. Microscopic lesions (lymphoid depletion and granulomatous inflammation) and amount of PCV2-antigen as determined 
by IHC in the lymph node pool (tracheobronchial, superficial inguinal, external iliac, mediastinal, and mesenteric lymph nodes) in 
PCV2-infected Duroc, Landrace, and Large White pigs with different antibody status at the time of PCV2 inoculation. Data 
presented as incidence (mean group severity score [mean severity for affected animals]). 
Depletion (0=normal, 3=severe)  Inflammation (0=normal, 3=severe)  PCV2-antigen (0=undetectable, 3=large amount) Breed 
All pigs SERONEG* 
pigs 
SEROPOS† 
pigs 
      All pigs SERONEG*
Pigs 
SEROPOS† 
pigs 
All pigs SERONEG*
pigs 
SEROPOS† 
pigs 
 21 days post PCV2 inoculation 
Duroc    9/12 (1.1[1.4])I‡ 7/9 (1.2[1.6])Ie 2/3 (0.7[1.0])I 6/12 (0.7[1.3])I 5/9 (0.8[1.4])I 1/3 (0.3[1.0])I 6/12 (0.8[1.7])I 5/9 (1.0[1.8])I 1/3 (0.3[1.0])I
Landrace   
  
10/11 (1.8[2.0])I 6/6 (2.3[2.3])II 4/5 (1.2[1.5])I 6/11 (1.1[2.0])I 6/6 (2.0[2.0])I 0/5 (0.0[0.0])I 8/11 (1.4[1.9])I 6/6 (2.3[2.3])I 2/5 (0.4[1.0])I
Large 
White 
10/11 (1.4[1.5])I 6/6 (1.7[1.7])I,II 4/5 (1.0[1.3])I 6/11 (0.8[1.2])I 4/6 (1.2[1.8])I 2/5 (0.4[1.0])I 8/11 (1.3[1.7])I 5/6 (1.5[1.8])I 3/5 (1.0[1.7])I
 35 days post PCV2 inoculation 
Duroc   9/11 (0.9[1.1])I 7/9 (0.9[1.1])I 2/2 (1.0[1.0])I 5/11 (0.6[1.4])I 4/9 (0.6[1.3])I 1/2 (1.0[2.0])I 6/11 (0.9[1.7])I 4/9 (0.8[1.8])I 2/2 (1.5[1.5])I
Landrace   
  
8/8 (1.9[1.9])II 4/4 (2.0[2.0])II 4/4 (1.8[1.8])I 5/8 (0.7[1.2])I 3/4 (0.8[1.0])I 2/4 (0.8[1.5])I 7/8 (1.1[1.3])I 4/4 (1.3[1.3])I 3/4 (1.0[1.3])I
Large 
White 
9/10 (0.9[1.0])I 9/10 (0.9[1.0])I NA§  4/10 (0.4[1.0])I 4/10 (0.4[1.0])I NA  5/10 (0.7[1.4])I 5/10 (0.7[1.4])I NA 
235
* Seronegative pigs based on ELISA sample-to-positive ratio <0.2 on the day of PCV2-inoculation. 
† Seropositive pigs based on ELISA sample-to-positive ratio ranging from 0.2 to 0.3 on the day of PCV2-inoculation. 
‡ Different superscripts (I and II) within columns represent significantly (p<0.05) different mean group severity scores within columns for each day after inoculation 
§ NA=not applicable. 
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† Mean value from seven lymphoid tissues (tonsil, spleen, five lymph nodes) ranging from 0-9 (lymphoid depletion 0-3; inflammation 0-3; 
amount of PCV2 0-3); normal, score = 0; mild score = 1-3, moderate score = 4-6, severe score = 7-9. 
Table 4. Comparison of the Landrace pigs with lesions consistent with postweaning multisystemic wasting syndrome (PMWS) 
and their littermates. 
 
Pig No. 
 
PMWS 
 
Sire 
 
Dam 
S : P ratio* at 
10 Days of Age
S : P ratio* at Time 
of PCV2 Infection 
Age at PCV2 
Infection 
Overall Lymphoid Severity 
Score (Classification)† 
Necropsy (PID)‡
1 Yes A 1 0.025 0.032 51 days 8 (Severe)  21 
2 No A 1 0.011 0.009 51 days 5 (Moderate) 21 
3      
    
No A 1 0.731 0.265 51 days 1 (Mild) 21 
4 Yes A 2 0.255 0.175 48 days 8 (Severe) 21 
5      
    
No A 2 0.333 0.215 48 days 3 (Mild) 35 
6 Yes B 3 0.568 0.192 48 days 9 (Severe) 21§ 
7      
    
No B 3 0.480 0.211 48 days 2 (Mild) 21 
8 No B 3 0.567 0.173 48 days 3 (Mild) 21 
* PCV2 ELISA sample-to-positive ratio (S: P ratio ≥0.2 is considered positive [positive values are in bold-face type]). 
§ Originally selected for PID-35 necropsy. 
‡ Postinoculation day 
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SUMMARY 
There are marked differences in clinical expression of diseases associated with 
porcine circovirus type 2 (PCV2) in the field. The objective of this study was to compare the 
sequences and pathogenicity of PCV2 isolates from field cases with and without PCV2-
associated lesions. Forty-two specific-pathogen-free (SPF) pigs were randomly assigned to 
three groups of 14 pigs each. At seven weeks of age, group 1 pigs were sham-inoculated with 
saline, group 2 pigs were each inoculated with PCV2-4838 (isolated from a pig with no 
evidence of PCV2-associated lymphoid lesions), and group 3 pigs were each inoculated with 
PCV2-40895 (isolated from a pig with PCV2-associated lymphoid lesions and disease). The 
PCV2-4838 and PCV2-40895 isolates shared approximately 98.9% of their nucleotide 
sequence identity across the entire genome. A total of 9 amino acid changes in ORF2 and 2 
amino acid changes in ORF1 were identified between the two isolates. The PCV2-4838 
inoculated pigs had significantly (P < 0.0001) more genomic copy numbers of PCV2 in sera 
at seven days post inoculation (DPI) and significantly (P < 0.05) fewer genomic copy 
numbers at 14, 21, and 28 DPI compared to pigs inoculated with PCV2-40895 isolate. 
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Microscopic lesions in lymphoid tissues were significantly (P < 0.05) less severe and the 
amount of PCV2-antigen associated with these lesions was significantly lower (P < 0.05) in 
pigs inoculated with PCV2-4838. The results of this study suggested that PCV2-isolates 
differ in virulence in a SPF pig model typical of modern production systems in North 
America.  
 
INTRODUCTION 
Porcine circovirus (PCV) is an approximately 1.76 kb, single-stranded, non-
enveloped DNA virus containing a circular genome which was first recognized in 1974 as a 
contaminant of a continuous porcine kidney cell line (PK-15) (Tischer et al., 1974) and was 
further characterized in 1982 (Tischer et al., 1982). Until the late 1990’s, PCV was thought 
to be non-pathogenic for pigs. In 1991, a new disease syndrome in swine was recognized in 
western Canadian high health herds and, based on the clinical presentation, was described as 
“postweaning multisystemic wasting syndrome (PMWS)” (Harding & Clark, 1997). In 1998, 
researchers first reported on the association of PCV with PMWS (Allan et al., 1998; Ellis et 
al., 1998; Morozov et al., 1998). In order to distinguish the non-pathogenic PCV from the 
virus associated with PMWS, the non-pathogenic PCV is referred to as PCV1 and the 
PMWS-associated PCV as PCV2.  
PMWS is characterized by a clinical history of wasting or poor performance in 
weaned pigs and by lymphoid depletion and histiocytic replacement of follicles in lymphoid 
tissues. The detection of PCV2-antigen or DNA within characteristic microscopic lesions is 
required for the diagnosis of PMWS (Sorden, 2000). In addition to PMWS, PCV2 is also 
associated with sporadic reproductive failure (West et al., 1999), enteritis (Kim et al., 2004), 
porcine dermatitis and nephropathy syndrome (PDNS) (Rosell et al., 2000), and is 
considered an important part of the porcine respiratory disease complex in North America 
(Harms et al., 2002; Opriessnig et al., 2004a).  
The non-pathogenic PCV1 and the PMWS-associated PCV2 share approximately 75-
76% nucleotide sequence identity (Fenaux et al., 2000; Hamel et al., 1998; Meehan et al., 
1998). The lengths of the genomes of PCV1 isolates range from 1,758 to 1,760 bp (Fenaux et 
al., 2000), whereas the genomes of PCV2 isolates range from 1,767 to 1,768 bp in length 
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(Fenaux et al., 2000; Mankertz et al., 2000). PCV2 isolates from pigs in different countries 
share approximately 94.6-99% nucleotide sequence identities (De Boisséson et al., 2004; 
Fenaux et al., 2000). The two main viral genes are ORF1 and ORF2 which are oriented in 
opposite directions and represent approximately 93% of the PCV2 genome. ORF1 encodes 
the Rep proteins involved in virus replication, and is highly conserved among isolates 
(Mankertz et al., 1998). The ORF2 gene encodes for the capsid protein (Nawagitgul et al., 
2000, 2002) and shares approximately 91-100% nucleotide sequence identity and 90-100% 
amino acid sequence identity among PCV2 isolates (De Boisséson et al., 2004; Fenaux et al., 
2000). In addition to ORF1 and ORF2, there are several other potential ORFs with coding 
capacity of larger than 5kDa (Meehan et al., 1998). Recently, the ORF3 protein has been 
characterized in vitro and shown to be not essential for PCV2 replication but is involved in 
PCV2-induced apoptosis by activating caspase-8 and caspase-3 pathways (Liu et al., 2005). 
During productive infection of PK-15 cells, nine RNAs, capsid RNA, five Rep-associated 
RNAs (Rep, Rep’, Rep3a, Rep3b, and Rep3c), and three NS-associated RNAs (NS515, 
NS672, and NS0) are synthesized by PCV2 (Cheung, 2003c), and it was demonstrated that 
Rep and Rep’ are essential for PCV2 replication (Cheung, 2003b). PCV1 and PCV2 were 
found to differ from each other in expression levels of NS- and Rep3c-associated RNAs 
(Cheung 2003a).  
Several groups attempted to investigate the potential correlation between PCV2 
genomic sequences and pathogenicity. Mahé et al. (2000) identified four dominant 
immunoreactive epitopes in ORF2 by PEPSCAN analysis. Larochelle et al. (2002) identified 
three major regions of amino acid heterogeneity among PCV2 isolates, and two of the 
regions corresponded to two of the immunoreactive epitopes described by Mahé et al. 
(2000). Comparison of three immunodominant regions, however, revealed no link between 
capsid protein sequence variation and pathogenicity of PCV2 isolates (Larochelle et al., 
2002). There was no distinct difference in genomic sequences among PCV2 isolates 
recovered from healthy pigs and diseased pigs (Choi et al., 2002; De Boisséson et al., 2004; 
Grierson et al., 2004; Larochelle et al., 2002, 2003; Pogranichniy et al., 2002). These studies 
led to the assumption that there is no difference in pathogenicity among PCV2 isolates. 
However, recently it has been demonstrated that two amino acid changes in the PCV2 capsid 
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protein that occurred during serial in vitro passage enhanced the ability of PCV2 to grow in 
vitro and attenuated the virus in vivo (Fenaux et al., 2004b). 
The overall objectives of this study were to determine if there is a difference in PCV2 
virulence by experimentally inoculating specific-pathogen-free (SPF) pigs with PCV2 
isolates recovered from pigs with and without the hallmark PCV2-associated lymphoid 
lesions, and to determine if there are genetic changes in the PCV2 genome associated with 
the difference in virulence.  
 
METHODS 
PCV2 isolates. The PMWS-associated PCV2-40895 isolate (GenBank accession 
number AF264042) was recovered from a 40 kg pig that was diagnosed with PMWS in 1998 
in an Iowa farm. The pig had severe lymphoid depletion, moderate histiocytic replacement of 
follicles in lymphoid tissues and high amounts of PCV2-antigen associated with the lesions 
as determined by immunohistochemistry (IHC) (Sorden et al., 1999). PCV2 isolate 40895 
has been well characterized genetically (Fenaux et al., 2000) and in the SPF pig model 
(Fenaux et al., 2002, 2003 2004a, b; Opriessnig et al., 2003, 2004a, b, 2006a, b). The non-
PMWS-associated PCV2 isolate 4838 was recovered from a 45 kg pig that died from a 
respiratory disease in 2003 in an Iowa farm. Streptococcus suis and Pasteurella multocida 
type A were isolated from the lungs of the pig by routine culture and Mycoplasma 
hyopneumoniae antigen was also detected by routine fluorescent antibody (FA) test on frozen 
lung sections. In addition, swine influenza virus (SIV) antigen was detected in the lungs of 
this pig by IHC (Haines et al., 1993). The pig had been vaccinated against M. 
hyopneumoniae, SIV, Erysipelothrix rhusiopathiae, and Lawsonia intracellularis. There was 
no evidence of PCV2-associated lymphoid lesions in the pig from which PCV2 isolate 4838 
was recovered and IHC staining for PCV2 antigens was negative in lymphoid tissues and 
lungs. However, PCR for PCV2 DNA (Fenaux et al., 2000) was positive on pooled lymphoid 
tissues of this pig.  
Amplification and genetic analysis of the complete genomic sequence of PCV2 
isolate 4838. The PCV2 isolate 40895 from a pig with PMWS was sequenced in a previous 
study (Fenaux et al., 2000). To determine the complete genomic sequence of PCV2 isolate 
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4838 which was not associated with PMWS, DNA was extracted from pooled lymph node 
homogenates of pig 4838 according to the protocol of the QIAamp DNA Mini Kit (Qiagen, 
Valencia, CA). The complete genomic DNA of PCV2 4838 was amplified by PCR with 
PCV2-specific primers F-PCV2SacII and R-PCV2SacII as previously described (Fenaux et 
al., 2002) with the following modifications: The extracted DNA was amplified by PCR with 
Platinum® PCR SuperMix High Fidelity (Invitrogen Inc., Carlsbad, CA). The PCR consisted 
of an initial enzyme activation step at 94°C for 2 minutes followed by 35 cycles of 
denaturation at 94°C for 1 minute, annealing at 50 °C for 1 minute, and extension at 68°C for 
2 minutes, and a final extension at 68°C for 30 minutes. The amplified PCR product of PCV2 
isolate 4838 genome was excised from the gel, purified and subsequently cloned into the 
vector pCR 2.1 using the Original TA Cloning Kit (Invitrogen Inc.). The TA plasmid 
containing PCV2 isolate 4838 was subsequently sequenced using the M13 forward and 
reverse primers, as well as several PCV2-specific primers including AORF2 (5’-GCCCT-
GAATTTCCATATGAAATAAATTA-3’), BORF2 (5’-CCGAAGTGCGCTGGTAATA-
CTTAC-3’), UP (5’ GGTAACGCCTCCTTGGATACGTC 3’) and LP (5’ GGGCCAAAA-
AAGGTACAGTTCC 3’). The sequences were assembled using AssemblyLIGN (Accelrys, 
San Diego, CA). The complete sequence of the PCV2 isolate 4838 was then aligned and 
compared with that of PCV2 isolate 40895. The percentage of nucleotide sequence and 
amino acid sequence identities among PCV2 isolates 4838 and 40895 were determined using 
the MacVector computer program (Accelrys). 
Production of virus inocula. To generate an infectious stock of PCV2 isolate 4838 
for animal studies, the PCV2 isolate 4838 virus genome cloned in the TA vector was first 
digested with the SacII enzyme to release the complete viral genome. The expected virus 
genome band of approximately 1.7 kb was excised from the agarose gel and purified using 
the GeneClean Spin Kit (Q-biogene Inc., Morgan Irvine, CA). The concentration of the viral 
genomic DNA was determined on a 1% agarose gel using the molecular weight ladder, 
Hyperladder I (Bioline USA Inc., Randolph, MA). The purified viral genomic DNA was 
concatemerized using T4 DNA ligase (Stratagene Coop., La Jolla, CA) in an overnight 
ligation reaction at 4°C. To generate an infectious PCV2 stock, approximately 12 µg of the 
concatemerized PCV2 genomic DNA was transfected into each of seven T-25 flasks of 70% 
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confluent PK-15 cells using Lipofectamine and Plus Reagent (Invitrogen Inc.) essentially as 
previously described (Fenaux et al., 2002). Three days after transfection, the virus was 
harvested by freezing and thawing the transfected PK-15 cells three times. The infectivity 
titer of the PCV2 isolate 4383 virus stock was determined by inoculation of PK-15 cells with 
serially-diluted virus stock followed by immunofluorescence assay (IFA) with PCV2-specific 
antibodies as described by Fenaux et al. (2002). The infectivity titer for PCV2 isolate 4838 
virus stock was 0.5×104.5 50% tissue culture infective dose (TCID50) per ml. 
For PCV2 isolate 40895, the viral genome was excised from the PCV2-40895 
infectious DNA clone (Fenaux et al., 2002) using the SacII restriction enzyme. The purified 
viral genome was concatemerized, and subsequently transfected into each of fifteen T-25 
flasks of 70% confluent PK-15 cells using Lipofectamine and Plus Reagent as previously 
described (Fenaux et al., 2002). Three days after transfection, the virus stock was harvested 
and its infectivity titer was determined essentially the same as described for the PCV2 isolate 
4838 and as previously described (Fenaux et al., 2002). The infectivity titer of PCV2 isolate 
40895 virus stock was 0.5×105.8 TCID50 per ml. 
Experimental characterization of PCV2-4838 and PCV2-40895. Forty-two 
colostrum-fed, crossbred, SPF pigs were purchased from a herd that is routinely tested for 
major swine pathogens and known to be free of porcine reproductive and respiratory 
syndrome virus (PRRSV) and M. hyopneumoniae. The pigs were weaned at two weeks of 
age and transported to the Livestock Infectious Disease Isolation Facility at Iowa State 
University, Ames, Iowa. At the time of inoculation, seven of the 42 pigs had evidence of low 
levels of passively acquired antibodies to PCV2 as determined by PCV2 enzyme linked 
immunosorbent assay (ELISA) based on the recombinant PCV2 capsid protein for PCV2-
specific IgG antibodies (Nawagitgul et al., 2002). Those pigs were assigned to the negative 
control group 1. The remaining pigs were randomly assigned either to the control group or to 
one of the other two groups. The groups were housed in three separate rooms on raised wire 
decks. The rooms were identical in environmental controls and size. At seven weeks of age, 
group 1 pigs (n = 14) were sham-inoculated with 1.7 ml saline intramuscularly and 1.8 ml 
saline intranasally and served as the control group. Group 2 pigs (n = 14) were each 
inoculated with PCV2 isolate 4838: each pig received 1.7 ml intramuscularly and 1.8 ml 
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intranasally (approximately 104.7 TCID50 per pig). Group 3 pigs (n = 14) were each 
inoculated with PCV2 isolate 40895: each pig received 1 ml virus and 0.7 ml saline 
intramuscularly and 1 ml virus and 0.8 ml saline intranasally (approximately 104.7 TCID50 per 
pig).  
Serology. Blood samples were collected at arrival of the pigs in the research facility 
at 36 days and again at 27 and 5 days before PCV2 inoculation and sham-inoculation and at 
7, 14, 21, and 28 days post inoculation (DPI) and tested by PCV2 ELISA (Nawagitgul et al., 
2002). Samples were considered positive if the calculated sample-to-positive (S:P) ratio was 
0.2 or greater. We also used the same ORF2 capsid antigen to detect PCV2-specific IgM 
antibodies. Corrected optical density (OD) values were generated from the OD values against 
recombinant baculovirus carrying the ORF2 gene of PCV2 (AcMNPV.ORF2) subtracted 
from that against wild type baculovirus (AcMNPV.wt) which served as control antigen 
(Nawagitgul et al., 2002). 
The serum samples from 3 randomly selected pigs in each group taken on arrival at 
the research facility and taken at necropsy were tested for the presence of antibodies to 
PRRSV by PRRSV-ELISA (IDEXX Laboratories, Inc. Westbrook, MA), to porcine 
parvovirus (PPV) by hemagglutination inhibition (HI) assay (Mengeling et al., 1988), to M. 
hyopneumoniae by ELISA as described (Bereiter et al., 1990), and to H1N1 SIV and H3N2 
SIV by HI assays according to the protocol used at the Veterinary Diagnostic Laboratory at 
Iowa State University. 
Clinical evaluation. Following PCV2-inoculation, the pigs were monitored daily and 
scored for severity of clinical respiratory disease ranging from 0 (normal) to 6 (severe 
dyspnea and abdominal breathing) (Halbur et al., 1995). In addition, pigs were evaluated 
daily for clinical signs including sneezing ranging from 0 (no sneezing) to 3 (severe 
persistent sneezing), and jaundice. Rectal temperatures, wasting, and behavioral changes 
such as lethargy were recorded daily. The pigs were weighed on the day of PCV2 inoculation 
and at seven, 14, 21 and 28 DPI. 
PCV2 DNA quantification. DNA-extractions on sera collected five days prior to 
PCV2 inoculation and at 7, 14, 21 and 28 DPI were performed using the QIAamp® DNA 
Mini Kit (Qiagen). DNA-extracts were used for quantification of the copy number of PCV2 
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genomic DNA by real-time PCR as described previously (Opriessnig et al., 2003). 
Necropsy. Necropsies were performed on half of the pigs at 14 DPI and the 
remainder at 28 DPI. The total amount of macroscopic lung lesions ranging from 0 to 100% 
of the lung affected, and size of lymph nodes ranging from 0 (normal) to 3 (four times the 
normal size)] were estimated (Halbur et al., 1995; Opriessnig et al., 2004a). 
Lungs were insufflated with fixative as previously described (Halbur et al., 1995). 
Sections of lymph nodes (superficial inguinal, mediastinal, tracheobronchial, mesenteric), 
tonsil, thymus, ileum, kidney, colon, spleen, and liver were collected at necropsy and fixed in 
10% neutral-buffered formalin and routinely processed for histological examination.  
Histopathology. Microscopic lesions were evaluated in a blinded fashion. Lung 
sections were scored for presence and severity of interstitial pneumonia ranging from 0 
(normal) to 6 (severe diffuse) (20). Sections of heart, liver, kidney, ileum, and colon were 
evaluated for the presence of lymphohistiocytic inflammation and scored from 0 (none) to 3 
(severe). Lymphoid tissues including lymph nodes, tonsil, and spleen were evaluated for the 
presence of lymphoid depletion ranging from 0 (normal) to 3 (severe) and histiocytic 
inflammation and replacement of follicles ranging from 0 (normal) to 3 (severe) (Opriessnig 
et al., 2004a). 
Immunohistochemistry. IHC for detection of PCV2-specific antigen was performed 
on selected formalin-fixed and paraffin-embedded section of lymph nodes (superficial 
inguinal, mediastinal, tracheobronchial, and mesenteric), tonsil, spleen, and thymus using a 
rabbit polyclonal antiserum (Sorden et al., 1999). PCV2-antigen scoring was done in a 
blinded fashion and scores ranged from 0 (no signal) to 3 (more than 50% of the lymphoid 
follicles contain cells with PCV2-antigen staining) (Opriessnig et al., 2004a). The mean 
group score was determined for each tissue and compared among groups. 
PCR and sequencing. PCR products amplified from virus recovered from three 
selected pigs at 28 DPI in each inoculation group were sequenced and compared to the 
respective inoculum to confirm the origin of the infecting virus. A nested PCR was used to 
amplify the entire ORF2 gene for sequencing and sequence comparison. The PCR reaction 
for a 50-µl reaction (first and second rounds) contained 1 × Taq buffer (Promega, Madison, 
WI), 2 mM MgCl2 (Promega), 0.2 mM deoxynucleoside triphosphates, 0.20 µM of the primer 
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(outer or nested pair), 1.5 U Taq polymerase (Promega), and 8 µl of extracted DNA template 
or first-round product. The external primer pair for the first round PCR was N1ORF2 (5’-
GGAACTGTACCTTTTTTGGCCCG-3’) and N2ORF2 (5’-GAAGGATTATTCAGCGTG-
AACACCC-3’) and the internal primer pair for the nested PCR was AORF2 (5’-GCCCTG-
AATTTCCATATGAAATAAATTA-3’) and BORF2 (5’-CCGAAGTGCGCTGGTAATA-
CTTAC-3’). The first round PCR consisted of an initial denaturation step at 94°C for 5 min 
followed by 35 cycles of 94°C for 1 min, 52°C for 1 min, and 72°C for 1 min; 7 min final 
extension at 72°C; and a 4°C hold. The second round PCR consisted of an initial 
denaturation step at 94°C for 5 min followed by 35 cycles of 94°C for 1 min, 53°C for 1 min, 
and 72°C for 1 min; 7 min final extension at 72°C; and a 4°C hold.  
The PCR products were run on a 1% agarose gel and the expected 820 bp bands were 
excised, purified and sequenced at the Virginia Bioinformatics Institute at Virgina Tech 
using an Automated DNA Sequencer (Applied Biosystems Inc., Foster City, CA). The 
sequences were analyzed with the MacVector computer program and compared to the 
sequences of the original virus inocula. 
Statistical analysis. Summary statistics were calculated for all groups to assess the 
overall quality of the data. Continuous data were analyzed using analysis of variance 
(ANOVA). If an ANOVA was significant (P < 0.05), pairwise testing using the Tukey’s 
adjustment was performed to assess specific group differences. Differences between the 
PCV2 infected groups were compared by t-tests. In order to summarize and simplify the 
clinical observations, response feature analysis and chi-square test was used. The clinical 
scores for each pig were reduced to one weekly mean score and the resulting values were 
subject to statistical analysis. Daily rectal temperature data were analyzed with response 
feature analysis on average weekly temperature. Non-repeated measures of necropsy and 
histopathology data were assessed using non-parametric Kruskal-Wallis one-way ANOVA. 
If this non-parametric ANOVA test was significant (P < 0.05), then pairwise Wilcoxon tests 
were used to assess differences between groups.  
Nucleotide sequence accession number. The complete genomic sequence of PCV2 
isolate 4838 has been deposited with the GenBank database under accession number 
 
 246
DQ397521. The sequence of PCV2 isolate 40895 has been reported previously (GenBank 
accession number AF264042) (Fenaux et al., 2000). 
 
RESULTS 
Genetic characterization of PCV2 isolates 4838 and 40895. The complete genomes 
of PCV2-4838 and PCV2-40895 were both 1,768 bp in length. The nucleotide sequence 
identity between PCV2-4838 and PCV2-40895 across the entire genome was 98.9% with a 
total of 19 nucleotide differences between the two isolates. In ORF1, PCV2 isolates 40895 
and 4838 share approximately 99.5% nucleotide and 99.4% amino acid sequence identities. 
There were a total of 5 nucleotide differences between PMWS-associated PCV2 isolate 
40895 and the non-PMWS associated PCV2 isolate 4838. Two of the five nucleotide 
differences were non-silent and resulted in amino acid changes: at position 280, PCV2-4385 
had a serine compared to a phenylalanine in PCV2-40895, and at position 302, PCV2-4838 
had a proline compared to a serine in PCV2-40895. 
The ORF2 capsid gene of PCV2 isolates 40895 and 4838 share approximately 98.0% 
nucleotide and 96.1% amino acid identities with a total of 14 nucleotide differences between 
the two isolates. Eleven of the 14 nucleotide differences resulted in 9 amino acid changes 
between PCV2-4838 and PCV2-40895. The amino acid differences were found at positions 
59 (arginine vs alanine), 63 (threonine vs arginine), 75 (lysine vs asparagine), 76 (leucine vs 
isoleucine) 131 (proline vs threonine), 134 (proline vs threonine), 185 (leucine vs 
methionine), 206 (lysine vs isoleucine), and 232 (asparagine vs lysine) for PCV2-4838 vs 
PCV2-40895, respectively. 
In ORF3, PCV2 isolates 40895 and 4838 share approximately 99.0% nucleotide and 
99.7% amino acid sequence identities. There was only one nucleotide difference resulting in 
an amino acid change: at position 46 of the ORF3, PCV2-4838 had a phenyalanine whereas 
PCV2-40895 had a leucine.  
Antibody responses of PCV2-4838 and PCV2-40895 infections in pigs. Both 
PCV2-infected groups had significantly (P < 0.0001) higher PCV2-IgM corrected OD-values 
compared to negative control pigs by 14 DPI. PCV2-specific IgM antibodies peaked by 21 
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DPI in PCV2-40895 infected pigs (significantly [P < 0.0001] higher than in the PCV2-4838 
inoculated pigs) and waned by 28 DPI (Fig. 1).  
In the PCV2-4838 inoculated pigs, four of the 14 pigs seroconverted by 14 DPI, two 
of seven pigs were positive for PCV2-specific IgG by 21 DPI, and three of the seven pigs 
were positive for PCV2-specific IgG by 28 DPI. In the PCV2-40895 inoculated pigs, one of 
the 14 pigs, six of the 14 pigs, three of the seven pigs, and four of the seven pigs were 
positive for PCV2-specific IgG by 7, 14, 21, and 28 DPI, respectively. There were no 
significant differences in mean anti-PCV2-IgG S:P ratios (Fig. 2).  
Comparative pathogenicity of PCV2-4838 and PCV2-40895 in SPF pigs. To 
compare the virulence of the PMWS-associated PCV2 isolate 40895 and the non-PMWS 
PCV2 isolate 4838, various clinical, pathological, virological and serological parameters 
were compared. 
Clinical disease. There was clinical evidence of mild respiratory disease 
characterized by sporadic sneezing observed in both of the PCV2-inoculated groups from 
five to seven DPI. None of the pigs developed rectal temperatures above 40°C and there was 
no difference in mean rectal temperatures between the two PCV2-infected groups. The 
average daily weight gain was not different between groups.  
PCV2 viremia length and genomic copy numbers. Viremia was detected by PCR in 
12/14, 10/14, 5/7, and 6/7 pigs inoculated with PCV2-4848; and in 6/14, 13/14, 7/7, and 7/7 
pigs inoculated with PCV2 40895 at 7, 14, 21, and 28 DPI, respectively. The mean numbers 
of PCV2 genomic copies in serum are summarized in Fig. 3. At 7 DPI, the pigs inoculated 
with PCV2-4848 had significantly (P < 0.001) higher numbers of PCV2 genomic copies in 
sera compared to the pigs inoculated with PCV2-40895. At 14, 21, and 28 DPI, the number 
of PCV2 genomic copies in sera was significantly (P < 0.01, P < 0.01, and P < 0.05, 
respectively) higher in the pigs inoculated with PCV2-40895 compared to the pigs inoculated 
with PCV2-4838.  
Macroscopic lesions. At 14 DPI, one pig inoculated with PCV2-40895 had mottled-
tan lungs that failed to collapse. Lymph node enlargement was 1.4 ± 0.3 for the PCV2-4838-
inoculated pigs and it was 2.7 ± 0.2 for the PCV2-40895-inoculated group, which was 
significantly (P < 0.01) different. At 28 DPI, one pig inoculated with PCV2-40895 had renal 
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lymph nodes that were approximately five times the normal size and the kidneys had severe 
interstitial nephritis and multifocal renal infarcts. The average enlargement of the lymph 
nodes at 28 DPI was 0.1 ± 0.1 for the PCV2-4838 inoculated pigs and 1.7 ± 0.4 for the 
PCV2-40895 inoculated pigs, which again was a significantly (P < 0.01) different.  
Microscopic lesions and amount of intralesional PCV2-antigen. The PCV2-40895 
inoculated pigs developed moderate-to-severe, generalized lymphoid lesions with lymphoid 
depletion and histiocytic infiltration of depleted lymphoid follicles. The mean lymphoid 
depletion scores in the PCV2-40895 inoculated pigs were significantly (P < 0.05) more 
severe than those observed in the PCV2-4838-inoculated pigs (Table 1). It should also be 
noted that when lymphoid lesions were observed in the PCV2-4383 inoculated pigs they 
were often confined to one lymph node. The IHC results are summarized in Table 2. In the 
majority of the tissues evaluated, the PCV2-40895 inoculated pigs had significantly (P < 
0.05) higher amounts of PCV2-antigen compared to the PCV2-4838 inoculated pigs. In 
addition to the PCV2-associated lymphoid lesions, the PCV2-40895 inoculated pigs also had 
significantly (P < 0.02) more severe interstitial pneumonia which was associated with 
significantly (P < 0.01) higher amounts of PCV2-antigen at 14 DPI. There was also 
significantly (P < 0.001) more severe lymphohistiocytic hepatitis and significantly (P < 0.02) 
more severe lymphohistiocytic interstitial nephritis in the PCV2-40895 pigs at 14 DPI. At 
DPI 28, there was severe lymphohistiocytic interstitial nephritis associated with PCV2-
antigen in one of the PCV2-40895 inoculated pigs. 
The pathological lesions observed in the PCV2 infected pigs were solely 
attributable to the respective PCV2 inoculum. Several experiments were performed to 
confirm that the pathological lesions observed in inoculated pigs were indeed induced by 
respective PCV2 inoculum. 
Sequencing confirmation. The sequences recovered from three selected PCV2-4838 
inoculated pigs and from three selected PCV2-40895 inoculated pigs are identical to the 
respective sequences from the original virus inoculum.  
Negative PCV2 status of the source pigs. The passively acquired antibodies to PCV2 
in the seven control pigs decayed over the 14 days following arrival and all control pigs 
remained negative for PCV2-specific antibodies through the termination of the experiment. 
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All negative control pigs were negative for PCV2 DNA in serum for the entire duration of 
the study. Lymphoid tissues and lungs from the control pigs were negative for PCV2 antigen 
as determined by IHC (Table 2). PCV2-associated microscopic lymphoid lesions were not 
present in the control pigs (Table 1).  
Absence of other infectious agents in the pigs. All pigs tested were negative for 
PRRSV and M. hyopneumoniae-specific antibodies. The pigs had maternal antibodies to 
PPV, H1N1 SIV and H3N2 SIV which all decayed over time. Indication of seroconversion to 
PRRSV, PPV, H1N1 SIV or H3N2 SIV was lacking. All tissues from the control pigs were 
normal and there were no lesions suggestive of an infectious disease.  
  
DISCUSSION 
Most pig herds are infected with PCV2 and most pigs within herds are exposed to and 
seroconvert to PCV2 at some time during the growing period; however, many of the herds 
report no evidence of PCV2-associated disease or PMWS while others report high PMWS 
incidence and high mortality. Differences in virulence of PCV2 isolates could be one logical 
explanation for these observed differences in disease manifestation.  
The overall goals of this study were to determine if there is evidence of differences in 
virulence among PCV2 isolates that may at least in part explain differences in severity of 
clinical manifestation of PCV2-associated disease in the field, and to determine if there is a 
genetic basis associated with the difference in virulence. To our knowledge, a carefully 
controlled study comparing PCV2 isolates in experimentally-infected SPF pigs typical of 
those used in commercial production has not been done.  
Molecular studies to determine the genetic variations of PCV2 revealed that minor 
branches of PCV2 were associated with geographic origin rather than with differences in 
virulence (Fenaux et al., 2000; Hamel et al., 1998; Mankertz et al., 2000; Meehan et al, 
2001). Overall there were no interpretable differences between PMWS-associated isolates 
and PCV2 isolates recovered from cases not associated with PMWS (De Boisséson et al., 
2004; Larochelle et al., 2002, 2003; Grierson et al., 2004) and it was concluded that 
differences in primary nucleotide sequence do not explain the differences in virulence seen in 
the field. However, when seven different PCV2 strains were compared in PK-15 cells, it was 
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found that abortion-associated strains (GeneBank accession numbers AJ293867 and 
AJ293868) had different replication kinetics compared to PMWS or PDNS-associated PCV2 
strains (Meerts et al., 2005). A higher number of infected cells were observed at 24 hours 
post inoculation and the percentage of infected cells with nuclear localized antigens was 
lower compared to that of the other strains (Meerts et al., 2005). Wang et al. (2004) 
compared the ORF2 of Taiwanese PCV2 isolates recovered from four PMWS-associated 
cases, two PDNS-associated cases, one case with nervous signs, and one abortion-associated 
case, and found a small number of amino acid differences associated with the different 
clinical conditions. Farnham et al. (2003) further characterized two PCV2 isolates associated 
with abortions by ORF2 sequencing and found that the isolates were almost identical to each 
other and to other isolates associated with reproductive failure whereas there were at least 
two amino acids differences compared to PCV2 isolates associated with PMWS.  
The results of the present study indicate that the two PCV2 isolates 4838 and 40895 
differ significantly in several parameters in vivo including serum antibody profiles, amount 
of PCV2 genome in serum, amount of PCV2 antigen in lymphoid tissues, and severity of 
PCV2-associated gross and microscopic lesions. PCV2 isolate 4838 was less virulent 
compared to PCV2 isolate 40895 in this study. The two PCV2 isolates have an overall 
nucleotide sequence identity of 98.9%. Within the ORF2 capsid gene, a total of 11 non-silent 
nucleotide differences, resulting in 9 amino acid differences, were identified between these 
two isolates. Larochelle et al. (2002) identified three immunogenic regions in ORF2 at 
residues 59-80, residues 121-136, and at residues 180-191. Seven of the nine amino acid 
differences between PCV2-4838 and PCV2-40895 were located in these immunogenic 
regions. The T134P difference in PCV2-4838 was reported in a Canadian isolate recovered 
from a non-PMWS pig with generalized tremors (CAN-97V19; 27). De Boisséson et al. 
(2004) compared French PCV2-isolates and determined the most frequent mutations in 
PCV2 genomes. Five of the nine ORF2 amino acid differences between the two isolates 
observed in the present study (A59R, T63R, L185M, K206I, and N232K) corresponded to 
these most frequent mutations whereas the two ORF1 amino acid differences S280F and 
P302S were not among the most frequently reported ORF1 mutations (De Boisséson et al., 
2004). Moreover, comparison of the PCV2-4838 ORF1 change with 44 sequences from the 
 
 251
GeneBank (data not shown) did not result in any matches at position 302, thus it appears that 
this amino acid in ORF1-PCV2-4838 is unique. A chimeric virus created by substitution of 
the PCV2-ORF1 with that of PCV1 in the genomic backbone of PCV2 has shown to be 
attenuated in pigs (Fenaux et al., 2003).  
The sequence analysis does show that the two PCV2 isolates in this study, with 
apparent differences in virulence in the field and under experimental conditions, also differ 
genetically which is in contrast to other studies. At least two studies (De Boisséson et al., 
2004; Grierson et al., 2004) have found identical PCV2 sequences in clinically healthy and 
diseased pigs. More than one PCV2 sequence can be found in the same pig under field 
conditions (unpublished personal observation) and a possible explanation for finding 
identical PCV2 sequences in healthy and diseased pigs is that a copy of a rare variant in the 
population rather than the causative PCV2 was sequenced. This emphasizes the importance 
of in vivo comparison of isolates.  
It has been reported that differences in virulence of attenuated chicken anemia virus 
(CAV), another member of the Circoviridae family, obtained after a large number of 
passages in cell culture, are associated with a few nucleic acid changes in the CAV genome 
(Todd et al., 2002; Yamaguchi et al., 2001). Recently, we reported that two amino acid 
changes in the PCV2 capsid protein that occurred during serial in vitro passage slightly 
enhanced the ability of PCV2 to grow in vitro and attenuated the virus in vivo (Fenaux et al., 
2004b). None of the two previously described ORF2 amino acid mutations, P110A and 
R191S, were found in PCV2 isolate 4838. However, the current study is different in that 
isolate 4838 is a true field isolate and its genetic determinant(s) for virulence could be 
different from the ones identified during serial in vitro passages. In addition, other factors 
may also contribute to viral virulence. It is possible that the observed amino acid differences 
in the present study in ORF1 and ORF2 either alone or collectively may be responsible for 
the observed difference in virulence, and clearly further studies are warranted to fine-map the 
critical mutation(s) responsible for virulence. 
It has been demonstrated experimentally that PCV2 replication is enhanced and 
PCV2-associated lesions are more severe in pigs that are coinfected with pathogens such as 
PPV (Allan et al., 1999; Kennedy et al., 2000; Krakowka et al., 2000; Opriessnig et al., 
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2004), PRRSV (Allan et al., 2000a; Harms et al., 2001; Rovira et al., 2002), or M. 
hyopneumoniae (Opriessnig et al., 2004a). Several groups have also demonstrated that 
immunostimulation in the form of adjuvanted vaccines (Allan et al., 2000b; Opriessnig et al., 
2003) may also enhance the severity of PCV2-associated disease and lesions. We knew from 
previous studies that our isolate PCV2-40895 was of moderate-to-high virulence (Fenaux et 
al., 2002, 2003, 2004a, b; Opriessnig et al., 2003, 2004a, b, 2006a, b). We decided to use 
isolate PCV2-4838 from a field case where there was no evidence of PCV2-associated 
disease or lesions despite having multiple coinfections and use of adjuvanted vaccines in the 
growing pigs. Our reasoning was that the number and combination of other cofactors were 
such that conditions were optimum for this isolate to have expressed its virulence.  
Based on the parameters measured in this study, there are significant differences in 
virulence between the PCV2-40895 and PCV2-4838 isolates in experimentally infected SPF 
pigs. This knowledge does help explain differences observed in the field. Most herds are 
infected with PCV2 but relatively few have major losses associated with PCV2 infection, 
suggesting that perhaps the majority of the PCV2 isolates are non- or low-virulent. To further 
substantiate that these low virulent PCV2 isolates are not a relevant problem would require 
demonstrating that known cofactors such as concurrent infections or use of immune 
stimulants, such as adjuvanted vaccines, do not trigger progression of PCV2 infection to 
PMWS as has been demonstrated with the PCV2-40895 isolate (Opriessnig et al., 2004a, b). 
These low virulent isolates such as PCV2-4838 should also be inoculated into pigs known to 
have increased susceptibility to PCV2-associated disease, such as certain lines of Landrace 
pigs (Opriessnig et al., 2006a). 
To our knowledge, this is the first report to demonstrate a clear difference in 
virulence between two well-characterized PCV2 isolates in a controlled experimental setting 
using a SPF pig model typical of modern pork production. Since only a few genetic 
differences were found between the two isolates compared in this study, these two isolates 
and the identified genetic difference could serve as a launching pad for experimentally 
determining which genetic differences are important for virulence differences in the future. 
The availability of infectious PCV2 DNA clones and a well-defined pig model will position 
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scientists now to further understand the molecular basis of pathogenesis of PCV2-associated 
diseases, develop effective vaccines, and improved diagnostic assays. 
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 TABLE 1. Comparison of microscopic lymphoid lesions in pigs inoculated with porcine circovirus type 2 (PCV2)-4838, in pigs 
inoculated with PCV2-40895, and in sham-inoculated control pigs at 14 and 28 days post inoculation. Score ranges from 0 (no 
lesions) to 3 (severe) for lymphoid depletion (LD) and histiocytic replacement (HR) of lymphoid follicles. Data presented as 
incidence (mean group score ± SE) 
260
   Tracheobronchial Lymph Node Lymph Nodes Poola Spleen Tonsil
         LD HR LD HR LD HR LD HR
14 days post PCV2 inoculation 
PCV2-4838 (n = 7) 4/7 (0.9±0.3)Ab 3/7 (0.6±0.3)A,B 4/7 (0.7±0.3)A 3/7 (0.4±0.2)A 5/7 (0.7±0.2)A 4/7 (0.6±0.2)A 2/7 (0.3±0.2)A 2/7 (0.3±0.2)A
PCV2-40895 (n = 7) 7/7 (2.0±0.2)B 7/7 (1.3±0.2)A 7/7 (2.4±0.2)B 7/7 (1.9±0.3)B 7/7 (1.7±0.2)B 7/7 (1.7±0.2)B 7/7 (1.4±0.3)B 7/7 (1.1±0.1)B
Controls (n = 7) 3/7 (0.4±0.2)A 0/7 (0.0±0.0)B 3/7 (0.4±0.2)A 0/7 (0.0±0.0)A 1/7 (0.1±0.1)C 0/7 (0.0±0.0)C 1/7 (0.1±0.1)A 0/7 (0.0±0.0)A
28 days post PCV2 inoculation 
PCV2-4838 (n = 7) 3/7 (0.6±0.3) 2/7 (0.3±0.2) 3/7 (0.4±0.2)A 3/7 (0.0±0.0)A 5/7 (0.7±0.2)A 3/7 (0.4±0.2)A 2/7 (0.3±0.2) 1/7 (0.1±0.1) 
PCV2-40895 (n = 7) 6/7 (1.3±0.4) 4/7 (0.9±0.4) 7/7 (1.3±0.4)B 5/7 (1.3±0.4)B 7/7 (1.3±0.2)B 7/7 (1.4±0.2)B 5/7 (0.7±0.2) 4/7 (0.7±0.3) 
Controls (n = 7) 2/7 (0.3±0.2) 0/7 (0.0±0.0) 4/7 (0.6±0.2)A 0/7 (0.0±0.0)A 1/7 (0.1±0.1)A 0/7 (0.0±0.0)A 2/7 (0.3±0.2) 0/7 (0.0±0.0) 
a Superficial inguinal, external iliac, mediastinal, and mesenteric lymph nodes. 
b Different superscripts within columns (A, B, C) represent significantly (P < 0.05) different mean group scores within columns for each day post 
inoculation. 
 
261
 
 
Group    Lung Tracheobronchial
Lymph Nodes 
Lymph Node 
Poola
Spleen Tonsil Thymus
14 days post PCV2 inoculation 
PCV2-4838 (n = 7) 1/7 (0.1±0.1)Ab 1/7 (0.3±0.3)A 2/7 (0.4±0.3)A 2/7 (0.4±0.3)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A
PCV2-40895 (n = 7) 6/7 (1.2±0.4)B 7/7 (2.1±0.3)B 7/7 (2.4±0.3)B 7/7 (2.3±0.2)B 7/7 (1.7±0.4)B 4/7 (0.9±0.4)B
Controls (n = 7) 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A
28 days post PCV2 inoculation 
PCV2-4838 (n = 7) 0/7 (0.0±0.0) 1/7 (0.1±0.1)A 1/7 (0.1±0.1)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0) 
PCV2-40895 (n = 7) 1/7 (0.3±0.3) 6/7 (1.4±0.4)B 7/7 (1.9±0.3)B 6/7 (1.3±0.4)B 6/7 (1.6±0.4)B 0/7 (0.0±0.0) 
Controls (n = 7) 0/7 (0.0±0.0) 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0)A 0/7 (0.0±0.0) 
TABLE 2. Comparison of amount of porcine circovirus type 2 (PCV2)-antigen in tissues demonstrated by immunohistochemistry 
(IHC) in pigs inoculated with PCV2-4838, in pigs inoculated with PCV2-40895, and in sham-inoculated control pigs at 14 and 28 
days post inoculation. Score ranges from 0 (undetectable) to 3 (large amount of PCV2 antigen). Data presented as incidence (mean 
group score ± SE) 
b Different superscripts within columns (A, B) represent significantly (p<0.001 for all tissues except thymus: p<0.05) different 
mean group scores within columns for each DPI. 
a Superficial inguinal, external iliac, mediastinal, and mesenteric lymph nodes. 
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FIG. 1. Mean group IgM (Corrected optical density values) antibody response to porcine 
circovirus type 2 (PCV2)-4838 and PCV2-40895 at the day of inoculation and at 7, 14, 21, 
and 28 days post PCV2 inoculation (DPI). * = significant (P < 0.05) differences between 
groups. 
.
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FIG. 2. Mean group IgG (Serum-to-positive ratios) antibody response to porcine circovirus 
type 2 (PCV2)-4838 and PCV2-40895 at the day of inoculation and at 7, 14, 21, and 28 days 
post PCV2 inoculation (DPI). A = Residual passively acquired antibodies in 7of 14 of the 
control pigs. * = significant (P < 0.05) differences between groups. 
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FIG. 3. Mean group porcine circovirus type 2 (PCV2) genomic copy numbers obtained from 
pigs inoculated with PCV2-4838 and obtained from pigs inoculated with PCV2-40895 pigs at 
7, 14, 21, and 28 days post inoculation (DPI). Error bars represent standard errors. * = 
significant (P < 0.05) differences between groups. 
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CHAPTER 11.  GENERAL CONCLUSIONS 
 
Porcine circovirus type 2 (PCV2) is considered to be the third most important viral 
pathogen in the US pig population (Halbur et al., 2005). Its ubiquitous distribution in the pig 
population and its presence in healthy as well as in diseased herds distinguishes PCV2 from 
most classical swine pathogens. It is well known that the presence of PCV2 doesn’t 
necessarily equate to PCV2-associated disease. The reasons for this need to be better 
understood and our work described in this thesis has contributed substantially to the base of 
knowledge that is beginning to clarify the pathogenesis and epidemiology of PCV2-
associated diseases. 
PCV2 has been linked to “postweaning multisystemic wasting syndrome” or 
“PMWS” (Harding and Clark, 1997), and it has been proposed by Sorden (2000) that a pig 
has to show characteristic clinical signs and the hallmark microscopic lesions in lymphoid 
tissues associated with PCV2-antigen. Soon it became clear, that PMWS may not have been 
the best choice of names. Many common diseases can cause wasting and the name wasting 
causes confusion with the transmissible spongiform encephalopathies observed in cervidae. 
On the other hand, large amounts of PCV2 antigen can be found in older pigs or even fetuses 
and neonates that are not primarily affected by wasting. This has led to the creation of the 
new term “PCV2-asscociated diseases” (PCVD). PCV2-associated diseases are 
“multifactorial” i.e. there is involvement of more than one factor or pathogen but the 
presence of PCV2 is one necessity.  
This work describes our efforts to identify factors that contribute to PCV2-associated 
diseases in order to give researchers, diagnosticians, practitioners and pig producers tools to 
better understand and implement best practices for control of PCV2-associated problems. We 
looked at co-factors such as vaccine induced immunostimmulation and concurrent infections, 
we investigated host-specific factors such as differences in pig genetics, and finally, we 
assessed virus-specific factors such as differences in PCV2-isolates.   
The lack of PCV2 negative breeding herds is a major disadvantage for researchers 
focused on PCV2-related research. The specific-pathogen-free pig model is more suitable for 
application of research findings into field-situations than are the gnotobiotic pig model, the 
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cesarean-derived and colostrum-deprived (CDCD) pig model, or the colostrum-deprived 
(CD) pig model. We were successful in deriving pigs free of PCV2 and anti-PCV2 antibodies 
from commercial U.S. breeding herds by segregated early weaning and have documented this 
protocol (Opriessnig et al., 2004d). In rare cases, PCV2 has been shown to be transmitted 
vertically resulting in the birth of PCV2 positive piglets (Harms et al., 1999; Jolie et al., 
2000). In assuming that dams that shed PCV2 intermittent likely have high anti-PCV2-
antibody levels, we attempted to bypass the risk of bringing PCV2 positive piglets into our 
research facility by selecting piglets only from sows with negative or low levels of PCV2 
antibodies. In following the same protocol for several projects, we were always successful in 
deriving PCV2 negative pigs and we found our “restricted” segregated early weaning method 
useful (Opriessnig et al., 2004d).  
Evidence from European studies suggested that commercial vaccines can enhance 
PCV2-associated diseases in pigs (Allan et al., 2000c; Allan et al., 2002b, Kyriakis et al., 
2002). We confirmed that this is also true for the US and we found that vaccination with 
adjuvanted bacterins enhanced PCV2 replication and the incidence and severity of the 
hallmark microscopic lesions associated with PCV2-infection in conventional pigs 
(Opriessnig et al., 2003). It is assumed that the underlying mechanism of vaccine-induced 
enhancement of PCV2-associated diseases is the stimulating effect of adjuvants on triggering 
proliferation of cells of the immune system. The major cell type that supports PCV2 
replication in vivo has not been identified yet but the most likely scenario is that PCV2 
replicated in many different cell types including macrophages and lymphocytes (Shan Yu, 
unpublished). In a follow up study we found that oil-in-water adjuvanted vaccines are more 
likely to enhance PCV2-asssociated lesions than aqueous-carbopol or aluminum hydroxide 
adjuvanted vaccines are (Hoogland et al., 2006). A similar observation was also made by 
Krakowka et al. (2006) who infected gnotobiotic pigs at 1 day of age with PCV2 and 
vaccinated them at 1 or 1 and 3 weeks of age with commercially available bacterins. 
Krakowka clearly showed a detrimental effect of a particular oil-in-water product 
(Amphigen®, Pfizer Animal Health, Inc.) resulting in clinical PMWS in 7/11 piglets, 
whereas piglets vaccinated with other products (MetaStim®, Fort Dodge Animal Health, Inc; 
Impran®, Boehringer Ingelheim, Ltd.) did not develop disease (Krakowka et al., 2006).  
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It would appear that timing of vaccination is important and we found a trend towards 
no to minimal PCV2-associated lesions when pigs are vaccinated with a M. hyopneumoniae 
bacterin 2 to 4 weeks prior to PCV2 exposure (Opriessnig et al., 2006b). Based on the 
research data available to date, our recommendation for herds with PCV2-associated 
problems is to determine the time of PCV2 exposure by means of serology and PCR and to 
place vaccinations, especially those with oil-in-water adjuvanted products, as far away as 
possible from this time. If the time of exposure to PCV2 can not be determined, it might be 
beneficial to change the product used and to switch to a bacterin that is not adjuvanted with 
an oil-in-water-based product. 
By vaccinating pigs at the time of PCV2-infection with a modified-live porcine 
reproductive and respiratory syndrome virus (PRRSV) vaccine and by challenging the pigs 
with PRRSV to evaluate vaccine efficacy we found an adverse effect of PCV2 infection on 
development of protective immunity induced by the PRRSV vaccine (Opriessnig and Halbur, 
2005b). PCV2-associated lymphoid depletion is seen to some degree even in subclinically-
infected pigs and it has been found that there is a correlation of the degree of lymphoid 
depletion and the amount of PCV2 in lymphoid tissues (Darwich et al., 2002). In this regard, 
a decrease of cells of the immune system has been described (Chianini et al., 2003; Darwich 
et al.,2002; Nielsen et al. 2004; Segales et al., 2000; Segales et al., 2002). Segales et al. 
(2000) reported of lower mean lymphocyte percentages in PMWS-affected pigs compared to 
non-affected pigs. Further analysis revealed that pigs suffering from PMWS had lower 
proportions of CD4+ and IgM+ cells in blood than clinically healthy pigs (Segalés et al., 
2001). Darwich et al. (2002) found significantly decreased numbers of CD8+ and double-
positive cells in PMWS-pigs (Darwich et al., 2002). Nielsen et al. (2003) found primarily 
lymphopenia with all T lymphocyte subsets involved in experimentally PCV2-inoculated 
pigs. Future work needs to investigate if this PCV2-induced decrease in development of an 
effective immune response to PRRSV vaccine can be extrapolated to other vaccines (swine 
influenza virus, M. hyopneumoniae, Salmonella sp.) commonly used on PCV2-infected pigs. 
The adverse effect of PCV2 infection on the development of protective immunity against 
PRRSV and other respiratory pathogens may be an important, and perhaps an 
underappreciated factor in controlling porcine respiratory disease complex (PRDC) and other 
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diseases in pigs. It will be interesting to see what impact the soon-to-be-released commercial 
PCV2 vaccines have on control of PRDC which continues to be the most important disease 
problem facing the U.S. swine industry. 
In coinfecting pigs with porcine parvovirus (PPV) and PCV2 we confirmed that this 
coinfection results in clinical disease in conventional pigs (Opriessnig et al., 2004a). This 
work showed the importance of PPV in the PCV2-disease complex in conventional pigs. 
PPV is in many ways similar to PCV2. It is a small, non-enveloped DNA virus that is 
ubiquitously distributed in the pig population without being associated with disease except in 
pregnant females. Similar to PCV2, PPV has a strong cellular tropism for mitotically active 
tissues such as lymph nodes or heart muscle (Oraveerakul et al., 1993; Allan and Ellis, 2000). 
It is thought that stimulation of the host DNA to enter the S-phase of the cell cycle by PPV 
promotes PCV2 replication (Krakowka et al., 2000). A recent in vitro study found that PCV2 
replication is enhanced by both type I interferon (IFN-α) and type II IFN (IFN-γ) which are 
strong antiviral cytokines produced to control viral infections (Meertz et al., 2005b). 
Moreover, Chang et al. (2005) infected swine alveolar macrophages with PCV2 and PRRSV 
and found that PCV2 induced upregulation of IFN-α production. Taken together, these 
findings imply that concurrent viral infections indirectly enhance PCV2 replication by 
enhancing interferon production. Further work needs to establish if this mechanism is also 
true in vivo.  
In our work we have shown that the combination PPV and PCV2 can negatively 
impact a herd (Opriessnig et al., 2004a), and whatever the true mechanism of PPV-
enhancement on PCV2 replication is, this highlighted the need for PPV diagnosis in growing 
pigs. PPV diagnosis is typically done by immunofluorescence assays on frozen tissue 
sections of aborted fetuses. In all other growing stages, serology is the test of choice to 
confirm PPV infection. In our work we developed an immunohistochemistry assay for PPV 
which we have validated and adapted for use in diagnostic cases and have found it to be 
useful for detecting PPV-antigen in formal-fixed and paraffin-embedded tissues from field 
cases. This test has been especially useful on cases that have lymphohistiocytic liver or heart 
lesions. We recently reported cases where both PPV and PCV2 antigen were associated with 
mycocarditis lesions in growing pigs (Opriessnig et al., 2006c). Both pathogens are not 
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typically observed in heart tissues in growing pigs. Maybe this is due to a lack of awareness 
and lack of tools to look rather than due to a true low incidence. We now are aware that this 
occurs and have the tools to confirm or rule out PCV2/PPV infection or coinfection. 
The discovery that adjuvanted vaccines, and particularly M. hyopneumoniae vaccines, 
may enhance PCV2 replication and severity and incidence of PCV2-associated diseases has 
led some producers to discontinue successful M. hyopneumoniae vaccination programs. We 
found that M. hyopneumoniae potentiates the severity of PCV2-associated lung and lymphoid 
lesions, increases the amount and prolongs the presence of PCV2-antigen, and increases the 
incidence of PMWS in pigs (Opriessnig et al., 2004c). This model indicates that is it critical 
to control M. hyopneumoniae in herds where PCV2 and M. hyopneumonie coinfection occurs 
and reducing the effect of M. hyopneumoniae by either vaccination or chlortetracycline 
treatment has shown to be beneficial (Halbur et al., 2005). The potentiating mechanism of M. 
hyopneumoniae infection on PCV2 is not known. We speculate that induction of 
peribronchial lymphoid hyperplasia and the mitogenic activity of M. hyopneumoniae on 
alveolar macrophage proliferation enhances PCV2 replication at the site of infection. In an 
attempt to further characterize the effect of dual M. hyopneumoniae and PCV2 infection on a 
pig, we also recently characterized the cytokine gene expression profiles in tracheobronchial 
lymph nodes (unpublished). We found that single PCV2 infection was characterized by 
significantly increased IFN-γ, IL-8 and chemokine gene expression. Dual-infection with M. 
hyopneumoniae resulted in a significant increase of IL1β, IL-8 (CXCL-8), CCL5 (RANTES), 
and CXCL10 (IP-10), and weak stimulation of IFN-β and IL-6. IL-13 and IFN-α were 
significantly down regulated; ICAM1 was slightly down regulated. The most significant 
increase in IFN-γ gene expression was observed with the PCV2/M. hyopneumoniae 
coinfection, in contrast to previous findings of decreased IFN-γ mRNA in TBLN of pigs with 
recent naturally acquired PMWS (Darwich et al., 2003a). The increase in IFN-γ, as proposed 
by Meerts et al. (2005b) as being one way to enhance PCV2 in vitro, the increase in 
chemokines, and the decrease in IFN-α, in our study was correlated with increases in severity 
of microscopic lesions and amount of PCV2-antigen. Thus, in the context of M. 
hyopneumoniae coinfection, up-regulation of certain cytokines and chemokines during the 
course of inflammation above a certain level has more of a counterproductive effect on PCV2 
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subsequently leading to PMWS.  
In the field, PMWS is seen only in a small percentage of pigs infected with PCV2. 
We investigated the effect of host genetics in the susceptibility to PCV2 replication and 
PCV2-associated lesions and disease among pig breeds by comparing PCV2-associated 
disease and lesions in purebred Duroc, Landrace, and Large White in our SPF pig model. 
Clinical disease and microscopic lesions compatible with PMWS were only observed in the 
Landrace pigs suggesting a predisposition of the Landrace pigs used in this study (Opriessnig 
et al., 2006a). Although evidence from the field suggested there were differences in host 
susceptibility, this was the first experimental confirmation of differences among breeds in 
susceptibility to PCV2. This study was conducted with a small number of pigs from one 
farm. Some producers have taken this preliminary research data and evidence from the field 
and made decisions to change breeding programs on farms suffering major losses associated 
with PCV2. More solid data needs to be generated to support such major decisions. 
Anecdotally, it has been suggested that Pietrains are less susceptible to PCV2-associated 
diseases. Rose et al. (2004) conducted a cohort study on 4 PMWS affected farms to 
investigate susceptibility to PCV2-associated diseases by manipulating the genetics via 
artificial insemination. Half of the sows were inseminated with Pietrain semen, whereas the 
remaining sows received the semen that was typically used on the farms. The PCV2-
associated disease did not differ in the Pietrain offspring compared to that observed in the 
offspring from the other breeds (Rose et al., 2004). Nevertheless, France changed 80% of 
boar genetics towards Pietrain and the importance of PCV2-asscociated diseases decreased in 
this country (R. Desrosiers, PMWS Listening Session at the 2006 AASV Meeting, Kansas 
City, MI). Belgium, which appears less affected by PCV2-asscoiated diseases (Segalés, 
2006), uses 100% Pietrain semen for synthetic pig production. Comparing Landrace and 
Pietrain pigs in the same experimental model is a logical next step since this has not been 
done before and evidence from the field supports differences among these two breeds. 
Essentially nothing is known about the mechanism of susceptibility to PCV2-associated 
diseases. Once the results are confirmed in a larger number of pigs, researchers need to start 
looking closer at genes from pigs affected by PCV2-asscociated disease and their healthy 
littermates that share at least 50% of their genes. Genetic resistance may be associated with a 
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single gene, but usually it is associated with multiple genes and to investigate gene regulation 
by means of gene array analysis might be one way to continue this work. Using genetically 
engineered animals might be another approach.  
The recent increased incidence of PCV2-associated diseases combined with high 
mortality in eastern Canada and North Carolina has raised concerns over the emergence of a 
new, more virulent PCV2 strain. The international PCV2 research community in general 
continues to argue against differences in virulence among PCV2 strains. This is mainly based 
on genetic comparisons of sequences rather than on in vivo studies. We attempted to compare 
the pathogenicity of PCV2 isolates obtained from field cases with and without PCV2-
associated lymphoid lesions and disease in a controlled experimental trial. The two PCV2 
isolates that we used shared 98.9% of their nucleic acid sequence. Microscopic evaluation of 
tissues and comparison of amount of PCV2 antigen and nucleic acids by IHC and 
quantitative PCR indicated significant differences in incidence and severity of microscopic 
lesions and amount of PCV2 between the 2 isolates tested (Opriessnig et al., 2005a). This 
was the first evidence that highly homologous PCV2-isolates may differ significantly in 
virulence. This knowledge helps explain at least in part the differences in clinical 
manifestation of PCV2 in the field and has stimulated great interest in further 
characterization of PCV2 isolates. Based on ORF2 sequencing, our isolates are less than 95% 
homologous to recent eastern Canadian isolates. Future studies need to focus on comparing 
these possibly more virulent isolates to our moderate and low virulent PCV2 isolates. The 
virulence regions in PCV2 have to be determined to allow further testing including 
sequencing to distinguish virulent from non-virulent isolates. Meerts et al. (2005b) found that 
type I and type II IFNs did not influence PCV1 replication in PK-15 cells whereas both 
cytokines increased PCV2-replication in vitro. One possible next approach would be to 
measure if our two PCV2 isolates differ in their interaction with IFNs in vitro and also in 
vitro. The low virulent PCV2 isolate that we used in our study was isolated from a field case 
coinfected with several pathogens and a reduced interaction with IFN would explain the 
limited expression of PCV2 in this case.  
Overall, the information that there are differences in virulence among PCV2 isolates 
will impact the industry in that producers need to understand the risk of introducing new 
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PCV2 strains into a herd and that appropriate biosecurity protocols have to be established. 
Since most herds are already infected with PCV2 it will also be important to understand if 
infection with a resident strain is likely to confer immunity against a different stains. If so, 
concern about introduction of a different PCV2 strain is reduced and also commercial PCV2 
vaccines are more likely to be cross protective. If not, vaccine manufacturers may need to 
explore development of multivalent PCV2 vaccines and producers and veterinarians will 
need to develop appropriate biosecurity and testing to minimize the risk of introducing new 
strains of PCV2 to pig farms. Differences in virulence of PCV2 isolated may also impact 
international trade of pigs and pork products in that countries less affected by PCV2-
associated diseases such as Australia may chose to close their trading borders to countries 
that have documented severe PCV2-associated disease outbreaks such as Europe and Canada. 
Many people still question the role of PCV2 in disease. However, there is plenty of 
evidence in favor of an important role for PCV2 in pig diseases. High amounts of PCV2 
antigen are usually correlated with increased severity of microscopic lesions. The hallmark 
microscopic lymphoid lesions associated with PCV2 have been reproduced in specific-
pathogen-free pigs infected with a pure infectious PCV2 DNA clone (Fenaux et al., 2002). 
Finally, several research groups have succeeded in reproducing clinical disease in pigs 
experimentally infected with only PCV2 (Bolin et al., 2001, Harms et al., 2001, Okuda et al., 
2003, Ladekjær Mikkelsen et al., 2002, Opriessnig et al., 2006a). Trends of PCV2-associated 
diseases submitted to diagnostic laboratories show that PCV2-associated diseases are 
increasing and most likely will continue to gain importance in the future (Halbur et al., 
2005).  
This work has provided substantial new knowledge that will better enable researchers 
and veterinary practitioners to understand the pathogenesis and epidemiology of PCV2-
associated diseases and make important decisions on the most effective intervention 
strategies. We showed that PCV2-free pigs can be derived from positive breeding herds. We 
also showed that vaccination with commonly used bacterins can enhance PCV2-associated 
lesions but that this effect can be reduced by optimal timing of vaccination. We found 
indication of reduced vaccine efficacy when pigs are in the acute stages of PCV2 infection at 
the time they were vaccinated with a MLV PRRSV vaccine. We showed that PCV2 and PPV 
 
 273
coinfection results in clinical PMWS in a conventional pig model. Similarly, we showed that 
PCV2 and M. hyopneumoniae coinfection results in clinical PMWS in a conventional pig 
model. We found evidence that a certain line of Landrace pigs are more susceptible to 
develop PCV2-associated disease compared to Duroc and Large White pigs. Finally, we 
documented evidence for differences in virulence between PCV2 isolates. These new 
discoveries have impacted pork producers and shaped the direction of future research on 
PCV2-associated diseases. 
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APPENDIX A.  CARDIOVASCULAR LESIONS IN PIGS NATURALLY OR 
EXPERIMENTALLY INFECTED WITH PORCINE CIRCOVIRUS TYPE 2 
 
 
A paper published in the 
Journal of Comparative Pathology 134:105-110, 2006 
 
 
Tanja Opriessnig, Bruce H. Janke, Patrick G. Halbur 
 
 
 
Abstract 
Abundant intracytoplasmic porcine circovirus type 2 (PCV2) was associated with 
myocardiocyte swelling or necrosis, or myocardial fibrosis (or both) in three naturally-
infected pigs aged 4-7 weeks from three different farms. One 6 week old pig from a fourth 
farm had severe diffuse segmental to circumferential lymphohistiocytic and plasmacytic 
periarteritis and endarteritis in several organs, PCV2 antigen was demonstrated in endothelial 
cells, and inflammatory cells in the arterial walls. In three pigs experimentally infected with 
PCV2, viral antigen was also associated with obliterated blood vessels in areas of 
granulomatous and necrotizing lymphadenitis. Together these findings suggest that the 
cardiovascular system in general and endothelial cells in particular play an important role in 
the pathogenesis of PCV2-associated diseases.  
 
Summary of the Short Communication 
Porcine circovirus type 2 (PCV2) infection of growing pigs is characterized by depletion 
of lymphoid follicles and histiocytic-to-granulomatous inflammation of varying degrees in 
lymphoid tissues and certain organs (Sorden, 2000). If the lymphoid lesions are severe and 
accompanied by high amounts of intralesional PCV2 antigen or nucleic acids a diagnosis of 
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PCV2-associated postweaning multisystemic wasting syndrome (PMWS) (Sorden, 2000) can 
be confirmed.  
The pathogenesis of PCV2 infection and the major cell types that support PCV2 
replication are poorly understood. High amounts of PCV2 antigen or nucleic acids are often 
detected in the cytoplasm of macrophages and dendritic cells by immunohistochemistry 
(IHC) or in-situ-hybridization (ISH). To a lesser extent, PCV2 antigen is also found in 
epithelial cells in lungs and kidneys, in smooth muscle cells, and in endothelial cells in 
several tissues in pigs experimentally infected with PCV2 (Kennedy et al., 2000) as well as 
in pigs with naturally occurring PCV2-associated PMWS (McNeilly et al., 1999; Rosell et 
al., 1999). This report describes field and experimental cases in which PCV2 was associated 
with severe cardiovascular lesions in growing pigs. 
Pig 1. A previously healthy pig aged 4 weeks was found dead and submitted to the 
laboratory. On initial examination nutritional myocardiopathy was suspected. 
Histopathological changes included severe myocardial fibrosis and mixed leucocytic 
infiltration throughout the myocardium (Fig. 1a), mild multifocal chronic suppurative and 
histiocytic pericarditis, mild suppurative and lymphohistiocytic interstitial nephritis and 
hepatitis, and mild suppurative and lymphohistiocytic interstitial pneumonia. Routine 
immunohistochemistry (IHC) for porcine reproductive and respiratory syndrome virus 
(PRRSV), as described by Halbur et al. (1995), gave negative results on sections of heart and 
lung tissue. Similar IHC results were given by examination of these tissues with a 
pseudorabies virus (PRV) monoclonal antibody (VMRD, Pullman, WA, USA), diluted 1 in 
1000, overnight at 4°C, with protease pretreatment. Abundant PCV2 antigen was detected by 
IHC with a polyclonal antibody (Sorden et al., 1999) in the cytoplasm and nuclei of 
myocardiocytes, within vascular endothelial cells in the myocardium and in areas of 
myocardial fibrosis (Fig. 1b). IHC for porcine parvovirus (PPV), as described by Opriessnig 
et al. (2004), revealed strong labelling within inflammatory cells in areas of inflammation in 
the myocardium (Fig. 1c). IHC as carried out by Haines et al. (1992) gave negative results 
for bovine virus diarrhoea virus (BVDV) in the heart.  
Although there was no bacterial growth in culture, the lesions in this pig were consistent 
with chronic bacterial septicaemia and with PCV2- and PPV-associated myocarditis and 
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heart failure. Experimentally, PPV has been shown to enhance progression of PCV2-
infection towards clinical PMWS (Allan et al., 1999; Opriessnig et al., 2004); however, this 
pig had no PCV2-associated lymphoid lesions and died from heart failure rather than from 
PMWS. PCV2-induced myocarditis is typically observed in fetuses and newborn piglets 
(West et al., 1999). PPV has sporadically been associated with myocarditis in growing pigs 
(Bolt et al., 1997). 
Pigs 2 and 3. Both animals came from herds with a history of previously healthy animals 
being found dead. Pigs 2 (aged 5 weeks) and 3 (aged 7 weeks) came from herds of 1100 and 
4000, respectively. Both animals had severe transmural cardiac haemorrhages and the lungs 
were inflamed and oedematous, and nutritional myocardiopathy was initially suspected. In 
addition, pig 2 had fibrin tags adherent to the liver, and pig 3 had an enlarged spleen and 
pulmonary consolidation (bilateral, cranioventral, tan coloured) affecting 5-10% of the lung 
tissue. Microscopical examination revealed severe hepatic and pulmonary congestion and 
severe multifocal myocardial haemorrhage with swelling and necrosis of myofibers (Fig. 2a) 
in both pigs. No bacteria were cultured from the tissues. IHC gave negative results for 
PRRSV and PRV but strongly positive results for PCV2 in the hearts of both animals. PCV2 
antigen was detected within the cytoplasm of myocardiocytes and within vascular endothelial 
cells in the myocardium (Fig. 2b). Abundant PCV2 antigen also was demonstrated within 
Kupffer cells and in lesser amounts within hepatocytes in the liver. IHC for PPV and BVDV 
gave negative results on tissues from both pigs.  
Liver and heart vitamin E concentrations (Stahr, 1991) were both 2.1 ppm (reference 
range 1-3 ppm) in pig 2; and in this animal the selenium concentrations were 580 ppb and 
240 ppb (reference range 400-1200 ppb) in the liver and heart, respectively. Pig 3 had 2.6 
ppm vitamin E and 410 ppb selenium in the liver. From a retrospective study of 77 pigs with 
nutritional myocardiopathy, Pallarés et al. (2002) concluded that vitamin E concentrations of 
less than 2 ppm were deficient; all the pigs had adequate concentrations of liver selenium. In 
the present study, the vitamin E and selenium concentrations in the liver of pigs 2 and 3 were 
within the normal range.  
As with pig 1, pigs 2 and 3 showed abundant PCV2-antigen associated with myocardial 
lesions but no evidence of PRRSV- or PRV-associated myocarditis. The possibility that 
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PCV2 may have predisposed the pigs to heart failure should be borne in mind. Alternatively, 
PCV2 might have been an opportunistic invader of damaged myocardial cells. An increased 
incidence of heart failure in association with PCV2 has been reported by Marco (2002), who 
observed mild myocarditis with and without myofibrilar degeneration. In considering 
differential diagnosis it is relevant that pigs 2 and 3, like pig 1, came from an area free of 
foot-and mouth disease. The infectious porcine myocarditis syndrome recently recognized in 
Australia (McOrist et al., 2004) is thought to be due to a virus, as yet undefined but known 
not to be PCV2. 
Pig 4. A 6-week-old pig was submitted from a herd with a history of an increased 
incidence of sudden death in fast-growing pigs and an increased incidence of respiratory 
disease. Microscopical examination revealed small arterioles with diffuse, segmental to 
circumferential, moderate to severe, lymphohistiocytic and plasmacytic periarteritis and 
endarteritis, with segmental panarteritis and multifocal apoptosis of cells of the tunica intima 
and media. The affected arterioles were observed in the myocardium (Fig. 3a), meninges, 
lungs, kidneys (medulla and pelvis) and intestinal mesentery. Also observed were: 
lymphohistiocytic cuffing around small vessels in the grey matter of the brain; mild 
lymphoid depletion and histiocytic replacement of lymphoid follicles in the lymph nodes, 
tonsil and spleen; mild diffuse lymphohistiocytic interstitial pneumonia; and mild multifocal 
lymphohistiocytic hepatitis. Haemophilus parasuis was isolated from the lungs. Abundant 
PCV2 antigen was detected by IHC in the cytoplasm and occasionally in the nuclei of 
endothelial-like cells and smooth muscle-like cells (Fig. 3b) and to a lesser extent in 
infiltrating inflammatory cells in the walls of arterioles. In the liver, PCV2 antigen was 
demonstrated in the cytoplasm and nuclei of the majority of endothelial cells lining sinusoids, 
and occasionally in hepatocytes. PCV2 antigen was also demonstrated in the cytoplasm of 
myocardiocytes. Lymphoid tissues were negative for PCV2 antigen. Severe polyarteritis, 
such as that observed in pig 4, is not a frequent observation in pigs submitted to diagnostic 
laboratories. Differential diagnosis should include PRRSV, African swine fever, classical 
swine fever, and BVDV infection in pigs (Terpstra and Wensvoort, 1988; Paton and Done, 
1994). Neither African nor classical swine fever is present in the US, and IHC for PRRSV 
and BVDV was negative.  
 
 278
Pigs 5-7. Two 14-week-old pigs (nos. 5 and 6) (Opriessnig et al., 2005) and one 13-
week-old pig (no. 7) from two different PCV2 inoculation experiments had generalized 
lymphadenopathy at 42 days post-inoculation. There was multifocal accumulation of high 
numbers of macrophages and multinucleated giant cells and multifocal to coalescing necrotic 
areas with central mineralization (Fig. 4a) in the lymph nodes. PCV2 antigen was 
demonstrated in the outer zone of the necrotic areas by IHC (Fig. 4b). The necrotic areas 
were positive by IHC for (1) smooth muscle actin by incubation for 30 min at room 
temperature with a monoclonal anti-human antibody (BioGenex, San Ramon, CA, USA) 
diluted 1 in 200 (Fig. 4c), and (2) endothelial cell marker, after pretreatment with protease, 
by incubation overnight at 4°C with an anti-Factor VIII-related antigen polyclonal antibody 
(Zymed® Laboratories, South San Francisco, CA, USA) diluted 1 in 20 (Fig. 4d). Masson’s 
trichrome staining (Sheehan and Hrapchak, 1980) demonstrated that many of the foci of 
necrosis had an outer layer of collagen. These findings suggest that the necrotic areas were 
associated with damaged vessels.  
Routine bacterial cultures on tissues of these pigs were negative. Similarly, Ziehl-
Nielsen, periodic acid-Schiff (PAS), and Brown and Hopp’s gram stain (Sheehan and 
Hrapchak, 1980) gave negative results. Serum was negative for PRRSV and PPV specific 
antibodies by enzyme-linked immunosorbent assay (ELISA) (HerdChek® PRRS virus 
antibody test kit; IDEXX Laboratories, Westbrook, MA, USA) and haemagglutination 
inhibition (HI) assay (Mengeling et al., 1988), respectively.  
Rodríguez-Arrioja et al. (1999) and Segalés et al. (2004) described necrotizing lesions in 
lymph nodes of pigs with naturally occurring PMWS with and without concurrent PRV 
infection. Pigs 5-7 were all negative for antibodies to PRV and the lymphoid tissues were 
negative for PRV antigen. Pigs with septicaemic salmonellosis also may have necrotizing 
lymphadenitis, but such infection was excluded by culture. The pigs had seroconverted by 
ELISA (Nawagitgul et al., 2002) to PCV2 with sample-to-positive (S:P) ratios >1.0 (“cut-
off” <0.20) in the two older pigs and an S:P ratio of 0.24 in the younger pig. A recent case-
control study on pigs with porcine dermatitis and nephropathy syndrome (PDNS) found a 
relation between PDNS and high amounts of PCV2-specific antibodies, consistent with a 
hypersensitivity type III-like reaction (Wellenberg et al., 2004). It is possible that primary 
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PCV2-associated damage occurred in endothelial cells of the central lymph follicle vessel 
which, due to altered cytokine and chemokine signalling, initiated an inflammatory response 
that subsequently interfered with homing of lymphocytes, resulting in the pattern of 
lymphoid depletion and granulomatous lymphadenitis observed in these pigs.  
This report describes distinctive PCV2-associated lesions in growing pigs naturally or 
experimentally infected with PCV2. The infection was associated with heart failure due to 
acute necrotizing or chronic fibrosing myocarditis, and with chronic vasculitis in heart, 
kidney and lymphoid tissues. Together these findings suggest that the cardiovascular system 
in general and endothelial cells in particular play an important role in the pathogenesis of 
PCV2-associated diseases.  
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Fig. 1 a-c. Section of ventricle (myocardium) from pig 1. (a) There is mild-to-moderate, 
multifocal fibrosis and necrosis and moderate lymphohistiocytic inflammation in the 
heart. HE. Bar, 100 µm. (b) PCV2-antigen positive cells include fibroblast-like cells 
(arrow) and inflammatory cells resembling macrophages or lymphocytes. IHC 
(streptavidin-biotin peroxidase complex method, haematoxylin counterstain). Bar, 40 
µm. (c) There is abundant PPV labelling in many macrophage- and lymphocyte-like 
cells in areas of myocardial fibrosis. IHC (streptavidin-biotin peroxidase complex 
method, haematoxylin counterstain). Bar, 40 µm. 
 
 
 284
 
Fig. 2 a, b. Section of ventricle (myocardium) from pig 2. (a) There is myocardial 
haemorrhage and acute necrosis of myocardiocytes. HE. Bar, 130 µm. (b) Many 
myocardiocytes and endothelial-like cells (arrows) have PCV2-antigen within their 
cytoplasm. IHC (streptavidin-biotin peroxidase complex method, haematoxylin 
counterstain). Bar, 40 µm. 
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Fig. 3 a, b. Section of ventricle (myocardium and epicardium) from pig 4. (a) There is 
moderate lymphohistiocytic and plasmacytic periarteritis and endarteritis with focal 
apoptosis within the tunica intima and media. HE. Bar, 80 µm. (b) PCV2-antigen 
positive cells are mainly in the intima and media. IHC (streptavidin-biotin peroxidase 
complex method, haematoxylin counterstain). Bar, 80 µm. 
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Fig. 4 a-d. Section of lymph node from pig 5, aged 14 weeks, experimentally infected with 
PCV2 42 days previously. (a) There is focal necrosis of a lymph node follicle with 
central mineralization surrounded by granulomatous inflammation and fibrosis. HE. 
Bar, 150 µm. (b) In the area adjacent to the necrotic lymph node follicle there are 
many PCV2-positive cells (arrows). IHC (streptavidin-biotin peroxidase complex 
method, haematoxylin counterstain). Bar, 150 µm. (c) There is abundant labeling of 
smooth muscle actin in the zone around the necrotic lymph node follicle. IHC 
(streptavidin-biotin peroxidase complex method, haematoxylin counterstain). Bar, 
150 µm. (d) There are many Factor VIII-positive cells in the area around the necrotic 
lymph node follicle. IHC (streptavidin-biotin peroxidase complex method, 
haematoxylin counterstain). Bar, 150 µm. 
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